sample	id	disease_type	case_id	submitter_id	primary_site	alcohol_history.exposures	race.demographic	gender.demographic	ethnicity.demographic	vital_status.demographic	age_at_index.demographic	days_to_birth.demographic	year_of_birth.demographic	year_of_death.demographic	primary_site.project	project_id.project	disease_type.project	name.project	name.program.project	tissue_source_site_id.tissue_source_site	code.tissue_source_site	name.tissue_source_site	project.tissue_source_site	bcr_id.tissue_source_site	days_to_death.demographic	entity_submitter_id.annotations	notes.annotations	submitter_id.annotations	classification.annotations	entity_id.annotations	created_datetime.annotations	annotation_id.annotations	entity_type.annotations	updated_datetime.annotations	case_id.annotations	state.annotations	category.annotations	status.annotations	case_submitter_id.annotations	figo_stage.diagnoses	synchronous_malignancy.diagnoses	days_to_diagnosis.diagnoses	last_known_disease_status.diagnoses	tissue_or_organ_of_origin.diagnoses	days_to_last_follow_up.diagnoses	age_at_diagnosis.diagnoses	primary_diagnosis.diagnoses	prior_malignancy.diagnoses	year_of_diagnosis.diagnoses	prior_treatment.diagnoses	morphology.diagnoses	classification_of_tumor.diagnoses	icd_10_code.diagnoses	site_of_resection_or_biopsy.diagnoses	tumor_grade.diagnoses	progression_or_recurrence.diagnoses	age_at_earliest_diagnosis.diagnoses.xena_derived	age_at_earliest_diagnosis_in_years.diagnoses.xena_derived	updated_datetime.treatments.diagnoses	treatment_id.treatments.diagnoses	submitter_id.treatments.diagnoses	treatment_type.treatments.diagnoses	state.treatments.diagnoses	treatment_or_therapy.treatments.diagnoses	created_datetime.treatments.diagnoses	sample_type_id.samples	tumor_descriptor.samples	sample_id.samples	sample_type.samples	composition.samples	days_to_collection.samples	initial_weight.samples	preservation_method.samples	pathology_report_uuid.samples	oct_embedded.samples	specimen_type.samples	is_ffpe.samples	tissue_type.samples
TCGA-AJ-A3NC-01A	c8fb94dd-c535-48f4-9419-aac2bf47bbb4	Adenomas and Adenocarcinomas	c8fb94dd-c535-48f4-9419-aac2bf47bbb4	TCGA-AJ-A3NC	Corpus uteri	Not Reported	white	female	not reported	Alive	63.0	-23353.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1125.0	23353.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23353.0	63.98082191780822	['2019-07-31T22:30:19.024059-05:00', '2019-07-31T22:30:19.024059-05:00']	['0bfff125-be0b-51b9-a1b6-c3be59e73898', '0d89d31e-efaf-57e6-8b73-96f44d04b02c']	['TCGA-AJ-A3NC_treatment', 'TCGA-AJ-A3NC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:30:27.519435-05:00']	01	Primary	2398c565-2432-4fe9-bf9a-13ed877badea	Primary Tumor	Not Reported	282.0	300.0	Unknown	B6DB87F4-E88A-4209-92E2-75ADB364FB28	false	Solid Tissue	False	Tumor
TCGA-AJ-A3NC-11A	c8fb94dd-c535-48f4-9419-aac2bf47bbb4	Adenomas and Adenocarcinomas	c8fb94dd-c535-48f4-9419-aac2bf47bbb4	TCGA-AJ-A3NC	Corpus uteri	Not Reported	white	female	not reported	Alive	63.0	-23353.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1125.0	23353.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23353.0	63.98082191780822	['2019-07-31T22:30:19.024059-05:00', '2019-07-31T22:30:19.024059-05:00']	['0bfff125-be0b-51b9-a1b6-c3be59e73898', '0d89d31e-efaf-57e6-8b73-96f44d04b02c']	['TCGA-AJ-A3NC_treatment', 'TCGA-AJ-A3NC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:30:27.519435-05:00']	11	Not Applicable	df404299-c2eb-4edd-9a9a-c20619b0f7c6	Solid Tissue Normal	Not Reported	282.0	70.0	Unknown		false	Solid Tissue	False	Normal
TCGA-KP-A3W0-01A	c9ebaeff-6a27-4a6c-a34c-5337a3508a52	Cystic, Mucinous and Serous Neoplasms	c9ebaeff-6a27-4a6c-a34c-5337a3508a52	TCGA-KP-A3W0	Corpus uteri	Not Reported	not reported	female	not reported	Alive	72.0	-26378.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	821aedb4-8788-5cb9-ae05-e670f0be1f9f	KP	British Columbia Cancer Agency	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	404.0	26378.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26378.0	72.26849315068493	['2019-07-31T22:30:21.988151-05:00', '2019-07-31T22:30:21.988151-05:00']	['267ad052-a47f-566c-b65b-bf25b5550753', 'efacfcbd-c51e-520f-8901-fd4d7e6ab6e4']	['TCGA-KP-A3W0_treatment', 'TCGA-KP-A3W0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:30:29.912095-05:00']	01	Primary	570bb596-bad8-4a83-a7d7-e9fa8c9e16aa	Primary Tumor	Not Reported	351.0	90.0	OCT	8623B627-C3E3-469B-A640-2F8BCFC0B711	true	Solid Tissue	False	Tumor
TCGA-B5-A11N-01A	ca594f56-9c68-4b7e-84b2-669f1004e3a4	Adenomas and Adenocarcinomas	ca594f56-9c68-4b7e-84b2-669f1004e3a4	TCGA-B5-A11N	Corpus uteri	Not Reported	white	female	not reported	Alive	69.0	-25442.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1876.0	25442.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25442.0	69.7041095890411	['2019-07-31T22:30:25.055645-05:00', '2019-07-31T22:30:25.055645-05:00']	['7b1f84de-9f7e-5439-8422-81d4e2d451f7', 'b573c252-049a-5aa8-9ba9-258f89313a21']	['TCGA-B5-A11N_treatment_1', 'TCGA-B5-A11N_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:32.328567-05:00', '']	01	Primary	d3222a2c-6715-4eea-88b0-4006f61c736b	Primary Tumor	Not Reported	1140.0	370.0	OCT	A4C1DE15-A45A-4D31-B363-C6652370C09C	true	Solid Tissue	False	Tumor
TCGA-BS-A0V7-01A	ca858743-1f06-40e3-accf-395d08375b63	Adenomas and Adenocarcinomas	ca858743-1f06-40e3-accf-395d08375b63	TCGA-BS-A0V7	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	48.0	-17810.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1934.0	17810.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17810.0	48.794520547945204	['2019-07-31T22:30:31.245588-05:00', '2019-07-31T22:30:31.245588-05:00']	['49ad8f83-7029-5bbe-adb5-bdb07847a250', '615da570-874a-5d63-b27b-a5b5d7f92d9e']	['TCGA-BS-A0V7_treatment_1', 'TCGA-BS-A0V7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:37.207797-05:00', '']	01	Primary	a772ab94-cb06-464c-9a5a-fa4978510f9b	Primary Tumor	Not Reported	1455.0	130.0	Unknown	A4515806-9888-48E8-8F9E-491527FFC29C	false	Solid Tissue	False	Tumor
TCGA-D1-A17Q-01A	ca8dbbfd-8928-4e25-94c6-b875de631bbd	Adenomas and Adenocarcinomas	ca8dbbfd-8928-4e25-94c6-b875de631bbd	TCGA-D1-A17Q	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	54.0	-20015.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	54.0	20015.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20015.0	54.83561643835616	['2019-07-31T22:30:34.354668-05:00', '2019-07-31T22:30:34.354668-05:00']	['764d184b-eb23-5ac5-aab8-3c4dca414dd0', 'e38e41c4-7639-565f-b930-b00d395a01d6']	['TCGA-D1-A17Q_treatment_1', 'TCGA-D1-A17Q_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:39.718348-05:00', '']	01	Primary	b6abeb01-b6ea-4ab4-aa00-ae16cfc88b7c	Primary Tumor	Not Reported	434.0	130.0	Unknown	698079B6-EB07-4491-9672-4BDE4E5DAC49	false	Solid Tissue	False	Tumor
TCGA-BG-A0VT-01A	cc058b8c-df40-4f9e-88e3-3d1131b22b41	Adenomas and Adenocarcinomas	cc058b8c-df40-4f9e-88e3-3d1131b22b41	TCGA-BG-A0VT	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20602.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1568.0	20602.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20602.0	56.443835616438356	['2019-07-31T22:30:43.382311-05:00', '2019-07-31T22:30:43.382311-05:00']	['56e89139-ad72-5a22-961d-c5865816bc0c', 'bbf985c6-be68-5b22-a9e8-7db4a78c66f1']	['TCGA-BG-A0VT_treatment', 'TCGA-BG-A0VT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:30:47.037338-05:00']	01	Primary	0cfbcb61-c5e2-47f7-beb6-504f3cd4605b	Primary Tumor	Not Reported	87.0	70.0	OCT	0BC38740-A7B9-4086-9F03-A139287B33CC	true	Solid Tissue	False	Tumor
TCGA-AP-A0LG-01A	cca5717d-226d-4390-a99b-c7aed6d9d70e	Adenomas and Adenocarcinomas	cca5717d-226d-4390-a99b-c7aed6d9d70e	TCGA-AP-A0LG	Corpus uteri	Not Reported	white	female	not reported	Alive	54.0	-20047.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2015.0	20047.0	Endometrioid adenocarcinoma, NOS	no	2002.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20047.0	54.92328767123288	['2019-07-31T22:30:49.608270-05:00', '2019-07-31T22:30:49.608270-05:00']	['43137e75-90d0-50c2-9d61-d0df7efe29d1', '695886f4-309d-58ac-aefc-e2c3eb137fae']	['TCGA-AP-A0LG_treatment_1', 'TCGA-AP-A0LG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:30:51.892220-05:00', '']	01	Primary	031667f8-38d9-4df3-a18e-32cc426d234b	Primary Tumor	Not Reported	2833.0	360.0	OCT	7343A9B5-276E-4EE1-AC06-27835D63B0E2	true	Solid Tissue	False	Tumor
TCGA-AP-A0LL-01A	d17668c4-5d66-4e16-8b70-b54616581aae	Adenomas and Adenocarcinomas	d17668c4-5d66-4e16-8b70-b54616581aae	TCGA-AP-A0LL	Corpus uteri	Not Reported	white	female	not reported	Alive	56.0	-20700.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2554.0	20700.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20700.0	56.71232876712329	['2019-07-31T22:31:04.463972-05:00', '2019-07-31T22:31:04.463972-05:00']	['897e754a-2682-5790-952a-90ecf5096aef', 'dd87bb90-17c4-50db-8dfb-1429fa3080b0']	['TCGA-AP-A0LL_treatment', 'TCGA-AP-A0LL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:03.796194-05:00']	01	Primary	488a7462-8348-422c-91d3-7d9f0c39d25e	Primary Tumor	Not Reported	2066.0	160.0	OCT	B4A6F5DE-E477-48FD-ADA1-EAE436FBC576	true	Solid Tissue	False	Tumor
TCGA-AX-A060-01A	d1b615f4-50c9-497b-8a69-8de78aa17e09	Adenomas and Adenocarcinomas	d1b615f4-50c9-497b-8a69-8de78aa17e09	TCGA-AX-A060	Corpus uteri	Not Reported	american indian or alaska native	female	not hispanic or latino	Alive	77.0	-28472.0	1930.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	1075.0	28472.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28472.0	78.0054794520548	['2019-07-31T22:31:07.464102-05:00', '2019-07-31T22:31:07.464102-05:00']	['360282af-35d5-56da-8d28-a126b0eb6aa4', '8d747551-451b-5b61-8052-319604eba5dd']	['TCGA-AX-A060_treatment_1', 'TCGA-AX-A060_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:31:06.115775-05:00', '']	01	Primary	7b7fd42b-451a-40d8-8b00-cbf745493115	Primary Tumor	Not Reported	1033.0	170.0	Unknown	9086A79B-F764-42D4-BD9A-4C4F9F65C92B	false	Solid Tissue	False	Tumor
TCGA-E6-A2P8-01A	d213da3a-ff1c-4fbd-8d4e-7f9e6a2318d0	Cystic, Mucinous and Serous Neoplasms	d213da3a-ff1c-4fbd-8d4e-7f9e6a2318d0	TCGA-E6-A2P8	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	53.0	-19448.0	1957.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	39aa3c67-c7d9-5001-8ed1-3bf83eac7872	E6	Roswell Park	Uterine Corpus Endometrial Carcinoma	NCH	72.0															Stage IV	No	0.0	not reported	Endometrium		19448.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	19448.0	53.28219178082192	['2019-07-31T22:31:13.257622-05:00', '2019-07-31T22:31:13.257622-05:00']	['1ace1606-ee88-5554-8696-63819b2606aa', '7fc67d33-4b33-5615-a5de-93374f71a600']	['TCGA-E6-A2P8_treatment', 'TCGA-E6-A2P8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:31:10.987805-05:00']	01	Primary	04dea046-32c8-4bd8-a5b2-944957072bdc	Primary Tumor	Not Reported	254.0	100.0	OCT	B67CD692-73B4-4A61-A65B-65964AA3ACF4	true	Solid Tissue	False	Tumor
TCGA-EO-A3AV-01A	d383008a-a1bf-4689-b243-3c464c79b818	Adenomas and Adenocarcinomas	d383008a-a1bf-4689-b243-3c464c79b818	TCGA-EO-A3AV	Corpus uteri	Not Reported	not reported	female	not reported	Alive	51.0	-18713.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	1069.0	18713.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18713.0	51.26849315068493	['2019-07-31T22:31:19.246875-05:00', '2019-07-31T22:31:19.246875-05:00']	['5893966a-a0ec-5e21-ab19-d66f9fa5d99c', 'c6b3a35f-f5c9-5c8e-8e97-baca09dd2367']	['TCGA-EO-A3AV_treatment_1', 'TCGA-EO-A3AV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:31:15.899645-05:00', '']	01	Primary	c3beeb0b-07f7-44e6-ab4b-8015472b0dd1	Primary Tumor	Not Reported	407.0	130.0	Unknown	9FF6FADC-4F38-41A2-8B96-24CB1EB2010E	false	Solid Tissue	False	Tumor
TCGA-AJ-A23M-01A	d39df936-4bc6-404d-9e1d-f6416cc5a34c	Cystic, Mucinous and Serous Neoplasms	d39df936-4bc6-404d-9e1d-f6416cc5a34c	TCGA-AJ-A23M	Corpus uteri	Not Reported	white	female	not reported	Dead	61.0	-22430.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	616.0															Stage II	No	0.0	not reported	Endometrium	36.0	22430.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22430.0	61.45205479452055	['2019-07-31T22:31:22.271068-05:00', '2019-07-31T22:31:22.271068-05:00']	['a161dcb0-d222-5abf-ba4e-669ad3d80968', 'e4ebb107-fb9c-52ce-aea7-1f2713c7e8d9']	['TCGA-AJ-A23M_treatment', 'TCGA-AJ-A23M_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:18.253447-05:00']	01	Primary	acbbc556-4e4e-4ebc-b408-55d69720a87d	Primary Tumor	Not Reported	274.0	90.0	Unknown	B9651546-290B-405B-8275-24C8A53A10A3	false	Solid Tissue	False	Tumor
TCGA-B5-A5OE-01A	d5ee39e8-a1d2-4244-9c38-07d7c5c1baba	Cystic, Mucinous and Serous Neoplasms	d5ee39e8-a1d2-4244-9c38-07d7c5c1baba	TCGA-B5-A5OE	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	68.0	-24905.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	1063.0	24905.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24905.0	68.23287671232876	['2019-07-31T22:31:37.767255-05:00', '2019-07-31T22:31:37.767255-05:00']	['a1de606d-210d-5d88-ab82-eff7e6b4ab75', 'ff7dc17e-8b3e-5eca-9135-4ed468fa4d58']	['TCGA-B5-A5OE_treatment', 'TCGA-B5-A5OE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:31:30.488381-05:00']	01	Primary	df9184ec-0a56-4227-a0f7-ce92e5e6203e	Primary Tumor	Not Reported	609.0	1540.0	OCT	82A668E5-6B89-4C94-BEED-F4FF227BD0B1	true	Solid Tissue	False	Tumor
TCGA-D1-A1NW-01A	d7258a64-3ea0-40fc-b3f4-b581a1725fff	Cystic, Mucinous and Serous Neoplasms	d7258a64-3ea0-40fc-b3f4-b581a1725fff	TCGA-D1-A1NW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	72.0	-26556.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	No	0.0	not reported	Endometrium	22.0	26556.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26556.0	72.75616438356164	['2019-07-31T22:31:49.870444-05:00', '2019-07-31T22:31:49.870444-05:00']	['683c480b-caa4-509d-9f18-23dbd20d4781', 'c5fc2054-6e39-55e6-b1e1-df513c98bfa2']	['TCGA-D1-A1NW_treatment', 'TCGA-D1-A1NW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:31:40.377016-05:00']	01	Primary	b79a1d9c-02ef-4192-beb3-bca8b362eb2e	Primary Tumor	Not Reported	199.0	80.0	Unknown	10E1E872-408C-458D-9438-00F5ECA3083A	false	Solid Tissue	False	Tumor
TCGA-D1-A0ZU-01A	d74bc72e-8103-4aed-8958-5f40953d48eb	Adenomas and Adenocarcinomas	d74bc72e-8103-4aed-8958-5f40953d48eb	TCGA-D1-A0ZU	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	34.0	-12458.0	1975.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	872.0	12458.0	Endometrioid adenocarcinoma, secretory variant	no	2009.0	No	8382/3	not reported	C54.1	Endometrium	Not Reported	not reported	12458.0	34.131506849315066	['2019-07-31T22:31:52.788619-05:00', '2019-07-31T22:31:52.788619-05:00']	['6e8af011-3c03-57b3-8a0b-40bdfc7655c3', 'f617f60d-ba67-57f1-8c10-3a954855dece']	['TCGA-D1-A0ZU_treatment', 'TCGA-D1-A0ZU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:42.935848-05:00']	01	Primary	7b90b0fe-1088-48e9-8903-6102f27e4485	Primary Tumor	Not Reported	508.0	180.0	Unknown	D0BC0903-390B-4344-A613-48ABF71CF08D	false	Solid Tissue	False	Tumor
TCGA-AP-A054-01A	d77e4dbc-b239-4742-8cb7-efd427010d13	Adenomas and Adenocarcinomas	d77e4dbc-b239-4742-8cb7-efd427010d13	TCGA-AP-A054	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23404.0	1940.0	2005.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	709.0															Stage IIIC1	No	0.0	not reported	Endometrium		23404.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23404.0	64.12054794520547	['2019-07-31T22:31:55.495164-05:00', '2019-07-31T22:31:55.495164-05:00']	['d52f864d-01b9-58be-a741-bdc69913e30b', 'f4e752ef-f88e-5b9b-8a14-31201292e799']	['TCGA-AP-A054_treatment_1', 'TCGA-AP-A054_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:31:45.466494-05:00', '']	01	Primary	ddffb9c7-185f-402f-99b8-8058b40086d9	Primary Tumor	Not Reported	2086.0	410.0	OCT	72028DF7-DAD0-487E-914B-C3AA69A1E6C4	true	Solid Tissue	False	Tumor
TCGA-BG-A0YV-01A	d8e57746-37a1-482a-a3d3-a11bd00cdc11	Cystic, Mucinous and Serous Neoplasms	d8e57746-37a1-482a-a3d3-a11bd00cdc11	TCGA-BG-A0YV	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24567.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	Not Reported	0.0	not reported	Endometrium	382.0	24567.0	Serous cystadenocarcinoma, NOS	yes	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24567.0	67.30684931506849	['2019-07-31T22:32:01.907056-05:00', '2019-07-31T22:32:01.907056-05:00']	['1c1cda1f-b8d3-5f9b-9eb2-ef8ebed93596', '67ea746a-e0d7-5b2c-856d-28b2bcbcf127']	['TCGA-BG-A0YV_treatment', 'TCGA-BG-A0YV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:50.542533-05:00']	01	Primary	13db3af5-5f71-49b8-95f6-d452062c7ea4	Primary Tumor	Not Reported	62.0	330.0	OCT	D037EFD1-22CB-43FE-BE0A-F2189C5FB202	true	Solid Tissue	False	Tumor
TCGA-AX-A0IW-01A	db21fccf-40cb-4235-a34d-336a03b8c8f4	Cystic, Mucinous and Serous Neoplasms	db21fccf-40cb-4235-a34d-336a03b8c8f4	TCGA-AX-A0IW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24488.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1149.0	24488.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24488.0	67.09041095890412	['2019-07-31T22:32:10.520084-05:00', '2019-07-31T22:32:10.520084-05:00']	['7fee2d3c-3619-51b0-8c3a-a734219ca77e', 'ee423f00-bfe4-5830-87a7-c05f85ecef5d']	['TCGA-AX-A0IW_treatment', 'TCGA-AX-A0IW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:31:57.655792-05:00']	01	Primary	874a1c5c-229b-4bce-b612-55eff238d533	Primary Tumor	Not Reported	854.0	190.0	Unknown	DE971C2D-31E8-42AC-A943-29E76FCD8F68	false	Solid Tissue	False	Tumor
TCGA-AJ-A2QK-01A	de5abe44-6d9d-4797-a57a-5adfd71383f0	Adenomas and Adenocarcinomas	de5abe44-6d9d-4797-a57a-5adfd71383f0	TCGA-AJ-A2QK	Corpus uteri	Not Reported	white	female	hispanic or latino	Alive	65.0	-23945.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	643.0	23945.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23945.0	65.6027397260274	['2019-07-31T22:32:34.983958-05:00', '2019-07-31T22:32:34.983958-05:00']	['89a9ddbf-ac23-557e-81c0-67450079650e', 'ee6d2a2b-9030-5817-a44f-7a4abbfcdf01']	['TCGA-AJ-A2QK_treatment_1', 'TCGA-AJ-A2QK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:32:16.691703-05:00', '']	01	Primary	0959f580-cc84-4702-81b8-d6ef96f5469f	Primary Tumor	Not Reported	146.0	170.0	Unknown	01A114A2-098F-4AAD-9010-54910FB89B4A	false	Solid Tissue	False	Tumor
TCGA-A5-A7WK-01A	ded408ee-053a-43ed-9bcf-1d15cd203051	Cystic, Mucinous and Serous Neoplasms	ded408ee-053a-43ed-9bcf-1d15cd203051	TCGA-A5-A7WK	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	71.0	-26044.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	560.0	26044.0	Serous cystadenocarcinoma, NOS	no	2013.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26044.0	71.35342465753425	['2019-07-31T22:32:37.963737-05:00', '2019-07-31T22:32:37.963737-05:00']	['78db435b-9f3c-537a-98b3-7a59b1a25697', '7da59e80-2907-55af-b71d-1d08c6f2fb06']	['TCGA-A5-A7WK_treatment', 'TCGA-A5-A7WK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:32:19.209360-05:00']	01	Primary	69c891f3-536d-4cb8-bbd4-a387534c1283	Primary Tumor	Not Reported	253.0	160.0	OCT	9101DD17-9216-4526-9A87-8C4E94B1F435	true	Solid Tissue	False	Tumor
TCGA-B5-A11H-01A	dee43082-4aa7-4650-981c-a779e9fe7b55	Adenomas and Adenocarcinomas	dee43082-4aa7-4650-981c-a779e9fe7b55	TCGA-B5-A11H	Corpus uteri	Not Reported	white	female	not reported	Alive	67.0	-24556.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	2687.0	24556.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24556.0	67.27671232876712	['2019-07-31T22:32:41.233697-05:00', '2019-07-31T22:32:41.233697-05:00']	['7b9e9fce-7f4c-5ef6-b175-dc004e617630', 'f8ae1bf0-ec07-529d-8d7d-1f9be209aee6']	['TCGA-B5-A11H_treatment_1', 'TCGA-B5-A11H_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:32:21.654849-05:00', '']	01	Primary	d78d2f6b-3eb3-4082-a7ea-f7b6202cdc58	Primary Tumor	Not Reported	2324.0	620.0	OCT	40813C61-4B78-4677-89A4-4B9488613F57	true	Solid Tissue	False	Tumor
TCGA-QF-A5YS-01A	df15901c-2508-42c9-bf06-026efd89e51f	Cystic, Mucinous and Serous Neoplasms	df15901c-2508-42c9-bf06-026efd89e51f	TCGA-QF-A5YS	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	57.0	-20841.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	d777d40e-e930-5f47-995e-89adc81e9900	QF	BLN - Baylor	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Isthmus uteri	689.0	20841.0	Serous cystadenocarcinoma, NOS	no	2012.0	No	8441/3	not reported	C54.1	Isthmus uteri	Not Reported	not reported	20841.0	57.0986301369863	['2019-07-31T22:32:47.112477-05:00', '2019-07-31T22:32:47.112477-05:00']	['21c41dfa-dcf3-54b4-961f-382fae73116b', 'e12441b5-1346-533a-b2d2-679afc1d2711']	['TCGA-QF-A5YS_treatment_1', 'TCGA-QF-A5YS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:32:26.557485-05:00', '']	01	Primary	a7646717-9292-4321-9ea1-259573d8a1f0	Primary Tumor	Not Reported	158.0	120.0	Unknown	2608B03E-0D29-49EF-BC3D-A26D5017C265	false	Solid Tissue	False	Tumor
TCGA-BS-A0TI-01A	df857bc6-fd6a-4713-bef9-6ee1301e5fb1	Adenomas and Adenocarcinomas	df857bc6-fd6a-4713-bef9-6ee1301e5fb1	TCGA-BS-A0TI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23705.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	1882.0	23705.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23705.0	64.94520547945206	['2019-07-31T22:32:53.322748-05:00', '2019-07-31T22:32:53.322748-05:00']	['bafba2f7-f1e5-5613-b47d-316f08719439', 'ee281f79-1eb7-5d72-94ad-1140fddc2cdd']	['TCGA-BS-A0TI_treatment', 'TCGA-BS-A0TI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:32:31.418281-05:00']	01	Primary	2f52c850-8e70-4eab-88f3-d35dc55e385b	Primary Tumor	Not Reported	1507.0	250.0	Unknown	60212550-2757-4AB0-B778-723AE046F6BE	false	Solid Tissue	False	Tumor
TCGA-AJ-A2QN-01A	e00f6dc5-bc8b-472d-bac3-c7823364f01e	Adenomas and Adenocarcinomas	e00f6dc5-bc8b-472d-bac3-c7823364f01e	TCGA-AJ-A2QN	Corpus uteri	Not Reported	white	female	not reported	Alive	60.0	-21915.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	1069.0	21915.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21915.0	60.04109589041096	['2019-07-31T22:32:59.310546-05:00', '2019-07-31T22:32:59.310546-05:00']	['0e34cc70-9e6d-5096-8ef4-7033a91c848d', 'bba86fe0-bfb5-5c65-90fc-60aa3a77429e']	['TCGA-AJ-A2QN_treatment', 'TCGA-AJ-A2QN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:32:36.229138-05:00']	01	Primary	3fd07879-b069-4595-a704-cd7d11733f01	Primary Tumor	Not Reported	289.0	25.0	Unknown	F92EF591-695A-4E48-9ACF-67497880AC20	false	Solid Tissue	False	Tumor
TCGA-BS-A0WQ-01A	e095a927-d985-4fbd-8093-46c1c6ace4de	Adenomas and Adenocarcinomas	e095a927-d985-4fbd-8093-46c1c6ace4de	TCGA-BS-A0WQ	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	55.0	-20131.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2022.0	20131.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20131.0	55.153424657534245	['2019-07-31T22:33:02.370065-05:00', '2019-07-31T22:33:02.370065-05:00']	['7a936b9c-c7a8-5a25-8f58-b40bf18b979a', 'cb6ae894-4038-5502-9a71-501fa8b8bc77']	['TCGA-BS-A0WQ_treatment_1', 'TCGA-BS-A0WQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:32:38.667517-05:00', '']	01	Primary	b19275ba-cff5-4ec7-ac23-d6be497adef2	Primary Tumor	Not Reported	1696.0	140.0	Unknown	207B2565-ABB2-4F05-8B54-2280DAC57AD3	false	Solid Tissue	False	Tumor
TCGA-EY-A1GT-01A	e0d13e2d-cf48-4b66-bfc2-88f872f67d79	Adenomas and Adenocarcinomas	e0d13e2d-cf48-4b66-bfc2-88f872f67d79	TCGA-EY-A1GT	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25151.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	490.0	25151.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25151.0	68.9068493150685	['2019-07-31T22:33:05.420862-05:00', '2019-07-31T22:33:05.420862-05:00']	['88e25456-5d9d-5ca9-a0b4-02d3597fd5fa', 'e36d3534-acfc-5e37-bd23-6b571fac137e']	['TCGA-EY-A1GT_treatment_1', 'TCGA-EY-A1GT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:32:41.303786-05:00', '']	01	Primary	20983a85-478b-4cc1-bbf9-e136773f6288	Primary Tumor	Not Reported	225.0	380.0	Unknown	2F5AE4E7-9411-461D-ACD9-EB7D51CEF872	false	Solid Tissue	False	Tumor
TCGA-AP-A0LI-01A	e1e8dc66-467c-48a5-be56-3db4f665b9f1	Cystic, Mucinous and Serous Neoplasms	e1e8dc66-467c-48a5-be56-3db4f665b9f1	TCGA-AP-A0LI	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	67.0	-24573.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	2972.0	24573.0	Serous cystadenocarcinoma, NOS	no	2003.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24573.0	67.32328767123288	['2019-07-31T22:33:11.588376-05:00', '2019-07-31T22:33:11.588376-05:00']	['45dce2a1-41d9-5f94-8652-e9cb0b0c05eb', 'a56653f5-bf8e-5714-a186-8c47c1dc15c8']	['TCGA-AP-A0LI_treatment', 'TCGA-AP-A0LI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:32:45.952210-05:00']	01	Primary	981d9e3b-63c5-41e9-827f-7f1d268d62f4	Primary Tumor	Not Reported	2567.0	180.0	OCT	EFEA05D7-E720-4FE4-977C-6A6369B1BA2E	true	Solid Tissue	False	Tumor
TCGA-BS-A0UT-01A	e2b1d0de-5221-44a1-8fad-9708a3cada14	Adenomas and Adenocarcinomas	e2b1d0de-5221-44a1-8fad-9708a3cada14	TCGA-BS-A0UT	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	62.0	-22775.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	2212.0	22775.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22775.0	62.397260273972606	['2019-07-31T22:33:17.517307-05:00', '2019-07-31T22:33:17.517307-05:00']	['29186fb6-45f3-5483-8932-aa5d44e38dda', 'c84b6211-ff3a-5f74-a2c2-a3f49115c195']	['TCGA-BS-A0UT_treatment_1', 'TCGA-BS-A0UT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:32:51.168432-05:00', '']	01	Primary	824d0dbc-293f-4893-a68c-24dedd437ea5	Primary Tumor	Not Reported	1886.0	90.0	Unknown	326838B8-D069-4F9C-9353-F806B56DCA48	false	Solid Tissue	False	Tumor
TCGA-AX-A3G6-01A	e31db89c-15ac-45a4-9788-afb339b0f3bc	Cystic, Mucinous and Serous Neoplasms	e31db89c-15ac-45a4-9788-afb339b0f3bc	TCGA-AX-A3G6	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24681.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	8.0	24681.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24681.0	67.61917808219178	['2019-07-31T22:33:23.762928-05:00', '2019-07-31T22:33:23.762928-05:00']	['5ef75fe4-e78d-5d0d-b0f0-9ab6045ab437', '91ddc979-9d46-5c1d-b995-49b4de1fbb37']	['TCGA-AX-A3G6_treatment_1', 'TCGA-AX-A3G6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:32:56.141799-05:00', '']	01	Primary	576ab148-2110-4f35-948a-4a0d00b4f48e	Primary Tumor	Not Reported	456.0	50.0	Unknown	53586ED5-5C68-4517-8543-7508AF37F68C	false	Solid Tissue	False	Tumor
TCGA-EY-A1GV-01A	e3e39474-c2b0-45af-bbe1-4c24f17cc284	Cystic, Mucinous and Serous Neoplasms	e3e39474-c2b0-45af-bbe1-4c24f17cc284	TCGA-EY-A1GV	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	75.0	-27581.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	481.0	27581.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27581.0	75.56438356164384	['2019-07-31T22:33:29.658261-05:00', '2019-07-31T22:33:29.658261-05:00']	['4fa3fe24-d5cc-5db6-a49e-080d72e596d9', 'b46d9d81-0276-5a48-8320-45c712937ffd']	['TCGA-EY-A1GV_treatment_1', 'TCGA-EY-A1GV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:33:00.907902-05:00', '']	01	Primary	8e9dd4fb-3de9-4bce-bf90-1692904088ca	Primary Tumor	Not Reported	156.0	300.0	Unknown	87A6A698-71B7-41D8-AE28-C2FCC92F9A94	false	Solid Tissue	False	Tumor
TCGA-D1-A17B-01A	e55dd65a-c75e-4a3c-bb24-8b3af4d65321	Adenomas and Adenocarcinomas	e55dd65a-c75e-4a3c-bb24-8b3af4d65321	TCGA-D1-A17B	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25504.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	213.0	25504.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25504.0	69.87397260273973	['2019-07-31T22:34:01.470054-05:00', '2019-07-31T22:34:01.470054-05:00']	['09790e88-02a7-52cf-8f3b-2fc5cb358fe1', 'e5846de8-424b-5e80-ab3c-0a1e668c8f94']	['TCGA-D1-A17B_treatment_1', 'TCGA-D1-A17B_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:33:25.066529-05:00', '']	01	Primary	37c92c44-320d-4881-8cb3-357cc8bace5c	Primary Tumor	Not Reported	685.0	140.0	Unknown	FBE330EA-52BC-4B16-A046-3858318348F5	false	Solid Tissue	False	Tumor
TCGA-AX-A05U-01A	e56c6abc-b36c-4667-a347-0a541ce4791d	Adenomas and Adenocarcinomas	e56c6abc-b36c-4667-a347-0a541ce4791d	TCGA-AX-A05U	Corpus uteri	Not Reported	american indian or alaska native	female	not hispanic or latino	Alive	56.0	-20533.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	903.0	20533.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20533.0	56.25479452054795	['2019-07-31T22:34:07.365403-05:00', '2019-07-31T22:34:07.365403-05:00']	['02b75a17-b9e5-53f9-913b-093874a7ec3b', '2cb4a64a-ca0a-5265-93fb-ba6d2088e0dc']	['TCGA-AX-A05U_treatment', 'TCGA-AX-A05U_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:33:30.201526-05:00']	01	Primary	6327ef54-8216-4fd3-bde4-01f3192c653f	Primary Tumor	Not Reported	500.0	180.0	Unknown	1F51E982-37A1-40C6-BFAC-782B93D9967F	false	Solid Tissue	False	Tumor
TCGA-AJ-A3I9-01A	e5d64754-15e8-494e-b7f7-25cf2819fe4c	Adenomas and Adenocarcinomas	e5d64754-15e8-494e-b7f7-25cf2819fe4c	TCGA-AJ-A3I9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	52.0	-19139.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	519.0															Stage II	No	0.0	not reported	Endometrium	39.0	19139.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19139.0	52.43561643835616	['2019-07-31T22:34:10.331377-05:00', '2019-07-31T22:34:10.331377-05:00']	['59d2d0dc-a1a6-549c-9015-6ef9941fda7a', 'd54609df-37f6-560c-aa3b-5d650d6f6dec']	['TCGA-AJ-A3I9_treatment_1', 'TCGA-AJ-A3I9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:33:32.575707-05:00', '']	01	Primary	53e1feb9-81c1-473d-a8ae-eb481a26b726	Primary Tumor	Not Reported	84.0	27.0	Unknown	095789FC-7C20-4A6A-A6F0-13315481EBD0	false	Solid Tissue	False	Tumor
TCGA-AX-A06H-01A	e5d74e47-b63f-410a-8b7a-c9aacc9aa337	Adenomas and Adenocarcinomas	e5d74e47-b63f-410a-8b7a-c9aacc9aa337	TCGA-AX-A06H	Corpus uteri	Not Reported	american indian or alaska native	female	not hispanic or latino	Alive	60.0	-22270.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	833.0	22270.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22270.0	61.013698630136986	['2019-07-31T22:34:13.353802-05:00', '2019-07-31T22:34:13.353802-05:00']	['6d411677-f621-5521-95b9-710fa6689eb4', 'e46d0195-311d-5cee-81b3-ed09a98dec6a']	['TCGA-AX-A06H_treatment_1', 'TCGA-AX-A06H_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:33:34.943397-05:00', '']	01	Primary	b26a6c7e-5eef-4129-b635-cc40e60df0dd	Primary Tumor	Not Reported	654.0	110.0	Unknown	493C5DDA-E629-4324-8574-AEC67223DA9E	false	Solid Tissue	False	Tumor
TCGA-D1-A177-01A	e8c58d8b-51d7-4599-af79-469ee6f269db	Adenomas and Adenocarcinomas	e8c58d8b-51d7-4599-af79-469ee6f269db	TCGA-D1-A177	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	70.0	-25602.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	548.0	25602.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25602.0	70.14246575342466	['2019-07-31T22:34:32.024132-05:00', '2019-07-31T22:34:32.024132-05:00']	['5b69be75-99d1-5c22-bb7f-f3f7fe51088a', '6c6439c1-efed-586c-900f-bcee6e3bd0a0']	['TCGA-D1-A177_treatment', 'TCGA-D1-A177_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:33:49.470160-05:00']	01	Primary	97587fd4-0f6f-4af5-ac0a-7328abb40e9c	Primary Tumor	Not Reported	227.0	190.0	Unknown	28FF1BEE-6F93-4BCA-A6DC-56A1EA8EA337	false	Solid Tissue	False	Tumor
TCGA-PG-A6IB-01A	e8c7195b-a26b-4d98-b1c5-0aa18385e9c8	Cystic, Mucinous and Serous Neoplasms	e8c7195b-a26b-4d98-b1c5-0aa18385e9c8	TCGA-PG-A6IB	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	68.0	-24969.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	69bd8326-4904-56a0-8230-1615a777173b	PG	Montefiore Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	648.0	24969.0	Serous cystadenocarcinoma, NOS	no	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24969.0	68.40821917808219	['2019-07-31T22:34:34.944369-05:00', '2019-07-31T22:34:34.944369-05:00']	['0bad11d8-8e1b-5320-864d-e636cebccba9', '821d2dad-7451-59a4-aa06-39c1cfcdff67']	['TCGA-PG-A6IB_treatment', 'TCGA-PG-A6IB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:33:51.860010-05:00']	01	Primary	c9c01ae7-bfdf-4077-b9d7-5d3698afd32f	Primary Tumor	Not Reported	160.0	100.0	OCT	C975AE5D-7370-4D1D-81AE-D3ABE5364055	true	Solid Tissue	False	Tumor
TCGA-PG-A915-01A	ea95897e-3fe0-4c79-b170-88b0f229794c	Cystic, Mucinous and Serous Neoplasms	ea95897e-3fe0-4c79-b170-88b0f229794c	TCGA-PG-A915	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	60.0	-22119.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	69bd8326-4904-56a0-8230-1615a777173b	PG	Montefiore Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	249.0	22119.0	Serous cystadenocarcinoma, NOS	no	2013.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22119.0	60.6	['2019-07-31T22:34:44.084311-05:00', '2019-07-31T22:34:44.084311-05:00']	['0d32ff43-4916-57da-8e7d-dc5c19ad1bf2', '395b3137-55c4-5cba-9839-2c11f999844e']	['TCGA-PG-A915_treatment_1', 'TCGA-PG-A915_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:33:59.456854-05:00', '']	01	Primary	caffe64c-1fb0-4229-b355-4b798d9506b0	Primary Tumor	Not Reported	238.0	410.0	OCT	F2869E10-B5EB-4AB7-9CC9-A7B2E5DDBB7C	true	Solid Tissue	False	Tumor
TCGA-B5-A3FC-01A	ec2040a3-788b-4f2c-a093-c5c4b3dc4b6c	Adenomas and Adenocarcinomas	ec2040a3-788b-4f2c-a093-c5c4b3dc4b6c	TCGA-B5-A3FC	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	53.0	-19422.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	2185.0	19422.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19422.0	53.21095890410959	['2019-07-31T22:34:53.408864-05:00', '2019-07-31T22:34:53.408864-05:00']	['9cdb9604-d03b-5b83-89a5-dcf3bb540db6', 'f3176092-333e-52ee-8d52-6f340ed83f29']	['TCGA-B5-A3FC_treatment_1', 'TCGA-B5-A3FC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:34:06.575735-05:00', '']	01	Primary	cb538aff-c08c-455d-8dd8-e3cd0d404e00	Primary Tumor	Not Reported	1814.0	150.0	OCT	4A63436E-BBC1-4F02-9B72-7ED4CC2AC1CD	true	Solid Tissue	False	Tumor
TCGA-BG-A0VZ-01A	edee2bf5-284c-4d77-823a-d037fe4c4b9e	Adenomas and Adenocarcinomas	edee2bf5-284c-4d77-823a-d037fe4c4b9e	TCGA-BG-A0VZ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21414.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1601.0	21414.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21414.0	58.66849315068493	['2019-07-31T22:35:00.296081-05:00', '2019-07-31T22:35:00.296081-05:00']	['783cb635-dec3-5650-bb1a-53bc90e6ba8d', 'a2c944f8-8d9b-5965-b09f-a309743498d3']	['TCGA-BG-A0VZ_treatment_1', 'TCGA-BG-A0VZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:34:11.546924-05:00', '']	01	Primary	fa28a6f2-c6d2-4cf1-8026-fed92675bdb9	Primary Tumor	Not Reported	876.0	70.0	OCT	6CCCA758-AB3D-4260-BD25-16716E34B3BB	true	Solid Tissue	False	Tumor
TCGA-DI-A2QT-01A	ee932b34-0114-41dc-b119-210c0ed84bcb	Cystic, Mucinous and Serous Neoplasms	ee932b34-0114-41dc-b119-210c0ed84bcb	TCGA-DI-A2QT	Corpus uteri	Not Reported	american indian or alaska native	female	hispanic or latino	Dead	51.0	-18835.0	1957.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH	377.0															Stage IIIC	No	0.0	not reported	Endometrium		18835.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	18835.0	51.602739726027394	['2019-07-31T22:35:03.385916-05:00', '2019-07-31T22:35:03.385916-05:00']	['d7bb4b46-3f72-5749-aef0-54d592a446e6', 'e2366ea4-7525-56a1-a416-c0402295c794']	['TCGA-DI-A2QT_treatment', 'TCGA-DI-A2QT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:34:14.102178-05:00']	01	Primary	41ee0d15-a55b-47a4-9f5a-02a29e89e8dd	Primary Tumor	Not Reported	1186.0	280.0	Unknown	416DF035-67B0-4461-9523-EB4A4A1FBA5B	false	Solid Tissue	False	Tumor
TCGA-B5-A3FD-01A	eeb327b4-b705-4161-ba94-647f0e14f5b4	Adenomas and Adenocarcinomas	eeb327b4-b705-4161-ba94-647f0e14f5b4	TCGA-B5-A3FD	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	70.0	-25813.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	1197.0															Stage IA	No	0.0	not reported	Endometrium	1007.0	25813.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25813.0	70.72054794520548	['2019-07-31T22:35:06.236107-05:00', '2019-07-31T22:35:06.236107-05:00']	['57be0f53-06e3-5939-a196-52352520324b', 'c70af701-4ee1-504a-8b31-ae9f6ce69bde']	['TCGA-B5-A3FD_treatment', 'TCGA-B5-A3FD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:34:16.703291-05:00']	01	Primary	d496dc3a-fc5b-4177-8570-e8725778d186	Primary Tumor	Not Reported	679.0	370.0	OCT	7AC30D60-097A-4FED-A928-7A4BCAFB6C8D	true	Solid Tissue	False	Tumor
TCGA-D1-A1O5-01A	f054a123-322f-444a-9971-53d3df371753	Adenomas and Adenocarcinomas	f054a123-322f-444a-9971-53d3df371753	TCGA-D1-A1O5	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22580.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	458.0	22580.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22580.0	61.863013698630134	['2019-07-31T22:35:17.763449-05:00', '2019-07-31T22:35:17.763449-05:00']	['de030ee2-e829-5b56-a962-2c5b08bec0ba', 'e156ff87-429e-5ea0-9c16-36a6681ee555']	['TCGA-D1-A1O5_treatment', 'TCGA-D1-A1O5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:34:26.415163-05:00']	01	Primary	a2a2d119-29a0-4cdb-bbed-44219adddfcf	Primary Tumor	Not Reported	174.0	100.0	Unknown	F8BEE46E-D0C9-4977-B1C3-DA87AF089B6D	false	Solid Tissue	False	Tumor
TCGA-AX-A06D-01A	905291b0-f077-48f7-9c14-5cfa9d8a3e6e	Adenomas and Adenocarcinomas	905291b0-f077-48f7-9c14-5cfa9d8a3e6e	TCGA-AX-A06D	Corpus uteri	Not Reported	white	female	not reported	Dead	82.0	-30024.0	1925.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	373.0	TCGA-AX-A06D	systemic treatment given to the prior/other malignancy	20762	Notification	905291b0-f077-48f7-9c14-5cfa9d8a3e6e	2014-06-16T00:00:00	083c982a-4842-5f50-b2c6-00d6ac8f951c	case	2018-08-23T16:28:11.210272-05:00	905291b0-f077-48f7-9c14-5cfa9d8a3e6e	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-AX-A06D	Stage IIIA	Not Reported	0.0	not reported	Endometrium		30024.0	Endometrioid adenocarcinoma, NOS	yes	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30024.0	82.25753424657535	['2019-07-31T22:25:11.128615-05:00', '2019-07-31T22:25:11.128615-05:00']	['d9dad5fc-bea9-5b35-bb49-ebd3974f9f05', 'eee79523-feab-597c-b5f8-7fff1a9faa18']	['TCGA-AX-A06D_treatment', 'TCGA-AX-A06D_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:26:17.267268-05:00']	01	Primary	f97bb30a-759e-44b9-889a-b5bde9855b29	Primary Tumor	Not Reported	1066.0	190.0	Unknown	B523C3E8-6FE7-4D6A-B6CE-7DEA1C32D33F	false	Solid Tissue	False	Tumor
TCGA-KP-A3VZ-01A	6b35a816-f9c4-44d4-9824-5dee4804b80d	Cystic, Mucinous and Serous Neoplasms	6b35a816-f9c4-44d4-9824-5dee4804b80d	TCGA-KP-A3VZ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25366.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	821aedb4-8788-5cb9-ae05-e670f0be1f9f	KP	British Columbia Cancer Agency	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-KP-A3VZ	Patient had a previous basaloid squamous cell carcinoma of the nose. No systemic radiation or chemotherapy.	16117	Notification	6b35a816-f9c4-44d4-9824-5dee4804b80d	2013-05-16T00:00:00	2187a363-8e0b-5c5d-8b66-61ca6f82c511	case	2018-08-23T16:28:11.210272-05:00	6b35a816-f9c4-44d4-9824-5dee4804b80d	released	Prior malignancy	Approved	TCGA-KP-A3VZ	Stage IV	Not Reported	0.0	not reported	Endometrium	722.0	25366.0	Serous cystadenocarcinoma, NOS	yes	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25366.0	69.4958904109589	['2019-07-31T22:21:48.132964-05:00', '2019-07-31T22:21:48.132964-05:00']	['7ee161da-2958-5ec8-b78d-b2204b1306cb', 'f07d9c4e-0ad6-593a-bcf3-664ac82f95b2']	['TCGA-KP-A3VZ_treatment', 'TCGA-KP-A3VZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:23:31.370745-05:00']	01	Primary	f73c1ce5-2813-45b2-951f-8ab539b32988	Primary Tumor	Not Reported	633.0	200.0	OCT	FF834E31-78F7-4A56-8EC0-E026BE940FD4	true	Solid Tissue	False	Tumor
TCGA-EC-A1QX-01A	f17bb238-2651-48a5-9a47-5077218efe08	Adenomas and Adenocarcinomas	f17bb238-2651-48a5-9a47-5077218efe08	TCGA-EC-A1QX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	71.0	-26259.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	acc43e64-d63e-554c-a488-8bf6b93bec91	EC	Asterand	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	224.0	26259.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26259.0	71.94246575342466	['2019-07-31T22:35:23.347371-05:00', '2019-07-31T22:35:23.347371-05:00']	['7f9cfa80-e1c9-5b7b-af8a-df6c711f29af', 'd6f6ad2c-8f3b-5519-afed-311957dc9366']	['TCGA-EC-A1QX_treatment', 'TCGA-EC-A1QX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:34:31.292695-05:00']	01	Primary	a86cd958-656b-45d1-ab59-453896a9e839	Primary Tumor	Not Reported	81.0	560.0	OCT	0C3EABFA-0F72-47C9-9A8B-6B14F2CD2D12	true	Solid Tissue	False	Tumor
TCGA-B5-A1MU-01A	f5261330-596e-4632-a5a3-8d3a2aa5de38	Cystic, Mucinous and Serous Neoplasms	f5261330-596e-4632-a5a3-8d3a2aa5de38	TCGA-B5-A1MU	Corpus uteri	Not Reported	white	female	not reported	Dead	79.0	-29027.0	1927.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	1548.0															Stage IVB	No	0.0	not reported	Endometrium		29027.0	Serous cystadenocarcinoma, NOS	no	2006.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	29027.0	79.52602739726028	['2019-07-31T22:35:41.757014-05:00', '2019-07-31T22:35:41.757014-05:00']	['bd99e4b0-d6e0-5668-acf5-1ad44f11685f', 'c8387477-25d3-53c1-b867-4a69dc0cb943']	['TCGA-B5-A1MU_treatment_1', 'TCGA-B5-A1MU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:34:45.772919-05:00', '']	01	Primary	bb3bdc38-8011-4427-a863-eba7a6cfff69	Primary Tumor	Not Reported	1834.0	260.0	OCT	FC3D9B79-4CAD-4F62-892C-C830B24E50DD	true	Solid Tissue	False	Tumor
TCGA-BG-A220-01A	41dcafa0-b196-46dd-ab07-58cb747c9ebc	Adenomas and Adenocarcinomas	41dcafa0-b196-46dd-ab07-58cb747c9ebc	TCGA-BG-A220	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25346.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH		['TCGA-BG-A220', 'TCGA-BG-A220']	['systemic treatment given to the prior/other malignancy', 'Patient had a prior kidney clear cell carcinoma treated with locoregional radation and systemic chemotherapy.']	['20769', '16133']	['Notification', 'Notification']	['41dcafa0-b196-46dd-ab07-58cb747c9ebc', '41dcafa0-b196-46dd-ab07-58cb747c9ebc']	['2014-06-16T00:00:00', '2013-05-17T00:00:00']	['2a3f54fe-0e48-5085-8faa-486279732149', 'a9aa55cf-a333-585d-be96-3458cd90d4ab']	['case', 'case']	['2018-08-23T16:28:11.210272-05:00', '2018-08-23T16:32:20.747393-05:00']	['41dcafa0-b196-46dd-ab07-58cb747c9ebc', '41dcafa0-b196-46dd-ab07-58cb747c9ebc']	['released', 'released']	['History of unacceptable prior treatment related to a prior/other malignancy', 'History of unacceptable prior treatment related to a prior/other malignancy']	['Approved', 'Approved']	['TCGA-BG-A220', 'TCGA-BG-A220']	Stage IA	Not Reported	0.0	not reported	Endometrium	434.0	25346.0	Endometrioid adenocarcinoma, NOS	yes	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25346.0	69.44109589041096	['2019-07-31T22:17:15.062267-05:00', '2019-07-31T22:17:15.062267-05:00']	['04c547cc-072b-57a6-b4d3-5d996fb47dfe', '3dbf65d0-939e-57f4-bf21-beb814d5d388']	['TCGA-BG-A220_treatment', 'TCGA-BG-A220_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:19:53.787252-05:00']	01	Primary	b88002d7-76cb-4ea7-b894-8572d49411ab	Primary Tumor	Not Reported	110.0	190.0	OCT	59CD459F-FB2B-4B0E-9E16-3E26BDF252E1	true	Solid Tissue	False	Tumor
TCGA-B5-A11X-01A	f70a64a8-3faa-468a-a6f3-4815eb01e5a3	Epithelial Neoplasms, NOS	f70a64a8-3faa-468a-a6f3-4815eb01e5a3	TCGA-B5-A11X	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	66.0	-24217.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	596.0	24217.0	Carcinoma, undifferentiated, NOS	no	2010.0	No	8020/3	not reported	C54.1	Endometrium	Not Reported	not reported	24217.0	66.34794520547945	['2019-07-31T22:35:54.795957-05:00', '2019-07-31T22:35:54.795957-05:00']	['b8017e12-f0d8-57f3-aa71-e8d91c8bab64', 'cf8429a4-6848-527f-b3f8-915414b8c938']	['TCGA-B5-A11X_treatment', 'TCGA-B5-A11X_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:34:55.552071-05:00']	01	Primary	0a9e02d6-62db-4b0e-ac92-677db018ec9c	Primary Tumor	Not Reported	246.0	530.0	OCT	89C9704E-F43C-440C-970F-872835910268	true	Solid Tissue	False	Tumor
TCGA-EY-A2OP-01A	f7165dea-c528-44f3-954f-e111a3d77b4e	Adenomas and Adenocarcinomas	f7165dea-c528-44f3-954f-e111a3d77b4e	TCGA-EY-A2OP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23090.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	944.0	23090.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23090.0	63.26027397260274	['2019-07-31T22:35:57.863680-05:00', '2019-07-31T22:35:57.863680-05:00']	['c1f9616a-549e-5f50-a86e-42a932b2c5a4', 'ef0fc883-1043-5e72-9912-967f0b552c99']	['TCGA-EY-A2OP_treatment_1', 'TCGA-EY-A2OP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:34:57.999881-05:00', '']	01	Primary	53076e0c-46b7-4b5a-8082-2c14fabbfa73	Primary Tumor	Not Reported	521.0	1.0	Unknown	E16B08BE-7F2E-4F0E-9FC8-40FCC29F7BC7	false	Solid Tissue	False	Tumor
TCGA-BS-A0TJ-01A	f74da4c6-4291-46d2-abd4-7d7f6ef03b00	Adenomas and Adenocarcinomas	f74da4c6-4291-46d2-abd4-7d7f6ef03b00	TCGA-BS-A0TJ	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	59.0	-21663.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	2068.0	21663.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21663.0	59.35068493150685	['2019-07-31T22:36:00.788703-05:00', '2019-07-31T22:36:00.788703-05:00']	['a095d2df-1b1f-5865-b1a8-2c7e842f67cf', 'a6902149-e5e1-5fa4-b2bf-ba353bdb5130']	['TCGA-BS-A0TJ_treatment_1', 'TCGA-BS-A0TJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:35:00.654535-05:00', '']	01	Primary	ac35307b-ac7f-49fc-a237-5e03ab2e2276	Primary Tumor	Not Reported	1431.0	270.0	Unknown	17D921D9-F2ED-4F8E-8C6F-729C9A0FE5B0	false	Solid Tissue	False	Tumor
TCGA-FL-A1YM-11A	f8360744-6bc8-4f53-b1fc-a133789455a8	Not Reported	f8360744-6bc8-4f53-b1fc-a133789455a8	TCGA-FL-A1YM	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	c7add734-286a-4b4f-8d6c-1b30f6a2d1b0	Solid Tissue Normal	Not Reported		80.0	Unknown	5FCF83F3-5851-476C-87F6-2DEDF2669A6C	false	Solid Tissue	False	Normal
TCGA-EY-A1GK-01A	972db411-9744-46f0-89c7-efe14135f1b4	Adenomas and Adenocarcinomas	972db411-9744-46f0-89c7-efe14135f1b4	TCGA-EY-A1GK	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27127.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-EY-A1GK	Patient had a previous cancer of the ureter. No systemic radiation or chemotherapy.	16127	Notification	972db411-9744-46f0-89c7-efe14135f1b4	2013-05-16T00:00:00	37644a40-3b71-5532-9ce9-6903a9cf4f2a	case	2018-08-23T16:28:11.210272-05:00	972db411-9744-46f0-89c7-efe14135f1b4	released	Prior malignancy	Approved	TCGA-EY-A1GK	Stage IB	Not Reported	0.0	not reported	Endometrium	693.0	27127.0	Endometrioid adenocarcinoma, NOS	yes	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27127.0	74.32054794520548	['2019-07-31T22:25:43.701353-05:00', '2019-07-31T22:25:43.701353-05:00']	['801a2fc9-6ecf-5e3f-9b60-e4e48e544179', 'eadfaefa-b7e0-5250-8054-4990da8651fd']	['TCGA-EY-A1GK_treatment', 'TCGA-EY-A1GK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:26:44.541301-05:00']	01	Primary	d4e702a9-8e4a-4ad7-8b45-691c95dcf298	Primary Tumor	Not Reported	409.0	120.0	Unknown	B5024D10-E23D-4B3B-8C54-13EBAA423A04	false	Solid Tissue	False	Tumor
TCGA-EY-A1GW-01A	f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae	Adenomas and Adenocarcinomas	f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae	TCGA-EY-A1GW	Corpus uteri	Not Reported	white	female	hispanic or latino	Dead	73.0	-26979.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	337.0															Stage IVB	No	0.0	not reported	Fundus uteri	260.0	26979.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Fundus uteri	Not Reported	not reported	26979.0	73.91506849315068	['2019-07-31T22:36:15.357402-05:00', '2019-07-31T22:36:15.357402-05:00']	['7aea9ca2-c003-5a61-8202-159e716ac652', 'e65a442e-f81e-5114-ba82-20b6a91aa90c']	['TCGA-EY-A1GW_treatment_1', 'TCGA-EY-A1GW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:35:12.948039-05:00', '']	01	Primary	22cb3d87-7fab-419a-b071-1adc6b810719	Primary Tumor	Not Reported	155.0	410.0	Unknown	52C26330-540E-4409-ACDF-4D56EA1E7D7F	false	Solid Tissue	False	Tumor
TCGA-AP-A053-01A	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	Adenomas and Adenocarcinomas	af37d8f0-fea0-47f6-be0a-2fb55a5da5c4	TCGA-AP-A053	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	90.0	-32872.0	1914.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	0.0	['TCGA-AP-A053', 'TCGA-AP-A053']	['Case had Prior malignancy', 'systemic treatment given to the prior/other malignancy']	['1056', '20761']	['Notification', 'Notification']	['af37d8f0-fea0-47f6-be0a-2fb55a5da5c4', 'af37d8f0-fea0-47f6-be0a-2fb55a5da5c4']	['2010-12-14T00:00:00', '2014-06-16T00:00:00']	['73debae2-2df5-56f5-a3c7-0bd15ea5c7a3', 'df893e6a-fad5-557b-aef0-d0de8db63b56']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['af37d8f0-fea0-47f6-be0a-2fb55a5da5c4', 'af37d8f0-fea0-47f6-be0a-2fb55a5da5c4']	['released', 'released']	['Prior malignancy', 'History of unacceptable prior treatment related to a prior/other malignancy']	['Approved', 'Approved']	['TCGA-AP-A053', 'TCGA-AP-A053']	Stage IA	Not Reported	0.0	not reported	Endometrium	0.0	32872.0	Endometrioid adenocarcinoma, NOS	yes	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	32872.0	90.06027397260274	['2019-07-31T22:28:23.936461-05:00', '2019-07-31T22:28:23.936461-05:00']	['ee2b668c-4755-57c2-a82e-ae080f38b4c4', 'f2c07f84-a8ab-57ee-bbc9-3c579efeb595']	['TCGA-AP-A053_treatment_1', 'TCGA-AP-A053_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:28:54.148855-05:00', '']	01	Primary	e1121a9e-bc27-44eb-a1ad-eb0ab10b7c3a	Primary Tumor	Not Reported	2163.0	220.0	OCT	6179478F-93BE-4C03-9F65-D74E66AFE449	true	Solid Tissue	False	Tumor
TCGA-AX-A1CI-11A	fba80122-d8b2-4d8d-a032-9767e8160f9f	Adenomas and Adenocarcinomas	fba80122-d8b2-4d8d-a032-9767e8160f9f	TCGA-AX-A1CI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22582.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2600.0	22582.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22582.0	61.868493150684934	['2019-07-31T22:36:27.921838-05:00', '2019-07-31T22:36:27.921838-05:00']	['1f9b8368-d0f0-5fd1-8a3f-04bbd166956c', 'a69ff0d7-1ba1-51d6-9d28-de1cf44521a9']	['TCGA-AX-A1CI_treatment_1', 'TCGA-AX-A1CI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:35:22.431846-05:00', '']	11	Not Applicable	cad6c89d-f722-470b-93bc-e8b24c033f0f	Solid Tissue Normal	Not Reported	2222.0	100.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A1CI-01A	fba80122-d8b2-4d8d-a032-9767e8160f9f	Adenomas and Adenocarcinomas	fba80122-d8b2-4d8d-a032-9767e8160f9f	TCGA-AX-A1CI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22582.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2600.0	22582.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22582.0	61.868493150684934	['2019-07-31T22:36:27.921838-05:00', '2019-07-31T22:36:27.921838-05:00']	['1f9b8368-d0f0-5fd1-8a3f-04bbd166956c', 'a69ff0d7-1ba1-51d6-9d28-de1cf44521a9']	['TCGA-AX-A1CI_treatment_1', 'TCGA-AX-A1CI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:35:22.431846-05:00', '']	01	Primary	ddd2f9e0-0aa3-425b-9d74-74fcc638cb08	Primary Tumor	Not Reported	2222.0	120.0	Unknown	7F264403-0A76-4FAD-9A57-7C555F69375C	false	Solid Tissue	False	Tumor
TCGA-B5-A11M-01A	fd370e9d-2719-45e0-b8f1-048ed1ee602f	Adenomas and Adenocarcinomas	fd370e9d-2719-45e0-b8f1-048ed1ee602f	TCGA-B5-A11M	Corpus uteri	Not Reported	white	female	not reported	Alive	43.0	-16063.0	1964.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1362.0	16063.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16063.0	44.00821917808219	['2019-07-31T22:36:37.730873-05:00', '2019-07-31T22:36:37.730873-05:00']	['3e4550eb-57c8-5930-870b-461edb575bdb', '93a496e5-582e-526b-8b46-82a03de9ffe4']	['TCGA-B5-A11M_treatment', 'TCGA-B5-A11M_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:35:29.585976-05:00']	01	Primary	82f33c0d-f9dc-4463-8ab5-ae7283e85431	Primary Tumor	Not Reported	1085.0	40.0	OCT	3C00B510-8D9C-4DD4-9E7C-FC058230BE97	true	Solid Tissue	False	Tumor
TCGA-EY-A1G7-01A	6b2e93b9-8271-4205-842e-0b7292b8115a	Adenomas and Adenocarcinomas	6b2e93b9-8271-4205-842e-0b7292b8115a	TCGA-EY-A1G7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	86.0	-31603.0	1922.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	189.0	['TCGA-EY-A1G7', 'TCGA-EY-A1G7']	['Patient had a previous uterine adenocarcinoma of the uterus treated with locoregional radiation. No systemic chemotherapy.', 'patient had a prior endometrial maligancy']	['16128', '20772']	['Notification', 'Notification']	['6b2e93b9-8271-4205-842e-0b7292b8115a', '6b2e93b9-8271-4205-842e-0b7292b8115a']	['2013-05-16T00:00:00', '2014-06-16T00:00:00']	['670cf347-931d-5d22-a8c1-693d1a2cae31', 'd93b22a0-6c6f-5ee5-8160-b51a515c2419']	['case', 'case']	['2018-08-23T16:32:20.747393-05:00', '2018-08-23T16:32:20.747393-05:00']	['6b2e93b9-8271-4205-842e-0b7292b8115a', '6b2e93b9-8271-4205-842e-0b7292b8115a']	['released', 'released']	['History of unacceptable prior treatment related to a prior/other malignancy', 'Case submitted is found to be a recurrence after submission']	['Approved', 'Approved']	['TCGA-EY-A1G7', 'TCGA-EY-A1G7']	Stage II	Not Reported	0.0	not reported	Endometrium		31603.0	Endometrioid adenocarcinoma, NOS	yes	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31603.0	86.58356164383562	['2019-07-31T22:21:45.053575-05:00', '2019-07-31T22:21:45.053575-05:00']	['15b3c6f7-a6b4-5882-bfd0-fa971adbc01a', '52864ae8-530f-537e-a9eb-04e7a720d395']	['TCGA-EY-A1G7_treatment_1', 'TCGA-EY-A1G7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:23:28.803507-05:00', '']	01	Primary	730cb784-2266-4b5c-98b9-6cd7ebbe989d	Primary Tumor	Not Reported	1002.0	140.0	Unknown	2803014E-7E68-463F-BF3C-C5E4DF9FA421	false	Solid Tissue	False	Tumor
TCGA-BG-A18A-01A	feb3e930-3638-44b4-ac0f-a5dcb01fed76	Adenomas and Adenocarcinomas	feb3e930-3638-44b4-ac0f-a5dcb01fed76	TCGA-BG-A18A	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27086.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	426.0	27086.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27086.0	74.20821917808219	['2019-07-31T22:36:55.576533-05:00', '2019-07-31T22:36:55.576533-05:00']	['3858cbca-1afb-5859-a4d7-9c10d0f02411', 'a7dcd32c-bf34-53bf-8426-a47a05900608']	['TCGA-BG-A18A_treatment', 'TCGA-BG-A18A_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:35:45.084027-05:00']	01	Primary	8fd0971d-40ba-46c2-b3c4-8e48a3e6c122	Primary Tumor	Not Reported	146.0	130.0	OCT	099561AC-A5E7-4CA9-8F07-EEA7B3A96EEA	true	Solid Tissue	False	Tumor
TCGA-BG-A0M8-01A	e055db71-f3da-43d3-a9b2-2f65dfb23d3e	Adenomas and Adenocarcinomas	e055db71-f3da-43d3-a9b2-2f65dfb23d3e	TCGA-BG-A0M8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	50.0	-18308.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-BG-A0M8	During Enrollment it was found that patient had a prior left breast ductal malignany that was treated with systemic pharma treatment (Adriamycin/Cytoxan) 7 years prior to TCGA tumor procurement	25420	Notification	e055db71-f3da-43d3-a9b2-2f65dfb23d3e	2015-02-16T00:00:00	6e524f2d-824e-58d0-8e41-a0cd10c684c3	case	2018-08-23T16:32:20.747393-05:00	e055db71-f3da-43d3-a9b2-2f65dfb23d3e	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-BG-A0M8	Stage IA	Not Reported	0.0	not reported	Endometrium	2020.0	18308.0	Endometrioid adenocarcinoma, NOS	yes	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18308.0	50.15890410958904	['2019-07-31T17:24:43.270039-05:00', '2019-07-31T17:24:43.270039-05:00']	['173d02c7-bcf6-5f10-b06a-9c846e38021b', 'bef2a3e3-afc0-5318-8936-e2584a8e56f3']	['TCGA-BG-A0M8_treatment', 'TCGA-BG-A0M8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:21:44.095508-05:00']	01	Primary	9cfb7290-ef60-4fda-abd7-9552ae11e4e7	Primary Tumor	Not Reported	734.0	630.0	OCT	42DBC6F7-E413-41A6-994E-1391099818A0	true	Solid Tissue	False	Tumor
TCGA-BS-A0UJ-01A	ff82548a-f1bb-4daa-a8f7-b3831b5843ad	Adenomas and Adenocarcinomas	ff82548a-f1bb-4daa-a8f7-b3831b5843ad	TCGA-BS-A0UJ	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	68.0	-25149.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2506.0	25149.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25149.0	68.9013698630137	['2019-07-31T22:37:01.073910-05:00', '2019-07-31T22:37:01.073910-05:00']	['315f5766-1e01-59a8-bbd6-ab384e315d38', '49f364b9-f520-5866-ac3d-bbca23797d11']	['TCGA-BS-A0UJ_treatment_1', 'TCGA-BS-A0UJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:35:49.977941-05:00', '']	01	Primary	2ea1339f-a5eb-4552-ac13-858fa70e606e	Primary Tumor	Not Reported	2180.0	160.0	Unknown	DEE9AA2E-DA73-4074-9588-C75DDEC4D29B	false	Solid Tissue	False	Tumor
TCGA-EO-A3KU-01A	db67a9cd-65ba-4d6f-a799-031b6b3df599	Cystic, Mucinous and Serous Neoplasms	db67a9cd-65ba-4d6f-a799-031b6b3df599	TCGA-EO-A3KU	Corpus uteri	Not Reported	not reported	female	not reported	Alive	68.0	-25116.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-EO-A3KU	Patient received neoadjuvant therapy (Carboplatin and Taxol) 1 month prior to the TCGA cancer procurement.	28762	Notification	db67a9cd-65ba-4d6f-a799-031b6b3df599	2015-07-29T00:00:00	854f5fd2-eee8-568d-b785-e81b5fbd2c68	case	2018-08-23T16:32:20.747393-05:00	db67a9cd-65ba-4d6f-a799-031b6b3df599	released	Neoadjuvant therapy	Approved	TCGA-EO-A3KU	Stage II	No	0.0	not reported	Endometrium	677.0	25116.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25116.0	68.81095890410958	['2019-07-31T22:32:16.154338-05:00', '2019-07-31T22:32:16.154338-05:00']	['1f18a7e3-3945-5bf9-8943-3437b951df50', '50e72d78-bc73-5f88-860b-4a7970920fbe']	['TCGA-EO-A3KU_treatment', 'TCGA-EO-A3KU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:32:02.391435-05:00']	01	Primary	72940768-0848-4134-8d1d-c81a02f92134	Primary Tumor	Not Reported	93.0	110.0	Unknown	B6945BE4-FA4A-4ED4-9233-B32123F41C95	false	Solid Tissue	False	Tumor
TCGA-A5-A0GM-01A	976bb47a-d999-4e24-ad08-452fea73c846	Adenomas and Adenocarcinomas	976bb47a-d999-4e24-ad08-452fea73c846	TCGA-A5-A0GM	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19452.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-A5-A0GM	Case had Prior malignancy	1054	Notification	976bb47a-d999-4e24-ad08-452fea73c846	2010-12-14T00:00:00	b43d365d-73fc-58a3-b822-d290ac274a3d	case	2018-08-23T16:32:20.747393-05:00	976bb47a-d999-4e24-ad08-452fea73c846	released	Prior malignancy	Approved	TCGA-A5-A0GM	Stage IA	Not Reported	0.0	not reported	Endometrium	1841.0	19452.0	Endometrioid adenocarcinoma, NOS	yes	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19452.0	53.293150684931504	['2019-07-31T22:25:50.069821-05:00', '2019-07-31T22:25:50.069821-05:00']	['36398500-9353-5583-99ad-f6f25bf08f19', '84cd1149-7f47-5e2c-a7b9-0d3946c006e8']	['TCGA-A5-A0GM_treatment_1', 'TCGA-A5-A0GM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:26:49.506162-05:00', '']	01	Primary	a0eccb29-0485-459a-a881-9bb5c59f4371	Primary Tumor	Not Reported	1518.0	360.0	OCT	4AAFF034-45D3-4F4F-A283-262BA641D03A	true	Solid Tissue	False	Tumor
TCGA-B5-A0KB-01B	e604f5d4-f2c0-4404-9073-b8dbc8396778	Adenomas and Adenocarcinomas	e604f5d4-f2c0-4404-9073-b8dbc8396778	TCGA-B5-A0KB	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	62.0	-22669.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-B5-A0KB	systemic treatment given to the prior/other malignancy	20768	Notification	e604f5d4-f2c0-4404-9073-b8dbc8396778	2014-06-16T00:00:00	8b2296a5-8c20-5fea-8d10-bd289704a2d1	case	2018-08-23T16:32:20.747393-05:00	e604f5d4-f2c0-4404-9073-b8dbc8396778	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-B5-A0KB	Stage IB	Not Reported	0.0	not reported	Endometrium	824.0	22669.0	Endometrioid adenocarcinoma, NOS	yes	2010.0	Yes	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22669.0	62.106849315068494	['2019-07-31T17:23:30.699388-05:00', '2019-07-31T17:23:30.699388-05:00']	['493a5768-0a02-5641-8d1e-e699503848c8', 'a4dbf4c9-f936-5397-b5bc-a8ce8ada2980']	['TCGA-B5-A0KB_treatment_1', 'TCGA-B5-A0KB_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T10:20:45.293013-05:00', '']	01	Primary	fb68c314-c79f-41fb-8a28-afe26c8e5580	Primary Tumor	Not Reported	368.0	430.0	OCT	2C744545-8FF8-4A07-A8F2-A47D28B2A8E2	true	Solid Tissue	False	Tumor
TCGA-D1-A3JP-01A	4846cb23-d7e7-47f4-972f-3abe229f7bdb	Cystic, Mucinous and Serous Neoplasms	4846cb23-d7e7-47f4-972f-3abe229f7bdb	TCGA-D1-A3JP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22538.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-D1-A3JP	unknown treatment history	20771	Notification	4846cb23-d7e7-47f4-972f-3abe229f7bdb	2014-06-16T00:00:00	8b7d9ec1-b976-570b-84d7-eb28f792fe5d	case	2018-08-23T16:32:20.747393-05:00	4846cb23-d7e7-47f4-972f-3abe229f7bdb	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-D1-A3JP	Stage IA	Not Reported	0.0	not reported	Endometrium	515.0	22538.0	Serous cystadenocarcinoma, NOS	yes	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22538.0	61.74794520547945	['2019-07-31T22:18:09.294670-05:00', '2019-07-31T22:18:09.294670-05:00']	['1d2b01ca-2306-55aa-ac04-ca88863f82d0', '81dee702-5f57-5326-8857-fc80b738e1e9']	['TCGA-D1-A3JP_treatment_1', 'TCGA-D1-A3JP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:20:37.319887-05:00', '']	01	Primary	29a581ed-3dca-4a65-ab6b-5a9656674f92	Primary Tumor	Not Reported	101.0	170.0	OCT	62290E86-409F-4590-AA2C-D3D2F77148FF	true	Solid Tissue	False	Tumor
TCGA-AP-A05D-01A	f7e06a10-74ca-4f52-a944-b3f22c016998	Cystic, Mucinous and Serous Neoplasms	f7e06a10-74ca-4f52-a944-b3f22c016998	TCGA-AP-A05D	Corpus uteri	Not Reported	white	female	not reported	Alive	67.0	-24597.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-AP-A05D	from Jay Bowen/NWCH	1227	Notification	f7e06a10-74ca-4f52-a944-b3f22c016998	2011-01-25T00:00:00	9f1ae8f0-3651-5652-93a8-bcba5b3a92ea	case	2018-08-23T16:32:20.747393-05:00	f7e06a10-74ca-4f52-a944-b3f22c016998	released	Prior malignancy	Approved	TCGA-AP-A05D	Stage IIIC2	Not Reported	0.0	not reported	Endometrium	1758.0	24597.0	Serous cystadenocarcinoma, NOS	yes	2007.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24597.0	67.3890410958904	['2019-07-31T22:36:09.884483-05:00', '2019-07-31T22:36:09.884483-05:00']	['36c4c5cd-0858-5640-ac78-fa7409287255', 'aaf0e00f-c511-5b67-bd52-a587e3ca359c']	['TCGA-AP-A05D_treatment_1', 'TCGA-AP-A05D_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:35:08.094656-05:00', '']	01	Primary	5b19af28-1179-42cb-a474-856ef2048d5b	Primary Tumor	Not Reported	1063.0	190.0	OCT	3312F531-00A3-4104-8C9C-8734C32C89C0	true	Solid Tissue	False	Tumor
TCGA-EY-A215-01A	48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db	Adenomas and Adenocarcinomas	48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db	TCGA-EY-A215	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22076.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-EY-A215	Patient had a previous chondrosarcoma. No systemic radiation or chemotherapy.	16122	Notification	48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db	2013-05-16T00:00:00	9fb85dab-5544-5a5e-b53d-367002ddeb99	case	2018-08-23T16:32:20.747393-05:00	48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db	released	Prior malignancy	Approved	TCGA-EY-A215	Stage IB	Not Reported	0.0	not reported	Endometrium	574.0	22076.0	Endometrioid adenocarcinoma, NOS	yes	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22076.0	60.48219178082192	['2019-07-31T22:18:12.157194-05:00', '2019-07-31T22:18:12.157194-05:00']	['cf2d2856-e544-52a9-b6ae-0cfb24dd90be', 'ed0a5ef1-8e27-595b-b379-323f7ea2c86b']	['TCGA-EY-A215_treatment_1', 'TCGA-EY-A215_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:20:39.821314-05:00', '']	01	Primary	4d692dbb-bbd7-429b-894e-ccb215ca41cc	Primary Tumor	Not Reported	293.0	210.0	Unknown	C0F970E3-E534-4A34-B87A-4383FD261B53	false	Solid Tissue	False	Tumor
TCGA-D1-A2G5-01A	016e515e-7f78-4997-9b97-3628464d9222	Adenomas and Adenocarcinomas	016e515e-7f78-4997-9b97-3628464d9222	TCGA-D1-A2G5	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	50.0	-18322.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-D1-A2G5	Patient had a prior kidney tumor. No systemic radation or chemotherapy.	16130	Notification	016e515e-7f78-4997-9b97-3628464d9222	2013-05-17T00:00:00	b51d54d3-45ca-5f0c-b9ee-aea312b177b6	case	2018-08-23T16:32:20.747393-05:00	016e515e-7f78-4997-9b97-3628464d9222	released	Prior malignancy	Approved	TCGA-D1-A2G5	Stage IB	Not Reported	0.0	not reported	Endometrium	1455.0	18322.0	Endometrioid adenocarcinoma, NOS	yes	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18322.0	50.1972602739726	['2019-07-31T22:10:04.661953-05:00', '2019-07-31T22:10:04.661953-05:00']	['1a5f6f8a-873c-56fe-968d-810328798059', '5d60145f-6e8d-5f2e-8b98-842d5c1f511f']	['TCGA-D1-A2G5_treatment', 'TCGA-D1-A2G5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:14:05.610136-05:00']	01	Primary	7aafad6c-6329-41e5-ba2e-74ae104ddcb1	Primary Tumor	Not Reported	1354.0	70.0	OCT	741AB1D9-493E-4659-BC2E-BF77A7E1CC14	true	Solid Tissue	False	Tumor
TCGA-2E-A9G8-01A	9583c10b-b21a-4863-98fa-61e735e64ea5	Adenomas and Adenocarcinomas	9583c10b-b21a-4863-98fa-61e735e64ea5	TCGA-2E-A9G8	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	59.0		1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	436d9f32-46d2-5742-8f24-4108512a84e1	2E	University of Kansas Medical Center	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-2E-A9G8	Per the tissue source site: chemotherapy is mentioned once in the medical record, however, there is no record of the chemotherapy being administered or any reference to chemo type treatment.	22357	Observation	9583c10b-b21a-4863-98fa-61e735e64ea5	2014-09-19T00:00:00	c7809389-a217-5260-874a-a69515dd6b73	case	2018-08-23T16:32:20.747393-05:00	9583c10b-b21a-4863-98fa-61e735e64ea5	released	Item may not meet study protocol	Approved	TCGA-2E-A9G8	Stage III	Not Reported	0.0	not reported	Fundus uteri	1249.0		Endometrioid adenocarcinoma, NOS	yes	2011.0	No	8380/3	not reported	C54.3	Fundus uteri	Not Reported	not reported			['2019-07-31T22:25:35.203139-05:00', '2019-07-31T22:25:35.203139-05:00']	['95733b1f-c327-5380-96e5-596874487088', 'b9ef309c-d76b-5d51-ac45-633e7da24e3f']	['TCGA-2E-A9G8_treatment_1', 'TCGA-2E-A9G8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:26:36.959285-05:00', '']	01	Primary	792e23a2-aed7-40f6-966b-281697eb7c85	Primary Tumor	Not Reported	957.0	90.0	Unknown	921E6140-A03E-4FBD-9FB8-554AE96FD16C	false	Solid Tissue	False	Tumor
TCGA-AX-A1CR-01A	3abaa1b6-7513-40e0-b79c-b968e788e932	Cystic, Mucinous and Serous Neoplasms	3abaa1b6-7513-40e0-b79c-b968e788e932	TCGA-AX-A1CR	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	70.0	-25812.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-AX-A1CR	unknown treatment history	20764	Notification	3abaa1b6-7513-40e0-b79c-b968e788e932	2014-06-16T00:00:00	d0227d0e-e71c-5f07-8f99-51a3c297b3a0	case	2018-08-23T16:32:20.747393-05:00	3abaa1b6-7513-40e0-b79c-b968e788e932	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-AX-A1CR	Stage IIB	Not Reported	0.0	not reported	Endometrium	701.0	25812.0	Serous cystadenocarcinoma, NOS	yes	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25812.0	70.71780821917808	['2019-07-31T22:16:06.651087-05:00', '2019-07-31T22:16:06.651087-05:00']	['b1a9b813-6a53-5263-a6dd-ee5e7d5812f9', 'bbf6352f-bef4-5a59-a639-3b39a64bc7aa']	['TCGA-AX-A1CR_treatment', 'TCGA-AX-A1CR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:19:00.202097-05:00']	01	Primary	8d14edd5-b754-48af-b636-4e655fce9cbe	Primary Tumor	Not Reported	274.0	110.0	Unknown	7623CA86-87C5-43E8-A0A7-25BD9526D1AA	false	Solid Tissue	False	Tumor
TCGA-KJ-A3U4-01A	1a36d5de-a097-4323-90e9-f1b924a8a5d8	Cystic, Mucinous and Serous Neoplasms	1a36d5de-a097-4323-90e9-f1b924a8a5d8	TCGA-KJ-A3U4	Corpus uteri	Not Reported	white	female	hispanic or latino	Alive	55.0	-20392.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	9f510fcc-aa89-5390-8090-ad65821881e5	KJ	University of Miami	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-KJ-A3U4	Patient had a previous invasive ductal adenocarcinoma of the breast that was treated with locoregional radiation and systemic chemotherapy.	16118	Notification	1a36d5de-a097-4323-90e9-f1b924a8a5d8	2013-05-16T00:00:00	d32df453-f4a4-522f-8db7-8674e26721d1	case	2018-08-23T16:32:20.747393-05:00	1a36d5de-a097-4323-90e9-f1b924a8a5d8	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-KJ-A3U4	Stage IA	Not Reported	0.0	not reported	Endometrium	1095.0	20392.0	Serous cystadenocarcinoma, NOS	yes	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	20392.0	55.868493150684934	['2019-07-31T22:13:01.666737-05:00', '2019-07-31T22:13:01.666737-05:00']	['0d132b73-1dfe-5233-9592-6d9194d74605', 'a0056717-f4b8-51ad-91d3-4ac111417a87']	['TCGA-KJ-A3U4_treatment', 'TCGA-KJ-A3U4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:16:30.217460-05:00']	01	Primary	7fcbd3e2-4a71-4ef2-96df-d4be66352d9e	Primary Tumor	Not Reported	56.0	420.0	OCT	F0B04416-21FE-4DBC-84BB-7188131399B6	true	Solid Tissue	False	Tumor
TCGA-D1-A0ZO-01A	b3d635b3-d7ac-4cf8-a318-0a9dd0073e89	Adenomas and Adenocarcinomas	b3d635b3-d7ac-4cf8-a318-0a9dd0073e89	TCGA-D1-A0ZO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	75.0	-27482.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-D1-A0ZO		16132	Notification	b3d635b3-d7ac-4cf8-a318-0a9dd0073e89	2013-05-17T00:00:00	d706907a-a836-54cc-96b9-a11ce0376268	case	2018-08-23T16:32:20.747393-05:00	b3d635b3-d7ac-4cf8-a318-0a9dd0073e89	released	Prior malignancy	Approved	TCGA-D1-A0ZO	Stage IB	Not Reported	0.0	not reported	Endometrium	602.0	27482.0	Endometrioid adenocarcinoma, NOS	yes	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27482.0	75.2931506849315	['2019-07-31T22:28:51.161347-05:00', '2019-07-31T22:28:51.161347-05:00']	['2b9b9915-99c8-5453-bbb7-27d0b367108f', '86376fa5-b08c-5bba-b265-e6d30d562a90']	['TCGA-D1-A0ZO_treatment_1', 'TCGA-D1-A0ZO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:29:16.229736-05:00', '']	01	Primary	9c617822-c9a8-42c5-aab7-d6f22887c325	Primary Tumor	Not Reported	586.0	50.0	Unknown	13826E23-2184-4D03-B67C-B312BF4FA87E	false	Solid Tissue	False	Tumor
TCGA-A5-A0GI-01A	3b21b47e-a15c-4b10-9702-62a14afdfb8c	Adenomas and Adenocarcinomas	3b21b47e-a15c-4b10-9702-62a14afdfb8c	TCGA-A5-A0GI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23195.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-A5-A0GI	Case had Prior malignancy	1053	Notification	3b21b47e-a15c-4b10-9702-62a14afdfb8c	2010-12-14T00:00:00	f3e7d168-40cc-5b89-b784-26c837051ed9	case	2018-08-23T16:32:20.747393-05:00	3b21b47e-a15c-4b10-9702-62a14afdfb8c	released	Prior malignancy	Approved	TCGA-A5-A0GI	Stage IA	Not Reported	0.0	not reported	Endometrium	2682.0	23195.0	Endometrioid adenocarcinoma, NOS	yes	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23195.0	63.54794520547945	['2019-07-31T22:16:12.772247-05:00', '2019-07-31T22:16:12.772247-05:00']	['0ac03464-cc57-51b5-a427-3e0e8b6ae472', 'b48a7164-669b-571d-8b86-cf730587bd3a']	['TCGA-A5-A0GI_treatment', 'TCGA-A5-A0GI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:19:04.885031-05:00']	01	Primary	dd02a477-06c0-4bda-9752-896491eddd95	Primary Tumor	Not Reported	1779.0	130.0	OCT	F1D23669-8247-4727-8D38-BD444C16FAAE	true	Solid Tissue	False	Tumor
TCGA-AX-A2HF-01A	7a077812-f6ee-4820-a084-1a52c7ef062c	Cystic, Mucinous and Serous Neoplasms	7a077812-f6ee-4820-a084-1a52c7ef062c	TCGA-AX-A2HF	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24689.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-AX-A2HF	unknown treatment history	20766	Notification	7a077812-f6ee-4820-a084-1a52c7ef062c	2014-06-16T00:00:00	d91aa156-5fec-5f87-b24c-1822ac21fd44	case	2018-08-23T16:32:20.747393-05:00	7a077812-f6ee-4820-a084-1a52c7ef062c	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-AX-A2HF	Stage IB	Not Reported	0.0	not reported	Endometrium	848.0	24689.0	Serous cystadenocarcinoma, NOS	yes	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24689.0	67.64109589041095	['2019-07-31T22:23:18.553421-05:00', '2019-07-31T22:23:18.553421-05:00']	['1209070c-e58c-54bb-a716-e937788c9491', 'c287c649-8af9-52d6-907d-483fbd5bbdb2']	['TCGA-AX-A2HF_treatment_1', 'TCGA-AX-A2HF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:24:44.396642-05:00', '']	01	Primary	137e9776-ca5c-47f3-9ef7-8726d021fbb2	Primary Tumor	Not Reported	440.0	140.0	Unknown	5454BF58-3D26-4D61-B0A8-30A06ECD0E60	false	Solid Tissue	False	Tumor
TCGA-AX-A2H8-01A	da0474b3-48ab-4398-ae4b-f15e27e99b2d	Adenomas and Adenocarcinomas	da0474b3-48ab-4398-ae4b-f15e27e99b2d	TCGA-AX-A2H8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23448.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-AX-A2H8	unknown treatment history	20765	Notification	da0474b3-48ab-4398-ae4b-f15e27e99b2d	2014-06-16T00:00:00	ea04225b-4bfb-5270-b177-ccaf723f261a	case	2018-08-23T16:32:20.747393-05:00	da0474b3-48ab-4398-ae4b-f15e27e99b2d	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-AX-A2H8	Stage IB	Not Reported	0.0	not reported	Endometrium	1861.0	23448.0	Endometrioid adenocarcinoma, NOS	yes	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23448.0	64.24109589041096	['2019-07-31T22:32:07.555670-05:00', '2019-07-31T22:32:07.555670-05:00']	['a405c0db-a0a9-5eb9-a91d-da06b48951d4', 'e56d9121-28b4-568f-8869-45f20d539c36']	['TCGA-AX-A2H8_treatment', 'TCGA-AX-A2H8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:31:55.300196-05:00']	01	Primary	5b39cf2f-3ada-4c86-aab1-05734e817664	Primary Tumor	Not Reported	1974.0	150.0	Unknown	1D1AF737-8A5A-4274-B9AD-2F4BA3127DDD	false	Solid Tissue	False	Tumor
TCGA-AX-A2H8-11A	da0474b3-48ab-4398-ae4b-f15e27e99b2d	Adenomas and Adenocarcinomas	da0474b3-48ab-4398-ae4b-f15e27e99b2d	TCGA-AX-A2H8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23448.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-AX-A2H8	unknown treatment history	20765	Notification	da0474b3-48ab-4398-ae4b-f15e27e99b2d	2014-06-16T00:00:00	ea04225b-4bfb-5270-b177-ccaf723f261a	case	2018-08-23T16:32:20.747393-05:00	da0474b3-48ab-4398-ae4b-f15e27e99b2d	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-AX-A2H8	Stage IB	Not Reported	0.0	not reported	Endometrium	1861.0	23448.0	Endometrioid adenocarcinoma, NOS	yes	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23448.0	64.24109589041096	['2019-07-31T22:32:07.555670-05:00', '2019-07-31T22:32:07.555670-05:00']	['a405c0db-a0a9-5eb9-a91d-da06b48951d4', 'e56d9121-28b4-568f-8869-45f20d539c36']	['TCGA-AX-A2H8_treatment', 'TCGA-AX-A2H8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:31:55.300196-05:00']	11	Not Applicable	98d62bf5-889b-40f9-b4da-fc29313acf9e	Solid Tissue Normal	Not Reported	1974.0	140.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FI-A2D5-01A	dcfbe781-a92a-45b5-b80a-e3bb3bdc0d9a	Adenomas and Adenocarcinomas	dcfbe781-a92a-45b5-b80a-e3bb3bdc0d9a	TCGA-FI-A2D5	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	56.0	-20666.0	1953.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH	421.0	TCGA-FI-A2D5	Patient had synchronous lung adenocarcinoma, NOS. No systemic radiation or chemotherapy.	16120	Notification	dcfbe781-a92a-45b5-b80a-e3bb3bdc0d9a	2013-05-16T00:00:00	f695558e-aee3-57c0-83ce-b3dded1fa0ec	case	2018-08-23T16:32:20.747393-05:00	dcfbe781-a92a-45b5-b80a-e3bb3bdc0d9a	released	Synchronous malignancy	Approved	TCGA-FI-A2D5	Stage IVB	Not Reported	0.0	not reported	Endometrium		20666.0	Endometrioid adenocarcinoma, NOS	yes	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20666.0	56.61917808219178	['2019-07-31T22:32:25.839375-05:00', '2019-07-31T22:32:25.839375-05:00']	['04c3a52f-064d-5e78-9d54-dbcacd9140c7', '8f0ae61c-8d77-5780-a711-4cae1180eca2']	['TCGA-FI-A2D5_treatment', 'TCGA-FI-A2D5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:32:09.350069-05:00']	01	Primary	d5f6444e-c388-42e9-8b20-7b3a4db8e0db	Primary Tumor	Not Reported	702.0	60.0	OCT	A8F4B3DC-7B7D-4F1F-A909-E23DAE23E52C	true	Solid Tissue	False	Tumor
TCGA-D1-A102-01A	f9cf4125-0db3-4b66-b51b-bc2f0240c9ef	Adenomas and Adenocarcinomas	f9cf4125-0db3-4b66-b51b-bc2f0240c9ef	TCGA-D1-A102	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	49.0	-17991.0	1960.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-D1-A102	Patient had a prior parotid gland tumor of unknown histology. No systemic radation or chemotherapy.	16131	Notification	f9cf4125-0db3-4b66-b51b-bc2f0240c9ef	2013-05-17T00:00:00	fbe69835-2e78-5d8c-9869-f8d70ccb4f89	case	2018-08-23T16:32:20.747393-05:00	f9cf4125-0db3-4b66-b51b-bc2f0240c9ef	released	Prior malignancy	Approved	TCGA-D1-A102	Stage IB	Not Reported	0.0	not reported	Endometrium	135.0	17991.0	Endometrioid adenocarcinoma, NOS	yes	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17991.0	49.29041095890411	['2019-07-31T22:36:18.381813-05:00', '2019-07-31T22:36:18.381813-05:00']	['3d8bf7b7-1423-5bb3-ae68-af654337e0b9', 'a32d810d-412c-5bd1-bd83-21ea59fba3b7']	['TCGA-D1-A102_treatment', 'TCGA-D1-A102_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:35:15.387561-05:00']	01	Primary	eef5bd16-dc47-47da-baa9-295b8c28361b	Primary Tumor	Not Reported	380.0	200.0	Unknown	9983D576-706A-48D2-93EE-70EABB3BD77C	false	Solid Tissue	False	Tumor
TCGA-AX-A1C5-01A	caebdce0-f954-471a-ac63-5daaa2e76d97	Adenomas and Adenocarcinomas	caebdce0-f954-471a-ac63-5daaa2e76d97	TCGA-AX-A1C5	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	47.0	-17383.0	1962.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1001.0	17383.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17383.0	47.62465753424657	['2019-07-31T22:30:37.326856-05:00', '2019-07-31T22:30:37.326856-05:00']	['4d527fed-b773-56b2-8322-5f1a13edbc75', '7c8a22d1-d380-5319-9440-b69bdc7d9fa5']	['TCGA-AX-A1C5_treatment_1', 'TCGA-AX-A1C5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:30:42.137320-05:00', '']	01	Primary	cb8bc1f7-c7a2-4378-9f91-a4d76a70435b	Primary Tumor	Not Reported	517.0	130.0	Unknown	6F79B83A-90B4-45DF-8542-A6BC2F93470D	false	Solid Tissue	False	Tumor
TCGA-A5-A0GX-01A	553f0ccd-4e6f-4ae2-9b39-97529eb3d826	Adenomas and Adenocarcinomas	553f0ccd-4e6f-4ae2-9b39-97529eb3d826	TCGA-A5-A0GX	Corpus uteri	Not Reported	white	female	not reported	Alive	53.0	-19625.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2088.0	19625.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19625.0	53.76712328767123	['2019-07-31T22:19:33.385939-05:00', '2019-07-31T22:19:33.385939-05:00']	['7f31b194-84d2-520a-ad5c-e5a6ace5ab8b', 'ee7b412c-c0e9-51e3-99ca-d3e0d7af96a2']	['TCGA-A5-A0GX_treatment', 'TCGA-A5-A0GX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:21:43.551150-05:00']	01	Primary	983a35a9-c825-4961-86c0-4c6133b5c9c1	Primary Tumor	Not Reported	1654.0	250.0	OCT	AE5229ED-8906-4D55-9B11-4E8E214D6446	true	Solid Tissue	False	Tumor
TCGA-AP-A051-01A	b045f24b-f822-4df9-9ffa-47308edcec8c	Adenomas and Adenocarcinomas	b045f24b-f822-4df9-9ffa-47308edcec8c	TCGA-AP-A051	Corpus uteri	Not Reported	white	female	not reported	Alive	69.0	-25269.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	3948.0	25269.0	Endometrioid adenocarcinoma, NOS	no	2003.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25269.0	69.23013698630137	['2019-07-31T16:41:21.236341-05:00', '2019-07-31T16:41:21.236341-05:00']	['c0d288be-fd7c-5c7a-89f7-78af27dd68b8', 'dcefc2e5-fa75-54a4-b60f-34b5b44f0ee1']	['TCGA-AP-A051_treatment_1', 'TCGA-AP-A051_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T09:46:20.441679-05:00', '']	01	Primary	417cff62-b034-4197-9cfd-e640d55f3094	Primary Tumor	Not Reported	2475.0	430.0	OCT	2146A2FC-99EE-4939-AD9F-086BB77D2B21	true	Solid Tissue	False	Tumor
TCGA-AJ-A3OL-01A	7f91a0c5-d639-48ea-b3f7-b6f385e047ed	Adenomas and Adenocarcinomas	7f91a0c5-d639-48ea-b3f7-b6f385e047ed	TCGA-AJ-A3OL	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	55.0	-20115.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	449.0															Stage IIIA	No	0.0	not reported	Endometrium	57.0	20115.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20115.0	55.10958904109589	['2019-07-31T22:23:49.622497-05:00', '2019-07-31T22:23:49.622497-05:00']	['58be442d-f29e-5e69-9276-8fa9f65b08e8', 'eab6425a-3109-512d-a77c-afc947890f66']	['TCGA-AJ-A3OL_treatment_1', 'TCGA-AJ-A3OL_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:25:08.462822-05:00', '']	01	Primary	029e5e0d-9f4e-4031-a5f2-0187c2b70879	Primary Tumor	Not Reported	81.0	190.0	Unknown	B42FF342-34F0-4611-A275-B979D7658510	false	Solid Tissue	False	Tumor
TCGA-AX-A2HD-11A	a8def1a0-a136-47f4-9ad9-60ebcf9b726b	Adenomas and Adenocarcinomas	a8def1a0-a136-47f4-9ad9-60ebcf9b726b	TCGA-AX-A2HD	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25499.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1414.0	25499.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25499.0	69.86027397260274	['2019-07-31T22:27:36.117848-05:00', '2019-07-31T22:27:36.117848-05:00']	['335e6652-9cdb-5121-b941-fb07f550b61f', '61f8a04d-cded-5f19-aa28-ea114d0f140d']	['TCGA-AX-A2HD_treatment_1', 'TCGA-AX-A2HD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:28:14.241623-05:00', '']	11	Not Applicable	26bc3b4c-b0bc-4d05-9dbf-334f27f1cb89	Solid Tissue Normal	Not Reported	1175.0	110.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A2HD-01A	a8def1a0-a136-47f4-9ad9-60ebcf9b726b	Adenomas and Adenocarcinomas	a8def1a0-a136-47f4-9ad9-60ebcf9b726b	TCGA-AX-A2HD	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25499.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1414.0	25499.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25499.0	69.86027397260274	['2019-07-31T22:27:36.117848-05:00', '2019-07-31T22:27:36.117848-05:00']	['335e6652-9cdb-5121-b941-fb07f550b61f', '61f8a04d-cded-5f19-aa28-ea114d0f140d']	['TCGA-AX-A2HD_treatment_1', 'TCGA-AX-A2HD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:28:14.241623-05:00', '']	01	Primary	5a2ede97-0cf7-44d7-a789-92ee9bda3d6c	Primary Tumor	Not Reported	1175.0	100.0	Unknown	83BDA3FE-254F-4F99-B41E-FC1F8C128906	false	Solid Tissue	False	Tumor
TCGA-B5-A3F9-01A	21941181-8ed5-4211-867d-516ad09fbe06	Adenomas and Adenocarcinomas	21941181-8ed5-4211-867d-516ad09fbe06	TCGA-B5-A3F9	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	56.0	-20523.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	4155.0	20523.0	Endometrioid adenocarcinoma, NOS	no	2003.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20523.0	56.227397260273975	['2019-07-31T22:13:32.675390-05:00', '2019-07-31T22:13:32.675390-05:00']	['12cec3dc-23cb-5cfd-aa5e-04c54aff0f15', '56621181-87be-5d42-bdb2-fcfc5e0c6101']	['TCGA-B5-A3F9_treatment_1', 'TCGA-B5-A3F9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:16:55.427339-05:00', '']	01	Primary	7fc15cfc-2cd8-49af-bf92-913f0bc4c1a8	Primary Tumor	Not Reported	3159.0	110.0	OCT	E4AD1574-653C-444D-BB43-B4DE701B109F	true	Solid Tissue	False	Tumor
TCGA-FL-A1YU-11A	a94de778-9c21-410d-8b9d-0f9240036bb8	Not Reported	a94de778-9c21-410d-8b9d-0f9240036bb8	TCGA-FL-A1YU	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	b28c3b96-d5a6-4209-831f-5e1f0277d825	Solid Tissue Normal	Not Reported		50.0	Unknown	50EB1015-2B54-4B28-B581-1F0707604595	false	Solid Tissue	False	Normal
TCGA-AX-A2H2-01A	e4510c66-a60b-4b09-a4e8-74ec5b26a3a5	Cystic, Mucinous and Serous Neoplasms	e4510c66-a60b-4b09-a4e8-74ec5b26a3a5	TCGA-AX-A2H2	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	86.0	-31524.0	1922.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	145.0															Stage IIA	No	0.0	not reported	Endometrium		31524.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	31524.0	86.36712328767123	['2019-07-31T22:33:45.293072-05:00', '2019-07-31T22:33:45.293072-05:00']	['1aa150f8-865a-5e73-a0cb-61fd3cafaeec', 'a824de28-1788-519d-9a7d-9f4448bcda6a']	['TCGA-AX-A2H2_treatment', 'TCGA-AX-A2H2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:33:13.133327-05:00']	01	Primary	6d3fb251-74e8-40d5-8262-f265a5a3395a	Primary Tumor	Not Reported	1079.0	160.0	Unknown	1BDF6880-A5E1-4DD8-A7E5-1E91BBCF8F60	false	Solid Tissue	False	Tumor
TCGA-AX-A1C7-01A	755d7ab7-4563-408a-9135-f852048af975	Cystic, Mucinous and Serous Neoplasms	755d7ab7-4563-408a-9135-f852048af975	TCGA-AX-A1C7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28198.0	1932.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1054.0	28198.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	28198.0	77.25479452054795	['2019-07-31T22:22:51.613347-05:00', '2019-07-31T22:22:51.613347-05:00']	['0827e0de-da65-50ef-b937-bf0d23a55873', 'b11177ae-1be7-5e18-ab9b-95d6ec4915ed']	['TCGA-AX-A1C7_treatment', 'TCGA-AX-A1C7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:24:22.782716-05:00']	01	Primary	a4b56935-7bb9-4c84-9176-e8d694f37faa	Primary Tumor	Not Reported	423.0	90.0	Unknown	10458026-49D7-40EC-BC7B-0D6A381FB025	false	Solid Tissue	False	Tumor
TCGA-EY-A1GL-01A	d46d5af5-62ae-43eb-a885-4c078e0c956e	Adenomas and Adenocarcinomas	d46d5af5-62ae-43eb-a885-4c078e0c956e	TCGA-EY-A1GL	Corpus uteri	Not Reported	white	female	not reported	Alive	51.0	-18761.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	1014.0	18761.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18761.0	51.4	['2019-07-31T22:31:34.861976-05:00', '2019-07-31T22:31:34.861976-05:00']	['40f1eca8-b298-578e-81fa-6f9d0e263ce7', '729b0ba4-eec9-5f8d-abd6-1d84c6f1099c']	['TCGA-EY-A1GL_treatment', 'TCGA-EY-A1GL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:31:27.707233-05:00']	01	Primary	4032607d-6cf1-4b53-941e-0c50cb3d0f10	Primary Tumor	Not Reported	366.0	300.0	Unknown	449C1D9F-6A1F-4523-8C86-AFED911D95D4	false	Solid Tissue	False	Tumor
TCGA-BG-A0YU-01A	957ac10a-7365-47b1-bbed-47e5d42fbfdf	Adenomas and Adenocarcinomas	957ac10a-7365-47b1-bbed-47e5d42fbfdf	TCGA-BG-A0YU	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	37.0	-13644.0	1973.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	451.0	13644.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	13644.0	37.38082191780822	['2019-07-31T22:25:32.001872-05:00', '2019-07-31T22:25:32.001872-05:00']	['b1082cf6-f173-5473-8cbf-f4b7931b6341', 'c488d165-0f54-5350-8aea-2ffc0ea8ac7d']	['TCGA-BG-A0YU_treatment', 'TCGA-BG-A0YU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:26:34.518994-05:00']	01	Primary	61a80dcf-f83b-4b4f-806f-8ad3882ecfe4	Primary Tumor	Not Reported	166.0	310.0	OCT	5E3AA4BA-20F6-4241-AD70-8E5DEDA9D129	true	Solid Tissue	False	Tumor
TCGA-AP-A3K1-01A	211b2c52-1ad8-4d33-af0b-69ec1a56c821	Cystic, Mucinous and Serous Neoplasms	211b2c52-1ad8-4d33-af0b-69ec1a56c821	TCGA-AP-A3K1	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	56.0	-20594.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	666.0															Stage IVB	No	0.0	not reported	Endometrium	555.0	20594.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	20594.0	56.42191780821918	['2019-07-31T22:13:26.565397-05:00', '2019-07-31T22:13:26.565397-05:00']	['34a8fec3-6fb1-541e-b1f8-5cfc283ebe33', '6fc79bdc-4403-54d8-801a-e8030d10d55c']	['TCGA-AP-A3K1_treatment_1', 'TCGA-AP-A3K1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:16:50.725609-05:00', '']	01	Primary	8a78f37c-8bc5-4a51-bb76-e77ded648289	Primary Tumor	Not Reported	450.0	190.0	OCT	A2E4C9FE-F82D-440E-AA52-88379EBC2442	true	Solid Tissue	False	Tumor
TCGA-B5-A11W-01A	f5bd3902-ff7f-4233-8f74-beef3676af9a	Adenomas and Adenocarcinomas	f5bd3902-ff7f-4233-8f74-beef3676af9a	TCGA-B5-A11W	Corpus uteri	Not Reported	white	female	not reported	Alive	61.0	-22365.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	593.0	22365.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22365.0	61.273972602739725	['2019-07-31T22:35:44.649282-05:00', '2019-07-31T22:35:44.649282-05:00']	['173b84aa-6570-5313-97b8-0fbeaea72636', 'b0f777ba-d81d-502e-bc54-1018f82cfc98']	['TCGA-B5-A11W_treatment_1', 'TCGA-B5-A11W_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:34:48.388170-05:00', '']	01	Primary	ac3c028c-d36b-489b-a3d9-a7f4783de5eb	Primary Tumor	Not Reported	258.0	310.0	OCT	C5762F7C-AB69-40D0-A9D0-71A6281F30AF	true	Solid Tissue	False	Tumor
TCGA-A5-A2K5-01A	cf77afe9-3785-45d4-ba2a-61c9cb706225	Adenomas and Adenocarcinomas	cf77afe9-3785-45d4-ba2a-61c9cb706225	TCGA-A5-A2K5	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	76.0	-28057.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	752.0	28057.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28057.0	76.86849315068493	['2019-07-31T22:30:55.273443-05:00', '2019-07-31T22:30:55.273443-05:00']	['7bdd99de-48e8-57b1-bb12-a620fab6d995', 'db2b6dff-7eba-530d-8b9f-5d5db50d1ff3']	['TCGA-A5-A2K5_treatment_1', 'TCGA-A5-A2K5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:30:56.670599-05:00', '']	01	Primary	eca91844-e767-4045-a87f-e43dafbcc17a	Primary Tumor	Not Reported	171.0	290.0	OCT	FF305857-5814-4815-90D3-B54BAA0DACB4	true	Solid Tissue	False	Tumor
TCGA-BG-A0MH-01A	bfac45a6-fa01-4edb-9807-6898ea82e80e	Adenomas and Adenocarcinomas	bfac45a6-fa01-4edb-9807-6898ea82e80e	TCGA-BG-A0MH	Corpus uteri	Not Reported	white	female	not reported	Alive	61.0	-22475.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	1930.0	22475.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22475.0	61.57534246575342	['2019-07-31T17:26:51.287347-05:00', '2019-07-31T17:26:51.287347-05:00']	['d8dbd48e-b7aa-5997-8adf-8fc04c12d19c', 'f7509265-bfe3-5212-ab86-ea1e3f36b03b']	['TCGA-BG-A0MH_treatment_1', 'TCGA-BG-A0MH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T10:23:30.916397-05:00', '']	01	Primary	8ad77275-6034-4d01-832f-d8bf3668e6bb	Primary Tumor	Not Reported	1000.0	790.0	OCT	F641C526-7A0D-46C3-92EE-CD9CB0D13960	true	Solid Tissue	False	Tumor
TCGA-BG-A2AD-11A	49adc60f-211b-4547-84f6-094257767409	Adenomas and Adenocarcinomas	49adc60f-211b-4547-84f6-094257767409	TCGA-BG-A2AD	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23064.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIB	No	0.0	not reported	Endometrium	609.0	23064.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23064.0	63.18904109589041	['2019-07-31T22:18:21.120612-05:00', '2019-07-31T22:18:21.120612-05:00']	['8c0ef4a5-2f57-5167-b4fb-6c811871c8ad', 'a32d23ad-7cfa-5bdd-bb76-801a6eae45e6']	['TCGA-BG-A2AD_treatment', 'TCGA-BG-A2AD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:20:46.901367-05:00']	11	Not Applicable	7d188988-d02b-4874-b3af-925c6173f51f	Solid Tissue Normal	Not Reported	45.0	120.0	OCT		true	Solid Tissue	False	Normal
TCGA-BG-A2AD-01A	49adc60f-211b-4547-84f6-094257767409	Adenomas and Adenocarcinomas	49adc60f-211b-4547-84f6-094257767409	TCGA-BG-A2AD	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23064.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIB	No	0.0	not reported	Endometrium	609.0	23064.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23064.0	63.18904109589041	['2019-07-31T22:18:21.120612-05:00', '2019-07-31T22:18:21.120612-05:00']	['8c0ef4a5-2f57-5167-b4fb-6c811871c8ad', 'a32d23ad-7cfa-5bdd-bb76-801a6eae45e6']	['TCGA-BG-A2AD_treatment', 'TCGA-BG-A2AD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:20:46.901367-05:00']	01	Primary	d07bb656-7b30-4d4c-a804-e3336c881a20	Primary Tumor	Not Reported	45.0	770.0	OCT	E3FBF856-C09F-4F3A-975E-A1D07286A0EB	true	Solid Tissue	False	Tumor
TCGA-AP-A1E1-01A	2b85b84f-e680-4b5c-93ea-3c71567227e8	Adenomas and Adenocarcinomas	2b85b84f-e680-4b5c-93ea-3c71567227e8	TCGA-AP-A1E1	Corpus uteri	Not Reported	white	female	not reported	Alive	74.0	-27072.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1395.0	27072.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27072.0	74.16986301369863	['2019-07-31T22:14:29.667119-05:00', '2019-07-31T22:14:29.667119-05:00']	['1be9f7ae-9f83-5cfe-a210-5e9017390a4a', '2fbb8ff6-5b57-5765-87b7-703703ff0c3f']	['TCGA-AP-A1E1_treatment_1', 'TCGA-AP-A1E1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:17:39.514047-05:00', '']	01	Primary	1a9a1020-c9ee-4bbf-98e8-fbe5041a6099	Primary Tumor	Not Reported	470.0	260.0	OCT	E8873536-294D-4E41-9165-EE403A11B439	true	Solid Tissue	False	Tumor
TCGA-EY-A1GR-01A	70cdb758-26c9-4c11-a495-0c31cbc84949	Adenomas and Adenocarcinomas	70cdb758-26c9-4c11-a495-0c31cbc84949	TCGA-EY-A1GR	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	67.0	-24784.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	536.0	24784.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24784.0	67.9013698630137	['2019-07-31T22:22:21.784013-05:00', '2019-07-31T22:22:21.784013-05:00']	['3c2a2349-2808-5e89-92d7-101c61829ba2', '9c88ae47-62a1-5eaf-89c6-2d353ab15c79']	['TCGA-EY-A1GR_treatment', 'TCGA-EY-A1GR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:58.358720-05:00']	01	Primary	1c1d49ed-4dea-4fd0-9952-393470502e81	Primary Tumor	Not Reported	263.0	410.0	Unknown	1C53C957-1A0A-46AF-A53B-0287683D52F6	false	Solid Tissue	False	Tumor
TCGA-A5-A0G2-01A	4abbd258-0f0c-4428-901d-625d47ad363a	Cystic, Mucinous and Serous Neoplasms	4abbd258-0f0c-4428-901d-625d47ad363a	TCGA-A5-A0G2	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	57.0	-20953.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIB	No	0.0	not reported	Endometrium	4549.0	20953.0	Serous cystadenocarcinoma, NOS	no	1997.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	20953.0	57.40547945205479	['2019-07-31T22:18:25.410149-05:00', '2019-07-31T22:18:25.410149-05:00']	['a1be7e6f-327b-5c5d-a093-b322ea54089b', 'f807d385-a797-5faa-ab2f-89396c895cba']	['TCGA-A5-A0G2_treatment_1', 'TCGA-A5-A0G2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:20:49.494995-05:00', '']	01	Primary	771811e3-740e-42fe-be9c-fd485997eaae	Primary Tumor	Not Reported	4825.0	200.0	OCT	A3CD42AF-D356-415B-958D-D14D7AC52693	true	Solid Tissue	False	Tumor
TCGA-BK-A139-01C	8d9e4917-334b-4c76-aee1-1e22be772db0	Adenomas and Adenocarcinomas	8d9e4917-334b-4c76-aee1-1e22be772db0	TCGA-BK-A139	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	74.0	-27077.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH	943.0															Stage IB	No	0.0	not reported	Endometrium	309.0	27077.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27077.0	74.18356164383562	['2019-07-31T17:25:30.369967-05:00', '2019-07-31T17:25:30.369967-05:00']	['6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e', 'de6d0cd2-02d1-51e0-9e71-feb4f4d24986']	['TCGA-BK-A139_treatment', 'TCGA-BK-A139_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:22:24.471608-05:00']	01	Primary	0c2e9ba3-0e50-41e0-bfcd-9c221383df4c	Primary Tumor	Not Reported	551.0		FFPE	5F8C376B-31F8-4566-8EBF-21E7F4E6499D	false	Solid Tissue	True	Tumor
TCGA-BK-A139-02A	8d9e4917-334b-4c76-aee1-1e22be772db0	Adenomas and Adenocarcinomas	8d9e4917-334b-4c76-aee1-1e22be772db0	TCGA-BK-A139	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	74.0	-27077.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH	943.0															Stage IB	No	0.0	not reported	Endometrium	309.0	27077.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27077.0	74.18356164383562	['2019-07-31T17:25:30.369967-05:00', '2019-07-31T17:25:30.369967-05:00']	['6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e', 'de6d0cd2-02d1-51e0-9e71-feb4f4d24986']	['TCGA-BK-A139_treatment', 'TCGA-BK-A139_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:22:24.471608-05:00']	02	Recurrence	a4ee1cc7-9cac-4e7e-96db-d38981e5f506	Recurrent Tumor	Not Reported	874.0	430.0	Unknown	FE6C557C-6F28-4F5C-B48C-E2A3BB7EF14F	false	Solid Tissue	False	Tumor
TCGA-BK-A139-01A	8d9e4917-334b-4c76-aee1-1e22be772db0	Adenomas and Adenocarcinomas	8d9e4917-334b-4c76-aee1-1e22be772db0	TCGA-BK-A139	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	74.0	-27077.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH	943.0															Stage IB	No	0.0	not reported	Endometrium	309.0	27077.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27077.0	74.18356164383562	['2019-07-31T17:25:30.369967-05:00', '2019-07-31T17:25:30.369967-05:00']	['6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e', 'de6d0cd2-02d1-51e0-9e71-feb4f4d24986']	['TCGA-BK-A139_treatment', 'TCGA-BK-A139_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T10:22:24.471608-05:00']	01	Primary	d777e49b-cb47-44f3-ad42-4d23af7e296c	Primary Tumor	Not Reported	175.0	770.0	Unknown	5F8C376B-31F8-4566-8EBF-21E7F4E6499D	false	Solid Tissue	False	Tumor
TCGA-E6-A2P9-01A	077bdc90-1bbd-49ec-93a5-729b1ac1ba8d	Adenomas and Adenocarcinomas	077bdc90-1bbd-49ec-93a5-729b1ac1ba8d	TCGA-E6-A2P9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	65.0	-24088.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	39aa3c67-c7d9-5001-8ed1-3bf83eac7872	E6	Roswell Park	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1386.0	24088.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24088.0	65.9945205479452	['2019-07-31T22:10:51.577607-05:00', '2019-07-31T22:10:51.577607-05:00']	['4f3204f9-4457-5947-aa41-c820c5e13e37', '5c509bb2-9e60-5357-b17b-4706277ea7e5']	['TCGA-E6-A2P9_treatment_1', 'TCGA-E6-A2P9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:14:43.624282-05:00', '']	01	Primary	9c35e13b-87fc-4dc4-a847-dba192079ec1	Primary Tumor	Not Reported	189.0	230.0	OCT	EF7B01C4-0952-4FE8-B128-2A43FA31E6F5	true	Solid Tissue	False	Tumor
TCGA-EO-A3AY-01A	0878e44d-bdc8-4d5f-9bf4-31101f14f797	Adenomas and Adenocarcinomas	0878e44d-bdc8-4d5f-9bf4-31101f14f797	TCGA-EO-A3AY	Corpus uteri	Not Reported	not reported	female	not reported	Alive	58.0	-21291.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1158.0	21291.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21291.0	58.33150684931507	['2019-07-31T22:11:06.980564-05:00', '2019-07-31T22:11:06.980564-05:00']	['75f0791d-3b7c-5396-b531-351ae7721a14', 'ab0cdeb3-034c-5006-afe9-3964d0eda6f7']	['TCGA-EO-A3AY_treatment_1', 'TCGA-EO-A3AY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:14:55.534513-05:00', '']	01	Primary	47bf70a1-6738-495f-9e61-92feaf33c28c	Primary Tumor	Not Reported	227.0	150.0	Unknown	330AEFE0-D564-4799-8928-B05280BACA91	false	Solid Tissue	False	Tumor
TCGA-B5-A11Z-01A	cc141997-edab-4aae-a056-0c079eaa7362	Adenomas and Adenocarcinomas	cc141997-edab-4aae-a056-0c079eaa7362	TCGA-B5-A11Z	Corpus uteri	Not Reported	white	female	not reported	Alive	61.0	-22505.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	528.0	22505.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22505.0	61.657534246575345	['2019-07-31T22:30:46.421077-05:00', '2019-07-31T22:30:46.421077-05:00']	['5f3f631b-6729-5489-a9ab-cfaa34c91631', 'aad7d2a8-7ec4-5b6b-a91e-014001e0d2d4']	['TCGA-B5-A11Z_treatment', 'TCGA-B5-A11Z_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:30:49.502784-05:00']	01	Primary	2a8af07b-b514-4cd0-bf20-03a5f5abdb38	Primary Tumor	Not Reported	213.0	340.0	OCT	62C170A9-710F-45C0-B6BB-3F491A86A7E4	true	Solid Tissue	False	Tumor
TCGA-BG-A3EW-11A	a31554af-d77a-4862-8aed-4581fb2bd877	Adenomas and Adenocarcinomas	a31554af-d77a-4862-8aed-4581fb2bd877	TCGA-BG-A3EW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	62.0	-22705.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage III	No	0.0	not reported	Endometrium	344.0	22705.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22705.0	62.205479452054796	['2019-07-31T22:26:50.662557-05:00', '2019-07-31T22:26:50.662557-05:00']	['5a52d132-8e17-587a-adba-b3fa180144f6', '767ce000-1aca-5b64-8590-d5f4f52bed49']	['TCGA-BG-A3EW_treatment', 'TCGA-BG-A3EW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:37.481785-05:00']	11	Not Applicable	44dcbef9-4ff8-425d-895e-127f7f5c4d4d	Solid Tissue Normal	Not Reported	24.0	220.0	OCT		true	Solid Tissue	False	Normal
TCGA-BG-A3EW-01A	a31554af-d77a-4862-8aed-4581fb2bd877	Adenomas and Adenocarcinomas	a31554af-d77a-4862-8aed-4581fb2bd877	TCGA-BG-A3EW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	62.0	-22705.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage III	No	0.0	not reported	Endometrium	344.0	22705.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22705.0	62.205479452054796	['2019-07-31T22:26:50.662557-05:00', '2019-07-31T22:26:50.662557-05:00']	['5a52d132-8e17-587a-adba-b3fa180144f6', '767ce000-1aca-5b64-8590-d5f4f52bed49']	['TCGA-BG-A3EW_treatment', 'TCGA-BG-A3EW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:37.481785-05:00']	01	Primary	be387236-f691-4303-aa47-be1d67cbdd5e	Primary Tumor	Not Reported	24.0	130.0	OCT	0463CA05-339C-4AB9-A236-CEAE733AD5F6	true	Solid Tissue	False	Tumor
TCGA-AX-A3G9-01A	f7527b5e-5330-49ea-82ce-f6f2cdccbadc	Adenomas and Adenocarcinomas	f7527b5e-5330-49ea-82ce-f6f2cdccbadc	TCGA-AX-A3G9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23361.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	558.0	23361.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23361.0	64.0027397260274	['2019-07-31T22:36:03.600178-05:00', '2019-07-31T22:36:03.600178-05:00']	['97e1cb75-6659-5045-b7fe-ceef7634f7ea', 'f024d7ea-1923-5a24-9e35-13e968eb4ddb']	['TCGA-AX-A3G9_treatment', 'TCGA-AX-A3G9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:35:03.199730-05:00']	01	Primary	739cf2f3-e9eb-4f4a-8310-2d7413e323e4	Primary Tumor	Not Reported	560.0	110.0	Unknown	FADFF649-7518-4EFB-B96C-9390DD308DBD	false	Solid Tissue	False	Tumor
TCGA-B5-A0K6-01A	5cba9441-6812-49c0-a0f6-7928ed4e5b81	Adenomas and Adenocarcinomas	5cba9441-6812-49c0-a0f6-7928ed4e5b81	TCGA-B5-A0K6	Corpus uteri	Not Reported	white	female	not reported	Alive	58.0	-21515.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1953.0	21515.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21515.0	58.945205479452056	['2019-07-31T22:20:06.288929-05:00', '2019-07-31T22:20:06.288929-05:00']	['503605e8-109f-5b95-880b-f8ef58552673', 'bbf61d65-7947-5faa-bfdd-36430a9d5153']	['TCGA-B5-A0K6_treatment', 'TCGA-B5-A0K6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:22:09.745109-05:00']	01	Primary	69bf0d3a-b7ae-4ee1-b7d1-18a32fcfa67c	Primary Tumor	Not Reported	206.0	110.0	OCT	B7F34F79-DB7F-4C98-B1B3-80C3187AE91C	true	Solid Tissue	False	Tumor
TCGA-BG-A0W2-01A	f47df5f9-7c60-4b1a-b574-7036245af341	Adenomas and Adenocarcinomas	f47df5f9-7c60-4b1a-b574-7036245af341	TCGA-BG-A0W2	Corpus uteri	Not Reported	white	female	not reported	Alive	57.0	-20998.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1721.0	20998.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20998.0	57.52876712328767	['2019-07-31T22:35:35.953662-05:00', '2019-07-31T22:35:35.953662-05:00']	['378ea897-c35f-53f3-8fda-3de9b9394435', '5b5345bb-7ddc-5847-96f9-a93cb5aca5c1']	['TCGA-BG-A0W2_treatment', 'TCGA-BG-A0W2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:34:40.812765-05:00']	01	Primary	0945d625-8d4b-4f5a-a863-a61dad5ecd34	Primary Tumor	Not Reported	1073.0	80.0	OCT	D9BDB0FB-9205-4E41-9D7D-B12C206A608E	true	Solid Tissue	False	Tumor
TCGA-BG-A186-01A	fe4db898-3a9f-4dff-adcb-7b8c30137350	Adenomas and Adenocarcinomas	fe4db898-3a9f-4dff-adcb-7b8c30137350	TCGA-BG-A186	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	61.0	-22370.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	419.0	22370.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22370.0	61.28767123287671	['2019-07-31T22:36:46.875840-05:00', '2019-07-31T22:36:46.875840-05:00']	['2c10ea7f-da05-57fc-a377-0336e6869672', '4fdf1d6a-ec9f-5044-9065-46ad5558a922']	['TCGA-BG-A186_treatment', 'TCGA-BG-A186_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:35:37.332651-05:00']	01	Primary	b1645a83-57b7-4357-b977-63a5b6aee39e	Primary Tumor	Not Reported	104.0	100.0	OCT	76C588F1-ED43-485D-8FFF-32F4C5D92202	true	Solid Tissue	False	Tumor
TCGA-EC-A24G-01A	b5c1e511-baf2-45b3-9919-110e8941e3c2	Adenomas and Adenocarcinomas	b5c1e511-baf2-45b3-9919-110e8941e3c2	TCGA-EC-A24G	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-20857.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	acc43e64-d63e-554c-a488-8bf6b93bec91	EC	Asterand	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	511.0	20857.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20857.0	57.14246575342466	['2019-07-31T22:29:01.065566-05:00', '2019-07-31T22:29:01.065566-05:00']	['002afe07-a1a0-5d19-babf-29c713364fa6', '7b92cbd0-16a5-525f-abbe-e0d9e6c4c8e9']	['TCGA-EC-A24G_treatment', 'TCGA-EC-A24G_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:29:23.797018-05:00']	01	Primary	2fea9b96-3434-4a38-bd69-a5fec3d8f960	Primary Tumor	Not Reported	78.0	410.0	OCT	5DE142C5-7A0D-4C5E-8EF6-2809B10378C4	true	Solid Tissue	False	Tumor
TCGA-EY-A1GC-01A	ebc25a41-becb-4395-ae33-483a304b07d8	Adenomas and Adenocarcinomas	ebc25a41-becb-4395-ae33-483a304b07d8	TCGA-EY-A1GC	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	62.0	-22656.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1647.0	22656.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22656.0	62.07123287671233	['2019-07-31T22:34:49.884182-05:00', '2019-07-31T22:34:49.884182-05:00']	['381dfebc-8325-5e88-b190-1ac9d2d9166e', '4adad445-8682-5298-bfcd-8fd99153a7d8']	['TCGA-EY-A1GC_treatment', 'TCGA-EY-A1GC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:34:04.260190-05:00']	01	Primary	06be0e15-e48e-4243-ad8d-86cca9da68f9	Primary Tumor	Not Reported	519.0	290.0	Unknown	62D18250-0D82-43AB-AADE-E152D6FF74BB	false	Solid Tissue	False	Tumor
TCGA-B5-A0JU-01B	65ef7168-69c6-4910-a141-d7558d0027c9	Adenomas and Adenocarcinomas	65ef7168-69c6-4910-a141-d7558d0027c9	TCGA-B5-A0JU	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	57.0	-21159.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1802.0	21159.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21159.0	57.96986301369863	['2019-07-31T22:21:19.891232-05:00', '2019-07-31T22:21:19.891232-05:00']	['be3d891f-2bb1-5be4-9495-44d08e769dce', 'fd84a4f0-a0dc-5c60-bcf0-e634d7bad2b4']	['TCGA-B5-A0JU_treatment_1', 'TCGA-B5-A0JU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:23:09.221824-05:00', '']	01	Primary	a4e7601a-9828-453a-8616-17f19de6f997	Primary Tumor	Not Reported	1345.0	300.0	OCT	1EB80878-50FF-4E79-AF16-E809E6EE7DEC	true	Solid Tissue	False	Tumor
TCGA-AX-A063-01A	e8909bdf-460c-4291-8e9b-7be12f343eae	Adenomas and Adenocarcinomas	e8909bdf-460c-4291-8e9b-7be12f343eae	TCGA-AX-A063	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23045.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2417.0	23045.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23045.0	63.136986301369866	['2019-07-31T22:34:28.756842-05:00', '2019-07-31T22:34:28.756842-05:00']	['08195a94-cd95-50bb-b651-52ab075fb0d9', 'c53da578-a68f-5ca8-9f73-1f1615f427e2']	['TCGA-AX-A063_treatment_1', 'TCGA-AX-A063_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:33:47.267318-05:00', '']	01	Primary	d5c708b2-29b0-42e0-980d-f54fe5e7fea1	Primary Tumor	Not Reported	1950.0	190.0	Unknown	E911408A-8447-4CB8-8A3F-B2C24875ACF0	false	Solid Tissue	False	Tumor
TCGA-BG-A0RY-01A	f299ad43-bb16-46ce-9617-48cc6c6f29e7	Adenomas and Adenocarcinomas	f299ad43-bb16-46ce-9617-48cc6c6f29e7	TCGA-BG-A0RY	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-24952.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	469.0	24952.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24952.0	68.36164383561643	['2019-07-31T17:26:45.607523-05:00', '2019-07-31T17:26:45.607523-05:00']	['671d6fe3-ff61-5bfd-b548-3d3b8c5b60e9', 'cc9535db-b08f-5d96-875b-c6ae3c40b80b']	['TCGA-BG-A0RY_treatment_1', 'TCGA-BG-A0RY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T10:23:26.054975-05:00', '']	01	Primary	260692e1-9b2c-4f8b-952d-1b95c042e659	Primary Tumor	Not Reported	49.0	450.0	OCT	170B34D7-94B3-4129-9B4D-E36AF7A09897	true	Solid Tissue	False	Tumor
TCGA-BS-A0UF-01A	f77d7256-2ccf-42a7-9b30-332ac24ca812	Adenomas and Adenocarcinomas	f77d7256-2ccf-42a7-9b30-332ac24ca812	TCGA-BS-A0UF	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	65.0	-23771.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Fundus uteri	2611.0	23771.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Fundus uteri	Not Reported	not reported	23771.0	65.12602739726027	['2019-07-31T22:36:06.506363-05:00', '2019-07-31T22:36:06.506363-05:00']	['02704251-e595-565e-8de7-3aed721a87c0', 'ef1b78b1-ccc3-5c1a-aee8-0eec4a79e6e6']	['TCGA-BS-A0UF_treatment', 'TCGA-BS-A0UF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:35:05.609456-05:00']	01	Primary	c805f55a-322f-4a11-ae0c-4bbc365d1bd6	Primary Tumor	Not Reported	2285.0	270.0	Unknown	719E2A48-0E04-4EAD-A5CC-6416450FC68F	false	Solid Tissue	False	Tumor
TCGA-EY-A2ON-01A	bee58be0-c2b0-4cdc-adf6-b99243da586a	Cystic, Mucinous and Serous Neoplasms	bee58be0-c2b0-4cdc-adf6-b99243da586a	TCGA-EY-A2ON	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	61.0	-22624.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	610.0															Stage IVB	No	0.0	not reported	Endometrium	409.0	22624.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22624.0	61.983561643835614	['2019-07-31T22:29:25.019900-05:00', '2019-07-31T22:29:25.019900-05:00']	['4e69586c-ef15-5f0f-bba8-e7583936a955', 'ee98f21c-ff70-5cab-a7e2-4bca9e5979eb']	['TCGA-EY-A2ON_treatment_1', 'TCGA-EY-A2ON_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:29:44.002625-05:00', '']	01	Primary	d7090a2c-648a-43dc-a639-a78dfda2a0ec	Primary Tumor	Not Reported	80.0	650.0	Unknown	AB1B272C-E1ED-4E7B-AAD2-F6B7E741E134	false	Solid Tissue	False	Tumor
TCGA-B5-A1MW-01A	e2b48d0d-57ca-400b-8598-55ef132e350e	Adenomas and Adenocarcinomas	e2b48d0d-57ca-400b-8598-55ef132e350e	TCGA-B5-A1MW	Corpus uteri	Not Reported	white	female	not reported	Alive	55.0	-20183.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	447.0	20183.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20183.0	55.295890410958904	['2019-07-31T22:33:20.476391-05:00', '2019-07-31T22:33:20.476391-05:00']	['4a1f4fbb-1ca4-50f7-84ec-4ef35f6c15ea', '71b4f124-cc0d-5635-a32b-00c5fba3011f']	['TCGA-B5-A1MW_treatment', 'TCGA-B5-A1MW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:32:53.679097-05:00']	01	Primary	f886aacc-64f9-4f9e-8123-8ad25ce54d0c	Primary Tumor	Not Reported	148.0	340.0	OCT	870882D8-D89A-4A89-B516-DADAB95BE285	true	Solid Tissue	False	Tumor
TCGA-D1-A16O-01A	8f508b78-cdc6-4a3d-b86e-520746d78653	Adenomas and Adenocarcinomas	8f508b78-cdc6-4a3d-b86e-520746d78653	TCGA-D1-A16O	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	44.0	-16114.0	1964.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1023.0	16114.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16114.0	44.14794520547945	['2019-07-31T22:25:05.164058-05:00', '2019-07-31T22:25:05.164058-05:00']	['a2438fdc-5246-5b10-8e25-58542cb1c948', 'cdd898c9-c824-5c8c-a89d-2dabdd694ff3']	['TCGA-D1-A16O_treatment', 'TCGA-D1-A16O_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:26:12.401656-05:00']	01	Primary	a2befa03-27ec-4d5a-bf12-6ded95a4dd18	Primary Tumor	Not Reported	756.0	120.0	Unknown	B4EFFDB8-CB4C-46D7-96AD-9D33DF7163C0	false	Solid Tissue	False	Tumor
TCGA-KP-A3W4-01A	62df1bd8-23a8-4e52-a483-6895b2f02494	Cystic, Mucinous and Serous Neoplasms	62df1bd8-23a8-4e52-a483-6895b2f02494	TCGA-KP-A3W4	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	63.0	-23200.0	1947.0	2011.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	821aedb4-8788-5cb9-ae05-e670f0be1f9f	KP	British Columbia Cancer Agency	Uterine Corpus Endometrial Carcinoma	NCH	554.0															Stage IIIA	No	0.0	not reported	Endometrium		23200.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23200.0	63.56164383561644	['2019-07-31T22:21:04.654818-05:00', '2019-07-31T22:21:04.654818-05:00']	['51d54d31-2627-51c3-97b3-f931f30da97e', 'ed102a95-c140-572c-8132-cc949b135ae8']	['TCGA-KP-A3W4_treatment_1', 'TCGA-KP-A3W4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:22:57.058203-05:00', '']	01	Primary	85363534-a7c9-481e-8d37-b961ce1ad7ae	Primary Tumor	Not Reported	688.0	540.0	OCT	5B8C1B60-7046-4A3A-9D65-ECCB91BF9847	true	Solid Tissue	False	Tumor
TCGA-AJ-A3NG-01A	1addcd66-79ab-4976-9679-37f0f31ba1df	Cystic, Mucinous and Serous Neoplasms	1addcd66-79ab-4976-9679-37f0f31ba1df	TCGA-AJ-A3NG	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	83.0	-30351.0	1928.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	475.0	30351.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30351.0	83.15342465753425	['2019-07-31T22:13:04.821325-05:00', '2019-07-31T22:13:04.821325-05:00']	['1d73f60c-5dd4-5d8c-a79d-9ec14b486e78', '51e10d11-d571-5c7e-8c20-4e979e44bb94']	['TCGA-AJ-A3NG_treatment', 'TCGA-AJ-A3NG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:16:32.814589-05:00']	01	Primary	c19de866-bec5-4ce7-9d50-883fec094838	Primary Tumor	Not Reported	101.0	150.0	Unknown	32C3C850-5F65-424E-894C-75B4725BBD09	false	Solid Tissue	False	Tumor
TCGA-B5-A0JY-01A	61935424-44d0-4211-81c1-c925e436eac5	Epithelial Neoplasms, NOS	61935424-44d0-4211-81c1-c925e436eac5	TCGA-B5-A0JY	Corpus uteri	Not Reported	white	female	not reported	Alive	50.0	-18475.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	2107.0	18475.0	Carcinoma, undifferentiated, NOS	no	2008.0	No	8020/3	not reported	C54.1	Endometrium	Not Reported	not reported	18475.0	50.61643835616438	['2019-07-31T22:20:55.832775-05:00', '2019-07-31T22:20:55.832775-05:00']	['95c875fd-1ad1-59e8-8ae0-213498c177db', 'd14fcf6e-a034-51d1-b2ee-ebe610657b5d']	['TCGA-B5-A0JY_treatment', 'TCGA-B5-A0JY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:22:50.177072-05:00']	01	Primary	95f418ce-fcd9-4402-bc24-1520f45cb6b7	Primary Tumor	Not Reported	632.0	1170.0	OCT	9708BE95-175D-458B-8BA1-02D9C488225D	true	Solid Tissue	False	Tumor
TCGA-AX-A06F-01A	f17e446a-c145-45be-8335-a856acb0b9b8	Adenomas and Adenocarcinomas	f17e446a-c145-45be-8335-a856acb0b9b8	TCGA-AX-A06F	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	59.0	-21624.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVA	No	0.0	not reported	Endometrium	1748.0	21624.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21624.0	59.24383561643835	['2019-07-31T22:35:26.418301-05:00', '2019-07-31T22:35:26.418301-05:00']	['3089e8d4-03ad-53e4-bb31-134d12003550', '7a55644c-13a0-53ea-a6d0-6c4a07cb84cc']	['TCGA-AX-A06F_treatment', 'TCGA-AX-A06F_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:34:33.736945-05:00']	01	Primary	38df14c0-30d9-404f-a10c-f8ed4c947cea	Primary Tumor	Not Reported	1267.0	210.0	Unknown	4904C404-B17E-4471-AA2F-6DC705E4FBF2	false	Solid Tissue	False	Tumor
TCGA-BS-A0V6-01A	a9b6cd65-f042-4073-9000-4143a2c55373	Adenomas and Adenocarcinomas	a9b6cd65-f042-4073-9000-4143a2c55373	TCGA-BS-A0V6	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	55.0	-20369.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2725.0	20369.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20369.0	55.8054794520548	['2019-07-31T22:27:47.878240-05:00', '2019-07-31T22:27:47.878240-05:00']	['37347f9c-ef2d-5dd8-80ca-5ce0b6e7470c', 'a29ed7c9-472f-5e82-aa48-b3ce4b8057bd']	['TCGA-BS-A0V6_treatment_1', 'TCGA-BS-A0V6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:28:24.171553-05:00', '']	01	Primary	1c337d11-f2ac-48cf-9c8f-ec27550876ea	Primary Tumor	Not Reported	1462.0	80.0	Unknown	657466BC-3CA2-4568-BF64-2905571C3666	false	Solid Tissue	False	Tumor
TCGA-DI-A1BY-01A	e46b6434-ee88-4630-9fc3-441afc431745	Cystic, Mucinous and Serous Neoplasms	e46b6434-ee88-4630-9fc3-441afc431745	TCGA-DI-A1BY	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23113.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	1114.0	23113.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23113.0	63.323287671232876	['2019-07-31T22:33:48.192141-05:00', '2019-07-31T22:33:48.192141-05:00']	['35ae15d7-a300-558e-b83b-8d9362dd3dce', 'f200b505-2aca-5fea-a12b-439a054714dd']	['TCGA-DI-A1BY_treatment', 'TCGA-DI-A1BY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:33:15.519407-05:00']	01	Primary	7a5cf7c9-1b05-4de9-af5d-a859171049d6	Primary Tumor	Not Reported	989.0	140.0	Unknown	8B96371D-5E42-461B-B7A2-AB9641D842CD	false	Solid Tissue	False	Tumor
TCGA-AX-A2HA-01A	9d84dff8-6c19-4881-93c6-56c98a3049b5	Adenomas and Adenocarcinomas	9d84dff8-6c19-4881-93c6-56c98a3049b5	TCGA-AX-A2HA	Corpus uteri	Not Reported	white	female	not reported	Alive	35.0	-13142.0	1970.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2475.0	13142.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	13142.0	36.00547945205479	['2019-07-31T22:26:14.040971-05:00', '2019-07-31T22:26:14.040971-05:00']	['9fc2141a-cb1f-52c6-a705-83396cfe0c7b', 'e3b3df41-6297-5045-b26d-fa07f07bb858']	['TCGA-AX-A2HA_treatment', 'TCGA-AX-A2HA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:27:08.767191-05:00']	01	Primary	76742cf8-a932-47bd-acf9-c507184e02c3	Primary Tumor	Not Reported	2188.0	100.0	Unknown	E44408C9-53DE-4FF7-8D8E-6BFAB24302C3	false	Solid Tissue	False	Tumor
TCGA-AX-A2HA-11A	9d84dff8-6c19-4881-93c6-56c98a3049b5	Adenomas and Adenocarcinomas	9d84dff8-6c19-4881-93c6-56c98a3049b5	TCGA-AX-A2HA	Corpus uteri	Not Reported	white	female	not reported	Alive	35.0	-13142.0	1970.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2475.0	13142.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	13142.0	36.00547945205479	['2019-07-31T22:26:14.040971-05:00', '2019-07-31T22:26:14.040971-05:00']	['9fc2141a-cb1f-52c6-a705-83396cfe0c7b', 'e3b3df41-6297-5045-b26d-fa07f07bb858']	['TCGA-AX-A2HA_treatment', 'TCGA-AX-A2HA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:27:08.767191-05:00']	11	Not Applicable	94bc7e3c-bfae-4148-8995-8ab104370a8f	Solid Tissue Normal	Not Reported	2188.0	100.0	Unknown		false	Solid Tissue	False	Normal
TCGA-B5-A11F-01A	3ea53b15-37f0-446e-a130-6bb2dee56865	Adenomas and Adenocarcinomas	3ea53b15-37f0-446e-a130-6bb2dee56865	TCGA-B5-A11F	Corpus uteri	Not Reported	white	female	not reported	Alive	55.0	-20171.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	5651.0	20171.0	Endometrioid adenocarcinoma, NOS	no	1995.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20171.0	55.26301369863014	['2019-07-31T22:16:44.276969-05:00', '2019-07-31T22:16:44.276969-05:00']	['0e128094-cd09-58df-ae15-7738a966ef59', 'ce53c4f9-9b2b-502b-a11c-01006033761f']	['TCGA-B5-A11F_treatment', 'TCGA-B5-A11F_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:19:29.660211-05:00']	01	Primary	a4dabdb5-4a72-4e31-981b-2c501c8dc7ab	Primary Tumor	Not Reported	5482.0	380.0	OCT	228E437D-FB45-452B-A5A0-299C125F4CC4	true	Solid Tissue	False	Tumor
TCGA-B5-A121-01A	19511f9e-7b0e-4a06-998d-c1837d37c6ec	Adenomas and Adenocarcinomas	19511f9e-7b0e-4a06-998d-c1837d37c6ec	TCGA-B5-A121	Corpus uteri	Not Reported	white	female	not reported	Alive	57.0	-21018.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	504.0	21018.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21018.0	57.583561643835615	['2019-07-31T22:12:55.812089-05:00', '2019-07-31T22:12:55.812089-05:00']	['9628bbe7-f630-591b-b8d4-a05ad6f7eddd', '976f508e-d8b5-5c40-a894-cab323008808']	['TCGA-B5-A121_treatment', 'TCGA-B5-A121_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:16:25.168422-05:00']	01	Primary	d7a7ecf1-7771-49c0-9756-302adba3a2c9	Primary Tumor	Not Reported	188.0	280.0	OCT	82B20A1F-99AC-4CC8-BAF2-B7132809D4F2	true	Solid Tissue	False	Tumor
TCGA-D1-A1NZ-01A	e49f545f-3268-4d25-b7a3-4da8e6ab2578	Adenomas and Adenocarcinomas	e49f545f-3268-4d25-b7a3-4da8e6ab2578	TCGA-D1-A1NZ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22027.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	548.0	22027.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22027.0	60.347945205479455	['2019-07-31T22:33:54.850336-05:00', '2019-07-31T22:33:54.850336-05:00']	['413c8fad-cff8-5dc0-a9f6-f79a7b5e1c27', 'b23d96d7-841c-597e-990b-2d37386e3069']	['TCGA-D1-A1NZ_treatment', 'TCGA-D1-A1NZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:33:20.279422-05:00']	01	Primary	7239e42a-f0ef-43dd-9d1f-a5a507e0e66c	Primary Tumor	Not Reported	191.0	140.0	Unknown	0AFDCBC0-FA0A-4138-A0BE-E374AEB3CB25	false	Solid Tissue	False	Tumor
TCGA-EY-A1GS-01A	c10b2885-70ea-4d32-bc48-8b85530df702	Cystic, Mucinous and Serous Neoplasms	c10b2885-70ea-4d32-bc48-8b85530df702	TCGA-EY-A1GS	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	71.0	-26012.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	670.0															Stage IVB	No	0.0	not reported	Endometrium	459.0	26012.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26012.0	71.26575342465753	['2019-07-31T22:29:37.590390-05:00', '2019-07-31T22:29:37.590390-05:00']	['a7576901-6053-541e-b0b6-b53150db5aa8', 'e44b5e05-f54a-58d2-8475-b71bc199220a']	['TCGA-EY-A1GS_treatment', 'TCGA-EY-A1GS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:29:53.462148-05:00']	01	Primary	99540910-61a1-434b-9937-216dfac5f719	Primary Tumor	Not Reported	211.0	270.0	Unknown	3F953015-45DC-4678-A8B3-DC55339DE717	false	Solid Tissue	False	Tumor
TCGA-AP-A05P-01A	3cb83517-78a4-47b8-8b1e-57e765dbdd2e	Adenomas and Adenocarcinomas	3cb83517-78a4-47b8-8b1e-57e765dbdd2e	TCGA-AP-A05P	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	54.0	-20017.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	636.0	20017.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20017.0	54.84109589041096	['2019-07-31T22:16:21.888028-05:00', '2019-07-31T22:16:21.888028-05:00']	['99169b6f-d00c-509d-88e1-4b8f86a8ef39', 'c8b1c095-7106-5184-b148-62f9893d35b1']	['TCGA-AP-A05P_treatment_1', 'TCGA-AP-A05P_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:19:12.242771-05:00', '']	01	Primary	f51f7b0e-3ea6-4232-9de4-a4dd63b23bb5	Primary Tumor	Not Reported	203.0	170.0	OCT	5BA23C70-805A-4356-B739-AFBAFD29D7FC	true	Solid Tissue	False	Tumor
TCGA-AP-A0L9-01A	7b9947d5-e86b-4006-8890-ea5209584a88	Cystic, Mucinous and Serous Neoplasms	7b9947d5-e86b-4006-8890-ea5209584a88	TCGA-AP-A0L9	Corpus uteri	Not Reported	white	female	not reported	Alive	71.0	-26185.0	1930.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	3815.0	26185.0	Serous cystadenocarcinoma, NOS	no	2001.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26185.0	71.73972602739725	['2019-07-31T22:23:30.658287-05:00', '2019-07-31T22:23:30.658287-05:00']	['4efab499-95b4-51eb-9c79-96e89696e61f', '83ce7d6f-6a49-5874-b3bb-270f70367536']	['TCGA-AP-A0L9_treatment', 'TCGA-AP-A0L9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:24:54.268785-05:00']	01	Primary	53d0521f-10d6-4f70-9277-d99025a6b963	Primary Tumor	Not Reported	3402.0	140.0	OCT	62E44C56-838D-4318-B8F7-80476A148C03	true	Solid Tissue	False	Tumor
TCGA-A5-A0G3-01A	8432401d-799f-4f2f-b536-e79e1e8be064	Cystic, Mucinous and Serous Neoplasms	8432401d-799f-4f2f-b536-e79e1e8be064	TCGA-A5-A0G3	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	61.0	-22421.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	1428.0	22421.0	Serous cystadenocarcinoma, NOS	no	2007.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22421.0	61.42739726027397	['2019-07-31T22:24:07.644731-05:00', '2019-07-31T22:24:07.644731-05:00']	['4facaada-2fc8-505e-96c6-a06fc372e47d', 'c73162f8-a544-5db3-9016-966af22d8bd8']	['TCGA-A5-A0G3_treatment_1', 'TCGA-A5-A0G3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:25:23.781161-05:00', '']	01	Primary	e462c0f0-4a2e-4571-af18-879e41d01aad	Primary Tumor	Not Reported	987.0	230.0	OCT	66DEDB33-CA2C-4967-8074-1EFC1FC3CF29	true	Solid Tissue	False	Tumor
TCGA-FI-A2EX-01A	3878f58e-76ba-4480-a784-88505bd464d0	Cystic, Mucinous and Serous Neoplasms	3878f58e-76ba-4480-a784-88505bd464d0	TCGA-FI-A2EX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21489.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	284.0	21489.0	Serous cystadenocarcinoma, NOS	no	2005.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21489.0	58.87397260273973	['2019-07-31T22:15:46.690585-05:00', '2019-07-31T22:15:46.690585-05:00']	['6d67896e-62db-55d5-9b58-684b6cab980b', 'f14ce906-d403-51e4-bf63-21aee21356b9']	['TCGA-FI-A2EX_treatment_1', 'TCGA-FI-A2EX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:18:42.757629-05:00', '']	01	Primary	0a2eaf88-6c98-409f-bf63-4d62c844193c	Primary Tumor	Not Reported	2201.0	110.0	OCT	68355069-2D77-4C5C-9AA9-E93A0C3CFD94	true	Solid Tissue	False	Tumor
TCGA-AP-A1DP-01A	a93c47a9-65b5-4785-af4f-a2078db4514e	Adenomas and Adenocarcinomas	a93c47a9-65b5-4785-af4f-a2078db4514e	TCGA-AP-A1DP	Corpus uteri	Not Reported	white	female	not reported	Dead	70.0	-25601.0	1938.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	1081.0															Stage IA	No	0.0	not reported	Endometrium		25601.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25601.0	70.13972602739726	['2019-07-31T22:27:42.019095-05:00', '2019-07-31T22:27:42.019095-05:00']	['1168dd58-4d30-5eae-99b5-1936e213435e', 'fd8f072a-5782-5bf8-bf2e-dc5f6faebb5f']	['TCGA-AP-A1DP_treatment_1', 'TCGA-AP-A1DP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:28:19.215409-05:00', '']	01	Primary	b5206087-88de-4963-9239-189d159f7b35	Primary Tumor	Not Reported	1105.0	230.0	OCT	20EEB047-0185-4B65-9A6A-43D6C97307C8	true	Solid Tissue	False	Tumor
TCGA-D1-A3JQ-01A	07c805c2-ff09-4d5a-95f8-1d7d9f84c33c	Cystic, Mucinous and Serous Neoplasms	07c805c2-ff09-4d5a-95f8-1d7d9f84c33c	TCGA-D1-A3JQ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22297.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	526.0	22297.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22297.0	61.087671232876716	['2019-07-31T22:10:58.371390-05:00', '2019-07-31T22:10:58.371390-05:00']	['17bebdf5-1210-5e2f-b896-eef5a4b083c3', 'ae83943f-8697-5029-adb3-d384e8911b45']	['TCGA-D1-A3JQ_treatment_1', 'TCGA-D1-A3JQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:14:48.351210-05:00', '']	01	Primary	720b03f2-b46f-43a0-9ab0-fb0734e691f1	Primary Tumor	Not Reported	77.0	150.0	OCT	2001A1EC-1385-4EB3-BC9E-7E48143FD663	true	Solid Tissue	False	Tumor
TCGA-AP-A1DR-01A	0f064588-2d7e-439a-90a6-dfa17bb8af15	Adenomas and Adenocarcinomas	0f064588-2d7e-439a-90a6-dfa17bb8af15	TCGA-AP-A1DR	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	59.0	-21904.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	1495.0	21904.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21904.0	60.010958904109586	['2019-07-31T22:11:46.327093-05:00', '2019-07-31T22:11:46.327093-05:00']	['7d3bee46-6a25-5eae-be92-a210085b7b0a', 'c3f81d20-552e-5271-b6ca-65243b33e894']	['TCGA-AP-A1DR_treatment', 'TCGA-AP-A1DR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:15:27.763562-05:00']	01	Primary	438480e7-9b80-44a4-89d8-6b7a27028f35	Primary Tumor	Not Reported	1095.0	270.0	OCT	75A10A08-04CB-49C2-8086-5F7B1D57524E	true	Solid Tissue	False	Tumor
TCGA-A5-A7WJ-01A	a3e728ce-0874-4f4b-a83d-8c679f4bd938	Adenomas and Adenocarcinomas	a3e728ce-0874-4f4b-a83d-8c679f4bd938	TCGA-A5-A7WJ	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	64.0	-23723.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	341.0	23723.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23723.0	64.9945205479452	['2019-07-31T22:26:53.934000-05:00', '2019-07-31T22:26:53.934000-05:00']	['97dc1fa8-2101-5c6a-a8c4-06bf0f9d1dc3', 'cca169e6-85f5-5896-a2b2-1a7fa4f8b2ae']	['TCGA-A5-A7WJ_treatment_1', 'TCGA-A5-A7WJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:27:39.894614-05:00', '']	01	Primary	6595c691-70d1-4b5f-a8c3-ed0167e07249	Primary Tumor	Not Reported	439.0	140.0	OCT	402A6ED4-B9EC-43A0-B47C-A0B95282678D	true	Solid Tissue	False	Tumor
TCGA-FL-A1YG-11A	7d8e6965-51ea-4864-968e-5cecfb7da48a	Not Reported	7d8e6965-51ea-4864-968e-5cecfb7da48a	TCGA-FL-A1YG	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	7ce9c6ea-2d0b-448e-9d5f-3ab19714d979	Solid Tissue Normal	Not Reported		170.0	Unknown	5E88F0A0-6949-485D-89BA-9769A8847919	false	Solid Tissue	False	Normal
TCGA-PG-A5BC-01A	22669a01-21d3-404c-ac19-cf0a6c03bb1d	Cystic, Mucinous and Serous Neoplasms	22669a01-21d3-404c-ac19-cf0a6c03bb1d	TCGA-PG-A5BC	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	72.0	-26436.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	69bd8326-4904-56a0-8230-1615a777173b	PG	Montefiore Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	707.0	26436.0	Serous cystadenocarcinoma, NOS	no	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26436.0	72.42739726027398	['2019-07-31T22:13:42.375188-05:00', '2019-07-31T22:13:42.375188-05:00']	['0efbfe60-a787-5529-a05d-3399466a47a1', '5863c32e-d724-5b85-a9c2-f47747a3d26a']	['TCGA-PG-A5BC_treatment', 'TCGA-PG-A5BC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:17:02.906364-05:00']	01	Primary	0a63bf84-a720-4b8b-8312-4ec59d14982e	Primary Tumor	Not Reported	205.0	120.0	OCT	040F4583-2683-42A8-B185-56A08874F3A0	true	Solid Tissue	False	Tumor
TCGA-A5-A2K3-01A	c3096984-bd11-44a0-8ee0-47f07ad04d81	Cystic, Mucinous and Serous Neoplasms	c3096984-bd11-44a0-8ee0-47f07ad04d81	TCGA-A5-A2K3	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-24907.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2012.0	24907.0	Serous cystadenocarcinoma, NOS	no	2007.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24907.0	68.23835616438356	['2019-07-31T22:29:46.307139-05:00', '2019-07-31T22:29:46.307139-05:00']	['3accfced-92be-5249-8170-f255470aad79', '538fdc1e-e7d0-5284-8368-f0c43a33be73']	['TCGA-A5-A2K3_treatment', 'TCGA-A5-A2K3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:30:00.695637-05:00']	01	Primary	b6e6722f-cefe-4eb7-8545-94383659db9a	Primary Tumor	Not Reported	1431.0	120.0	OCT	D38D2FD4-78EF-4F49-976E-529055A6D9A9	true	Solid Tissue	False	Tumor
TCGA-A5-A0GU-01A	adc22472-e31d-419f-aeae-cb01b9423343	Adenomas and Adenocarcinomas	adc22472-e31d-419f-aeae-cb01b9423343	TCGA-A5-A0GU	Corpus uteri	Not Reported	white	female	not reported	Alive	58.0	-21192.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	860.0	21192.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21192.0	58.06027397260274	['2019-07-31T22:28:14.991725-05:00', '2019-07-31T22:28:14.991725-05:00']	['125e20f3-d3d5-536b-8d55-e3ff461b486c', 'a8734643-9e1d-5435-8295-b23b0ece4ff1']	['TCGA-A5-A0GU_treatment_1', 'TCGA-A5-A0GU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:28:46.538550-05:00', '']	01	Primary	074d4466-e072-42cd-9a6c-a595dc9363e7	Primary Tumor	Not Reported	471.0	190.0	OCT	B284E409-4AC1-45E5-9133-39659987D7F9	true	Solid Tissue	False	Tumor
TCGA-B5-A0JS-01A	0da7bbd4-ed8d-474b-b494-cb93c5fa811e	Adenomas and Adenocarcinomas	0da7bbd4-ed8d-474b-b494-cb93c5fa811e	TCGA-B5-A0JS	Corpus uteri	Not Reported	white	female	not reported	Alive	54.0	-19995.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2627.0	19995.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19995.0	54.78082191780822	['2019-07-31T22:11:40.138273-05:00', '2019-07-31T22:11:40.138273-05:00']	['96cf4c75-104b-516c-be24-5c709faaa2cc', 'bfb14e12-ab5a-5e53-a472-d1a908c45af1']	['TCGA-B5-A0JS_treatment', 'TCGA-B5-A0JS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:15:22.907303-05:00']	01	Primary	d0b88b1c-150d-4abc-9f9e-8c51cb208efa	Primary Tumor	Not Reported	1183.0	140.0	OCT	56BA86BF-9345-4956-952A-8EBA8C05926A	true	Solid Tissue	False	Tumor
TCGA-DF-A2L0-01A	7adaf608-19a5-4184-8b79-bbc6f9cf24ae	Adenomas and Adenocarcinomas	7adaf608-19a5-4184-8b79-bbc6f9cf24ae	TCGA-DF-A2L0	Corpus uteri	Not Reported	not reported	female	not reported	Dead	60.0	-22200.0			['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH	788.0															Stage IIIC	No		not reported	Endometrium		22200.0	Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22200.0	60.821917808219176	['2019-07-31T22:23:24.338129-05:00', '2019-07-31T22:23:24.338129-05:00']	['ca5efbea-4f5d-57b2-9571-57100bd95bc2', 'f81005bd-863b-5789-a34b-4673f41b4475']	['TCGA-DF-A2L0_treatment', 'TCGA-DF-A2L0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:24:49.308524-05:00']	01	Primary	e3f9c326-544d-46e2-a58e-fc95e5ecd702	Primary Tumor	Not Reported		520.0	Unknown	1679CA2C-86BF-41D1-96E1-62FC89D9AAA7	false	Solid Tissue	False	Tumor
TCGA-D1-A17C-01A	6f4f0cdd-8387-45d0-a9e8-efce6260159d	Adenomas and Adenocarcinomas	6f4f0cdd-8387-45d0-a9e8-efce6260159d	TCGA-D1-A17C	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	78.0	-28571.0	1932.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	30.0	28571.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28571.0	78.27671232876712	['2019-07-31T22:22:09.525762-05:00', '2019-07-31T22:22:09.525762-05:00']	['2bf2e225-b089-5162-a321-f27fa348557f', 'c5cd9d53-fc15-5469-b213-a17dca36b2d1']	['TCGA-D1-A17C_treatment', 'TCGA-D1-A17C_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:48.459813-05:00']	01	Primary	2d5ac7fc-bed4-4c7f-927d-9b44846324c4	Primary Tumor	Not Reported	249.0	130.0	Unknown	213A073E-C5E1-4BA8-B4D5-23C92E539FA5	false	Solid Tissue	False	Tumor
TCGA-A5-A0GG-01A	a8614c49-c7f1-4de9-bd2f-4764b094d604	Adenomas and Adenocarcinomas	a8614c49-c7f1-4de9-bd2f-4764b094d604	TCGA-A5-A0GG	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	76.0	-27809.0	1927.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	3762.0	27809.0	Endometrioid adenocarcinoma, NOS	no	2003.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27809.0	76.18904109589042	['2019-07-31T22:27:33.015533-05:00', '2019-07-31T22:27:33.015533-05:00']	['19d885f4-6fac-5704-b9c2-0bb8de64112a', '80b36487-b93d-5818-b76c-37a327462440']	['TCGA-A5-A0GG_treatment_1', 'TCGA-A5-A0GG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:28:11.851800-05:00', '']	01	Primary	b5b941e3-f828-4091-b9b1-6b38d1493847	Primary Tumor	Not Reported	2369.0	220.0	OCT	6867E576-1020-41D7-BC18-25160FE17F81	true	Solid Tissue	False	Tumor
TCGA-H5-A2HR-01A	fdb395e7-ff30-400d-861e-0cf2462ee390	Adenomas and Adenocarcinomas	fdb395e7-ff30-400d-861e-0cf2462ee390	TCGA-H5-A2HR	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	71.0	-25986.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cd7b9deb-2687-5366-b602-1566113bab7a	H5	Medical College of Georgia	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	53.0	25986.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25986.0	71.1945205479452	['2019-07-31T22:36:40.729165-05:00', '2019-07-31T22:36:40.729165-05:00']	['f42dee54-3a30-5cee-95ce-a39707542863', 'f499d198-0fcd-5570-8409-f9d0707c2205']	['TCGA-H5-A2HR_treatment_1', 'TCGA-H5-A2HR_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:35:32.263348-05:00', '']	01	Primary	731428d0-5cc9-4e8d-a2be-e2e3d57745b7	Primary Tumor	Not Reported	1627.0	110.0	Unknown	3747A4AC-811E-49A1-8459-93807BB363C6	false	Solid Tissue	False	Tumor
TCGA-AX-A06B-01A	95e6d327-9ab7-45de-9527-f5634b3995c3	Adenomas and Adenocarcinomas	95e6d327-9ab7-45de-9527-f5634b3995c3	TCGA-AX-A06B	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	72.0	-26348.0	1933.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIA	Not Reported	0.0	not reported	Endometrium	2058.0	26348.0	Endometrioid adenocarcinoma, NOS	yes	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26348.0	72.18630136986302	['2019-07-31T22:25:37.906942-05:00', '2019-07-31T22:25:37.906942-05:00']	['230b2a57-9530-52a9-9064-01268181f7d1', '2c0edc5d-dd45-5c1f-b9e1-854580e3588c']	['TCGA-AX-A06B_treatment_1', 'TCGA-AX-A06B_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:26:39.484316-05:00', '']	01	Primary	a43f90b7-4a6c-423c-82de-ad2c330ae0fb	Primary Tumor	Not Reported	1563.0	210.0	Unknown	394E8BCD-1BE6-44C4-BDAC-D251A6C08E2B	false	Solid Tissue	False	Tumor
TCGA-EY-A1GP-01A	75fb484d-cd12-4cf0-a99d-faf27aead118	Adenomas and Adenocarcinomas	75fb484d-cd12-4cf0-a99d-faf27aead118	TCGA-EY-A1GP	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	54.0	-20011.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	573.0	20011.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20011.0	54.824657534246576	['2019-07-31T22:22:57.694488-05:00', '2019-07-31T22:22:57.694488-05:00']	['2ac31c35-3472-5389-818d-f067f899b839', 'abc3728a-2f51-5a65-89c1-7d7c301bcc20']	['TCGA-EY-A1GP_treatment', 'TCGA-EY-A1GP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:24:27.615564-05:00']	01	Primary	13c41beb-c86d-423f-97a4-8f18bff149be	Primary Tumor	Not Reported	262.0	90.0	Unknown	D9933BA3-3D3B-4B93-AD6C-22ED47C4DBB1	false	Solid Tissue	False	Tumor
TCGA-AP-A1E4-01A	0b2eb188-dd23-4dbf-91bb-02e3c81a69bc	Adenomas and Adenocarcinomas	0b2eb188-dd23-4dbf-91bb-02e3c81a69bc	TCGA-AP-A1E4	Corpus uteri	Not Reported	white	female	not reported	Alive	54.0	-19814.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1555.0	19814.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19814.0	54.28493150684932	['2019-07-31T22:11:19.134013-05:00', '2019-07-31T22:11:19.134013-05:00']	['ce60360f-b83a-5d49-a6b8-476323774531', 'f31bafdc-f2a9-5f90-adb3-f5ac66931044']	['TCGA-AP-A1E4_treatment_1', 'TCGA-AP-A1E4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:15:05.187326-05:00', '']	01	Primary	0e845d2c-7928-46a8-a751-a5df677e8041	Primary Tumor	Not Reported	154.0	90.0	OCT	1E33ABA3-0B55-4021-A370-DB8E2CA4C022	true	Solid Tissue	False	Tumor
TCGA-D1-A174-01A	fc7315b0-9f48-4206-b197-2268c0518eb4	Adenomas and Adenocarcinomas	fc7315b0-9f48-4206-b197-2268c0518eb4	TCGA-D1-A174	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	51.0	-18702.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	594.0	18702.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18702.0	51.23835616438356	['2019-07-31T22:36:34.636135-05:00', '2019-07-31T22:36:34.636135-05:00']	['1e006a92-c7dd-5a99-aa84-e7bee88b91f6', 'eefaed13-fc04-5511-bd0e-91822bdc9213']	['TCGA-D1-A174_treatment', 'TCGA-D1-A174_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:35:27.146736-05:00']	01	Primary	ad5a9cb6-b3f9-4651-b6d1-13c78010bd88	Primary Tumor	Not Reported	219.0	80.0	Unknown	E45B2436-C0B2-44C3-B400-49C668114B01	false	Solid Tissue	False	Tumor
TCGA-DF-A2KV-01A	59cebae6-632d-4632-b695-c48ae46b2e67	Adenomas and Adenocarcinomas	59cebae6-632d-4632-b695-c48ae46b2e67	TCGA-DF-A2KV	Corpus uteri	Not Reported	not reported	female	not reported	Alive	55.0	-20160.0			['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2717.0	20160.0	Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20160.0	55.23287671232877	['2019-07-31T22:19:48.627114-05:00', '2019-07-31T22:19:48.627114-05:00']	['02be3f87-9cd1-581f-80c7-78100f58abf4', '7ac458ed-700a-5a49-8c54-4ab7d0ab1553']	['TCGA-DF-A2KV_treatment', 'TCGA-DF-A2KV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:21:55.904593-05:00']	01	Primary	0c713392-8713-40f2-93cf-4272be99427f	Primary Tumor	Not Reported		580.0	Unknown	5717937B-AC81-452E-9B4D-3301FDA7CD0B	false	Solid Tissue	False	Tumor
TCGA-AP-A1DM-01A	ca7f9d8b-2abc-4606-bf95-4c42791b38bd	Adenomas and Adenocarcinomas	ca7f9d8b-2abc-4606-bf95-4c42791b38bd	TCGA-AP-A1DM	Corpus uteri	Not Reported	white	female	not reported	Alive	60.0	-22239.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1700.0	22239.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22239.0	60.92876712328767	['2019-07-31T22:30:28.052649-05:00', '2019-07-31T22:30:28.052649-05:00']	['83c24cd8-ff03-58dc-8f63-07839c3f1456', 'd8ab8db5-e508-5401-90af-1c41911ce5f6']	['TCGA-AP-A1DM_treatment', 'TCGA-AP-A1DM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:30:34.666305-05:00']	01	Primary	7f4344cf-a5d7-4623-abe8-9f046723ea0a	Primary Tumor	Not Reported	1309.0	110.0	OCT	E25BA7AD-5C24-4953-B9C3-7509AE6E9F4C	true	Solid Tissue	False	Tumor
TCGA-AX-A3G1-01A	9cc1b44a-ac26-408d-b12b-084e982ccadf	Adenomas and Adenocarcinomas	9cc1b44a-ac26-408d-b12b-084e982ccadf	TCGA-AX-A3G1	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	84.0	-31037.0	1925.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	624.0															Stage IC	No	0.0	not reported	Endometrium		31037.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31037.0	85.03287671232877	['2019-07-31T22:26:07.800807-05:00', '2019-07-31T22:26:07.800807-05:00']	['5b5cc22c-3bd2-578e-b127-f6b882a2cd6f', 'c2cf532f-34f5-5000-8181-a48f52295b59']	['TCGA-AX-A3G1_treatment_1', 'TCGA-AX-A3G1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:27:04.062967-05:00', '']	01	Primary	582513c5-474c-484e-ad98-811f0d4e07c6	Primary Tumor	Not Reported	765.0	40.0	Unknown	AEAB9EBE-7BDA-45E4-B2D8-82680BE9B4D4	false	Solid Tissue	False	Tumor
TCGA-DF-A2KS-01A	46e064cc-933b-444b-9e15-80fadbc53487	Adenomas and Adenocarcinomas	46e064cc-933b-444b-9e15-80fadbc53487	TCGA-DF-A2KS	Corpus uteri	Not Reported	not reported	female	not reported	Alive	69.0	-25313.0			['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No		not reported	Endometrium	3318.0	25313.0	Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25313.0	69.35068493150685	['2019-07-31T22:18:03.268617-05:00', '2019-07-31T22:18:03.268617-05:00']	['663f12f7-7918-52dd-b85c-ede15e48cbaf', 'e69b49da-4c68-5663-bc0e-a86af502a5ef']	['TCGA-DF-A2KS_treatment_1', 'TCGA-DF-A2KS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:20:32.426533-05:00', '']	01	Primary	0e438d6a-52a7-473f-bb85-7805d63df150	Primary Tumor	Not Reported		120.0	Unknown	C6638C17-4F05-491F-86ED-6D7DDB1B8FDE	false	Solid Tissue	False	Tumor
TCGA-A5-A1OJ-01A	0f361166-2b7d-4ef5-9f8f-ee2488548a0b	Adenomas and Adenocarcinomas	0f361166-2b7d-4ef5-9f8f-ee2488548a0b	TCGA-A5-A1OJ	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	31.0	-11635.0	1979.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1006.0	11635.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	11635.0	31.876712328767123	['2019-07-31T22:11:49.222299-05:00', '2019-07-31T22:11:49.222299-05:00']	['f2737e46-f6d1-5acd-a707-0daed1edd884', 'f7b38a93-8a10-5b74-aac3-efa65cdee4f1']	['TCGA-A5-A1OJ_treatment', 'TCGA-A5-A1OJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:15:30.360762-05:00']	01	Primary	effd3ebc-fa75-4317-a3cb-37ca27d3208c	Primary Tumor	Not Reported	161.0	170.0	OCT	F696BCE9-707C-4825-8A53-EFED20EBF656	true	Solid Tissue	False	Tumor
TCGA-AX-A062-01A	4af65655-a3bd-4252-9b2f-2b2c4394f95c	Adenomas and Adenocarcinomas	4af65655-a3bd-4252-9b2f-2b2c4394f95c	TCGA-AX-A062	Corpus uteri	Not Reported	white	female	not reported	Alive	53.0	-19643.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1399.0	19643.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19643.0	53.81643835616438	['2019-07-31T22:18:31.645018-05:00', '2019-07-31T22:18:31.645018-05:00']	['51e14872-a3ee-5ce1-9210-cd65c5e23e3f', 'dfbd7fb2-ab5b-5a4e-b9be-dcb03e361957']	['TCGA-AX-A062_treatment_1', 'TCGA-AX-A062_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:20:54.354464-05:00', '']	01	Primary	9eac701b-9927-4aca-81eb-b516f90c643c	Primary Tumor	Not Reported	1610.0	200.0	Unknown	FAAFB078-A6DF-4E1B-BD5F-A3B30E45BE1E	false	Solid Tissue	False	Tumor
TCGA-D1-A1O7-01A	01ed791e-3187-4e24-a5ff-afff0778c152	Adenomas and Adenocarcinomas	01ed791e-3187-4e24-a5ff-afff0778c152	TCGA-D1-A1O7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22037.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	32.0	22037.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22037.0	60.37534246575343	['2019-07-31T22:10:07.682754-05:00', '2019-07-31T22:10:07.682754-05:00']	['235fafd2-6cc7-5be6-a1be-e11fd76f1a84', '6ba8558a-6098-5e37-a4fc-77b928bb5387']	['TCGA-D1-A1O7_treatment', 'TCGA-D1-A1O7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:14:08.097698-05:00']	01	Primary	c38210f9-bb16-471c-91e1-2cdebfe23345	Primary Tumor	Not Reported	154.0	50.0	Unknown	37C25226-AD56-487E-969B-1538E6E00A5D	false	Solid Tissue	False	Tumor
TCGA-D1-A0ZS-01A	80105773-372e-4552-a10b-5df188b15b16	Adenomas and Adenocarcinomas	80105773-372e-4552-a10b-5df188b15b16	TCGA-D1-A0ZS	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	54.0	-19821.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	148.0	19821.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19821.0	54.3041095890411	['2019-07-31T22:23:52.689981-05:00', '2019-07-31T22:23:52.689981-05:00']	['92545594-0cb0-5a9f-9019-a716304b9586', 'a2bdc8dc-af6a-5911-aa76-4e50615ff563']	['TCGA-D1-A0ZS_treatment', 'TCGA-D1-A0ZS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:25:11.019986-05:00']	01	Primary	e914e3db-e907-495a-9b59-43e07132052a	Primary Tumor	Not Reported	308.0	120.0	Unknown	313BCAEC-965D-4FF4-BAAA-3CAF48C739C6	false	Solid Tissue	False	Tumor
TCGA-AX-A3FX-01A	6f45a2e9-1ca5-438c-b06f-1cd8eb845465	Adenomas and Adenocarcinomas	6f45a2e9-1ca5-438c-b06f-1cd8eb845465	TCGA-AX-A3FX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	69.0	-25260.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	1333.0															Stage IIB	No	0.0	not reported	Endometrium	4.0	25260.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25260.0	69.20547945205479	['2019-07-31T22:22:06.549791-05:00', '2019-07-31T22:22:06.549791-05:00']	['4706a7d9-c0c1-545b-bac1-932a4851a26c', 'c14178c7-2c26-5cc4-8279-a98e9aa27017']	['TCGA-AX-A3FX_treatment_1', 'TCGA-AX-A3FX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:23:46.036459-05:00', '']	01	Primary	375bec4c-5e9b-4bc0-9f28-5854a159d655	Primary Tumor	Not Reported	736.0	100.0	Unknown	B3326BA1-71E3-4207-9727-B157A3E195E7	false	Solid Tissue	False	Tumor
TCGA-D1-A15W-01A	d6562acf-6d82-4f08-a779-82cdc5df16f9	Adenomas and Adenocarcinomas	d6562acf-6d82-4f08-a779-82cdc5df16f9	TCGA-D1-A15W	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21545.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	915.0	21545.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21545.0	59.02739726027397	['2019-07-31T22:31:43.674940-05:00', '2019-07-31T22:31:43.674940-05:00']	['6ea57f75-1f3e-5422-b62a-ba1a9e573765', '7f44b25d-a78a-598a-ada2-79df465e7314']	['TCGA-D1-A15W_treatment', 'TCGA-D1-A15W_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:35.228386-05:00']	01	Primary	1ac48153-0577-4bc0-ab8c-f77453ebfbb0	Primary Tumor	Not Reported	906.0	190.0	Unknown	1C938760-9492-4F4E-87CE-85CE3C15BBCA	false	Solid Tissue	False	Tumor
TCGA-FI-A2EU-01A	4284a85d-d9b6-40ee-aac4-c2c03554528e	Cystic, Mucinous and Serous Neoplasms	4284a85d-d9b6-40ee-aac4-c2c03554528e	TCGA-FI-A2EU	Corpus uteri	Not Reported	not reported	female	not hispanic or latino	Alive	68.0	-24837.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2941.0	24837.0	Serous cystadenocarcinoma, NOS	no	2003.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24837.0	68.04657534246576	['2019-07-31T22:17:24.013415-05:00', '2019-07-31T22:17:24.013415-05:00']	['5ff0ab24-6512-58c4-b147-2a0aad2850be', 'e8da3386-253c-50a7-be00-de53c9d70318']	['TCGA-FI-A2EU_treatment', 'TCGA-FI-A2EU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:20:00.638605-05:00']	01	Primary	af843246-e00f-40f4-849f-3c5ba74a7479	Primary Tumor	Not Reported	2779.0	110.0	OCT	95F8FB60-A533-4A37-8B4B-FC6811A77636	true	Solid Tissue	False	Tumor
TCGA-D1-A0ZP-01A	ac216bb5-15e4-4462-955e-8a522380690e	Cystic, Mucinous and Serous Neoplasms	ac216bb5-15e4-4462-955e-8a522380690e	TCGA-D1-A0ZP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	59.0	-21581.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVA	No	0.0	not reported	Endometrium	911.0	21581.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21581.0	59.12602739726027	['2019-07-31T22:28:03.736194-05:00', '2019-07-31T22:28:03.736194-05:00']	['f1b231a6-bbdb-5a33-8a1a-4e9fc0585b84', 'fcd9ff96-5359-57f4-af80-fec6a0b3f573']	['TCGA-D1-A0ZP_treatment', 'TCGA-D1-A0ZP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:28:36.582469-05:00']	01	Primary	41a4ef51-9560-4089-a08a-624a64a168d5	Primary Tumor	Not Reported	552.0	180.0	Unknown	FD46BB74-914F-4B4E-819A-5AD5F4548672	false	Solid Tissue	False	Tumor
TCGA-DI-A1NO-01A	d3e93d76-6565-454a-a085-4492024350e9	Adenomas and Adenocarcinomas	d3e93d76-6565-454a-a085-4492024350e9	TCGA-DI-A1NO	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	68.0	-24996.0	1941.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH	285.0															Stage IIIA	No	0.0	not reported	Endometrium		24996.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24996.0	68.48219178082192	['2019-07-31T22:31:28.625753-05:00', '2019-07-31T22:31:28.625753-05:00']	['17b2e08d-7ce3-5b8a-be40-26cb248c2958', 'fd99f745-6d70-5394-a9c0-be334264d4ff']	['TCGA-DI-A1NO_treatment_1', 'TCGA-DI-A1NO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:31:22.897578-05:00', '']	01	Primary	002a3a28-71c7-4a8c-960a-14a239ffb433	Primary Tumor	Not Reported	688.0	270.0	Unknown	11CEAAB6-3853-48EB-94CE-1B11FEF45B4C	false	Solid Tissue	False	Tumor
TCGA-DI-A1NO-11A	d3e93d76-6565-454a-a085-4492024350e9	Adenomas and Adenocarcinomas	d3e93d76-6565-454a-a085-4492024350e9	TCGA-DI-A1NO	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	68.0	-24996.0	1941.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH	285.0															Stage IIIA	No	0.0	not reported	Endometrium		24996.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24996.0	68.48219178082192	['2019-07-31T22:31:28.625753-05:00', '2019-07-31T22:31:28.625753-05:00']	['17b2e08d-7ce3-5b8a-be40-26cb248c2958', 'fd99f745-6d70-5394-a9c0-be334264d4ff']	['TCGA-DI-A1NO_treatment_1', 'TCGA-DI-A1NO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:31:22.897578-05:00', '']	11	Not Applicable	7aaf991a-6cf7-4a53-9235-d0bc73208152	Solid Tissue Normal	Not Reported	688.0	240.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BK-A0C9-01A	92a2cae3-b8ee-4ebb-ac5c-01e58749448f	Adenomas and Adenocarcinomas	92a2cae3-b8ee-4ebb-ac5c-01e58749448f	TCGA-BK-A0C9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-20876.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1092.0	20876.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20876.0	57.1945205479452	['2019-07-31T16:42:44.085477-05:00', '2019-07-31T16:42:44.085477-05:00']	['2a0db852-977a-5cde-989b-044b31b32bfa', 'fbf028c5-5bd5-503a-8f53-a097d431b239']	['TCGA-BK-A0C9_treatment_1', 'TCGA-BK-A0C9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T09:47:23.573358-05:00', '']	01	Primary	155181e3-7733-44be-8ef8-7e24cebb59a4	Primary Tumor	Not Reported	192.0	490.0	Unknown	3E14F5F3-2C40-403F-A499-BE64857E8559	false	Solid Tissue	False	Tumor
TCGA-AP-A1DK-01A	51de7e94-e2fa-420b-9aa2-3637d17fc6ea	Adenomas and Adenocarcinomas	51de7e94-e2fa-420b-9aa2-3637d17fc6ea	TCGA-AP-A1DK	Corpus uteri	Not Reported	white	female	not reported	Alive	53.0	-19509.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2767.0	19509.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19509.0	53.44931506849315	['2019-07-31T22:19:02.406002-05:00', '2019-07-31T22:19:02.406002-05:00']	['3f4425e9-8e50-5558-9a49-80680266ae7e', 'cade30f7-823d-5dc5-8b5c-9ac25fb692c4']	['TCGA-AP-A1DK_treatment', 'TCGA-AP-A1DK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:21:18.610825-05:00']	01	Primary	1cb12a0f-0081-441f-a86e-71d76ef5b8d0	Primary Tumor	Not Reported	1541.0	70.0	OCT	9A3BB88B-F16F-4773-8912-CF519B847354	true	Solid Tissue	False	Tumor
TCGA-A5-A1OK-01A	2fe46394-cfc5-44bb-81a9-e438a0126f5b	Adenomas and Adenocarcinomas	2fe46394-cfc5-44bb-81a9-e438a0126f5b	TCGA-A5-A1OK	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23179.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	Not Reported	0.0	not reported	Endometrium	917.0	23179.0	Endometrioid adenocarcinoma, NOS	yes	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23179.0	63.50410958904109	['2019-07-31T22:14:57.184583-05:00', '2019-07-31T22:14:57.184583-05:00']	['59b1d10b-6e11-599b-b664-f48e0bf1bc14', '5bc4acba-a824-5553-8889-6694f82f393b']	['TCGA-A5-A1OK_treatment', 'TCGA-A5-A1OK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:18:02.961103-05:00']	01	Primary	0eaf63cf-3cf6-4049-b0ab-aedb65db648d	Primary Tumor	Not Reported	113.0	250.0	OCT	1B0C95FC-7AA7-4F82-807D-85C579B6BF74	true	Solid Tissue	False	Tumor
TCGA-D1-A17A-01A	c68dd983-b199-4f53-ac0c-b2d8dd6a7931	Adenomas and Adenocarcinomas	c68dd983-b199-4f53-ac0c-b2d8dd6a7931	TCGA-D1-A17A	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	59.0	-21560.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIA	No	0.0	not reported	Endometrium	48.0	21560.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21560.0	59.06849315068493	['2019-07-31T22:30:01.580129-05:00', '2019-07-31T22:30:01.580129-05:00']	['625ec38d-fbf6-5564-84bb-ad79f0e51c01', '9522a52c-1ca1-5b97-b212-33b0b26519fe']	['TCGA-D1-A17A_treatment_1', 'TCGA-D1-A17A_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:12.658262-05:00', '']	01	Primary	a0083336-5187-4969-85bb-993fa72fbd75	Primary Tumor	Not Reported	553.0	60.0	Unknown	9E0E5CDA-AE46-4ABC-8AF7-C89FE86B7472	false	Solid Tissue	False	Tumor
TCGA-PG-A916-01A	5edaed6d-9914-4df2-a843-d6009c36cbcc	Adenomas and Adenocarcinomas	5edaed6d-9914-4df2-a843-d6009c36cbcc	TCGA-PG-A916	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	70.0	-25617.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	69bd8326-4904-56a0-8230-1615a777173b	PG	Montefiore Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage I	No	0.0	not reported	Endometrium	522.0	25617.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25617.0	70.18356164383562	['2019-07-31T22:20:21.667228-05:00', '2019-07-31T22:20:21.667228-05:00']	['c134329d-eccc-568c-b3de-2453a1c6b0fb', 'f2410677-ed5a-5ee7-8abf-9cdebe514bdb']	['TCGA-PG-A916_treatment_1', 'TCGA-PG-A916_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:22:22.389095-05:00', '']	01	Primary	2004ff38-a2bf-43be-8b72-b2994a53d890	Primary Tumor	Not Reported	224.0	220.0	OCT	3E66FA38-0D87-47CA-A72D-63C0619A2182	true	Solid Tissue	False	Tumor
TCGA-AJ-A5DW-01A	c0b684d1-b96c-4420-9285-172402b7b123	Adenomas and Adenocarcinomas	c0b684d1-b96c-4420-9285-172402b7b123	TCGA-AJ-A5DW	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	56.0	-20711.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	390.0	20711.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20711.0	56.74246575342466	['2019-07-31T22:29:34.242519-05:00', '2019-07-31T22:29:34.242519-05:00']	['0ad8b192-dff7-5abb-b7fb-c27e0ff926e2', 'd2bfeef2-549f-5886-ad2a-5761a5d1f908']	['TCGA-AJ-A5DW_treatment_1', 'TCGA-AJ-A5DW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:29:51.131169-05:00', '']	01	Primary	ae83512d-3739-4e4d-9f27-8b01e6400479	Primary Tumor	Not Reported	133.0	80.0	Unknown	8B641F9B-ACF5-448B-9AC3-8C8E6B1F0724	false	Solid Tissue	False	Tumor
TCGA-AP-A05J-01A	38f9fe64-de79-498c-b3ca-1c83af0ed72a	Cystic, Mucinous and Serous Neoplasms	38f9fe64-de79-498c-b3ca-1c83af0ed72a	TCGA-AP-A05J	Corpus uteri	Not Reported	white	female	not reported	Alive	66.0	-24119.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	1122.0	24119.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24119.0	66.07945205479452	['2019-07-31T22:15:55.265715-05:00', '2019-07-31T22:15:55.265715-05:00']	['7a3dfec1-6e94-5740-a56f-17dae998b581', 'ededbc12-b3a4-5573-8147-4944c94e1d7f']	['TCGA-AP-A05J_treatment', 'TCGA-AP-A05J_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:18:50.127406-05:00']	01	Primary	203c6ed3-2e18-400d-83ee-69a8fd9bb386	Primary Tumor	Not Reported	566.0	170.0	OCT	C6426DA0-86C5-49CC-9983-A0002DA0D4F2	true	Solid Tissue	False	Tumor
TCGA-B5-A11R-01A	f04befed-6c81-4676-8715-b8c6a33cb9d1	Adenomas and Adenocarcinomas	f04befed-6c81-4676-8715-b8c6a33cb9d1	TCGA-B5-A11R	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	51.0	-18878.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	2349.0	18878.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18878.0	51.72054794520548	['2019-07-31T22:35:15.007736-05:00', '2019-07-31T22:35:15.007736-05:00']	['6633efae-5f7a-54f6-a9d0-d8502eb4c9e9', '6e9c26cf-668b-5358-8c88-ba394d7eb615']	['TCGA-B5-A11R_treatment_1', 'TCGA-B5-A11R_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:34:23.980693-05:00', '']	01	Primary	1583391d-1489-4489-9cb8-30cd6529b307	Primary Tumor	Not Reported	734.0	100.0	OCT	0AC5670B-7EA6-438C-9326-843BB7A6A81C	true	Solid Tissue	False	Tumor
TCGA-AX-A05Y-01A	cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf	Adenomas and Adenocarcinomas	cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf	TCGA-AX-A05Y	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-20904.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2684.0	20904.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20904.0	57.271232876712325	['2019-07-31T22:30:40.252309-05:00', '2019-07-31T22:30:40.252309-05:00']	['1917c6c3-0e9f-5905-9067-4116d6638e67', '722a709c-684a-5209-9163-28a3e8b6d946']	['TCGA-AX-A05Y_treatment_1', 'TCGA-AX-A05Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:44.537547-05:00', '']	01	Primary	60e1de46-8c8f-4fa9-bc51-ce975d02d5ac	Primary Tumor	Not Reported	1967.0	230.0	Unknown	7E7D9403-AA77-4F14-9017-3B69F66D8EBC	false	Solid Tissue	False	Tumor
TCGA-AX-A05Y-11A	cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf	Adenomas and Adenocarcinomas	cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf	TCGA-AX-A05Y	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-20904.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2684.0	20904.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20904.0	57.271232876712325	['2019-07-31T22:30:40.252309-05:00', '2019-07-31T22:30:40.252309-05:00']	['1917c6c3-0e9f-5905-9067-4116d6638e67', '722a709c-684a-5209-9163-28a3e8b6d946']	['TCGA-AX-A05Y_treatment_1', 'TCGA-AX-A05Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:44.537547-05:00', '']	11	Not Applicable	82790b63-1c88-49b8-b09f-8b42f0a93c2b	Solid Tissue Normal	Not Reported	2391.0	140.0	Unknown		false	Solid Tissue	False	Normal
TCGA-E6-A1LX-01A	435b57e7-5cd4-486a-b3d4-ccb1ef160d52	Adenomas and Adenocarcinomas	435b57e7-5cd4-486a-b3d4-ccb1ef160d52	TCGA-E6-A1LX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	40.0	-14731.0	1966.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	39aa3c67-c7d9-5001-8ed1-3bf83eac7872	E6	Roswell Park	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	711.0	14731.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	14731.0	40.35890410958904	['2019-07-31T22:17:32.988384-05:00', '2019-07-31T22:17:32.988384-05:00']	['983b3c1a-e094-5753-95f5-b91eb0156132', 'ebf951ca-aefc-568b-9f87-6d13e7cda3e5']	['TCGA-E6-A1LX_treatment_1', 'TCGA-E6-A1LX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:20:07.863933-05:00', '']	01	Primary	840ff7bf-7acc-400b-8395-d048e38674ee	Primary Tumor	Not Reported	1539.0	190.0	Unknown	73CEBF93-0E7C-4EF9-A695-AF489AF3F0F0	false	Solid Tissue	False	Tumor
TCGA-D1-A168-01A	41893e97-7e90-4b03-b738-260f288ade4c	Adenomas and Adenocarcinomas	41893e97-7e90-4b03-b738-260f288ade4c	TCGA-D1-A168	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24586.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1098.0	24586.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24586.0	67.35890410958905	['2019-07-31T22:17:11.999508-05:00', '2019-07-31T22:17:11.999508-05:00']	['21bac08b-e29c-5198-ae5c-4eea3bb311b6', '549d415c-5742-571f-9db0-a6fef5c2a229']	['TCGA-D1-A168_treatment', 'TCGA-D1-A168_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:19:51.623444-05:00']	01	Primary	b44c673e-9560-4b59-9ff3-34ce230cad1c	Primary Tumor	Not Reported	821.0	120.0	Unknown	B9D9D808-17B1-415F-9E58-4FDBC1BF30C0	false	Solid Tissue	False	Tumor
TCGA-D1-A1O0-01A	a98bbe29-8817-4380-a738-3c1bf9f8e0cc	Adenomas and Adenocarcinomas	a98bbe29-8817-4380-a738-3c1bf9f8e0cc	TCGA-D1-A1O0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28162.0	1933.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	63.0	28162.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28162.0	77.15616438356165	['2019-07-31T22:27:45.007261-05:00', '2019-07-31T22:27:45.007261-05:00']	['1715ea84-3db6-5547-91f8-ad658901e88e', '83988d55-554c-54bc-b133-4faa168d9592']	['TCGA-D1-A1O0_treatment_1', 'TCGA-D1-A1O0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:28:21.671562-05:00', '']	01	Primary	e113e0f0-3ae5-48a3-a226-ad920f41259e	Primary Tumor	Not Reported	195.0	50.0	Unknown	2F5CADA5-176C-4B9D-9660-53BE86B1CD39	false	Solid Tissue	False	Tumor
TCGA-AJ-A3NF-01A	9fcbef9e-2cca-4033-b574-daab2a42198b	Cystic, Mucinous and Serous Neoplasms	9fcbef9e-2cca-4033-b574-daab2a42198b	TCGA-AJ-A3NF	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22210.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	645.0	22210.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22210.0	60.84931506849315	['2019-07-31T22:26:26.426763-05:00', '2019-07-31T22:26:26.426763-05:00']	['14770bb3-5de0-5295-ab7f-e37a3314024e', '157e018b-720a-5b87-ae61-da6ea743dd72']	['TCGA-AJ-A3NF_treatment', 'TCGA-AJ-A3NF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:27:18.557193-05:00']	01	Primary	964ffd81-4b84-4045-abdc-63e79975158e	Primary Tumor	Not Reported	85.0	22.0	Unknown	7003815D-F09A-46A0-8A8E-E0685A765788	false	Solid Tissue	False	Tumor
TCGA-FI-A2CY-01A	b9ab4ab9-ba9c-4a01-9f61-55c82b924936	Cystic, Mucinous and Serous Neoplasms	b9ab4ab9-ba9c-4a01-9f61-55c82b924936	TCGA-FI-A2CY	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	60.0	-22098.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2080.0	22098.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22098.0	60.54246575342466	['2019-07-31T22:29:09.512492-05:00', '2019-07-31T22:29:09.512492-05:00']	['40b84949-b683-5f68-9450-2324242bbeaa', 'da046201-0637-5609-998e-7b8f436ca222']	['TCGA-FI-A2CY_treatment_1', 'TCGA-FI-A2CY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:29:31.425631-05:00', '']	01	Primary	047b688c-aa29-4a63-b555-9275af4b0cee	Primary Tumor	Not Reported	1067.0	110.0	OCT	2C4CE5F5-AD46-427E-A787-529DF9FA891A	true	Solid Tissue	False	Tumor
TCGA-BG-A0VW-01A	62d71839-4fba-42e9-9929-8d937f0fe287	Adenomas and Adenocarcinomas	62d71839-4fba-42e9-9929-8d937f0fe287	TCGA-BG-A0VW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28383.0	1933.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1582.0	28383.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28383.0	77.76164383561644	['2019-07-31T22:21:01.621029-05:00', '2019-07-31T22:21:01.621029-05:00']	['6bf12f53-51d0-5efd-8e56-843debf1850e', 'e4c508a0-2edf-5f8b-974b-1652d00c1d88']	['TCGA-BG-A0VW_treatment_1', 'TCGA-BG-A0VW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:22:54.909172-05:00', '']	01	Primary	e5e61331-4cca-4742-83ab-87e9dddafaca	Primary Tumor	Not Reported	246.0	90.0	OCT	7663D410-13EC-4A5B-B655-F7DCCC9C8E8D	true	Solid Tissue	False	Tumor
TCGA-B5-A0K4-01A	a8f38e37-978b-4435-b676-e8d4c34da909	Adenomas and Adenocarcinomas	a8f38e37-978b-4435-b676-e8d4c34da909	TCGA-B5-A0K4	Corpus uteri	Not Reported	not reported	female	not reported	Alive	51.0	-18631.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1757.0	18631.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18631.0	51.04383561643836	['2019-07-31T22:27:38.914348-05:00', '2019-07-31T22:27:38.914348-05:00']	['3bd25fce-0b26-5005-8964-eb8fe3e90ae1', 'a93d1176-b083-536f-b90c-0b99e4578474']	['TCGA-B5-A0K4_treatment_1', 'TCGA-B5-A0K4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:28:16.807860-05:00', '']	01	Primary	a4ac1f6e-3411-47ae-9592-513b3d32223f	Primary Tumor	Not Reported	264.0	280.0	OCT	80DE2981-089A-47A2-B221-F7C28ECAF3F2	true	Solid Tissue	False	Tumor
TCGA-B5-A11S-01A	cfd096ac-4d0f-4b89-8822-00656bc7f516	Adenomas and Adenocarcinomas	cfd096ac-4d0f-4b89-8822-00656bc7f516	TCGA-B5-A11S	Corpus uteri	Not Reported	white	female	not reported	Alive	63.0	-23085.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2229.0	23085.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23085.0	63.24657534246575	['2019-07-31T22:30:58.211245-05:00', '2019-07-31T22:30:58.211245-05:00']	['24083fb0-14bf-5abf-bcbe-d0911ba93b0f', 'eedab425-5097-5870-b287-34a65a661e7e']	['TCGA-B5-A11S_treatment', 'TCGA-B5-A11S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:30:59.309127-05:00']	01	Primary	f36e52ee-22b3-4e9a-aacd-d74e7f7d4a51	Primary Tumor	Not Reported	615.0	200.0	OCT	A1E96BA3-7DFB-4E3C-A6CF-B0B99D4C44FA	true	Solid Tissue	False	Tumor
TCGA-BG-A0MT-01A	082e32c5-7f82-466a-b52d-a3293a8f8e57	Adenomas and Adenocarcinomas	082e32c5-7f82-466a-b52d-a3293a8f8e57	TCGA-BG-A0MT	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23574.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	644.0	23574.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23574.0	64.58630136986301	['2019-07-31T22:11:04.306934-05:00', '2019-07-31T22:11:04.306934-05:00']	['01012744-f996-5de6-92e4-8b7a2748ae4e', '9c471085-ad96-53a4-92c6-bd2b29b44bfb']	['TCGA-BG-A0MT_treatment', 'TCGA-BG-A0MT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:14:53.012884-05:00']	01	Primary	91f629f5-6938-4f5c-ba2e-1f519ce6b255	Primary Tumor	Not Reported	344.0	820.0	OCT	89610F48-AC0D-431D-8A9E-FC9E51CF8FC0	true	Solid Tissue	False	Tumor
TCGA-AX-A1CN-01A	d70b3c6e-04da-4abc-a832-a461e4cfcc94	Adenomas and Adenocarcinomas	d70b3c6e-04da-4abc-a832-a461e4cfcc94	TCGA-AX-A1CN	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	54.0	-19860.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	1143.0	19860.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19860.0	54.41095890410959	['2019-07-31T22:31:46.869476-05:00', '2019-07-31T22:31:46.869476-05:00']	['9bd36123-3304-590f-9379-8e77bab80731', 'ff0adede-d697-563d-b250-3b60006fddbc']	['TCGA-AX-A1CN_treatment_1', 'TCGA-AX-A1CN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:31:37.687137-05:00', '']	01	Primary	785a9c46-0629-4e15-90c0-9437644ff9bf	Primary Tumor	Not Reported	701.0	110.0	Unknown	D0FB2179-60D4-4B3C-9D88-B07D802F772E	false	Solid Tissue	False	Tumor
TCGA-AP-A1DH-01A	07d1aef3-31c7-4c44-a078-16a9eb096d58	Adenomas and Adenocarcinomas	07d1aef3-31c7-4c44-a078-16a9eb096d58	TCGA-AP-A1DH	Corpus uteri	Not Reported	white	female	not reported	Alive	62.0	-22652.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2180.0	22652.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22652.0	62.06027397260274	['2019-07-31T22:11:01.415000-05:00', '2019-07-31T22:11:01.415000-05:00']	['88d7374c-c7c5-592f-8902-6d0c75bdcdcd', 'bc3f0fcf-4ba7-5aa4-b86e-ec0f6972cf04']	['TCGA-AP-A1DH_treatment', 'TCGA-AP-A1DH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:14:50.789386-05:00']	01	Primary	da4b6bf2-0e9d-495a-8220-93359d2afa67	Primary Tumor	Not Reported	1843.0	150.0	OCT	B77EE1CD-716C-4441-B4A9-CCCC37BD1379	true	Solid Tissue	False	Tumor
TCGA-D1-A17U-01A	6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b	Adenomas and Adenocarcinomas	6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b	TCGA-D1-A17U	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19544.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	697.0	19544.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19544.0	53.54520547945206	['2019-07-31T22:21:13.491049-05:00', '2019-07-31T22:21:13.491049-05:00']	['3024d0f7-2147-561a-9ca3-51ccb99736ff', 'df41d07b-14db-5a29-bfa5-c1eaa22cb4aa']	['TCGA-D1-A17U_treatment_1', 'TCGA-D1-A17U_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:23:04.250039-05:00', '']	01	Primary	1f1945ee-4cf3-43a3-9998-1c4528c7a511	Primary Tumor	Not Reported	314.0	210.0	Unknown	A0A4164D-FD8D-4472-BAFA-A036469E22CC	false	Solid Tissue	False	Tumor
TCGA-AJ-A3OJ-01A	76f98002-e8df-4dfa-926e-8bb2d5114966	Adenomas and Adenocarcinomas	76f98002-e8df-4dfa-926e-8bb2d5114966	TCGA-AJ-A3OJ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	54.0	-19826.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	467.0	19826.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19826.0	54.31780821917808	['2019-07-31T22:23:01.091258-05:00', '2019-07-31T22:23:01.091258-05:00']	['09a45c05-f663-5293-8e4f-066f0455b87c', 'a6c5b0f8-3b07-5c3f-8b3f-29fcea31a3fe']	['TCGA-AJ-A3OJ_treatment', 'TCGA-AJ-A3OJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:24:30.070983-05:00']	01	Primary	654f67ed-7295-4360-ada6-830d4528b17d	Primary Tumor	Not Reported	97.0	260.0	Unknown	89CAF35B-187A-499C-9E01-3992A0DEBCFD	false	Solid Tissue	False	Tumor
TCGA-B5-A0K0-01A	29c8f468-5ac1-4d6c-8376-e36e6d246926	Adenomas and Adenocarcinomas	29c8f468-5ac1-4d6c-8376-e36e6d246926	TCGA-B5-A0K0	Corpus uteri	Not Reported	white	female	not reported	Alive	48.0	-17810.0	1960.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1478.0	17810.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17810.0	48.794520547945204	['2019-07-31T22:14:13.938538-05:00', '2019-07-31T22:14:13.938538-05:00']	['3e75bcaf-7d97-583a-abf0-2f7533965c5f', 'a4192721-05db-5d1a-8ae2-248c038bb76b']	['TCGA-B5-A0K0_treatment_1', 'TCGA-B5-A0K0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:17:27.450777-05:00', '']	01	Primary	11c43948-e7c9-4436-a654-82fa8033b625	Primary Tumor	Not Reported	615.0	440.0	OCT	6284E0A9-FACB-4297-ABC6-308715ABAFCD	true	Solid Tissue	False	Tumor
TCGA-EY-A210-01A	ea1c693d-490d-4816-b6e3-d12946ad7cc1	Cystic, Mucinous and Serous Neoplasms	ea1c693d-490d-4816-b6e3-d12946ad7cc1	TCGA-EY-A210	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	82.0	-30095.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	383.0	30095.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30095.0	82.45205479452055	['2019-07-31T22:34:41.351668-05:00', '2019-07-31T22:34:41.351668-05:00']	['04ef0a9b-f05f-570b-a62c-8c689c93eda4', 'e193af62-ea66-5196-8317-13ad9958b5a2']	['TCGA-EY-A210_treatment', 'TCGA-EY-A210_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:33:57.027220-05:00']	01	Primary	3879caa4-a747-4879-8923-05232476730d	Primary Tumor	Not Reported	70.0	840.0	Unknown	51A98C43-6A6A-4027-8E92-B3B9AA1A63D4	false	Solid Tissue	False	Tumor
TCGA-EO-A22R-11A	508bf716-46f9-44dc-8e39-09261dfb073e	Adenomas and Adenocarcinomas	508bf716-46f9-44dc-8e39-09261dfb073e	TCGA-EO-A22R	Corpus uteri	Not Reported	not reported	female	not reported	Alive	56.0	-20604.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1878.0	20604.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20604.0	56.44931506849315	['2019-07-31T22:18:59.311167-05:00', '2019-07-31T22:18:59.311167-05:00']	['2f65a41f-081b-58b1-927c-29cb81517c29', 'ddb9a6b2-8181-56b9-9b1e-f6c9e433a0ef']	['TCGA-EO-A22R_treatment', 'TCGA-EO-A22R_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:21:16.200588-05:00']	11	Not Applicable	55e27e15-5a84-463f-a26e-2d5ad16ba29a	Solid Tissue Normal	Not Reported	1058.0	70.0	Unknown		false	Solid Tissue	False	Normal
TCGA-EO-A22R-01A	508bf716-46f9-44dc-8e39-09261dfb073e	Adenomas and Adenocarcinomas	508bf716-46f9-44dc-8e39-09261dfb073e	TCGA-EO-A22R	Corpus uteri	Not Reported	not reported	female	not reported	Alive	56.0	-20604.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1878.0	20604.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20604.0	56.44931506849315	['2019-07-31T22:18:59.311167-05:00', '2019-07-31T22:18:59.311167-05:00']	['2f65a41f-081b-58b1-927c-29cb81517c29', 'ddb9a6b2-8181-56b9-9b1e-f6c9e433a0ef']	['TCGA-EO-A22R_treatment', 'TCGA-EO-A22R_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:21:16.200588-05:00']	01	Primary	8f1f3c76-1cad-434e-b77a-bc17c7742e76	Primary Tumor	Not Reported	925.0	130.0	Unknown	5B97D87A-5D28-417F-A942-21775156B46C	false	Solid Tissue	False	Tumor
TCGA-D1-A0ZQ-01A	38243a33-073a-479b-8cf6-c8847aeb5a48	Adenomas and Adenocarcinomas	38243a33-073a-479b-8cf6-c8847aeb5a48	TCGA-D1-A0ZQ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	90.0	-32872.0	1919.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	0.0	32872.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	32872.0	90.06027397260274	['2019-07-31T22:15:43.223456-05:00', '2019-07-31T22:15:43.223456-05:00']	['72391147-14ba-5ea1-a827-240e06a3589e', 'b2eda5ce-233a-53a7-9b16-0e87b8918ed3']	['TCGA-D1-A0ZQ_treatment_1', 'TCGA-D1-A0ZQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-30T16:18:27.725959-05:00', '']	01	Primary	e20471d5-a261-448b-9a6f-fd3be8ed5c04	Primary Tumor	Not Reported	540.0	120.0	Unknown	BAC6E925-0499-41AD-9F58-2CB8E3EE058E	false	Solid Tissue	False	Tumor
TCGA-B5-A3FB-01A	0c1946a8-ee54-4b9b-8054-9a7bece74d33	Adenomas and Adenocarcinomas	0c1946a8-ee54-4b9b-8054-9a7bece74d33	TCGA-B5-A3FB	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	73.0	-26779.0	1933.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2844.0	26779.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26779.0	73.36712328767123	['2019-07-31T22:11:30.769759-05:00', '2019-07-31T22:11:30.769759-05:00']	['597ee7fc-bf02-5e62-9081-33f15bc255fa', '5b19df24-b2b2-55ae-b69c-06bddd6e22aa']	['TCGA-B5-A3FB_treatment', 'TCGA-B5-A3FB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:15:15.438184-05:00']	01	Primary	0cea1bde-18ed-4e42-b5f6-3d4ff182b0c0	Primary Tumor	Not Reported	2066.0	350.0	OCT	FA278AFC-C294-48A5-BE7B-B26F4AE3FC5B	true	Solid Tissue	False	Tumor
TCGA-AP-A0LD-01A	1200c8b7-a058-4c01-bbe2-04ec09a65245	Adenomas and Adenocarcinomas	1200c8b7-a058-4c01-bbe2-04ec09a65245	TCGA-AP-A0LD	Corpus uteri	Not Reported	white	female	not reported	Alive	63.0	-23216.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	3589.0	23216.0	Endometrioid adenocarcinoma, NOS	no	2002.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23216.0	63.605479452054794	['2019-07-31T22:12:07.412749-05:00', '2019-07-31T22:12:07.412749-05:00']	['d22d5d18-7d63-51e9-aa3d-5153d5411a52', 'edeaddd9-bddb-507f-9589-3733e7be4968']	['TCGA-AP-A0LD_treatment_1', 'TCGA-AP-A0LD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:15:45.441088-05:00', '']	01	Primary	649dadda-5823-4b0d-b5a2-49f501adc029	Primary Tumor	Not Reported	2993.0	230.0	OCT	10B9E917-C1FB-480D-9DB2-8E93FA446ADC	true	Solid Tissue	False	Tumor
TCGA-EY-A549-01A	3d9828ae-eb65-4d0a-8d7a-cc09e98b5e99	Adenomas and Adenocarcinomas	3d9828ae-eb65-4d0a-8d7a-cc09e98b5e99	TCGA-EY-A549	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	78.0	-28570.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	Not Reported	0.0	not reported	Corpus uteri	605.0	28570.0	Endometrioid adenocarcinoma, NOS	yes	2012.0	No	8380/3	not reported	C54.9	Corpus uteri	Not Reported	not reported	28570.0	78.27397260273973	['2019-07-31T22:16:28.214550-05:00', '2019-07-31T22:16:28.214550-05:00']	['310fd4f3-023a-53aa-9891-13a7c23c3603', 'f6fe67bd-fdcd-50af-b5f7-66f286c11193']	['TCGA-EY-A549_treatment_1', 'TCGA-EY-A549_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:19:17.295308-05:00', '']	01	Primary	2b096dd7-4d46-4c71-91c3-fa084ade57cb	Primary Tumor	Not Reported	191.0	370.0	Unknown	F6D1F090-C601-4212-951E-BEE086DDD24F	false	Solid Tissue	False	Tumor
TCGA-D1-A176-01A	6d061ca9-ba7e-4b82-ab3c-34e33f244a54	Adenomas and Adenocarcinomas	6d061ca9-ba7e-4b82-ab3c-34e33f244a54	TCGA-D1-A176	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24521.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	917.0	24521.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24521.0	67.18082191780822	['2019-07-31T22:22:00.718592-05:00', '2019-07-31T22:22:00.718592-05:00']	['09de01e2-8c9c-5ffa-814c-be7c2f7fc5e2', '2e035b92-f20d-56c3-a10e-d057840da097']	['TCGA-D1-A176_treatment', 'TCGA-D1-A176_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:41.355220-05:00']	01	Primary	b66b5979-62a1-4938-a655-aeff90d2d472	Primary Tumor	Not Reported	555.0	100.0	Unknown	6F361A45-F13E-44F7-8F3C-00C8B30ACB7A	false	Solid Tissue	False	Tumor
TCGA-AJ-A23O-01A	70b4b353-10d4-49d0-bcc1-855616d8c8cc	Adenomas and Adenocarcinomas	70b4b353-10d4-49d0-bcc1-855616d8c8cc	TCGA-AJ-A23O	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	69.0	-25433.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	312.0															Stage IB	No	0.0	not reported	Fundus uteri	60.0	25433.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Fundus uteri	Not Reported	not reported	25433.0	69.67945205479452	['2019-07-31T22:22:18.819603-05:00', '2019-07-31T22:22:18.819603-05:00']	['70502229-873b-5d58-bc64-a2e57732f9d1', '87df5930-b274-58d8-940a-757afd5de79c']	['TCGA-AJ-A23O_treatment', 'TCGA-AJ-A23O_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:55.930590-05:00']	01	Primary	b8e857f7-25b5-481d-b374-075138925fb8	Primary Tumor	Not Reported	165.0	120.0	Unknown	4D477218-A4D1-4940-AEF5-D8F46931594C	false	Solid Tissue	False	Tumor
TCGA-A5-A0G1-01A	53707bb3-426a-43cb-830f-3eeed930295f	Cystic, Mucinous and Serous Neoplasms	53707bb3-426a-43cb-830f-3eeed930295f	TCGA-A5-A0G1	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	67.0	-24477.0	1929.0	2004.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH	3251.0															Stage IA	No	0.0	not reported	Endometrium		24477.0	Serous cystadenocarcinoma, NOS	no	1996.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24477.0	67.06027397260274	['2019-07-31T22:19:16.638364-05:00', '2019-07-31T22:19:16.638364-05:00']	['80033256-0bb7-53b5-a5d8-3a946ca42d16', 'cad785db-9221-54b2-b60b-9c527a28ea08']	['TCGA-A5-A0G1_treatment', 'TCGA-A5-A0G1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:21:31.175539-05:00']	01	Primary	b7fb82ee-0219-4fd0-b656-0509b9eda5f2	Primary Tumor	Not Reported	5015.0	190.0	OCT	A2EB7E85-E836-462E-ABBA-65D5110CEB1C	true	Solid Tissue	False	Tumor
TCGA-B5-A0JT-01A	d5f2bae1-7cd1-49bf-ae41-12d2aa44408e	Adenomas and Adenocarcinomas	d5f2bae1-7cd1-49bf-ae41-12d2aa44408e	TCGA-B5-A0JT	Corpus uteri	Not Reported	white	female	not reported	Alive	63.0	-23041.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1682.0	23041.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23041.0	63.12602739726027	['2019-07-31T16:37:55.092917-05:00', '2019-07-31T16:37:55.092917-05:00']	['45c03b7b-783e-5995-9fdb-aeaf67737262', '6016075b-070a-5f3c-83c3-6d6d46f646a0']	['TCGA-B5-A0JT_treatment', 'TCGA-B5-A0JT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T09:43:35.138124-05:00']	01	Primary	4188c8ea-fe84-4c30-a390-0bd9a6b10c7b	Primary Tumor	Not Reported	1128.0	750.0	OCT	CC6EE5B1-5548-4DE7-873F-332DBF81710F	true	Solid Tissue	False	Tumor
TCGA-FI-A3PV-01A	60e307dd-e11e-40ba-93c1-7e8a1f669f60	Cystic, Mucinous and Serous Neoplasms	60e307dd-e11e-40ba-93c1-7e8a1f669f60	TCGA-FI-A3PV	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	68.0	-24898.0	1935.0	2006.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH	1249.0															Stage IA	No	0.0	not reported	Endometrium		24898.0	Serous cystadenocarcinoma, NOS	no	2003.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24898.0	68.21369863013699	['2019-07-31T22:20:43.749363-05:00', '2019-07-31T22:20:43.749363-05:00']	['22470e63-4901-58a1-bd91-d730bfb65ada', '69245703-bdd8-5d77-9cf5-6487629c560d']	['TCGA-FI-A3PV_treatment', 'TCGA-FI-A3PV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:22:40.307958-05:00']	01	Primary	1d775e4c-dfb0-4db1-9495-13cea9aba532	Primary Tumor	Not Reported	3199.0	60.0	OCT	0EBA5D54-65AC-4F79-ACE9-29FB1F924E3A	true	Solid Tissue	False	Tumor
TCGA-A5-A0R6-01A	39609d3c-f5d3-4bc4-b356-1403c6dd1cb5	Cystic, Mucinous and Serous Neoplasms	39609d3c-f5d3-4bc4-b356-1403c6dd1cb5	TCGA-A5-A0R6	Corpus uteri	Not Reported	white	female	hispanic or latino	Alive	64.0	-23449.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	1153.0	23449.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23449.0	64.24383561643836	['2019-07-31T22:15:58.265039-05:00', '2019-07-31T22:15:58.265039-05:00']	['790f4370-75ac-582d-a918-aa5048071600', '9964b218-3c4a-55da-ad7e-96d271b904a5']	['TCGA-A5-A0R6_treatment', 'TCGA-A5-A0R6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:18:52.635445-05:00']	01	Primary	836bd487-091b-4728-bcd7-8065e5b76465	Primary Tumor	Not Reported	259.0	200.0	OCT	2F8BAD18-8A37-4F1A-A1BA-31494035E05F	true	Solid Tissue	False	Tumor
TCGA-D1-A16B-01A	bca1057a-1e96-404d-8a37-5a8dc1944ee7	Adenomas and Adenocarcinomas	bca1057a-1e96-404d-8a37-5a8dc1944ee7	TCGA-D1-A16B	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23450.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	1106.0	23450.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23450.0	64.24657534246575	['2019-07-31T22:29:18.561225-05:00', '2019-07-31T22:29:18.561225-05:00']	['ac7adcc2-9cb6-51c6-ac77-bd02d4346d48', 'c13bfe61-2eff-5ea2-89c9-1d78875a75f2']	['TCGA-D1-A16B_treatment', 'TCGA-D1-A16B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:29:38.850085-05:00']	01	Primary	6a59ff6e-7cc6-4d46-8983-7d9e6a48cc19	Primary Tumor	Not Reported	793.0	150.0	Unknown	1B9ED459-4046-4DD9-ABA5-E815A90601A3	false	Solid Tissue	False	Tumor
TCGA-D1-A103-01A	7427f9e8-1140-45fd-9613-78b72b13a7ba	Adenomas and Adenocarcinomas	7427f9e8-1140-45fd-9613-78b72b13a7ba	TCGA-D1-A103	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	87.0	-31841.0	1922.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	669.0	31841.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31841.0	87.23561643835616	['2019-07-31T22:22:45.715554-05:00', '2019-07-31T22:22:45.715554-05:00']	['1ec1ddde-d7ec-581b-9c2b-532e10d6cb8f', '2419ca98-9b41-54da-b276-03556e5c5346']	['TCGA-D1-A103_treatment', 'TCGA-D1-A103_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:24:17.960043-05:00']	01	Primary	7430a6c2-758a-4a56-8168-865b3463c2db	Primary Tumor	Not Reported	376.0	170.0	Unknown	AE2FAD3D-FA6A-4648-90A5-2D2C442796AF	false	Solid Tissue	False	Tumor
TCGA-BS-A0VI-01A	3405c549-7da5-48ee-ba48-177a67bbcc5d	Adenomas and Adenocarcinomas	3405c549-7da5-48ee-ba48-177a67bbcc5d	TCGA-BS-A0VI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21198.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	2646.0	21198.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21198.0	58.07671232876712	['2019-07-31T22:15:25.562388-05:00', '2019-07-31T22:15:25.562388-05:00']	['2fce146a-389a-5380-b325-fff653bc5446', '9dbd0bdf-cd3f-5af9-b384-e5cf6ba05f25']	['TCGA-BS-A0VI_treatment', 'TCGA-BS-A0VI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:18:24.976281-05:00']	01	Primary	698a5085-0137-4bd8-a8c0-f749d03fbd95	Primary Tumor	Not Reported	1514.0	340.0	Unknown	EC10AA0B-A597-4224-8807-52F7228C6D07	false	Solid Tissue	False	Tumor
TCGA-EY-A4KR-01A	df27b584-fa45-4a8f-bd12-a018cc63dca1	Cystic, Mucinous and Serous Neoplasms	df27b584-fa45-4a8f-bd12-a018cc63dca1	TCGA-EY-A4KR	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	56.0	-20669.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	346.0															Stage IIIC1	No	0.0	not reported	Endometrium	196.0	20669.0	Serous cystadenocarcinoma, NOS	no	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	20669.0	56.62739726027397	['2019-07-31T22:32:50.045363-05:00', '2019-07-31T22:32:50.045363-05:00']	['1ce1690e-760b-56fe-ab39-f43841a3dc1b', '4f1943dc-bbbe-5d61-9b6d-93a9e5ce3594']	['TCGA-EY-A4KR_treatment_1', 'TCGA-EY-A4KR_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:32:28.867009-05:00', '']	01	Primary	db625f3a-2cf7-4b99-8fa4-ab234f1dc22d	Primary Tumor	Not Reported	147.0	610.0	Unknown	D8669681-B1D2-4D39-B7BB-5207F901A937	false	Solid Tissue	False	Tumor
TCGA-AP-A05H-01A	fe5f4822-37a3-4f9e-8d33-8b9f36bf6895	Cystic, Mucinous and Serous Neoplasms	fe5f4822-37a3-4f9e-8d33-8b9f36bf6895	TCGA-AP-A05H	Corpus uteri	Not Reported	white	female	not reported	Alive	75.0	-27744.0	1933.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1385.0	27744.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27744.0	76.01095890410959	['2019-07-31T22:36:49.847826-05:00', '2019-07-31T22:36:49.847826-05:00']	['64c69722-979e-5ecd-8ce1-c3e6c4394bcb', '9ccec149-c224-5bcf-b6bf-42e6d9b6b6d0']	['TCGA-AP-A05H_treatment', 'TCGA-AP-A05H_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:35:39.944753-05:00']	01	Primary	e417cb26-f6e8-4a31-b7e0-5bb43fd587b1	Primary Tumor	Not Reported	706.0	210.0	OCT	805B997D-9755-4AC1-8695-294806148F25	true	Solid Tissue	False	Tumor
TCGA-B5-A0K2-01A	a8079ea5-c37b-4f77-aca0-b043bf420675	Adenomas and Adenocarcinomas	a8079ea5-c37b-4f77-aca0-b043bf420675	TCGA-B5-A0K2	Corpus uteri	Not Reported	white	female	not reported	Alive	54.0	-20080.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	2209.0	20080.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20080.0	55.013698630136986	['2019-07-31T22:27:29.829245-05:00', '2019-07-31T22:27:29.829245-05:00']	['1e1191a3-0b25-5019-82c7-0b995e1ccd88', 'a71ac3d7-b3a9-5cac-81e0-461a1eb4cd4c']	['TCGA-B5-A0K2_treatment', 'TCGA-B5-A0K2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:28:09.610676-05:00']	01	Primary	17122498-71c0-4094-a86e-863da3116463	Primary Tumor	Not Reported	534.0	270.0	OCT	5D780459-F4E6-4BB8-939D-5FDFD9BF7073	true	Solid Tissue	False	Tumor
TCGA-BK-A56F-01A	2d166dc0-8890-4b00-ab73-9e2dbb6c530d	Adenomas and Adenocarcinomas	2d166dc0-8890-4b00-ab73-9e2dbb6c530d	TCGA-BK-A56F	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	75.0	-27523.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	401.0	27523.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27523.0	75.40547945205479	['2019-07-31T22:14:38.859331-05:00', '2019-07-31T22:14:38.859331-05:00']	['e8ca6047-6cfd-5ff0-9bb0-29364dff36a7', 'f696ebef-3673-5382-8e0f-a270338019e9']	['TCGA-BK-A56F_treatment', 'TCGA-BK-A56F_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:17:46.965883-05:00']	01	Primary	ef8e84ff-3e1b-4543-99ee-56ee8687795c	Primary Tumor	Not Reported	93.0	360.0	Unknown	2778F3EE-0211-4B51-8FBE-050FC7A4D0FF	false	Solid Tissue	False	Tumor
TCGA-BG-A0M3-01A	8bdd4e0e-5bec-43f2-b9fa-d6e94a72fe05	Adenomas and Adenocarcinomas	8bdd4e0e-5bec-43f2-b9fa-d6e94a72fe05	TCGA-BG-A0M3	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27183.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1071.0	27183.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27183.0	74.47397260273972	['2019-07-31T22:24:43.887467-05:00', '2019-07-31T22:24:43.887467-05:00']	['2b8a8500-6f9a-53f3-8a19-307f83436619', '8da9a0a6-d51c-513f-8ad2-4828fa6efb5e']	['TCGA-BG-A0M3_treatment_1', 'TCGA-BG-A0M3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:25:54.759041-05:00', '']	01	Primary	1802cd6b-4d4a-45fa-b839-7450071e41ee	Primary Tumor	Not Reported	597.0	100.0	OCT	19AABBD8-3DC5-418E-9B62-37CF7500F174	true	Solid Tissue	False	Tumor
TCGA-B5-A11V-01A	d3c83c5e-acb1-4cb0-8f56-96341822582f	Adenomas and Adenocarcinomas	d3c83c5e-acb1-4cb0-8f56-96341822582f	TCGA-B5-A11V	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	64.0	-23630.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	595.0	23630.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23630.0	64.73972602739725	['2019-07-31T22:31:25.630194-05:00', '2019-07-31T22:31:25.630194-05:00']	['02746174-8cf1-5a4e-a797-2521c3af3b09', '45d01c6b-7ac8-58e1-b687-b2d440fac32b']	['TCGA-B5-A11V_treatment_1', 'TCGA-B5-A11V_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:31:20.705806-05:00', '']	01	Primary	1eb9c43a-17d8-4fa7-b779-9277ff828cb1	Primary Tumor	Not Reported	294.0	760.0	OCT	E1B5A941-5EEB-4207-84DC-F3BF22D5FC29	true	Solid Tissue	False	Tumor
TCGA-FI-A2EW-01A	93d6df4a-aea2-48c2-8b6a-4b3eca0bf26f	Cystic, Mucinous and Serous Neoplasms	93d6df4a-aea2-48c2-8b6a-4b3eca0bf26f	TCGA-FI-A2EW	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	71.0	-26267.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	1795.0	26267.0	Serous cystadenocarcinoma, NOS	no	2005.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26267.0	71.96438356164384	['2019-07-31T22:25:23.112760-05:00', '2019-07-31T22:25:23.112760-05:00']	['3dc0ea35-e22f-5639-b0e4-5fb7fbc8e19d', '4f90e1a2-5ddf-55d2-bd23-376da548d0f4']	['TCGA-FI-A2EW_treatment', 'TCGA-FI-A2EW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:26:27.036491-05:00']	01	Primary	c10f91bf-385f-4e50-a9ef-67cf43b279b1	Primary Tumor	Not Reported	2321.0	120.0	OCT	3DED6690-5A21-4EDC-B9D4-5E1F2F5A9CC1	true	Solid Tissue	False	Tumor
TCGA-BS-A0TD-01A	ffaa98a0-2b69-46dc-aee5-c5c3f2abbc38	Adenomas and Adenocarcinomas	ffaa98a0-2b69-46dc-aee5-c5c3f2abbc38	TCGA-BS-A0TD	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	65.0	-23950.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Corpus uteri	2379.0	23950.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.9	Corpus uteri	Not Reported	not reported	23950.0	65.61643835616438	['2019-07-31T22:37:04.027423-05:00', '2019-07-31T22:37:04.027423-05:00']	['18b3e8f2-d739-5b10-9088-c494df51ddb3', 'c70e675a-5824-505d-9e3f-9058682a71b3']	['TCGA-BS-A0TD_treatment_1', 'TCGA-BS-A0TD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:35:52.702462-05:00', '']	01	Primary	8bb3a057-8958-4f62-af81-976da2e92df7	Primary Tumor	Not Reported	2004.0	150.0	Unknown	51ABEFF0-EEA1-48CA-9E00-CC57D1A2DEB0	false	Solid Tissue	False	Tumor
TCGA-AX-A2HH-01A	52fef8a9-6860-48bd-b992-a56ccad1243c	Adenomas and Adenocarcinomas	52fef8a9-6860-48bd-b992-a56ccad1243c	TCGA-AX-A2HH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-21924.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	540.0	21924.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21924.0	60.06575342465754	['2019-07-31T22:19:10.815476-05:00', '2019-07-31T22:19:10.815476-05:00']	['667b911a-497b-5365-acb6-1e20e8d03571', 'b7522251-1f1c-5103-ac45-92e2008a62a9']	['TCGA-AX-A2HH_treatment_1', 'TCGA-AX-A2HH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:21:26.111318-05:00', '']	01	Primary	0e73eeac-251a-43fa-9141-636262ee3129	Primary Tumor	Not Reported	462.0	150.0	Unknown	2EE7245F-7069-456A-A215-41E59D9FE606	false	Solid Tissue	False	Tumor
TCGA-B5-A5OD-01A	3e240dc0-80b7-41ea-81b3-33ece2753c2b	Cystic, Mucinous and Serous Neoplasms	3e240dc0-80b7-41ea-81b3-33ece2753c2b	TCGA-B5-A5OD	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	67.0	-24775.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1038.0	24775.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24775.0	67.87671232876713	['2019-07-31T22:16:35.201976-05:00', '2019-07-31T22:16:35.201976-05:00']	['89c32f7a-7690-546f-b303-d1a69c53ad64', '9725ad32-fd3c-50be-8099-3dc0b2cb2f78']	['TCGA-B5-A5OD_treatment', 'TCGA-B5-A5OD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:19:22.266722-05:00']	01	Primary	71994580-4a7f-433d-80d3-71e408d44eb3	Primary Tumor	Not Reported	662.0	370.0	OCT	8A0B9737-98D2-4A61-95FF-18842056A6DE	true	Solid Tissue	False	Tumor
TCGA-BG-A0MC-01A	884fd57d-bd8e-40e7-82f6-0ba1c71101a9	Adenomas and Adenocarcinomas	884fd57d-bd8e-40e7-82f6-0ba1c71101a9	TCGA-BG-A0MC	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27136.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1263.0	27136.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27136.0	74.34520547945205	['2019-07-31T22:24:23.467392-05:00', '2019-07-31T22:24:23.467392-05:00']	['321d5fa3-73a7-55cf-8d9e-be6ae758f8f1', '6d91b950-ac08-5e7e-95f1-27820d5c7083']	['TCGA-BG-A0MC_treatment_1', 'TCGA-BG-A0MC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:25:36.347610-05:00', '']	01	Primary	46b48bf8-346b-4f25-916e-26a3cddfa00d	Primary Tumor	Not Reported	779.0	630.0	OCT	100F4900-491A-438B-9704-51D4E016B325	true	Solid Tissue	False	Tumor
TCGA-D1-A3DG-01A	7890628d-7120-4dbc-85ae-1f895b6660c2	Adenomas and Adenocarcinomas	7890628d-7120-4dbc-85ae-1f895b6660c2	TCGA-D1-A3DG	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	81.0	-29771.0	1930.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	130.0															Stage IVB	No	0.0	not reported	Endometrium	130.0	29771.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29771.0	81.56438356164384	['2019-07-31T22:23:12.654408-05:00', '2019-07-31T22:23:12.654408-05:00']	['5e372c3f-a63c-5eba-a549-6a82f4264378', 'b17f86ce-7b1c-5122-9bbb-c8055aba484e']	['TCGA-D1-A3DG_treatment_1', 'TCGA-D1-A3DG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:24:39.581176-05:00', '']	01	Primary	ad26154d-5587-4af9-975f-367d712a5749	Primary Tumor	Not Reported	49.0	140.0	OCT	97C44FFC-8D88-43DC-BCC9-F634151C7098	true	Solid Tissue	False	Tumor
TCGA-B5-A0K3-01A	79ecc142-8f6e-4260-a7ce-c8e2a6212c35	Adenomas and Adenocarcinomas	79ecc142-8f6e-4260-a7ce-c8e2a6212c35	TCGA-B5-A0K3	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	62.0	-22664.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	830.0															Stage IA	No	0.0	not reported	Endometrium	700.0	22664.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22664.0	62.09315068493151	['2019-07-31T22:23:15.478328-05:00', '2019-07-31T22:23:15.478328-05:00']	['4ffa9f48-e839-5b6a-9cff-92d0321c588a', 'c6541fbe-833d-596a-8b77-a3916bd71eca']	['TCGA-B5-A0K3_treatment', 'TCGA-B5-A0K3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:24:42.144646-05:00']	01	Primary	ed31ddc2-feda-496e-a642-0c4b5dce014d	Primary Tumor	Not Reported	523.0	390.0	OCT	2D78431C-7385-4BD3-B597-85E613D89BF6	true	Solid Tissue	False	Tumor
TCGA-EY-A1GO-01A	9370e189-8fb7-4bfa-8ef9-2220f3557188	Adenomas and Adenocarcinomas	9370e189-8fb7-4bfa-8ef9-2220f3557188	TCGA-EY-A1GO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	65.0	-23853.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	586.0	23853.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23853.0	65.35068493150685	['2019-07-31T22:25:20.225373-05:00', '2019-07-31T22:25:20.225373-05:00']	['1bf9e4d5-faeb-5ff7-8742-47defac8fd1c', '223e6b7e-50a5-5aac-8776-870c1b5ef5b9']	['TCGA-EY-A1GO_treatment', 'TCGA-EY-A1GO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:26:24.724007-05:00']	01	Primary	84c460ba-e8a0-43ea-a4c3-c838d5587f99	Primary Tumor	Not Reported	259.0	100.0	Unknown	82216372-E1EF-47F2-B57A-25C1DCB24E5E	false	Solid Tissue	False	Tumor
TCGA-EO-A3L0-01A	423da953-30aa-4f7e-96b5-1f6fd24f8874	Adenomas and Adenocarcinomas	423da953-30aa-4f7e-96b5-1f6fd24f8874	TCGA-EO-A3L0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	76.0	-28003.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1554.0	28003.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28003.0	76.72054794520548	['2019-07-31T22:17:21.141223-05:00', '2019-07-31T22:17:21.141223-05:00']	['771cc516-8641-5e44-9b2e-3b0fc459a779', 'fccef7e2-d697-541a-91fc-4807fca8bf5e']	['TCGA-EO-A3L0_treatment_1', 'TCGA-EO-A3L0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:19:58.191276-05:00', '']	01	Primary	73d4918c-8bab-4753-9d47-355b51dbbbfa	Primary Tumor	Not Reported	422.0	110.0	Unknown	AD1F0EEC-20B6-416B-9728-BC103D2B3B87	false	Solid Tissue	False	Tumor
TCGA-D1-A16D-01A	5693302a-4548-4c0b-8725-0cb7c67bc4f8	Adenomas and Adenocarcinomas	5693302a-4548-4c0b-8725-0cb7c67bc4f8	TCGA-D1-A16D	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	49.0	-17933.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	1141.0	17933.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17933.0	49.131506849315066	['2019-07-31T22:19:36.605106-05:00', '2019-07-31T22:19:36.605106-05:00']	['3a1896c3-892c-54a9-8571-1d92e02b85e2', 'f54eb415-176d-555a-b62f-b00ccdd0d020']	['TCGA-D1-A16D_treatment_1', 'TCGA-D1-A16D_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:21:45.939498-05:00', '']	01	Primary	007bdfd3-81b6-42c3-a4a6-c4ddaf1be0ae	Primary Tumor	Not Reported	799.0	130.0	Unknown	795A5264-493A-498D-A731-87ECB0A7F612	false	Solid Tissue	False	Tumor
TCGA-AJ-A3EJ-01A	672de064-3378-4004-a3ea-f79885e10d78	Cystic, Mucinous and Serous Neoplasms	672de064-3378-4004-a3ea-f79885e10d78	TCGA-AJ-A3EJ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	74.0	-27317.0	1936.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	50.0															Stage IIIC2	No	0.0	not reported	Endometrium		27317.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27317.0	74.84109589041095	['2019-07-31T22:21:29.632583-05:00', '2019-07-31T22:21:29.632583-05:00']	['8674bbae-61f4-5e98-a29c-ce0ef3e9f93f', 'eae709de-7991-5ee2-a4dd-2934087dc4a6']	['TCGA-AJ-A3EJ_treatment', 'TCGA-AJ-A3EJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:16.603016-05:00']	01	Primary	3960cc6d-3c1d-48c6-8ddb-4fc700060e1b	Primary Tumor	Not Reported	332.0	20.0	Unknown	FB99D237-4583-4298-844F-43B2F99F83E3	false	Solid Tissue	False	Tumor
TCGA-EO-A22T-11A	63170b0e-78cf-45d9-af9d-ce986ac66991	Adenomas and Adenocarcinomas	63170b0e-78cf-45d9-af9d-ce986ac66991	TCGA-EO-A22T	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	56.0	-20608.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	2035.0	20608.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20608.0	56.46027397260274	['2019-07-31T22:21:07.737200-05:00', '2019-07-31T22:21:07.737200-05:00']	['5c71a802-d5bc-5802-8810-d7e3509385bd', 'fb692730-85bf-5ac6-ad3e-318b0eb96063']	['TCGA-EO-A22T_treatment_1', 'TCGA-EO-A22T_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:22:59.578939-05:00', '']	11	Not Applicable	9695d28b-ca9d-42c9-bfef-9d234e257b05	Solid Tissue Normal	Not Reported	1049.0	180.0	Unknown		false	Solid Tissue	False	Normal
TCGA-EO-A22T-01A	63170b0e-78cf-45d9-af9d-ce986ac66991	Adenomas and Adenocarcinomas	63170b0e-78cf-45d9-af9d-ce986ac66991	TCGA-EO-A22T	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	56.0	-20608.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	2035.0	20608.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20608.0	56.46027397260274	['2019-07-31T22:21:07.737200-05:00', '2019-07-31T22:21:07.737200-05:00']	['5c71a802-d5bc-5802-8810-d7e3509385bd', 'fb692730-85bf-5ac6-ad3e-318b0eb96063']	['TCGA-EO-A22T_treatment_1', 'TCGA-EO-A22T_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:22:59.578939-05:00', '']	01	Primary	bf5a963a-4aa7-428b-acd6-606093a0ff2a	Primary Tumor	Not Reported	916.0	140.0	Unknown	1D5567D9-3015-452E-9888-2E67F91D6B20	false	Solid Tissue	False	Tumor
TCGA-B5-A0K1-01A	40a3ed98-3892-449c-b07e-7b7612bd997e	Adenomas and Adenocarcinomas	40a3ed98-3892-449c-b07e-7b7612bd997e	TCGA-B5-A0K1	Corpus uteri	Not Reported	white	female	not reported	Alive	69.0	-25291.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1110.0	25291.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25291.0	69.2904109589041	['2019-07-31T22:16:59.649168-05:00', '2019-07-31T22:16:59.649168-05:00']	['1f4e4efe-3923-5f9a-8402-62d6dd5ef2f2', '7de3abe3-f926-51d2-a411-a8730af5d70c']	['TCGA-B5-A0K1_treatment_1', 'TCGA-B5-A0K1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:19:42.105339-05:00', '']	01	Primary	b514f636-dee3-45f3-bb31-197ca6a171f1	Primary Tumor	Not Reported	636.0	180.0	OCT	826BF8E6-F928-4962-9322-78FA74F9FB0E	true	Solid Tissue	False	Tumor
TCGA-D1-A165-01A	9bc2f33f-3067-4000-bc8a-1c5bb671d101	Adenomas and Adenocarcinomas	9bc2f33f-3067-4000-bc8a-1c5bb671d101	TCGA-D1-A165	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23526.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	20.0	23526.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23526.0	64.45479452054795	['2019-07-31T22:25:59.081252-05:00', '2019-07-31T22:25:59.081252-05:00']	['302c56de-3836-5d29-9e73-f4532f4af26d', '716f4483-5982-5ad9-bb4e-e84176946e67']	['TCGA-D1-A165_treatment', 'TCGA-D1-A165_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:26:57.113962-05:00']	01	Primary	ba3d9cb2-0d1c-4f3b-b1b8-a6dd4ac9adef	Primary Tumor	Not Reported	848.0	90.0	Unknown	476F8219-DAAE-4DB3-BA31-C64AC24ACF65	false	Solid Tissue	False	Tumor
TCGA-A5-A0GP-01A	0547cdfa-c488-4da0-9bb5-4cc63a637179	Adenomas and Adenocarcinomas	0547cdfa-c488-4da0-9bb5-4cc63a637179	TCGA-A5-A0GP	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	58.0	-21365.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1416.0	21365.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21365.0	58.534246575342465	['2019-07-31T22:10:36.233268-05:00', '2019-07-31T22:10:36.233268-05:00']	['2682baa7-0d1d-5ec3-94ba-6653052f3a15', '29ef3264-88ac-59af-a9c9-e5a02dc63f2c']	['TCGA-A5-A0GP_treatment', 'TCGA-A5-A0GP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:14:31.079697-05:00']	01	Primary	1797c4d9-1677-4ff6-ba71-98331d53f6c6	Primary Tumor	Not Reported	1030.0	160.0	OCT	A730192C-227E-4A86-96B9-8670D3F5EF59	true	Solid Tissue	False	Tumor
TCGA-AP-A0LN-01A	60fcf50a-8598-475d-8dd0-6b3044661233	Adenomas and Adenocarcinomas	60fcf50a-8598-475d-8dd0-6b3044661233	TCGA-AP-A0LN	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	56.0	-20704.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2510.0	20704.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20704.0	56.723287671232875	['2019-07-31T22:20:46.655133-05:00', '2019-07-31T22:20:46.655133-05:00']	['537481e1-c300-5a82-9163-d9ffbbc574df', 'a1d28366-9d31-5e08-9b5a-b862b2421b63']	['TCGA-AP-A0LN_treatment_1', 'TCGA-AP-A0LN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:22:42.809263-05:00', '']	01	Primary	90a221e7-8579-4af2-9b39-40de3c42f71c	Primary Tumor	Not Reported	1907.0	250.0	OCT	D50C7207-D840-48A2-8D73-E1C71FFA73E1	true	Solid Tissue	False	Tumor
TCGA-D1-A17M-01A	02b2cd50-221f-437c-a1ce-6da1467ec809	Adenomas and Adenocarcinomas	02b2cd50-221f-437c-a1ce-6da1467ec809	TCGA-D1-A17M	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20685.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	311.0	20685.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20685.0	56.67123287671233	['2019-07-31T22:10:27.090764-05:00', '2019-07-31T22:10:27.090764-05:00']	['149d8bd2-4578-5e0a-af56-0a5873dcb7b7', 'c76664c7-f9f7-5ddc-b6c1-509eac7499a1']	['TCGA-D1-A17M_treatment_1', 'TCGA-D1-A17M_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:14:23.596115-05:00', '']	01	Primary	027f53c8-0687-495f-917a-4dc6894216a6	Primary Tumor	Not Reported	454.0	140.0	Unknown	E69EF984-AF58-4EB0-93D2-CADE53DF0A6D	false	Solid Tissue	False	Tumor
TCGA-B5-A11I-01A	f6d136c7-c250-4361-9fed-50f513959a40	Adenomas and Adenocarcinomas	f6d136c7-c250-4361-9fed-50f513959a40	TCGA-B5-A11I	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	65.0	-23857.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	No	0.0	not reported	Endometrium	2303.0	23857.0	Adenocarcinoma, NOS	no	2005.0	No	8140/3	not reported	C54.1	Endometrium	Not Reported	not reported	23857.0	65.36164383561643	['2019-07-31T22:35:47.581650-05:00', '2019-07-31T22:35:47.581650-05:00']	['1e269e8b-584c-5dbe-ad4d-2c5b8358bd59', 'e5c3b949-f6a9-508e-bd0b-b2108f426a4b']	['TCGA-B5-A11I_treatment', 'TCGA-B5-A11I_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:34:50.751503-05:00']	01	Primary	56652dde-33da-451e-a1c2-6e9884f9915a	Primary Tumor	Not Reported	1974.0	970.0	OCT	850EFCC5-484B-4E09-801A-2FAFB4CFD72B	true	Solid Tissue	False	Tumor
TCGA-BK-A13C-01A	ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38	Adenomas and Adenocarcinomas	ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38	TCGA-BK-A13C	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	47.0	-17317.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	760.0	17317.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17317.0	47.443835616438356	['2019-07-31T22:30:52.586440-05:00', '2019-07-31T22:30:52.586440-05:00']	['6ceb7a98-17df-53e0-a3b2-b49f1bfbecb4', 'ae363043-0668-5e9f-82b7-125cf2d2d6cc']	['TCGA-BK-A13C_treatment_1', 'TCGA-BK-A13C_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:54.278656-05:00', '']	01	Primary	7cc1bcb4-63a2-4585-b936-30a9e23caccc	Primary Tumor	Not Reported	146.0	310.0	Unknown	2043D579-6785-4775-8A28-CDE3F1400BA2	false	Solid Tissue	False	Tumor
TCGA-BK-A13C-11A	ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38	Adenomas and Adenocarcinomas	ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38	TCGA-BK-A13C	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	47.0	-17317.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	760.0	17317.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17317.0	47.443835616438356	['2019-07-31T22:30:52.586440-05:00', '2019-07-31T22:30:52.586440-05:00']	['6ceb7a98-17df-53e0-a3b2-b49f1bfbecb4', 'ae363043-0668-5e9f-82b7-125cf2d2d6cc']	['TCGA-BK-A13C_treatment_1', 'TCGA-BK-A13C_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:54.278656-05:00', '']	11	Not Applicable	badde2a2-91b8-4f92-9993-a854f408c887	Solid Tissue Normal	Not Reported	146.0	270.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BG-A0MQ-01A	12d36a1d-9922-4311-bbda-71f32ac2c03b	Adenomas and Adenocarcinomas	12d36a1d-9922-4311-bbda-71f32ac2c03b	TCGA-BG-A0MQ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	71.0	-26284.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1817.0	26284.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26284.0	72.01095890410959	['2019-07-31T22:12:13.133283-05:00', '2019-07-31T22:12:13.133283-05:00']	['85eb8154-5e49-5f0d-84fd-c80b6ee653b1', '8e109c6f-9371-54a9-ab59-163e7d560653']	['TCGA-BG-A0MQ_treatment', 'TCGA-BG-A0MQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:15:50.176633-05:00']	01	Primary	3d1fa321-d2e8-4460-ae87-356ab1ca6281	Primary Tumor	Not Reported	692.0	120.0	OCT	3252AEB3-3B0D-4066-B18E-31096F928D63	true	Solid Tissue	False	Tumor
TCGA-KP-A3W3-01A	0264c9c2-6b6a-485c-98f5-aed4f52ed0ca	Cystic, Mucinous and Serous Neoplasms	0264c9c2-6b6a-485c-98f5-aed4f52ed0ca	TCGA-KP-A3W3	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	72.0	-26310.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	821aedb4-8788-5cb9-ae05-e670f0be1f9f	KP	British Columbia Cancer Agency	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	794.0	26310.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26310.0	72.08219178082192	['2019-07-31T22:10:10.905062-05:00', '2019-07-31T22:10:10.905062-05:00']	['b16fb506-fb87-5411-9bfd-0ea0253156ab', 'f68f37cc-4f05-5ca2-b716-52f6a66f169a']	['TCGA-KP-A3W3_treatment_1', 'TCGA-KP-A3W3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:14:10.439888-05:00', '']	01	Primary	d54f4476-7191-4a52-a310-8392f62404cb	Primary Tumor	Not Reported	739.0	680.0	OCT	9D8F170A-A4B1-463A-B92C-357870762EAD	true	Solid Tissue	False	Tumor
TCGA-AX-A05S-01A	3a4a6aff-4720-41fc-a114-85f38610ebb1	Adenomas and Adenocarcinomas	3a4a6aff-4720-41fc-a114-85f38610ebb1	TCGA-AX-A05S	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	81.0	-29928.0	1927.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	413.0															Stage IIIC	No	0.0	not reported	Endometrium		29928.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29928.0	81.9945205479452	['2019-07-31T22:16:03.868518-05:00', '2019-07-31T22:16:03.868518-05:00']	['1e7dd1b8-dd21-5337-a2b7-893227fec9c5', '66071faf-6cc8-5867-9e12-8dac95934630']	['TCGA-AX-A05S_treatment_1', 'TCGA-AX-A05S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:18:57.572486-05:00', '']	01	Primary	3d8f263f-6866-4b92-aaee-743ec5514865	Primary Tumor	Not Reported	507.0	230.0	Unknown	571B1EC2-3698-4FF2-89DD-7C5A8A048660	false	Solid Tissue	False	Tumor
TCGA-B5-A0JZ-01A	d129ebb4-db21-4342-8d9b-318a67aefa56	Adenomas and Adenocarcinomas	d129ebb4-db21-4342-8d9b-318a67aefa56	TCGA-B5-A0JZ	Corpus uteri	Not Reported	white	female	not reported	Alive	60.0	-22106.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	2173.0	22106.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22106.0	60.56438356164384	['2019-07-31T22:31:01.434190-05:00', '2019-07-31T22:31:01.434190-05:00']	['52942e59-628b-5748-a05a-4cbe3aea5d2b', 'efecd461-e321-5e50-8a37-9da1c25d5b30']	['TCGA-B5-A0JZ_treatment', 'TCGA-B5-A0JZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:01.644429-05:00']	01	Primary	5e55ac8b-23b4-4cde-825a-753ed8c9208c	Primary Tumor	Not Reported	642.0	400.0	OCT	B275A085-067D-42ED-8E41-8461D5183A6E	true	Solid Tissue	False	Tumor
TCGA-AJ-A3BD-01A	ab68cd1b-5075-4b30-a829-d6d0f95871cb	Cystic, Mucinous and Serous Neoplasms	ab68cd1b-5075-4b30-a829-d6d0f95871cb	TCGA-AJ-A3BD	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-20998.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	1039.0	20998.0	Papillary serous cystadenocarcinoma	no	2011.0	No	8460/3	not reported	C54.1	Endometrium	Not Reported	not reported	20998.0	57.52876712328767	['2019-07-31T22:27:54.120777-05:00', '2019-07-31T22:27:54.120777-05:00']	['0f11beca-c742-5020-8e34-25c01a756d48', '63ac8123-6bc2-56c4-9e8d-9ea1c4bbfad7']	['TCGA-AJ-A3BD_treatment', 'TCGA-AJ-A3BD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:28:29.160830-05:00']	01	Primary	a41beebe-3c3a-41fc-a611-0e9b322f638b	Primary Tumor	Not Reported	170.0	200.0	Unknown	8B7CB7C6-86B5-41EA-A6CB-FC496C311888	false	Solid Tissue	False	Tumor
TCGA-EY-A1GM-01A	1a094c2b-9fba-4bb1-929d-bb2cdf874bee	Cystic, Mucinous and Serous Neoplasms	1a094c2b-9fba-4bb1-929d-bb2cdf874bee	TCGA-EY-A1GM	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	60.0	-22010.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	995.0															Stage IIIA	No	0.0	not reported	Endometrium	210.0	22010.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22010.0	60.3013698630137	['2019-07-31T22:12:58.806470-05:00', '2019-07-31T22:12:58.806470-05:00']	['4e2ae154-79b8-5258-9d89-3f465a92f361', 'd6040671-c8b0-554d-bfc9-a81c40f2a1c0']	['TCGA-EY-A1GM_treatment', 'TCGA-EY-A1GM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:16:27.698141-05:00']	01	Primary	95fded4f-677e-4dcf-a5c4-6b344fbccfd4	Primary Tumor	Not Reported	323.0	140.0	Unknown	C3599CB9-3B69-4083-AA2E-5BB52CF1ED93	false	Solid Tissue	False	Tumor
TCGA-AX-A2IN-01A	fe79ebe1-cd0a-4ce2-a86d-637c28354ed9	Adenomas and Adenocarcinomas	fe79ebe1-cd0a-4ce2-a86d-637c28354ed9	TCGA-AX-A2IN	Corpus uteri	Not Reported	white	female	not reported	Dead	63.0	-23275.0	1944.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	947.0															Stage IC	No	0.0	not reported	Endometrium		23275.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23275.0	63.76712328767123	['2019-07-31T22:36:52.804957-05:00', '2019-07-31T22:36:52.804957-05:00']	['afb31d48-c65b-5ff7-8d73-ee08eb562d16', 'fe24a5dc-c39d-5f73-a561-b0a6026b833e']	['TCGA-AX-A2IN_treatment', 'TCGA-AX-A2IN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:35:42.704117-05:00']	01	Primary	c28c7656-4790-485f-bd27-c8a6a35d2dd1	Primary Tumor	Not Reported	1321.0	60.0	Unknown	3C67A037-8A4C-4345-B842-43F1F0A6A53E	false	Solid Tissue	False	Tumor
TCGA-A5-A0VP-01A	2db0fb62-64ce-457c-9e22-dd05ef59f684	Adenomas and Adenocarcinomas	2db0fb62-64ce-457c-9e22-dd05ef59f684	TCGA-A5-A0VP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27335.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1288.0	27335.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27335.0	74.89041095890411	['2019-07-31T22:14:45.119431-05:00', '2019-07-31T22:14:45.119431-05:00']	['0f3609ac-7602-5079-a04b-e36bfe02b33d', 'a3666392-744d-5d18-800e-443e3171d222']	['TCGA-A5-A0VP_treatment_1', 'TCGA-A5-A0VP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:17:51.777378-05:00', '']	01	Primary	f1fbe4ac-f3fd-4609-9a2b-507820abe77e	Primary Tumor	Not Reported	930.0	210.0	OCT	960B26D6-F9BA-4099-B6F4-6D1DEA6C0F0F	true	Solid Tissue	False	Tumor
TCGA-EO-A2CG-01A	af363cec-bec9-4de3-8cc2-e98b0eed2858	Cystic, Mucinous and Serous Neoplasms	af363cec-bec9-4de3-8cc2-e98b0eed2858	TCGA-EO-A2CG	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	69.0	-25279.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1564.0	25279.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25279.0	69.25753424657535	['2019-07-31T22:28:20.884548-05:00', '2019-07-31T22:28:20.884548-05:00']	['1488e994-e459-5daf-ba2e-e37bba5831c0', '5f6c3462-b98b-589d-af5c-7f1e22c399d6']	['TCGA-EO-A2CG_treatment', 'TCGA-EO-A2CG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:28:51.574625-05:00']	01	Primary	cf894594-77cc-471e-b112-5eae1829c415	Primary Tumor	Not Reported	643.0	60.0	Unknown	CAF671DB-2DD1-43D5-99C8-185253775B37	false	Solid Tissue	False	Tumor
TCGA-D1-A16N-01A	dbbbddae-d711-40f5-bd10-863735885b1f	Adenomas and Adenocarcinomas	dbbbddae-d711-40f5-bd10-863735885b1f	TCGA-D1-A16N	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	51.0	-18787.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	945.0	18787.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18787.0	51.47123287671233	['2019-07-31T22:32:20.240805-05:00', '2019-07-31T22:32:20.240805-05:00']	['188d6bb5-c6e1-5006-accf-d5952a9a23b3', 'b957ae85-6a97-54ff-85af-bf337f8f225f']	['TCGA-D1-A16N_treatment_1', 'TCGA-D1-A16N_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:32:04.541760-05:00', '']	01	Primary	6d916a47-dcff-4c98-9e88-348aaa353f98	Primary Tumor	Not Reported	629.0	240.0	Unknown	81CFA07C-5FCE-41F3-88D1-FFD17840B293	false	Solid Tissue	False	Tumor
TCGA-D1-A2G7-01A	32b5d0e4-a242-44d1-ac20-6e5ca2f35b71	Cystic, Mucinous and Serous Neoplasms	32b5d0e4-a242-44d1-ac20-6e5ca2f35b71	TCGA-D1-A2G7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	65.0	-23913.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	1793.0															Stage IB	No	0.0	not reported	Endometrium	1365.0	23913.0	Serous cystadenocarcinoma, NOS	no	2007.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23913.0	65.51506849315068	['2019-07-31T22:15:13.053667-05:00', '2019-07-31T22:15:13.053667-05:00']	['96f6d679-6203-54a2-9a1e-b4162d4516ac', 'b3e5c23b-4c50-5d77-b375-7b4124427dd9']	['TCGA-D1-A2G7_treatment', 'TCGA-D1-A2G7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:18:15.228869-05:00']	01	Primary	9c10d27c-4372-4c1f-8a92-f84a387a1161	Primary Tumor	Not Reported	1339.0	110.0	OCT	5D25FD0B-EEE9-435C-82C7-BC44B0758A14	true	Solid Tissue	False	Tumor
TCGA-AX-A05Z-01A	bf632368-8ce7-4b4b-8842-d1b1801e62ef	Adenomas and Adenocarcinomas	bf632368-8ce7-4b4b-8842-d1b1801e62ef	TCGA-AX-A05Z	Corpus uteri	Not Reported	not reported	female	hispanic or latino	Alive	37.0	-13529.0	1969.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	2175.0	13529.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	13529.0	37.06575342465754	['2019-07-31T22:29:28.122417-05:00', '2019-07-31T22:29:28.122417-05:00']	['5109d5e8-9ef2-5e9e-914e-287c53658681', '7bb388ef-c59a-564b-aa63-5863916e2192']	['TCGA-AX-A05Z_treatment', 'TCGA-AX-A05Z_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:29:46.412063-05:00']	01	Primary	acda9261-6c73-4b31-aab3-97a40eddb9bd	Primary Tumor	Not Reported	1416.0	180.0	Unknown	5938A010-17E7-41FB-9F4D-8B4F1A3C0F2F	false	Solid Tissue	False	Tumor
TCGA-D1-A0ZV-01A	0c01c673-e396-47b2-9562-4144d7705ebf	Adenomas and Adenocarcinomas	0c01c673-e396-47b2-9562-4144d7705ebf	TCGA-D1-A0ZV	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21374.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	728.0	21374.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21374.0	58.558904109589044	['2019-07-31T22:11:27.748949-05:00', '2019-07-31T22:11:27.748949-05:00']	['9847d6e2-f1f8-5c53-a200-8ea26e33ecf5', 'd2cb5aa4-81a1-5ccc-8243-bfb7c9baf831']	['TCGA-D1-A0ZV_treatment', 'TCGA-D1-A0ZV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:15:12.754505-05:00']	01	Primary	a1cb5589-26dd-4d0e-9447-375ebeca6b78	Primary Tumor	Not Reported	324.0	110.0	Unknown	C9AE2762-705F-4061-B3B6-325426D0C0C8	false	Solid Tissue	False	Tumor
TCGA-EO-A1Y7-01A	71ed2681-79bb-4ffb-985c-6d3cf18e9168	Adenomas and Adenocarcinomas	71ed2681-79bb-4ffb-985c-6d3cf18e9168	TCGA-EO-A1Y7	Corpus uteri	Not Reported	not reported	female	not reported	Alive	65.0	-24085.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1495.0	24085.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24085.0	65.98630136986301	['2019-07-31T22:22:27.429795-05:00', '2019-07-31T22:22:27.429795-05:00']	['43e17df0-a242-5798-bda2-2e6444e243d4', 'e446f2a8-a89d-5181-9674-ccb2a9b095d4']	['TCGA-EO-A1Y7_treatment', 'TCGA-EO-A1Y7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:24:03.483322-05:00']	01	Primary	c27f13ab-69dd-403c-b81e-fc4bc4bfa329	Primary Tumor	Not Reported	196.0	140.0	Unknown	88AABD4B-ECB4-4748-B59F-BD4AE0621BFB	false	Solid Tissue	False	Tumor
TCGA-AX-A1CE-01A	4db38349-28d2-4af5-a12f-3d861937b0e0	Adenomas and Adenocarcinomas	4db38349-28d2-4af5-a12f-3d861937b0e0	TCGA-AX-A1CE	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-21969.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1037.0	21969.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21969.0	60.18904109589041	['2019-07-31T22:18:43.741986-05:00', '2019-07-31T22:18:43.741986-05:00']	['0772c2c5-f6e3-5f23-bc13-e77da523a86b', '25afc6f3-e19c-5de7-87c6-6cf7db53f79a']	['TCGA-AX-A1CE_treatment_1', 'TCGA-AX-A1CE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:21:04.134197-05:00', '']	01	Primary	cb0ceff2-34e2-420e-8924-51bb5872c6c5	Primary Tumor	Not Reported	504.0	130.0	Unknown	79482353-F9A0-4A36-97B3-F270241B2B50	false	Solid Tissue	False	Tumor
TCGA-B5-A11P-01B	d1c65e6a-098e-4c10-9183-c303ba66015a	Adenomas and Adenocarcinomas	d1c65e6a-098e-4c10-9183-c303ba66015a	TCGA-B5-A11P	Corpus uteri	Not Reported	white	female	not reported	Alive	87.0	-32047.0	1921.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	825.0	32047.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	32047.0	87.8	['2019-07-31T22:31:10.523152-05:00', '2019-07-31T22:31:10.523152-05:00']	['0ab65933-70af-536b-8007-a1b053b63419', '432c05d3-c1a2-5e2a-9aeb-dbf5075f0f96']	['TCGA-B5-A11P_treatment', 'TCGA-B5-A11P_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:31:08.598975-05:00']	01	Primary	64bf25f8-67bb-4f32-bad5-e879d1ad7736	Primary Tumor	Not Reported	979.0	120.0	OCT	77639636-9C18-4C81-9FCF-04BA2D92110E	true	Solid Tissue	False	Tumor
TCGA-FL-A1YV-11A	42ebfec9-6e28-4d72-9b9f-23a836800921	Not Reported	42ebfec9-6e28-4d72-9b9f-23a836800921	TCGA-FL-A1YV	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	2748d061-eb8e-4331-a88f-f4559a5433c3	Solid Tissue Normal	Not Reported		110.0	Unknown	DE7868BF-DA24-4C11-B331-6064E4CCCEAF	false	Solid Tissue	False	Normal
TCGA-EY-A3QX-01A	8bb89c0f-0f04-485e-8e08-801042dfcba9	Cystic, Mucinous and Serous Neoplasms	8bb89c0f-0f04-485e-8e08-801042dfcba9	TCGA-EY-A3QX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23663.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	989.0															Stage IVB	No	0.0	not reported	Endometrium	421.0	23663.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23663.0	64.83013698630137	['2019-07-31T22:24:40.665836-05:00', '2019-07-31T22:24:40.665836-05:00']	['2af2ea6f-38c3-5a69-93d1-349a4598bb99', '8df28490-bdfb-5835-8d4e-68c71fdb00c8']	['TCGA-EY-A3QX_treatment', 'TCGA-EY-A3QX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:25:52.387357-05:00']	01	Primary	8d1365a7-c67c-4073-8483-8693d4683ccd	Primary Tumor	Not Reported	112.0	659.0	Unknown	8AED036E-FB86-42D1-B840-FB4AD6E8D0EF	false	Solid Tissue	False	Tumor
TCGA-AX-A0J0-11A	1c7b41fc-daa7-4a6e-b553-aff73e8ebac6	Adenomas and Adenocarcinomas	1c7b41fc-daa7-4a6e-b553-aff73e8ebac6	TCGA-AX-A0J0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	47.0	-17466.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1220.0	17466.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17466.0	47.85205479452055	['2019-07-31T22:13:13.653227-05:00', '2019-07-31T22:13:13.653227-05:00']	['2835bf70-cfb3-5fd1-b16f-4beb3d0afb40', '3b53d30b-df55-5124-bb8e-b2b07424b9df']	['TCGA-AX-A0J0_treatment_1', 'TCGA-AX-A0J0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:16:40.013958-05:00', '']	11	Not Applicable	06731fda-e0ba-49d4-9d61-9c6cab663097	Solid Tissue Normal	Not Reported	1952.0	110.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A0J0-01A	1c7b41fc-daa7-4a6e-b553-aff73e8ebac6	Adenomas and Adenocarcinomas	1c7b41fc-daa7-4a6e-b553-aff73e8ebac6	TCGA-AX-A0J0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	47.0	-17466.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1220.0	17466.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17466.0	47.85205479452055	['2019-07-31T22:13:13.653227-05:00', '2019-07-31T22:13:13.653227-05:00']	['2835bf70-cfb3-5fd1-b16f-4beb3d0afb40', '3b53d30b-df55-5124-bb8e-b2b07424b9df']	['TCGA-AX-A0J0_treatment_1', 'TCGA-AX-A0J0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:16:40.013958-05:00', '']	01	Primary	e5dea504-d715-4682-ab51-fc6f52fc39a3	Primary Tumor	Not Reported	1581.0	180.0	Unknown	EC377A34-B219-4A4F-95DB-DF6E0050A63A	false	Solid Tissue	False	Tumor
TCGA-FI-A3PX-01A	3e8e34c8-766a-4514-97f4-8000b5350ab9	Cystic, Mucinous and Serous Neoplasms	3e8e34c8-766a-4514-97f4-8000b5350ab9	TCGA-FI-A3PX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-21063.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	2384.0	21063.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21063.0	57.706849315068496	['2019-07-31T22:16:40.820575-05:00', '2019-07-31T22:16:40.820575-05:00']	['90a0fd69-2c28-5d6c-bf20-9ff6caa18cf1', 'eb78b7e7-04c8-55d2-bb1a-0096881da26f']	['TCGA-FI-A3PX_treatment', 'TCGA-FI-A3PX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:19:27.148046-05:00']	01	Primary	9a1614c1-0c60-4a98-ac4c-447bfdf26576	Primary Tumor	Not Reported	1280.0	130.0	OCT	5E3FD49D-DE9B-4A5B-B4FC-2825CCB48B46	true	Solid Tissue	False	Tumor
TCGA-DI-A1NN-11A	944a102f-3475-45aa-9e30-4b92d1449f00	Cystic, Mucinous and Serous Neoplasms	944a102f-3475-45aa-9e30-4b92d1449f00	TCGA-DI-A1NN	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23026.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1076.0	23026.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23026.0	63.084931506849315	['2019-07-31T22:25:26.106059-05:00', '2019-07-31T22:25:26.106059-05:00']	['8cb75de4-f6ec-51d2-a0b4-feeb4135f148', 'f0d98b6f-8a12-5fa4-b2ff-bae5a61774fb']	['TCGA-DI-A1NN_treatment_1', 'TCGA-DI-A1NN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:26:29.486370-05:00', '']	11	Not Applicable	553fab81-fde1-4f15-8900-1fcef7c5cd63	Solid Tissue Normal	Not Reported	813.0	100.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DI-A1NN-01A	944a102f-3475-45aa-9e30-4b92d1449f00	Cystic, Mucinous and Serous Neoplasms	944a102f-3475-45aa-9e30-4b92d1449f00	TCGA-DI-A1NN	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23026.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1076.0	23026.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23026.0	63.084931506849315	['2019-07-31T22:25:26.106059-05:00', '2019-07-31T22:25:26.106059-05:00']	['8cb75de4-f6ec-51d2-a0b4-feeb4135f148', 'f0d98b6f-8a12-5fa4-b2ff-bae5a61774fb']	['TCGA-DI-A1NN_treatment_1', 'TCGA-DI-A1NN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:26:29.486370-05:00', '']	01	Primary	5fabce9c-0dfb-4b0d-8478-599fd181a84f	Primary Tumor	Not Reported	813.0	300.0	Unknown	EBBDE504-29C9-4662-8D06-44E8CBAD0741	false	Solid Tissue	False	Tumor
TCGA-AJ-A3TW-01A	9ee944ef-4293-4228-b750-cc34ab388eb3	Cystic, Mucinous and Serous Neoplasms	9ee944ef-4293-4228-b750-cc34ab388eb3	TCGA-AJ-A3TW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	78.0	-28559.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	513.0	28559.0	Serous cystadenocarcinoma, NOS	no	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	28559.0	78.24383561643836	['2019-07-31T22:26:20.481921-05:00', '2019-07-31T22:26:20.481921-05:00']	['23229ee4-af8d-5d34-8678-19aeb85322f8', '8386ff0e-9d6e-5d9d-a0ff-b0b95385c4bb']	['TCGA-AJ-A3TW_treatment', 'TCGA-AJ-A3TW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:13.397086-05:00']	01	Primary	25c226fa-c084-4128-8b49-62f1d5538aa0	Primary Tumor	Not Reported	71.0	230.0	Unknown	1271A645-AF29-453E-BEA8-420ECCD0DFDC	false	Solid Tissue	False	Tumor
TCGA-BG-A2AE-01A	f384eb3f-92ab-4327-87eb-45b5f72a1580	Cystic, Mucinous and Serous Neoplasms	f384eb3f-92ab-4327-87eb-45b5f72a1580	TCGA-BG-A2AE	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-21069.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	721.0	21069.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21069.0	57.723287671232875	['2019-07-31T22:35:29.762352-05:00', '2019-07-31T22:35:29.762352-05:00']	['8d7ad58c-5abb-5782-9834-3c6ac67f785b', 'ce1d2823-37fe-5088-8103-677f5225b794']	['TCGA-BG-A2AE_treatment_1', 'TCGA-BG-A2AE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:34:36.055675-05:00', '']	01	Primary	273a3b52-7613-400e-8ae1-a68c36ab6968	Primary Tumor	Not Reported	50.0	460.0	OCT	BA5BC88E-6A6C-425E-84B4-EC33DB9AC146	true	Solid Tissue	False	Tumor
TCGA-BG-A2AE-11A	f384eb3f-92ab-4327-87eb-45b5f72a1580	Cystic, Mucinous and Serous Neoplasms	f384eb3f-92ab-4327-87eb-45b5f72a1580	TCGA-BG-A2AE	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-21069.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	721.0	21069.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21069.0	57.723287671232875	['2019-07-31T22:35:29.762352-05:00', '2019-07-31T22:35:29.762352-05:00']	['8d7ad58c-5abb-5782-9834-3c6ac67f785b', 'ce1d2823-37fe-5088-8103-677f5225b794']	['TCGA-BG-A2AE_treatment_1', 'TCGA-BG-A2AE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:34:36.055675-05:00', '']	11	Not Applicable	479ee788-aefe-440d-9e45-3acbcd581272	Solid Tissue Normal	Not Reported	50.0	40.0	OCT		true	Solid Tissue	False	Normal
TCGA-KP-A3W1-01A	3bce9803-e74c-462e-bd40-8ec337a66f3a	Cystic, Mucinous and Serous Neoplasms	3bce9803-e74c-462e-bd40-8ec337a66f3a	TCGA-KP-A3W1	Corpus uteri	Not Reported	not reported	female	not reported	Alive	76.0	-27902.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	821aedb4-8788-5cb9-ae05-e670f0be1f9f	KP	British Columbia Cancer Agency	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	288.0	27902.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27902.0	76.44383561643835	['2019-07-31T22:16:15.687506-05:00', '2019-07-31T22:16:15.687506-05:00']	['5fb68338-f060-5745-b05e-d1e22e8dce57', '99fd35f6-5cc5-5425-baf3-1c742b048649']	['TCGA-KP-A3W1_treatment_1', 'TCGA-KP-A3W1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:19:07.258154-05:00', '']	01	Primary	1ad2a1ca-75e0-4f9f-808d-768cb14bdff3	Primary Tumor	Not Reported	198.0	710.0	OCT	58145248-B111-463A-A1CC-32DA993F0B26	true	Solid Tissue	False	Tumor
TCGA-D1-A1O8-01A	21faf1a4-f6d3-4cc6-a49a-04b8541ef598	Adenomas and Adenocarcinomas	21faf1a4-f6d3-4cc6-a49a-04b8541ef598	TCGA-D1-A1O8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	70.0	-25789.0	1940.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	120.0															Stage IIIC	No	0.0	not reported	Endometrium		25789.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25789.0	70.65479452054795	['2019-07-31T22:13:35.843886-05:00', '2019-07-31T22:13:35.843886-05:00']	['17f36da0-2cc8-5370-a870-ad3811c808c7', '19e75ecb-77be-502c-a084-819e38dde0d5']	['TCGA-D1-A1O8_treatment', 'TCGA-D1-A1O8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:16:57.872345-05:00']	01	Primary	1efc3a5a-d36d-4973-a725-2eeb73cce08e	Primary Tumor	Not Reported	147.0	200.0	Unknown	8E7FDFD5-892F-4671-8172-FC2BFB800AE9	false	Solid Tissue	False	Tumor
TCGA-D1-A16R-01A	40f43483-b504-4ea7-ad24-40682b10caac	Adenomas and Adenocarcinomas	40f43483-b504-4ea7-ad24-40682b10caac	TCGA-D1-A16R	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	39.0	-14465.0	1971.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	21.0	14465.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	14465.0	39.63013698630137	['2019-07-31T22:17:05.577561-05:00', '2019-07-31T22:17:05.577561-05:00']	['354197a5-3d09-509d-ae82-ba787b2a26be', '8132b1be-c8c3-5494-8c35-45da1a653c29']	['TCGA-D1-A16R_treatment', 'TCGA-D1-A16R_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:19:46.867231-05:00']	01	Primary	f57eb4ed-4393-4dc3-9362-a4757ef8b21d	Primary Tumor	Not Reported	161.0	290.0	Unknown	D9641375-D204-4469-989A-ED08DDE66408	false	Solid Tissue	False	Tumor
TCGA-D1-A162-01A	3f96b142-77b6-40a1-8e16-6581b964583b	Adenomas and Adenocarcinomas	3f96b142-77b6-40a1-8e16-6581b964583b	TCGA-D1-A162	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25543.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1145.0	25543.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25543.0	69.98082191780821	['2019-07-31T22:16:53.368889-05:00', '2019-07-31T22:16:53.368889-05:00']	['05fbac43-0b1f-5b1b-a1e1-b5d3b0c7d347', '3c3c641d-bca9-52cd-8ce6-a091443e8692']	['TCGA-D1-A162_treatment_1', 'TCGA-D1-A162_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:19:37.071322-05:00', '']	01	Primary	4357a0dc-7d05-4c36-949f-8b30e91e208a	Primary Tumor	Not Reported	874.0	180.0	Unknown	CB5E7FA1-33EE-492F-B2B0-F4C9332640A9	false	Solid Tissue	False	Tumor
TCGA-AX-A1CJ-11A	abaf757b-f79f-40bd-96e3-e2c0f63061f0	Adenomas and Adenocarcinomas	abaf757b-f79f-40bd-96e3-e2c0f63061f0	TCGA-AX-A1CJ	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	59.0	-21655.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	2233.0	21655.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21655.0	59.32876712328767	['2019-07-31T22:27:57.594413-05:00', '2019-07-31T22:27:57.594413-05:00']	['d6342517-fd86-5e1b-8941-d4ab81fd5212', 'f2e18f7d-746c-54ee-ba50-e6d17e039c4b']	['TCGA-AX-A1CJ_treatment_1', 'TCGA-AX-A1CJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:28:31.663139-05:00', '']	11	Not Applicable	210ae0ca-30cb-48ee-ae34-9228dbb7ee19	Solid Tissue Normal	Not Reported	1758.0	120.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A1CJ-01A	abaf757b-f79f-40bd-96e3-e2c0f63061f0	Adenomas and Adenocarcinomas	abaf757b-f79f-40bd-96e3-e2c0f63061f0	TCGA-AX-A1CJ	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	59.0	-21655.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	2233.0	21655.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21655.0	59.32876712328767	['2019-07-31T22:27:57.594413-05:00', '2019-07-31T22:27:57.594413-05:00']	['d6342517-fd86-5e1b-8941-d4ab81fd5212', 'f2e18f7d-746c-54ee-ba50-e6d17e039c4b']	['TCGA-AX-A1CJ_treatment_1', 'TCGA-AX-A1CJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:28:31.663139-05:00', '']	01	Primary	72d06ddf-9fb2-4577-bfdb-b0e463105b4a	Primary Tumor	Not Reported	1758.0	90.0	Unknown	AC9C3BB1-9B41-4B1F-BCEA-F6A0C68921B3	false	Solid Tissue	False	Tumor
TCGA-DI-A2QU-11A	e9fa66f5-282c-416a-9dcf-46714ea12fcf	Cystic, Mucinous and Serous Neoplasms	e9fa66f5-282c-416a-9dcf-46714ea12fcf	TCGA-DI-A2QU	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	67.0	-24488.0	1938.0	2007.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH	946.0															Stage IVB	No	0.0	not reported	Endometrium		24488.0	Serous cystadenocarcinoma, NOS	no	2005.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24488.0	67.09041095890412	['2019-07-31T22:34:38.246775-05:00', '2019-07-31T22:34:38.246775-05:00']	['6464122f-f103-5a47-8273-ed662ba9cedf', '9cafd343-2663-5552-9e0e-03ff493eb811']	['TCGA-DI-A2QU_treatment_1', 'TCGA-DI-A2QU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:33:54.560860-05:00', '']	11	Not Applicable	6e54d197-a5e5-41a1-b9b8-d2a76b58a31d	Solid Tissue Normal	Not Reported	2296.0	230.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DI-A2QU-01A	e9fa66f5-282c-416a-9dcf-46714ea12fcf	Cystic, Mucinous and Serous Neoplasms	e9fa66f5-282c-416a-9dcf-46714ea12fcf	TCGA-DI-A2QU	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	67.0	-24488.0	1938.0	2007.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH	946.0															Stage IVB	No	0.0	not reported	Endometrium		24488.0	Serous cystadenocarcinoma, NOS	no	2005.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24488.0	67.09041095890412	['2019-07-31T22:34:38.246775-05:00', '2019-07-31T22:34:38.246775-05:00']	['6464122f-f103-5a47-8273-ed662ba9cedf', '9cafd343-2663-5552-9e0e-03ff493eb811']	['TCGA-DI-A2QU_treatment_1', 'TCGA-DI-A2QU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:33:54.560860-05:00', '']	01	Primary	e319e562-6af4-4a5a-b82b-94ddfb325ae8	Primary Tumor	Not Reported	2296.0	240.0	Unknown	43F1EE09-6F10-4BCE-A55C-147084A26999	false	Solid Tissue	False	Tumor
TCGA-DI-A2QY-11A	6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915	Cystic, Mucinous and Serous Neoplasms	6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915	TCGA-DI-A2QY	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23398.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH	3349.0															Stage IIB	No	0.0	not reported	Endometrium	2797.0	23398.0	Serous cystadenocarcinoma, NOS	no	2003.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23398.0	64.1041095890411	['2019-07-31T22:21:16.650587-05:00', '2019-07-31T22:21:16.650587-05:00']	['80c89912-4642-58ff-9420-bcf75d9bb5a7', 'b96031fa-5e06-59d7-9021-f30999cfc018']	['TCGA-DI-A2QY_treatment', 'TCGA-DI-A2QY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:23:06.693381-05:00']	11	Not Applicable	dd23fc95-047a-46eb-858f-c411bc337aa0	Solid Tissue Normal	Not Reported	2957.0	110.0	Unknown		false	Solid Tissue	False	Normal
TCGA-DI-A2QY-01A	6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915	Cystic, Mucinous and Serous Neoplasms	6524a6d3-a9f0-4a46-ac0b-7beb0cd1b915	TCGA-DI-A2QY	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23398.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH	3349.0															Stage IIB	No	0.0	not reported	Endometrium	2797.0	23398.0	Serous cystadenocarcinoma, NOS	no	2003.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23398.0	64.1041095890411	['2019-07-31T22:21:16.650587-05:00', '2019-07-31T22:21:16.650587-05:00']	['80c89912-4642-58ff-9420-bcf75d9bb5a7', 'b96031fa-5e06-59d7-9021-f30999cfc018']	['TCGA-DI-A2QY_treatment', 'TCGA-DI-A2QY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:23:06.693381-05:00']	01	Primary	e86df94d-784d-41e0-8610-46ded1032f00	Primary Tumor	Not Reported	2957.0	120.0	Unknown	C78D0C27-34C3-44C4-9814-94EEE8A8AB95	false	Solid Tissue	False	Tumor
TCGA-D1-A2G6-01A	46cd8ded-f8a1-4f8c-a4c2-2d5b51c04f18	Adenomas and Adenocarcinomas	46cd8ded-f8a1-4f8c-a4c2-2d5b51c04f18	TCGA-D1-A2G6	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	53.0	-19547.0	1954.0	2007.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	258.0															Stage IIIC	No	0.0	not reported	Endometrium		19547.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19547.0	53.553424657534244	['2019-07-31T22:18:00.407035-05:00', '2019-07-31T22:18:00.407035-05:00']	['16cfc3b2-ae9c-5eb9-9c3b-558762cf49ea', '6a8afad1-f9b7-5be2-9bee-ef63deb26c03']	['TCGA-D1-A2G6_treatment_1', 'TCGA-D1-A2G6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:20:29.925742-05:00', '']	01	Primary	2127e58b-bd7b-490e-b34b-4f626b2a4053	Primary Tumor	Not Reported	1350.0	130.0	OCT	3375E2AF-173B-4263-84A8-8535DF33BA69	true	Solid Tissue	False	Tumor
TCGA-A5-A0GR-01A	82c51af5-4ba2-48fe-b5e2-a0f1c9d68f34	Adenomas and Adenocarcinomas	82c51af5-4ba2-48fe-b5e2-a0f1c9d68f34	TCGA-A5-A0GR	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	69.0	-25353.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1120.0	25353.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25353.0	69.46027397260274	['2019-07-31T22:23:55.664515-05:00', '2019-07-31T22:23:55.664515-05:00']	['302c22c2-e905-5abb-8d21-80b12d60607c', 'b8f159ae-fae9-5d56-b27a-491467b3fdc1']	['TCGA-A5-A0GR_treatment', 'TCGA-A5-A0GR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:25:13.610154-05:00']	01	Primary	1c8de102-85f6-47d5-87ce-50b6fe24bb7a	Primary Tumor	Not Reported	632.0	160.0	OCT	009B5049-74B7-49B8-8B64-28184A3ACA2B	true	Solid Tissue	False	Tumor
TCGA-BK-A13B-01A	e71b3ce1-41e0-4cfc-9570-367b8c2124c1	Adenomas and Adenocarcinomas	e71b3ce1-41e0-4cfc-9570-367b8c2124c1	TCGA-BK-A13B	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	58.0	-21493.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	966.0	21493.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21493.0	58.88493150684931	['2019-07-31T17:25:09.210029-05:00', '2019-07-31T17:25:09.210029-05:00']	['2b1a486b-d81a-5f2c-9f3a-8171782e237b', 'aa6aac97-328a-5955-966c-b5a21ed295e0']	['TCGA-BK-A13B_treatment', 'TCGA-BK-A13B_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T10:22:06.655498-05:00']	01	Primary	9530bfbb-dffc-4a16-9444-d51e24f8e843	Primary Tumor	Not Reported	140.0	830.0	Unknown	F8B15B22-27A6-4D7A-BCDC-B46EBCA5888E	false	Solid Tissue	False	Tumor
TCGA-A5-A2K7-01A	f42868c0-ff59-438b-90a7-489aea678de9	Adenomas and Adenocarcinomas	f42868c0-ff59-438b-90a7-489aea678de9	TCGA-A5-A2K7	Corpus uteri	Not Reported	not reported	female	hispanic or latino	Alive	41.0	-14980.0	1970.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	1063.0	14980.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	14980.0	41.04109589041096	['2019-07-31T22:35:32.535326-05:00', '2019-07-31T22:35:32.535326-05:00']	['25d41f28-b73e-50dc-aa15-c234be932e6d', 'c99515cd-3aa0-59dc-b93b-b9da399b1297']	['TCGA-A5-A2K7_treatment', 'TCGA-A5-A2K7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:34:38.481679-05:00']	01	Primary	b19b35dd-9431-4040-bbf1-e7490b037de7	Primary Tumor	Not Reported	195.0	170.0	OCT	1880F604-34C9-4B58-92DC-D67C7E656E3B	true	Solid Tissue	False	Tumor
TCGA-A5-A0VO-01A	0648f046-2206-4b97-9b6e-419c2e325b6d	Adenomas and Adenocarcinomas	0648f046-2206-4b97-9b6e-419c2e325b6d	TCGA-A5-A0VO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	64.0	-23547.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH	875.0															Stage IB	No	0.0	not reported	Endometrium	364.0	23547.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23547.0	64.5123287671233	['2019-07-31T22:10:39.388228-05:00', '2019-07-31T22:10:39.388228-05:00']	['1c203ba4-a944-5a35-8f30-275b1d3abe76', 'ee832260-5a10-5758-bfdb-26633664a9da']	['TCGA-A5-A0VO_treatment', 'TCGA-A5-A0VO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:14:33.550935-05:00']	01	Primary	925bc760-6132-4b03-961e-7570acf33d5e	Primary Tumor	Not Reported	133.0	320.0	OCT	6ABBA2C9-8920-4785-BFAB-40E560D2DBE6	true	Solid Tissue	False	Tumor
TCGA-AJ-A4ZG-01A	fae3dbd7-1c4e-45c0-8187-c09892279565	Cystic, Mucinous and Serous Neoplasms	fae3dbd7-1c4e-45c0-8187-c09892279565	TCGA-AJ-A4ZG	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	53.0	-19492.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	No	0.0	not reported	Endometrium	498.0	19492.0	Serous cystadenocarcinoma, NOS	no	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	19492.0	53.4027397260274	['2019-07-31T22:36:21.438002-05:00', '2019-07-31T22:36:21.438002-05:00']	['4b5f49f5-3781-5ea3-972e-a8e04a1b66b8', '4fee8fba-8343-5a1d-8cdc-6b40cfc89551']	['TCGA-AJ-A4ZG_treatment_1', 'TCGA-AJ-A4ZG_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:35:17.780932-05:00', '']	01	Primary	e8625cb2-1502-4174-9adc-e9bde7e483fe	Primary Tumor	Not Reported	57.0	90.0	Unknown	639D98FB-EFCA-4FDC-A4A0-308951C91710	false	Solid Tissue	False	Tumor
TCGA-B5-A11G-01A	d2aa7d70-a25f-4a9e-9d52-37e372461824	Adenomas and Adenocarcinomas	d2aa7d70-a25f-4a9e-9d52-37e372461824	TCGA-B5-A11G	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	71.0	-25995.0	1930.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	3448.0	25995.0	Endometrioid adenocarcinoma, NOS	no	2001.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25995.0	71.21917808219177	['2019-07-31T22:31:16.173321-05:00', '2019-07-31T22:31:16.173321-05:00']	['3c9f4783-73f1-5b34-abbd-878387de2a34', 'bb1fd701-a354-5145-9bc9-333f84801e7d']	['TCGA-B5-A11G_treatment', 'TCGA-B5-A11G_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:31:13.672625-05:00']	01	Primary	fe5d8e64-98b1-4ea7-adda-f28d12349a7e	Primary Tumor	Not Reported	3248.0	180.0	OCT	7021DC28-67C3-4BB6-9C8B-0FE7EFBCA1E1	true	Solid Tissue	False	Tumor
TCGA-4E-A92E-01A	b43de98d-4bb1-41a1-91f2-ce4e7ea4d0ca	Adenomas and Adenocarcinomas	b43de98d-4bb1-41a1-91f2-ce4e7ea4d0ca	TCGA-4E-A92E	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	54.0	-19818.0	1959.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	268087d4-78ec-52c3-accc-ca0dfea08954	4E	Molecular Response	Uterine Corpus Endometrial Carcinoma	NCH																Stage I	No	0.0	not reported	Endometrium	13.0	19818.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19818.0	54.295890410958904	['2019-07-31T22:28:54.719710-05:00', '2019-07-31T22:28:54.719710-05:00']	['05b9fb1e-52f1-5acd-9b36-559e012d02de', '77994ccf-925b-5aff-b2dd-99cd52583d5d']	['TCGA-4E-A92E_treatment', 'TCGA-4E-A92E_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:29:18.775270-05:00']	01	Primary	3043a6c9-3dce-4a5b-bbb1-9ad5a07f21e8	Primary Tumor	Not Reported	90.0	140.0	Unknown	BC43D6CA-235C-4217-BF72-F33B089C532B	false	Solid Tissue	False	Tumor
TCGA-5B-A90C-01A	16ac4341-cf8f-45e2-b90b-2d12d5f74a59	Adenomas and Adenocarcinomas	16ac4341-cf8f-45e2-b90b-2d12d5f74a59	TCGA-5B-A90C	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	69.0	-25518.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	52292193-7bbd-590c-82af-3a6c30a26cb4	5B	Medical College of Wisconsin	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1202.0	25518.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25518.0	69.91232876712328	['2019-07-31T22:12:40.096939-05:00', '2019-07-31T22:12:40.096939-05:00']	['5fcf1dee-9b8e-5790-bc80-e057d179af7b', 'd263a3e8-8229-540b-a6fa-44d003157433']	['TCGA-5B-A90C_treatment_1', 'TCGA-5B-A90C_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:16:12.380324-05:00', '']	01	Primary	f1fb39e5-8275-4f45-a349-af82d6cd6ff7	Primary Tumor	Not Reported	811.0	50.0	Unknown	608E2698-6A3A-4673-89D2-3BE98A74EBE5	false	Solid Tissue	False	Tumor
TCGA-EY-A548-01A	56bdb68c-a647-4aba-94ac-9cd52bb5344a	Adenomas and Adenocarcinomas	56bdb68c-a647-4aba-94ac-9cd52bb5344a	TCGA-EY-A548	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	83.0	-30544.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	430.0	30544.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30544.0	83.68219178082192	['2019-07-31T22:19:39.321857-05:00', '2019-07-31T22:19:39.321857-05:00']	['466e083e-273c-5254-973c-9e647ee558a1', '777d2841-457c-5ff1-8176-3de8bc70bc8e']	['TCGA-EY-A548_treatment_1', 'TCGA-EY-A548_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:21:48.324002-05:00', '']	01	Primary	081ac69b-8390-42b1-917a-d7cd231c0156	Primary Tumor	Not Reported	169.0	850.0	Unknown	A9ACF7BF-BB91-4B56-A398-C7A0FD473FC5	false	Solid Tissue	False	Tumor
TCGA-D1-A17S-01A	24434832-46fc-485a-9ff4-2aa95c3d3936	Adenomas and Adenocarcinomas	24434832-46fc-485a-9ff4-2aa95c3d3936	TCGA-D1-A17S	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	59.0	-21794.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	739.0	21794.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21794.0	59.70958904109589	['2019-07-31T22:13:54.811694-05:00', '2019-07-31T22:13:54.811694-05:00']	['491783be-d724-5305-bb44-aa53c2d2f7cd', 'b2ca04bc-72e6-5ed6-a825-ecf8f82abd79']	['TCGA-D1-A17S_treatment', 'TCGA-D1-A17S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:17:12.628803-05:00']	01	Primary	5f4de8f1-b75f-4a53-9b4d-6a2f5422d6ca	Primary Tumor	Not Reported	419.0	280.0	Unknown	54337BED-9366-4CB6-BA95-BB5999CBF342	false	Solid Tissue	False	Tumor
TCGA-BK-A4ZD-01A	1c4d225e-e065-4e26-9413-78f54a7e0cf5	Adenomas and Adenocarcinomas	1c4d225e-e065-4e26-9413-78f54a7e0cf5	TCGA-BK-A4ZD	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	42.0	-15536.0	1970.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	506.0	15536.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	15536.0	42.56438356164384	['2019-07-31T22:13:10.718015-05:00', '2019-07-31T22:13:10.718015-05:00']	['8b8b5ac1-2427-574c-aad5-0051111ddbf0', '9ef670d7-1bdf-5138-89c9-41ecea75db1e']	['TCGA-BK-A4ZD_treatment', 'TCGA-BK-A4ZD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:16:37.625690-05:00']	01	Primary	115d93c2-9396-48bd-ba90-4cc4888ab821	Primary Tumor	Not Reported	92.0	300.0	Unknown	388C7674-9CA2-446C-A67D-9639A28ADEB4	false	Solid Tissue	False	Tumor
TCGA-BK-A4ZD-11A	1c4d225e-e065-4e26-9413-78f54a7e0cf5	Adenomas and Adenocarcinomas	1c4d225e-e065-4e26-9413-78f54a7e0cf5	TCGA-BK-A4ZD	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	42.0	-15536.0	1970.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	506.0	15536.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	15536.0	42.56438356164384	['2019-07-31T22:13:10.718015-05:00', '2019-07-31T22:13:10.718015-05:00']	['8b8b5ac1-2427-574c-aad5-0051111ddbf0', '9ef670d7-1bdf-5138-89c9-41ecea75db1e']	['TCGA-BK-A4ZD_treatment', 'TCGA-BK-A4ZD_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:16:37.625690-05:00']	11	Not Applicable	a24e32e7-0ac4-481f-a69f-f42b1f1e3eef	Solid Tissue Normal	Not Reported	92.0	210.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A0J1-01A	ec7a9d74-8b3f-4747-8926-1739a016ab2b	Adenomas and Adenocarcinomas	ec7a9d74-8b3f-4747-8926-1739a016ab2b	TCGA-AX-A0J1	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	80.0	-29501.0	1925.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2354.0	29501.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29501.0	80.82465753424657	['2019-07-31T22:34:57.127914-05:00', '2019-07-31T22:34:57.127914-05:00']	['14c9dbd9-ed6d-54c4-b499-c38b825a0c15', '46084428-8366-5730-95d0-4857216622bb']	['TCGA-AX-A0J1_treatment_1', 'TCGA-AX-A0J1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:34:09.095578-05:00', '']	01	Primary	ac14e378-2de1-458a-b8cd-7c60131aa927	Primary Tumor	Not Reported	1721.0	220.0	Unknown	38FCBC4A-2CAB-46EF-805D-121BEF85912E	false	Solid Tissue	False	Tumor
TCGA-BG-A0MK-01A	1f9b1b71-8753-4cd5-a585-708bea8ff1fa	Adenomas and Adenocarcinomas	1f9b1b71-8753-4cd5-a585-708bea8ff1fa	TCGA-BG-A0MK	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	52.0	-19034.0	1954.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH	1317.0															Stage IIB	No	0.0	not reported	Endometrium		19034.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19034.0	52.14794520547945	['2019-07-31T17:11:26.941865-05:00', '2019-07-31T17:11:26.941865-05:00']	['a73bdb4d-be63-5b60-86b5-2ae334cd5c9c', 'd47a9609-4f1f-5aff-835b-5fba0d30095e']	['TCGA-BG-A0MK_treatment', 'TCGA-BG-A0MK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T10:10:45.431457-05:00']	01	Primary	24678d73-94e1-49b4-a772-bda6a02d6075	Primary Tumor	Not Reported	1399.0	1100.0	OCT	9D631FCB-78A9-4CA9-A033-D66CB78D8CA3	true	Solid Tissue	False	Tumor
TCGA-AP-A052-01A	bd4284a7-260d-48b3-9b48-a1c578c30d27	Cystic, Mucinous and Serous Neoplasms	bd4284a7-260d-48b3-9b48-a1c578c30d27	TCGA-AP-A052	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	59.0	-21721.0	1945.0	2005.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	669.0															Stage IVB	No	0.0	not reported	Endometrium		21721.0	Serous cystadenocarcinoma, NOS	no	2004.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21721.0	59.50958904109589	['2019-07-31T22:29:21.662015-05:00', '2019-07-31T22:29:21.662015-05:00']	['4c91f2d1-dbf7-58dd-95ca-6db6c735f694', 'd49aff5a-3cdb-588e-b460-5857cb142ecf']	['TCGA-AP-A052_treatment', 'TCGA-AP-A052_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:29:41.578544-05:00']	01	Primary	33c21dca-f3b3-48cd-9fc5-ad316598f23e	Primary Tumor	Not Reported	2211.0	500.0	OCT	830EF496-4672-4E9A-B662-DCB4678E99B0	true	Solid Tissue	False	Tumor
TCGA-AJ-A3BG-01A	77ed36ad-222f-4693-8668-0ecf9073d6e8	Cystic, Mucinous and Serous Neoplasms	77ed36ad-222f-4693-8668-0ecf9073d6e8	TCGA-AJ-A3BG	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	65.0	-23861.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	Not Reported	0.0	not reported	Endometrium	550.0	23861.0	Papillary serous cystadenocarcinoma	yes	2011.0	No	8460/3	not reported	C54.1	Endometrium	Not Reported	not reported	23861.0	65.37260273972603	['2019-07-31T22:23:04.045311-05:00', '2019-07-31T22:23:04.045311-05:00']	['195855e6-4a3c-5a3b-897a-3b8b5bae8ecf', '6ef8c588-82c4-5fff-9284-c93c8fd1b4eb']	['TCGA-AJ-A3BG_treatment', 'TCGA-AJ-A3BG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:24:32.417866-05:00']	01	Primary	0eeb2802-5276-4a2f-ae20-926a3feced91	Primary Tumor	Not Reported	137.0	24.0	Unknown	3D42566F-92B2-4530-BF6A-624DA6E979B9	false	Solid Tissue	False	Tumor
TCGA-D1-A16F-01A	60c65e5e-57a4-4f15-8b95-30bd2dbd9010	Adenomas and Adenocarcinomas	60c65e5e-57a4-4f15-8b95-30bd2dbd9010	TCGA-D1-A16F	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22242.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	80.0	22242.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22242.0	60.93698630136986	['2019-07-31T22:20:40.422606-05:00', '2019-07-31T22:20:40.422606-05:00']	['37a24e06-4f5f-5676-8e4f-9c28fe0910f1', 'bed42bf0-934d-537e-8dcb-b84efb137ab9']	['TCGA-D1-A16F_treatment', 'TCGA-D1-A16F_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:22:37.737873-05:00']	01	Primary	25b73036-0cd7-43e1-b40e-b2e01c1b7247	Primary Tumor	Not Reported	783.0	280.0	Unknown	E89C4CBF-45D5-405D-A673-F67186C206B3	false	Solid Tissue	False	Tumor
TCGA-EY-A1GH-01A	a45a2343-f425-4e62-9049-7782733b6234	Adenomas and Adenocarcinomas	a45a2343-f425-4e62-9049-7782733b6234	TCGA-EY-A1GH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	70.0	-25802.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	710.0	25802.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25802.0	70.69041095890411	['2019-07-31T22:27:00.187603-05:00', '2019-07-31T22:27:00.187603-05:00']	['de48ecc3-ccb3-5277-a6bc-17c88e6b4b55', 'f5d65e17-9e74-5109-b5a8-16f07cafdc9a']	['TCGA-EY-A1GH_treatment_1', 'TCGA-EY-A1GH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:27:44.927889-05:00', '']	01	Primary	b32b07ac-a84d-4b1d-89c9-ffe2e91ee037	Primary Tumor	Not Reported	452.0	280.0	Unknown	29D738E9-2F8D-4909-A427-7C056859B89A	false	Solid Tissue	False	Tumor
TCGA-AX-A1CK-11A	45effb44-0b5f-4081-a202-d85969c72f2b	Adenomas and Adenocarcinomas	45effb44-0b5f-4081-a202-d85969c72f2b	TCGA-AX-A1CK	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21200.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2441.0	21200.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21200.0	58.082191780821915	['2019-07-31T22:17:53.705210-05:00', '2019-07-31T22:17:53.705210-05:00']	['84d4a50f-57d8-543e-96de-b14d52a21af7', '96416453-a6f3-5ab5-9731-ab31a7791c16']	['TCGA-AX-A1CK_treatment', 'TCGA-AX-A1CK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:20:24.861626-05:00']	11	Not Applicable	03680874-bc46-4805-9a01-f02a24a46948	Solid Tissue Normal	Not Reported	2115.0	100.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A1CK-01A	45effb44-0b5f-4081-a202-d85969c72f2b	Adenomas and Adenocarcinomas	45effb44-0b5f-4081-a202-d85969c72f2b	TCGA-AX-A1CK	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21200.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2441.0	21200.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21200.0	58.082191780821915	['2019-07-31T22:17:53.705210-05:00', '2019-07-31T22:17:53.705210-05:00']	['84d4a50f-57d8-543e-96de-b14d52a21af7', '96416453-a6f3-5ab5-9731-ab31a7791c16']	['TCGA-AX-A1CK_treatment', 'TCGA-AX-A1CK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:20:24.861626-05:00']	01	Primary	7028ec96-26a1-4ec7-a044-9b263e50ca8d	Primary Tumor	Not Reported	2115.0	100.0	Unknown	5810919B-7778-4566-A024-2D70BDE9A4F5	false	Solid Tissue	False	Tumor
TCGA-FL-A1YF-11A	0b0a54ac-bb74-40a4-b647-d067fb9de1ff	Not Reported	0b0a54ac-bb74-40a4-b647-d067fb9de1ff	TCGA-FL-A1YF	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	2efbdfb5-99ec-4c46-af68-e10d7ea6f3ce	Solid Tissue Normal	Not Reported		130.0	Unknown	77548105-E280-4614-A76D-0177207D77D2	false	Solid Tissue	False	Normal
TCGA-DI-A0WH-01A	3dab68d3-232c-4b4f-81a4-ca8f72d69a43	Adenomas and Adenocarcinomas	3dab68d3-232c-4b4f-81a4-ca8f72d69a43	TCGA-DI-A0WH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23692.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	496.0	23692.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23692.0	64.90958904109588	['2019-07-31T22:16:31.747445-05:00', '2019-07-31T22:16:31.747445-05:00']	['0e7de8d6-20b5-5c37-a226-518a3b353fdd', '4102c9a2-0615-5daa-ba44-3e3762c431d2']	['TCGA-DI-A0WH_treatment_1', 'TCGA-DI-A0WH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:19:19.694463-05:00', '']	01	Primary	89f499fb-e061-4002-a8e8-dc3366e14a12	Primary Tumor	Not Reported	244.0	180.0	Unknown	3D6B2D82-2F6D-40E6-8138-4DBF33DE8BEF	false	Solid Tissue	False	Tumor
TCGA-EO-A22Y-01A	e6183a43-24b9-4fe1-95c3-4cff67e6c1ed	Adenomas and Adenocarcinomas	e6183a43-24b9-4fe1-95c3-4cff67e6c1ed	TCGA-EO-A22Y	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25127.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1567.0	25127.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25127.0	68.84109589041095	['2019-07-31T22:34:19.192712-05:00', '2019-07-31T22:34:19.192712-05:00']	['978dd27a-5047-5bba-8d5c-936dde124785', 'f8b5bb6c-83ad-5344-827a-dc977d0cd9d7']	['TCGA-EO-A22Y_treatment_1', 'TCGA-EO-A22Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:33:40.132566-05:00', '']	01	Primary	1fcdc9c7-5448-4a87-9ad5-cfb60837c296	Primary Tumor	Not Reported	692.0	110.0	Unknown	44F2A17C-265B-4C2A-9AA0-42C55A23B592	false	Solid Tissue	False	Tumor
TCGA-B5-A1MX-01A	37bac6ba-be93-42cc-892b-efd0bdb850bd	Adenomas and Adenocarcinomas	37bac6ba-be93-42cc-892b-efd0bdb850bd	TCGA-B5-A1MX	Corpus uteri	Not Reported	white	female	not reported	Alive	47.0	-17320.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1473.0	17320.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17320.0	47.45205479452055	['2019-07-31T22:15:37.200186-05:00', '2019-07-31T22:15:37.200186-05:00']	['6d931b5b-d0f1-5114-93a5-3b66ac68683c', 'e8d186bb-8b17-5f60-95ef-9caced8d79f1']	['TCGA-B5-A1MX_treatment_1', 'TCGA-B5-A1MX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:18:35.775811-05:00', '']	01	Primary	68e7d2d6-3313-4ffc-bb4f-ba9167a7b669	Primary Tumor	Not Reported	103.0	560.0	OCT	C8962646-1A09-4EAA-8864-2539A0CCEC4C	true	Solid Tissue	False	Tumor
TCGA-AX-A1CC-01A	bc02493a-0296-4329-939a-bf91a4d0c16a	Cystic, Mucinous and Serous Neoplasms	bc02493a-0296-4329-939a-bf91a4d0c16a	TCGA-AX-A1CC	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	65.0	-23795.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	788.0	23795.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23795.0	65.1917808219178	['2019-07-31T22:29:15.669420-05:00', '2019-07-31T22:29:15.669420-05:00']	['9eea8624-2472-5365-a62f-6678bea3b959', 'a514fe7b-c7df-5378-b76f-e3d705558bae']	['TCGA-AX-A1CC_treatment', 'TCGA-AX-A1CC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:29:36.391380-05:00']	01	Primary	86f051d5-f4a3-47e2-b377-88a516c29bc3	Primary Tumor	Not Reported	356.0	90.0	Unknown	C621C7A6-FF3F-453E-94A2-9789F66750E3	false	Solid Tissue	False	Tumor
TCGA-AX-A3FV-01A	a033fbea-7cd0-4e65-94c4-b54f2f80b895	Adenomas and Adenocarcinomas	a033fbea-7cd0-4e65-94c4-b54f2f80b895	TCGA-AX-A3FV	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	62.0	-22752.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	-6.0	22752.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22752.0	62.33424657534247	['2019-07-31T22:26:29.364681-05:00', '2019-07-31T22:26:29.364681-05:00']	['521523e4-353b-5e8d-bf02-62daef0086d1', '825bcf89-04f6-5d73-b31f-537a3f43b279']	['TCGA-AX-A3FV_treatment', 'TCGA-AX-A3FV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:27:20.948378-05:00']	01	Primary	1661922c-cd0a-4b1e-a9bf-4aefe10654a6	Primary Tumor	Not Reported	799.0	100.0	Unknown	0D1601D0-E0F4-4DBA-91EA-62092FE8621F	false	Solid Tissue	False	Tumor
TCGA-D1-A3DA-01A	e17a5fca-616c-4a74-abe7-778539ecdc0b	Adenomas and Adenocarcinomas	e17a5fca-616c-4a74-abe7-778539ecdc0b	TCGA-D1-A3DA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28142.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	483.0	28142.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28142.0	77.1013698630137	['2019-07-31T22:33:08.429073-05:00', '2019-07-31T22:33:08.429073-05:00']	['3e1e5ecf-534d-5c02-a40b-752b110084f7', '5303bc5b-0ef4-55c8-9357-e14c9c17fe69']	['TCGA-D1-A3DA_treatment_1', 'TCGA-D1-A3DA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:32:43.483783-05:00', '']	01	Primary	24be1526-b1ca-4206-bc2f-533d51548565	Primary Tumor	Not Reported	128.0	110.0	OCT	8F3D4AFC-2E70-4633-A58F-C98ED00A8964	true	Solid Tissue	False	Tumor
TCGA-D1-A17L-01A	67ccb182-3021-4621-bffb-6565574dbc58	Adenomas and Adenocarcinomas	67ccb182-3021-4621-bffb-6565574dbc58	TCGA-D1-A17L	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	81.0	-29899.0	1928.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	802.0	29899.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29899.0	81.91506849315068	['2019-07-31T22:21:35.896828-05:00', '2019-07-31T22:21:35.896828-05:00']	['a14edebd-e184-5a77-8b4a-8ff9f3925435', 'a36f788d-0a58-5518-9bff-1a14b262aec1']	['TCGA-D1-A17L_treatment_1', 'TCGA-D1-A17L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:23:21.408498-05:00', '']	01	Primary	5507cf56-068f-406e-aafd-8231f5943cbf	Primary Tumor	Not Reported	493.0	210.0	Unknown	BCF17C02-8F6E-419F-AEDF-3AC03AA883E7	false	Solid Tissue	False	Tumor
TCGA-BS-A0TA-01A	ad3d8420-f562-4cbe-ac82-c968bd4f782d	Adenomas and Adenocarcinomas	ad3d8420-f562-4cbe-ac82-c968bd4f782d	TCGA-BS-A0TA	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	hispanic or latino	Dead	58.0	-21505.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH	740.0															Stage IVB	No	0.0	not reported	Endometrium	714.0	21505.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21505.0	58.917808219178085	['2019-07-31T22:28:12.072940-05:00', '2019-07-31T22:28:12.072940-05:00']	['6c7b540e-e28c-55d2-bac3-c5f8abbb15b3', 'f85e4c69-fc08-5296-a038-1a34c2b7569c']	['TCGA-BS-A0TA_treatment_1', 'TCGA-BS-A0TA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:28:43.857126-05:00', '']	01	Primary	b6a042b6-f94a-4acc-98cb-a1a2fe72b9ad	Primary Tumor	Not Reported	1788.0	300.0	Unknown	5F009A9A-549F-4EEB-BB6D-C67353C7A292	false	Solid Tissue	False	Tumor
TCGA-AX-A05T-01A	0119eab6-00e7-4346-aa52-cbbeeba3621d	Adenomas and Adenocarcinomas	0119eab6-00e7-4346-aa52-cbbeeba3621d	TCGA-AX-A05T	Corpus uteri	Not Reported	white	female	not reported	Alive	82.0	-30137.0	1927.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1010.0	30137.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30137.0	82.56712328767124	['2019-07-31T22:10:02.012456-05:00', '2019-07-31T22:10:02.012456-05:00']	['035425d3-a234-51cb-990e-cacf2f6d8a49', 'b2dc2f65-00ed-57f1-a082-6c17efc5630d']	['TCGA-AX-A05T_treatment', 'TCGA-AX-A05T_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:14:03.443367-05:00']	01	Primary	bc2885b5-c7cd-4467-88a3-a32cf602b3d5	Primary Tumor	Not Reported	310.0	160.0	Unknown	85F75553-6E10-4AF5-9BDF-DAB52D00615B	false	Solid Tissue	False	Tumor
TCGA-AX-A0IU-01A	7e64ea6c-a3db-48eb-91be-131361510a92	Cystic, Mucinous and Serous Neoplasms	7e64ea6c-a3db-48eb-91be-131361510a92	TCGA-AX-A0IU	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	79.0	-29063.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1087.0	29063.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	29063.0	79.62465753424658	['2019-07-31T22:23:43.079230-05:00', '2019-07-31T22:23:43.079230-05:00']	['670a828e-0fd5-5692-b5ff-6c75352c17ae', '6a29e81c-0eaf-5629-82e9-8cc5da7b1f46']	['TCGA-AX-A0IU_treatment_1', 'TCGA-AX-A0IU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:25:03.859966-05:00', '']	01	Primary	dc4b3695-ce62-48d5-9f1d-7dd70d049c97	Primary Tumor	Not Reported	636.0	240.0	Unknown	454539FB-7B1B-43DF-87D1-E7E47C1776E7	false	Solid Tissue	False	Tumor
TCGA-E6-A1M0-01A	e3dcde4e-5def-4b89-97b4-047b8288919b	Adenomas and Adenocarcinomas	e3dcde4e-5def-4b89-97b4-047b8288919b	TCGA-E6-A1M0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20629.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	39aa3c67-c7d9-5001-8ed1-3bf83eac7872	E6	Roswell Park	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1793.0	20629.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20629.0	56.51780821917808	['2019-07-31T22:33:26.787258-05:00', '2019-07-31T22:33:26.787258-05:00']	['1669c85b-f008-5ec1-aa37-a5811767f345', '68bd4957-9fcd-52d8-9b4f-aac0187085ec']	['TCGA-E6-A1M0_treatment', 'TCGA-E6-A1M0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:32:58.605205-05:00']	01	Primary	7e75ca29-183d-4bad-9ddc-527871bd7554	Primary Tumor	Not Reported	360.0	160.0	Unknown	F1AF61FE-BF05-49E2-85DA-F4CE37596DEA	false	Solid Tissue	False	Tumor
TCGA-E6-A1M0-11A	e3dcde4e-5def-4b89-97b4-047b8288919b	Adenomas and Adenocarcinomas	e3dcde4e-5def-4b89-97b4-047b8288919b	TCGA-E6-A1M0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20629.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	39aa3c67-c7d9-5001-8ed1-3bf83eac7872	E6	Roswell Park	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1793.0	20629.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20629.0	56.51780821917808	['2019-07-31T22:33:26.787258-05:00', '2019-07-31T22:33:26.787258-05:00']	['1669c85b-f008-5ec1-aa37-a5811767f345', '68bd4957-9fcd-52d8-9b4f-aac0187085ec']	['TCGA-E6-A1M0_treatment', 'TCGA-E6-A1M0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:32:58.605205-05:00']	11	Not Applicable	abcd9bfe-3511-46e3-97fe-cb0c068fb491	Solid Tissue Normal	Not Reported	360.0	130.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A3G8-01A	6d3fdb58-fdc0-4937-ad38-3a455225ea51	Adenomas and Adenocarcinomas	6d3fdb58-fdc0-4937-ad38-3a455225ea51	TCGA-AX-A3G8	Corpus uteri	Not Reported	white	female	not reported	Alive	76.0	-27899.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	36.0	27899.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27899.0	76.43561643835616	['2019-07-31T22:22:03.616362-05:00', '2019-07-31T22:22:03.616362-05:00']	['a244c19e-ccc7-5b22-a17c-57c6f4d3c426', 'c31adf51-4c2c-5162-9eaf-7d34bbc9c4bb']	['TCGA-AX-A3G8_treatment', 'TCGA-AX-A3G8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:23:43.619709-05:00']	01	Primary	dfe35835-d03e-4ce3-a76a-fdb15e601257	Primary Tumor	Not Reported	350.0	110.0	Unknown	FD22A233-9333-4DA2-A913-4DBA90600247	false	Solid Tissue	False	Tumor
TCGA-BS-A0V4-01A	e3f515f8-a940-40d1-86b0-baed0f410f2c	Adenomas and Adenocarcinomas	e3f515f8-a940-40d1-86b0-baed0f410f2c	TCGA-BS-A0V4	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20777.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1810.0	20777.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20777.0	56.92328767123288	['2019-07-31T22:33:42.317981-05:00', '2019-07-31T22:33:42.317981-05:00']	['937db5d2-4dbc-5988-91e1-c6a0ab0775d3', 'a6b6e318-d64f-5f22-bf53-bdb8033d0902']	['TCGA-BS-A0V4_treatment_1', 'TCGA-BS-A0V4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:33:10.449584-05:00', '']	01	Primary	dd12111e-9001-4d8d-b8f3-5801b4ab529b	Primary Tumor	Not Reported	1576.0	310.0	Unknown	AA0FFBF8-693C-484E-A29D-02F859E1E4C5	false	Solid Tissue	False	Tumor
TCGA-DF-A2KN-01A	d438c58e-f038-47a3-8e62-485a5aca9695	Adenomas and Adenocarcinomas	d438c58e-f038-47a3-8e62-485a5aca9695	TCGA-DF-A2KN	Corpus uteri	Not Reported	not reported	female	not reported	Alive					['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No		not reported	Endometrium	67.0		Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported			['2019-07-31T22:31:31.899529-05:00', '2019-07-31T22:31:31.899529-05:00']	['075d1b78-14dd-5469-b5b3-d46dd30295a1', 'bd3d7d6a-606f-5bcc-83d2-9de0d36e2971']	['TCGA-DF-A2KN_treatment_1', 'TCGA-DF-A2KN_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'not reported']	['2019-04-28T14:31:25.202912-05:00', '']	01	Primary	4ad23a52-bceb-4b12-88aa-272153e01b01	Primary Tumor	Not Reported		200.0	Unknown	A61CE064-B18B-429E-93F1-BA0FC06AB310	false	Solid Tissue	False	Tumor
TCGA-QF-A5YT-01A	e4bccea0-0104-40c4-9e3c-2ad7262d918e	Adenomas and Adenocarcinomas	e4bccea0-0104-40c4-9e3c-2ad7262d918e	TCGA-QF-A5YT	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	57.0	-20981.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	d777d40e-e930-5f47-995e-89adc81e9900	QF	BLN - Baylor	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Isthmus uteri	1215.0	20981.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.0	Isthmus uteri	Not Reported	not reported	20981.0	57.48219178082192	['2019-07-31T22:33:58.245604-05:00', '2019-07-31T22:33:58.245604-05:00']	['0610ab27-0a85-5962-817c-8c854d4d564e', '167fe7b5-ed62-5ffb-b8ca-4e90b494e56a']	['TCGA-QF-A5YT_treatment', 'TCGA-QF-A5YT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:33:22.703755-05:00']	01	Primary	e62ea0d8-61cb-41ed-9d15-a0c5add11249	Primary Tumor	Not Reported	804.0	40.0	Unknown	1CCA2D47-BA5D-46A9-89F9-681C58EFC10D	false	Solid Tissue	False	Tumor
TCGA-B5-A0K8-01A	24118b8f-59fe-482a-aed3-7b1bde1571b7	Cystic, Mucinous and Serous Neoplasms	24118b8f-59fe-482a-aed3-7b1bde1571b7	TCGA-B5-A0K8	Corpus uteri	Not Reported	white	female	not reported	Alive	71.0	-25992.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	847.0	25992.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25992.0	71.21095890410959	['2019-07-31T22:13:51.889734-05:00', '2019-07-31T22:13:51.889734-05:00']	['2ced5e83-7a23-5470-90ce-bf1a17eb6d8a', '5d24a41d-346a-50e7-bbf8-65e21c19272c']	['TCGA-B5-A0K8_treatment_1', 'TCGA-B5-A0K8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:17:10.116409-05:00', '']	01	Primary	66184035-af3e-4c2b-901a-0709c49dc54e	Primary Tumor	Not Reported	191.0	260.0	OCT	1E7C9CA2-73AA-4443-A125-D5588F93BEF9	true	Solid Tissue	False	Tumor
TCGA-EO-A1Y8-01A	de4e13c8-5ad0-46d2-ae54-b9ca22b939d8	Cystic, Mucinous and Serous Neoplasms	de4e13c8-5ad0-46d2-ae54-b9ca22b939d8	TCGA-EO-A1Y8	Corpus uteri	Not Reported	not reported	female	not reported	Alive	87.0	-31971.0	1923.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	901.0	31971.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	31971.0	87.59178082191781	['2019-07-31T22:32:32.008818-05:00', '2019-07-31T22:32:32.008818-05:00']	['1b8397cd-9088-5192-8703-05ed16bc9429', '828ab711-9d7a-52de-99da-4314be36d2d8']	['TCGA-EO-A1Y8_treatment_1', 'TCGA-EO-A1Y8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:32:14.372662-05:00', '']	01	Primary	5b0a8519-3fea-46d6-8f6d-ec85c403b416	Primary Tumor	Not Reported	204.0	170.0	Unknown	61143E14-52BD-499F-901C-4BD1EA83DAC1	false	Solid Tissue	False	Tumor
TCGA-B5-A3FH-01A	139e2c5a-cc0c-43a2-b30e-b8ac17c0b5f2	Adenomas and Adenocarcinomas	139e2c5a-cc0c-43a2-b30e-b8ac17c0b5f2	TCGA-B5-A3FH	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	74.0	-27221.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	841.0	27221.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27221.0	74.57808219178082	['2019-07-31T22:12:19.221388-05:00', '2019-07-31T22:12:19.221388-05:00']	['ae7cb3be-ba87-597f-982a-6cf51a0604a4', 'bf84eb09-d3e2-50f8-a63c-9292ae243dee']	['TCGA-B5-A3FH_treatment_1', 'TCGA-B5-A3FH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:15:54.962245-05:00', '']	01	Primary	f7c02f75-ca0a-4d2d-bd45-d40e77fe74fc	Primary Tumor	Not Reported	97.0	480.0	OCT	05AD8EE1-E2F8-42F7-8E6A-380A8EE4770E	true	Solid Tissue	False	Tumor
TCGA-SJ-A6ZJ-01A	fbfed398-2a44-44a9-83cf-657c29cb7d28	Adenomas and Adenocarcinomas	fbfed398-2a44-44a9-83cf-657c29cb7d28	TCGA-SJ-A6ZJ	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	61.0	-22597.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73bf98ff-1984-5b37-9963-519695e99a1d	SJ	Albert Einstein Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	556.0	22597.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22597.0	61.90958904109589	['2019-07-31T22:36:30.842320-05:00', '2019-07-31T22:36:30.842320-05:00']	['55d48517-9c33-5a98-a77a-a00d9ab21ab0', 'cdf0c22b-fcc0-5ec8-8e54-02d949cd4822']	['TCGA-SJ-A6ZJ_treatment_1', 'TCGA-SJ-A6ZJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:35:24.832195-05:00', '']	01	Primary	c3064816-c2c1-4af0-8f0e-89d900e47d20	Primary Tumor	Not Reported	216.0	580.0	Unknown	B7C3C4EC-E494-4290-AFDA-FEFEBA8A3BA5	false	Solid Tissue	False	Tumor
TCGA-A5-A0R8-01A	06d16b6b-9ca6-4cec-a785-f27aa4323cec	Adenomas and Adenocarcinomas	06d16b6b-9ca6-4cec-a785-f27aa4323cec	TCGA-A5-A0R8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	81.0	-29777.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	596.0	29777.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29777.0	81.58082191780822	['2019-07-31T22:10:48.160289-05:00', '2019-07-31T22:10:48.160289-05:00']	['5271e7b4-b7b4-5dc1-ac6d-170f56e2d9d4', 'c9f8e06c-4088-5f56-9cb4-c442d897e3dd']	['TCGA-A5-A0R8_treatment', 'TCGA-A5-A0R8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:14:41.241022-05:00']	01	Primary	5b5cc2ba-6a10-4279-a0aa-8ddae94d56ea	Primary Tumor	Not Reported	155.0	180.0	OCT	CA537524-B83F-4AC5-B721-38570E5B21BB	true	Solid Tissue	False	Tumor
TCGA-A5-A0G9-01A	45d58088-d3f4-4eb0-b75c-bcb98c0981dc	Adenomas and Adenocarcinomas	45d58088-d3f4-4eb0-b75c-bcb98c0981dc	TCGA-A5-A0G9	Corpus uteri	Not Reported	white	female	not reported	Alive	79.0	-29122.0	1925.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2540.0	29122.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29122.0	79.78630136986301	['2019-07-31T22:33:36.116786-05:00', '2019-07-31T22:33:36.116786-05:00']	['67fb7f36-cf7d-5a8b-8fbe-2ec67c8ac3e8', '847742d4-328a-5ade-bbb9-b37c937bb5b7']	['TCGA-A5-A0G9_treatment_1', 'TCGA-A5-A0G9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:33:05.805501-05:00', '']	01	Primary	117a5b33-42c5-4a52-babe-d9712f3e7472	Primary Tumor	Not Reported	2095.0	210.0	OCT	32FB682E-B73F-4525-A845-7F240F9F40CE	true	Solid Tissue	False	Tumor
TCGA-A5-A1OH-01A	9bce44a2-dcee-4d1a-a522-c2bcb9a8e025	Cystic, Mucinous and Serous Neoplasms	9bce44a2-dcee-4d1a-a522-c2bcb9a8e025	TCGA-A5-A1OH	Corpus uteri	Not Reported	white	female	not reported	Alive	86.0	-31451.0	1924.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1105.0	31451.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	31451.0	86.16712328767123	['2019-07-31T22:26:02.287179-05:00', '2019-07-31T22:26:02.287179-05:00']	['23c8064e-dcf6-541d-aee1-838c0c225565', '3c9754da-2a89-52e4-bf33-cd1610f9c400']	['TCGA-A5-A1OH_treatment_1', 'TCGA-A5-A1OH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:26:59.344700-05:00', '']	01	Primary	8bf78dab-9910-48eb-ab6a-fc92502a71a3	Primary Tumor	Not Reported	358.0	200.0	OCT	AAF1B591-1A0D-48D2-BF59-95B0D605950A	true	Solid Tissue	False	Tumor
TCGA-A5-AB3J-01A	8a67ed86-156f-4b45-b460-000fe33da26b	Adenomas and Adenocarcinomas	8a67ed86-156f-4b45-b460-000fe33da26b	TCGA-A5-AB3J	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	52.0	-19020.0	1961.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	Not Reported	0.0	not reported	Endometrium	512.0	19020.0	Endometrioid adenocarcinoma, NOS	yes	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19020.0	52.10958904109589	['2019-07-31T22:24:31.813570-05:00', '2019-07-31T22:24:31.813570-05:00']	['5cffb7dc-c095-5a07-a445-89bceb62fcf2', '7f4e2af1-5d4c-5c4b-91d6-af0589fb9faf']	['TCGA-A5-AB3J_treatment', 'TCGA-A5-AB3J_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:25:45.163812-05:00']	01	Primary	396753d3-fae0-4a1a-b193-4121a47746d2	Primary Tumor	Not Reported	126.0	210.0	OCT	41CDFB48-33A6-4FCD-97CA-30C73A9E6FED	true	Solid Tissue	False	Tumor
TCGA-FI-A2EY-01A	787c3e2f-a708-4985-a5b1-b2383c7bfc52	Cystic, Mucinous and Serous Neoplasms	787c3e2f-a708-4985-a5b1-b2383c7bfc52	TCGA-FI-A2EY	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	63.0	-23042.0	1943.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH	880.0															Stage IIIA	No	0.0	not reported	Endometrium		23042.0	Serous cystadenocarcinoma, NOS	no	2006.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23042.0	63.12876712328767	['2019-07-31T22:23:06.790217-05:00', '2019-07-31T22:23:06.790217-05:00']	['1f4a9d3b-99cf-54b7-9eca-0db0104198b8', 'a1f852b2-9aec-5d51-8222-6cd8c64a1822']	['TCGA-FI-A2EY_treatment_1', 'TCGA-FI-A2EY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:24:34.817414-05:00', '']	01	Primary	8c8e5dd2-b8ef-4e5c-9cd6-7d3717e4cdef	Primary Tumor	Not Reported	1866.0	140.0	OCT	D529A633-2FC9-4C28-BEA4-994BABD51A48	true	Solid Tissue	False	Tumor
TCGA-A5-A0GW-01A	5b6b9d0f-787c-4ae9-afd4-de7ce6c57a42	Adenomas and Adenocarcinomas	5b6b9d0f-787c-4ae9-afd4-de7ce6c57a42	TCGA-A5-A0GW	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	46.0	-17092.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	706.0	17092.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17092.0	46.827397260273976	['2019-07-31T22:19:54.564412-05:00', '2019-07-31T22:19:54.564412-05:00']	['282c9f55-a907-5291-b34b-b81d61e31243', 'bcfbb83b-3ec2-572b-8f1f-83df371c1c62']	['TCGA-A5-A0GW_treatment_1', 'TCGA-A5-A0GW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:22:00.680462-05:00', '']	01	Primary	e84d0533-e892-4c1e-9415-99f92aa9a360	Primary Tumor	Not Reported	302.0	160.0	OCT	0EE4FD56-D0BA-43E8-A434-CD86B21F21BF	true	Solid Tissue	False	Tumor
TCGA-BS-A0UA-01A	a1a0177d-e670-4f2f-a99d-6f668a2f9e8a	Adenomas and Adenocarcinomas	a1a0177d-e670-4f2f-a99d-6f668a2f9e8a	TCGA-BS-A0UA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-24872.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	3495.0	24872.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24872.0	68.14246575342466	['2019-07-31T22:26:40.991006-05:00', '2019-07-31T22:26:40.991006-05:00']	['223ec108-3a8d-593c-9628-338927ee526d', 'fabd1354-6b0f-5413-9488-bb25397aea3a']	['TCGA-BS-A0UA_treatment', 'TCGA-BS-A0UA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:30.911648-05:00']	01	Primary	c72da85c-c6dc-4567-9db6-f15b044328dc	Primary Tumor	Not Reported	2361.0	50.0	Unknown	58DC7332-5100-408B-9A1E-F0282B013648	false	Solid Tissue	False	Tumor
TCGA-BK-A0CA-01B	51bd85e2-2c60-4654-bfcb-83dccef8964b	Cystic, Mucinous and Serous Neoplasms	51bd85e2-2c60-4654-bfcb-83dccef8964b	TCGA-BK-A0CA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22378.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1064.0	22378.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22378.0	61.30958904109589	['2019-07-31T17:26:54.276958-05:00', '2019-07-31T17:26:54.276958-05:00']	['86795392-d88c-5bbc-8ae3-67ede9060efc', '9e810137-bf8e-5eaa-b176-c2077477617c']	['TCGA-BK-A0CA_treatment', 'TCGA-BK-A0CA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:23:33.535638-05:00']	01	Primary	6d59526a-9360-4adb-8427-a97c1c419a96	Primary Tumor	Not Reported	679.0		FFPE	883D4832-75FB-495C-B93F-904FCA1AB18C	false	Solid Tissue	True	Tumor
TCGA-BK-A0CA-01A	51bd85e2-2c60-4654-bfcb-83dccef8964b	Cystic, Mucinous and Serous Neoplasms	51bd85e2-2c60-4654-bfcb-83dccef8964b	TCGA-BK-A0CA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22378.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1064.0	22378.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22378.0	61.30958904109589	['2019-07-31T17:26:54.276958-05:00', '2019-07-31T17:26:54.276958-05:00']	['86795392-d88c-5bbc-8ae3-67ede9060efc', '9e810137-bf8e-5eaa-b176-c2077477617c']	['TCGA-BK-A0CA_treatment', 'TCGA-BK-A0CA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:23:33.535638-05:00']	01	Primary	d836db96-83fb-4f25-a16c-aaaaf55d7b12	Primary Tumor	Not Reported	86.0	300.0	Unknown	883D4832-75FB-495C-B93F-904FCA1AB18C	false	Solid Tissue	False	Tumor
TCGA-D1-A163-01A	a438dce7-6592-4ea6-a401-57f5a8fe8ba6	Adenomas and Adenocarcinomas	a438dce7-6592-4ea6-a401-57f5a8fe8ba6	TCGA-D1-A163	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	50.0	-18604.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	991.0	18604.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18604.0	50.96986301369863	['2019-07-31T22:26:57.082837-05:00', '2019-07-31T22:26:57.082837-05:00']	['0d7b81ff-e322-5712-a0e6-fd86edb4d0c6', '7281bfd0-c3df-5071-9c27-4df40e1b39cc']	['TCGA-D1-A163_treatment_1', 'TCGA-D1-A163_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:27:42.439522-05:00', '']	01	Primary	8e3afec6-eb01-404f-ae76-08590b3c0ad0	Primary Tumor	Not Reported	854.0	170.0	Unknown	993B9CE9-7D25-4B2B-B246-F642550C70CD	false	Solid Tissue	False	Tumor
TCGA-EY-A1H0-01A	c71e0986-56c0-45f4-be8d-2236e4418604	Adenomas and Adenocarcinomas	c71e0986-56c0-45f4-be8d-2236e4418604	TCGA-EY-A1H0	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	57.0	-20937.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	588.0	20937.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20937.0	57.36164383561644	['2019-07-31T22:30:04.380985-05:00', '2019-07-31T22:30:04.380985-05:00']	['6106b9c8-845e-5722-aa46-0c0a637644a2', 'ca29138c-2c11-5fb3-8604-d250b93c5c82']	['TCGA-EY-A1H0_treatment', 'TCGA-EY-A1H0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:30:15.016707-05:00']	01	Primary	3e1472fb-a882-4bb1-b4c0-c0ff3c9e6e25	Primary Tumor	Not Reported	262.0	330.0	Unknown	CE7F1184-9FFC-4A30-926B-0008915893F2	false	Solid Tissue	False	Tumor
TCGA-AP-A0LF-01A	748e38b1-2ead-4a0a-8881-d640617b856b	Adenomas and Adenocarcinomas	748e38b1-2ead-4a0a-8881-d640617b856b	TCGA-AP-A0LF	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	82.0	-30027.0	1920.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	Not Reported	0.0	not reported	Endometrium	2845.0	30027.0	Endometrioid adenocarcinoma, NOS	yes	2002.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30027.0	82.26575342465753	['2019-07-31T22:22:48.620932-05:00', '2019-07-31T22:22:48.620932-05:00']	['001c8597-a3cd-52d3-bc75-f0b78f2a47fe', '071b4f71-ac6c-510a-97c4-4fa5c83397a4']	['TCGA-AP-A0LF_treatment_1', 'TCGA-AP-A0LF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:24:20.376384-05:00', '']	01	Primary	902e2dd8-81e5-4949-a57b-92b3efd86c63	Primary Tumor	Not Reported	2891.0	240.0	OCT	7112CE75-9EFD-4989-9F2A-4D0F517B8EDE	true	Solid Tissue	False	Tumor
TCGA-FL-A1YN-11A	d72264ec-d4d7-423a-9216-ae4485f81aba	Not Reported	d72264ec-d4d7-423a-9216-ae4485f81aba	TCGA-FL-A1YN	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	ec811767-6af1-485a-967d-231764ef6797	Solid Tissue Normal	Not Reported		60.0	Unknown	BA22BA6E-3DEF-4354-A52C-19B405A349FB	false	Solid Tissue	False	Normal
TCGA-E6-A8L9-01A	eb642568-30d4-4805-a295-bda314ccaaaf	Cystic, Mucinous and Serous Neoplasms	eb642568-30d4-4805-a295-bda314ccaaaf	TCGA-E6-A8L9	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	61.0	-22333.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	39aa3c67-c7d9-5001-8ed1-3bf83eac7872	E6	Roswell Park	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	Not Reported	0.0	not reported	Endometrium	1013.0	22333.0	Serous cystadenocarcinoma, NOS	yes	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22333.0	61.18630136986302	['2019-07-31T22:34:46.931799-05:00', '2019-07-31T22:34:46.931799-05:00']	['18e1ace4-5060-5dbf-a7f8-2ad8c28ea672', 'cfdb0473-ab2f-5c6b-856f-3843aa400c27']	['TCGA-E6-A8L9_treatment_1', 'TCGA-E6-A8L9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:34:01.919071-05:00', '']	01	Primary	04225ab6-5a39-4694-bab3-423f95d60421	Primary Tumor	Not Reported	657.0	200.0	OCT	40CB57C1-7E8C-45B0-BEDD-DFE531C9201E	true	Solid Tissue	False	Tumor
TCGA-AJ-A3EK-01A	14db56ef-ec5e-4775-a229-5d83e58e027c	Adenomas and Adenocarcinomas	14db56ef-ec5e-4775-a229-5d83e58e027c	TCGA-AJ-A3EK	Corpus uteri	Not Reported	white	female	hispanic or latino	Alive	53.0	-19609.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	446.0	19609.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19609.0	53.723287671232875	['2019-07-31T22:12:34.169253-05:00', '2019-07-31T22:12:34.169253-05:00']	['471a8465-9e03-5c43-ac81-aa90ee210f5e', 'd56171f3-e0a2-5203-8049-854969a8c633']	['TCGA-AJ-A3EK_treatment', 'TCGA-AJ-A3EK_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:16:07.407298-05:00']	01	Primary	01747185-0d0d-4b27-b956-115df4d90bed	Primary Tumor	Not Reported	127.0	220.0	Unknown	F153EAC2-7347-4CEF-916A-995C7BB8B0F1	false	Solid Tissue	False	Tumor
TCGA-AJ-A3NE-11A	1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07	Adenomas and Adenocarcinomas	1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07	TCGA-AJ-A3NE	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	46.0	-16957.0	1965.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	628.0	16957.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16957.0	46.45753424657534	['2019-07-31T22:13:20.696313-05:00', '2019-07-31T22:13:20.696313-05:00']	['2e5afb49-8cc8-53c3-8444-1b285a628db9', '7b26b77a-cff4-5353-82e8-06e49c19e026']	['TCGA-AJ-A3NE_treatment', 'TCGA-AJ-A3NE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:16:44.694396-05:00']	11	Not Applicable	6436be59-08e6-4db6-9d8d-fbecfbc00b7c	Solid Tissue Normal	Not Reported	134.0	80.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AJ-A3NE-01A	1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07	Adenomas and Adenocarcinomas	1dcf33e9-4c9b-4b2b-914e-15e6be5dcd07	TCGA-AJ-A3NE	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	46.0	-16957.0	1965.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	628.0	16957.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16957.0	46.45753424657534	['2019-07-31T22:13:20.696313-05:00', '2019-07-31T22:13:20.696313-05:00']	['2e5afb49-8cc8-53c3-8444-1b285a628db9', '7b26b77a-cff4-5353-82e8-06e49c19e026']	['TCGA-AJ-A3NE_treatment', 'TCGA-AJ-A3NE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:16:44.694396-05:00']	01	Primary	a1ec8680-c144-4a99-8d51-ae9a68f15d67	Primary Tumor	Not Reported	134.0	23.0	Unknown	4618A1F6-B969-4746-8190-7D856A21C25F	false	Solid Tissue	False	Tumor
TCGA-BG-A0M2-01A	9731e0b3-c62d-43cb-8ae7-8f973d69ab19	Adenomas and Adenocarcinomas	9731e0b3-c62d-43cb-8ae7-8f973d69ab19	TCGA-BG-A0M2	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	62.0	-22822.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	637.0	22822.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22822.0	62.52602739726027	['2019-07-31T22:25:46.978546-05:00', '2019-07-31T22:25:46.978546-05:00']	['6d321b91-5942-5738-9da3-b38aa763c3d8', '9fc5b4dd-f556-55a2-adb3-a32ab6ee1233']	['TCGA-BG-A0M2_treatment_1', 'TCGA-BG-A0M2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:26:46.959172-05:00', '']	01	Primary	2af18345-2a71-4574-ac8e-83ddeed3ad57	Primary Tumor	Not Reported	185.0	510.0	OCT	A0087300-81E9-4733-8497-95E0F95575B4	true	Solid Tissue	False	Tumor
TCGA-EY-A1GF-01A	615ea37d-6302-4d68-b253-d24efd947c3e	Adenomas and Adenocarcinomas	615ea37d-6302-4d68-b253-d24efd947c3e	TCGA-EY-A1GF	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	75.0	-27450.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	826.0	27450.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27450.0	75.20547945205479	['2019-07-31T22:20:49.638783-05:00', '2019-07-31T22:20:49.638783-05:00']	['16dd6398-da72-5801-8dd2-007510d0c0f4', '94a6859c-6e08-5f4b-83cc-133ed7f12163']	['TCGA-EY-A1GF_treatment', 'TCGA-EY-A1GF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:22:45.246771-05:00']	01	Primary	f6e156ad-3e24-4e44-94c0-bcf731ad7c80	Primary Tumor	Not Reported	504.0	160.0	Unknown	0C63BAC2-FD3E-49CB-A352-0B1653B78BDD	false	Solid Tissue	False	Tumor
TCGA-E6-A1LZ-01A	9205c164-7975-421a-90c3-edfe8def595c	Cystic, Mucinous and Serous Neoplasms	9205c164-7975-421a-90c3-edfe8def595c	TCGA-E6-A1LZ	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	76.0	-28054.0	1931.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	39aa3c67-c7d9-5001-8ed1-3bf83eac7872	E6	Roswell Park	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2406.0	28054.0	Serous cystadenocarcinoma, NOS	no	2007.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	28054.0	76.86027397260274	['2019-07-31T22:25:17.253975-05:00', '2019-07-31T22:25:17.253975-05:00']	['9d915d6b-aef4-59a9-bdc2-39c576c543bc', 'd958ad39-ce65-5ddb-942d-8f8894b84bca']	['TCGA-E6-A1LZ_treatment', 'TCGA-E6-A1LZ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:26:22.193019-05:00']	01	Primary	62bff77e-4fe6-4a9f-a867-345584608e7d	Primary Tumor	Not Reported	1233.0	350.0	Unknown	55F7B7D0-D30A-4E78-B91A-CE794784CA3C	false	Solid Tissue	False	Tumor
TCGA-BS-A0UL-01A	5428c4b2-37c2-4f8c-a474-39fe1aacb26b	Adenomas and Adenocarcinomas	5428c4b2-37c2-4f8c-a474-39fe1aacb26b	TCGA-BS-A0UL	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	54.0	-19982.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2481.0	19982.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19982.0	54.74520547945205	['2019-07-31T22:19:23.157664-05:00', '2019-07-31T22:19:23.157664-05:00']	['68545713-71ca-5a6e-af82-79a6edab5fbd', '77c46c07-7ce3-57e1-9ad5-c49955c8340f']	['TCGA-BS-A0UL_treatment_1', 'TCGA-BS-A0UL_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:21:36.065561-05:00', '']	01	Primary	d9a2756b-472f-4eee-9d76-91f4320f8a1a	Primary Tumor	Not Reported	2155.0	70.0	Unknown	323FC36E-D8E3-4F6B-A8FE-2040F3E44BB9	false	Solid Tissue	False	Tumor
TCGA-BG-A0M4-01A	73e5310d-ba8c-4cbc-aa4f-e06206f898f4	Adenomas and Adenocarcinomas	73e5310d-ba8c-4cbc-aa4f-e06206f898f4	TCGA-BG-A0M4	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22090.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2167.0	22090.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22090.0	60.52054794520548	['2019-07-31T22:22:42.895448-05:00', '2019-07-31T22:22:42.895448-05:00']	['05bb3713-7fa9-5116-b044-4cd4e7baa436', 'd44800d0-ae7d-5d29-bf22-b525a69afea8']	['TCGA-BG-A0M4_treatment_1', 'TCGA-BG-A0M4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:24:15.567051-05:00', '']	01	Primary	e6e7e411-45cf-47a1-bcf0-7ae800a61a8d	Primary Tumor	Not Reported	643.0	240.0	OCT	95002D96-C9D8-43BE-ADD1-072E93994194	true	Solid Tissue	False	Tumor
TCGA-AP-A0LQ-01A	252500d2-86a3-4090-a57f-1e8c3d44c573	Adenomas and Adenocarcinomas	252500d2-86a3-4090-a57f-1e8c3d44c573	TCGA-AP-A0LQ	Corpus uteri	Not Reported	white	female	not reported	Alive	59.0	-21629.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2457.0	21629.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21629.0	59.25753424657534	['2019-07-31T22:17:26.938626-05:00', '2019-07-31T22:17:26.938626-05:00']	['2ed29817-bb75-5cd9-adbe-f20642861e02', '399d3895-128c-5cb4-a84e-c0d92649198a']	['TCGA-AP-A0LQ_treatment_1', 'TCGA-AP-A0LQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:20:02.966528-05:00', '']	01	Primary	b75648dc-b25b-4ee6-850a-7d1f3a353e83	Primary Tumor	Not Reported	1848.0	170.0	OCT	D37DBE11-B7EA-4356-901C-35AF3A7FCC89	true	Solid Tissue	False	Tumor
TCGA-BS-A0U5-01A	c306d7e8-5486-41d3-84dd-9311ce3e2069	Adenomas and Adenocarcinomas	c306d7e8-5486-41d3-84dd-9311ce3e2069	TCGA-BS-A0U5	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	76.0	-27945.0	1927.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2935.0	27945.0	Endometrioid adenocarcinoma, NOS	no	2003.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27945.0	76.56164383561644	['2019-07-31T22:29:43.512541-05:00', '2019-07-31T22:29:43.512541-05:00']	['47b6ee27-11c5-5021-a1b7-8cd3c077914e', 'c8a1090d-555b-5b20-8083-3467e950f28d']	['TCGA-BS-A0U5_treatment_1', 'TCGA-BS-A0U5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:29:58.373082-05:00', '']	01	Primary	48a5e048-b35d-4207-b45b-e72ac51e041d	Primary Tumor	Not Reported	2525.0	110.0	Unknown	8024498D-449C-45C6-B57D-846DDBA3FF30	false	Solid Tissue	False	Tumor
TCGA-A5-A0R7-01A	02b25675-094d-4098-96da-51d121380fec	Adenomas and Adenocarcinomas	02b25675-094d-4098-96da-51d121380fec	TCGA-A5-A0R7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20250.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	535.0	20250.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20250.0	55.47945205479452	['2019-07-31T22:10:23.216451-05:00', '2019-07-31T22:10:23.216451-05:00']	['5ab445cf-b9da-5100-9c92-916dcfdd43be', '96d965aa-d2fe-523c-84d5-8f1af8af3517']	['TCGA-A5-A0R7_treatment', 'TCGA-A5-A0R7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:14:21.038624-05:00']	01	Primary	550c6341-260a-4156-b00c-0ae9031d647f	Primary Tumor	Not Reported	173.0	290.0	OCT	3BBA7591-082A-44CE-829F-23D16A91772D	true	Solid Tissue	False	Tumor
TCGA-AJ-A3OK-01A	12df24c6-1229-4777-ad90-7dd66259b65f	Cystic, Mucinous and Serous Neoplasms	12df24c6-1229-4777-ad90-7dd66259b65f	TCGA-AJ-A3OK	Corpus uteri	Not Reported	white	female	not reported	Alive	73.0	-26851.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	485.0	26851.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26851.0	73.56438356164384	['2019-07-31T22:12:16.109495-05:00', '2019-07-31T22:12:16.109495-05:00']	['0503fdd8-eefc-51f8-a34c-e7a2c88d9b85', 'd6d44d5d-f1f6-5a2e-bc44-823d5dfe6d98']	['TCGA-AJ-A3OK_treatment_1', 'TCGA-AJ-A3OK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:15:52.528534-05:00', '']	01	Primary	d349d257-56da-4693-815e-9b90aee59b23	Primary Tumor	Not Reported	162.0	80.0	Unknown	54D4BBBE-D458-44B2-8F7C-0185DD16D961	false	Solid Tissue	False	Tumor
TCGA-AX-A3G7-01A	71ed7d6d-8c44-4d37-a04a-7a78df21e514	Cystic, Mucinous and Serous Neoplasms	71ed7d6d-8c44-4d37-a04a-7a78df21e514	TCGA-AX-A3G7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	71.0	-26187.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	No	0.0	not reported	Endometrium	9.0	26187.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26187.0	71.74520547945205	['2019-07-31T22:22:30.584233-05:00', '2019-07-31T22:22:30.584233-05:00']	['28c5e7f1-4f7f-579a-8229-c849635d505e', '90e2a60c-42a3-578d-9176-ab514552434d']	['TCGA-AX-A3G7_treatment_1', 'TCGA-AX-A3G7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:24:05.934772-05:00', '']	01	Primary	b44fab01-7ae7-4628-aea8-0be35ea93180	Primary Tumor	Not Reported	520.0	50.0	Unknown	81608C78-6495-4FC7-9210-1132E9335D01	false	Solid Tissue	False	Tumor
TCGA-D1-A1NS-01A	a79a4e56-09bf-4691-b7e0-81a9c2620d0f	Adenomas and Adenocarcinomas	a79a4e56-09bf-4691-b7e0-81a9c2620d0f	TCGA-D1-A1NS	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19638.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	43.0	19638.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19638.0	53.8027397260274	['2019-07-31T22:27:17.887298-05:00', '2019-07-31T22:27:17.887298-05:00']	['10cd44cc-c7cc-5dff-b589-04115adc19a0', '58ac48dc-eb73-5970-bca7-25580da42c93']	['TCGA-D1-A1NS_treatment', 'TCGA-D1-A1NS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:27:59.728096-05:00']	01	Primary	88b09e18-049d-4cbe-b7cb-42f0add220bb	Primary Tumor	Not Reported	92.0	220.0	Unknown	FE397385-B600-4450-AE73-3CB62D5FEA3B	false	Solid Tissue	False	Tumor
TCGA-D1-A16J-01A	4db4d048-016a-4186-a519-bfbad237762f	Adenomas and Adenocarcinomas	4db4d048-016a-4186-a519-bfbad237762f	TCGA-D1-A16J	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22319.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	910.0	22319.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22319.0	61.14794520547945	['2019-07-31T22:18:46.969553-05:00', '2019-07-31T22:18:46.969553-05:00']	['7f670e55-3386-5dfb-95ba-8273d709d922', '86c7a846-9448-5ce9-883c-cd6c62becc83']	['TCGA-D1-A16J_treatment', 'TCGA-D1-A16J_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:21:06.480670-05:00']	01	Primary	535b69fc-e529-4615-b789-3756eddda1cd	Primary Tumor	Not Reported	735.0	150.0	Unknown	7A1F7567-5D17-4074-B099-1E60C8069FA1	false	Solid Tissue	False	Tumor
TCGA-AP-A056-01A	585a1f31-3804-43ca-81e9-4e571fe03642	Adenomas and Adenocarcinomas	585a1f31-3804-43ca-81e9-4e571fe03642	TCGA-AP-A056	Corpus uteri	Not Reported	white	female	not reported	Alive	64.0	-23707.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	2618.0	23707.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23707.0	64.95068493150686	['2019-07-31T22:19:42.494197-05:00', '2019-07-31T22:19:42.494197-05:00']	['5c8b1d8c-39b7-5624-8cd9-93f44f9220bc', 'f54698ec-b9dc-5d01-9a16-f55b8e6101da']	['TCGA-AP-A056_treatment', 'TCGA-AP-A056_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:21:50.850566-05:00']	01	Primary	1d811231-b972-4977-890d-1fbb9109d61d	Primary Tumor	Not Reported	2017.0	400.0	OCT	008786AD-6CA8-488D-A5AC-BA558985E765	true	Solid Tissue	False	Tumor
TCGA-A5-A0GE-01A	a587e62e-430e-4f1b-82b7-6fbe856fdaf1	Adenomas and Adenocarcinomas	a587e62e-430e-4f1b-82b7-6fbe856fdaf1	TCGA-A5-A0GE	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	38.0	-14170.0	1964.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	3205.0	14170.0	Endometrioid adenocarcinoma, NOS	no	2002.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	14170.0	38.821917808219176	['2019-07-31T22:27:03.052425-05:00', '2019-07-31T22:27:03.052425-05:00']	['06d9c77c-7ffb-58a7-b665-714c12ba4d4f', 'b1de703e-7e57-509d-bcd7-73fc90e95140']	['TCGA-A5-A0GE_treatment_1', 'TCGA-A5-A0GE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:27:47.375383-05:00', '']	01	Primary	20c3f64d-acf6-45b3-9ace-2f93b3a951c8	Primary Tumor	Not Reported	2941.0	200.0	OCT	7686A445-554F-43EF-BE79-6EA5E5C4DB21	true	Solid Tissue	False	Tumor
TCGA-BK-A26L-01C	ab7adf74-6e87-4117-9742-54e323348e06	Cystic, Mucinous and Serous Neoplasms	ab7adf74-6e87-4117-9742-54e323348e06	TCGA-BK-A26L	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	71.0	-26002.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	734.0	26002.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26002.0	71.23835616438356	['2019-07-31T22:28:36.047190-05:00', '2019-07-31T22:28:36.047190-05:00']	['3426f7dd-1628-5a65-b5a0-df833a4a6c5d', 'a800f1f1-88f2-5f57-be1e-c504f5f2d832']	['TCGA-BK-A26L_treatment_1', 'TCGA-BK-A26L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:29:04.071619-05:00', '']	01	Primary	7ac409d7-3f50-4228-9767-6bbf38a8d767	Primary Tumor	Not Reported	347.0		FFPE	979388A8-CC61-4C03-BADC-BEF9EC50C40A	false	Solid Tissue	True	Tumor
TCGA-BK-A26L-01A	ab7adf74-6e87-4117-9742-54e323348e06	Cystic, Mucinous and Serous Neoplasms	ab7adf74-6e87-4117-9742-54e323348e06	TCGA-BK-A26L	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	71.0	-26002.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	734.0	26002.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26002.0	71.23835616438356	['2019-07-31T22:28:36.047190-05:00', '2019-07-31T22:28:36.047190-05:00']	['3426f7dd-1628-5a65-b5a0-df833a4a6c5d', 'a800f1f1-88f2-5f57-be1e-c504f5f2d832']	['TCGA-BK-A26L_treatment_1', 'TCGA-BK-A26L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:29:04.071619-05:00', '']	01	Primary	cfde53b1-a992-4180-b747-b4c1d3ed2e2b	Primary Tumor	Not Reported	131.0	320.0	Unknown	979388A8-CC61-4C03-BADC-BEF9EC50C40A	false	Solid Tissue	False	Tumor
TCGA-EY-A1GD-01A	33efe6c6-9159-48e8-b759-fba9ddbde761	Adenomas and Adenocarcinomas	33efe6c6-9159-48e8-b759-fba9ddbde761	TCGA-EY-A1GD	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	51.0	-18638.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1639.0	18638.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18638.0	51.06301369863014	['2019-07-31T22:15:22.707690-05:00', '2019-07-31T22:15:22.707690-05:00']	['05658fd2-1ae4-5837-9768-468f177ea853', '1370eb32-cec4-518f-bf6d-6686ab485217']	['TCGA-EY-A1GD_treatment_1', 'TCGA-EY-A1GD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:18:22.511176-05:00', '']	01	Primary	486403dc-c250-4088-9eed-a4032391d9d8	Primary Tumor	Not Reported	511.0	230.0	Unknown	65C636F7-B24D-479C-A607-FEFEE7D7E30D	false	Solid Tissue	False	Tumor
TCGA-EO-A3KW-01A	5f764ac1-3de7-4cfd-a77a-d21baa418834	Cystic, Mucinous and Serous Neoplasms	5f764ac1-3de7-4cfd-a77a-d21baa418834	TCGA-EO-A3KW	Corpus uteri	Not Reported	not reported	female	not reported	Alive	72.0	-26492.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	497.0	26492.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26492.0	72.58082191780822	['2019-07-31T22:20:28.190700-05:00', '2019-07-31T22:20:28.190700-05:00']	['e04827fb-269e-56a8-b2b0-3d199d03235d', 'ef755f5e-2676-5747-b307-7eb36c72e6fb']	['TCGA-EO-A3KW_treatment_1', 'TCGA-EO-A3KW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:22:27.444274-05:00', '']	01	Primary	ac5073ea-51cf-466c-9b31-1d4fbb86f998	Primary Tumor	Not Reported	205.0	150.0	Unknown	C1CFE3DE-628B-4C0F-881B-588C613498DA	false	Solid Tissue	False	Tumor
TCGA-FI-A2D0-01A	1b35d083-f7c9-47d2-9a9e-718788f9e39a	Adenomas and Adenocarcinomas	1b35d083-f7c9-47d2-9a9e-718788f9e39a	TCGA-FI-A2D0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20393.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1213.0	20393.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20393.0	55.87123287671233	['2019-07-31T22:13:07.935851-05:00', '2019-07-31T22:13:07.935851-05:00']	['20757def-1205-5ee6-b575-8951dc6873c5', 'ef840ec7-a121-5fdf-ac01-541c3728ec9a']	['TCGA-FI-A2D0_treatment_1', 'TCGA-FI-A2D0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:16:35.377943-05:00', '']	01	Primary	a2d2a29a-5abc-48c3-ac17-76b8b9ee1717	Primary Tumor	Not Reported	945.0	80.0	OCT	DCA05B9F-A09D-459F-AAB3-63020E15069D	true	Solid Tissue	False	Tumor
TCGA-D1-A17T-01A	efa4c675-e35e-4f48-8d12-a40f30b63ddb	Adenomas and Adenocarcinomas	efa4c675-e35e-4f48-8d12-a40f30b63ddb	TCGA-D1-A17T	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24652.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	71.0	24652.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24652.0	67.53972602739726	['2019-07-31T22:35:08.922386-05:00', '2019-07-31T22:35:08.922386-05:00']	['862ff2bc-ac37-531b-b997-11f108a392c9', 'b6fdf276-53f0-5f64-a76d-2dc9f9805e8b']	['TCGA-D1-A17T_treatment', 'TCGA-D1-A17T_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:34:19.096434-05:00']	01	Primary	179bdb8c-c4fd-4949-8aca-eca735a5320f	Primary Tumor	Not Reported	318.0	130.0	Unknown	D5927418-5A2B-477D-9917-7CE912628CA4	false	Solid Tissue	False	Tumor
TCGA-AP-A1E0-01A	84b96f93-6273-4101-a259-9602000ae491	Adenomas and Adenocarcinomas	84b96f93-6273-4101-a259-9602000ae491	TCGA-AP-A1E0	Corpus uteri	Not Reported	white	female	not reported	Alive	40.0	-14653.0	1969.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	1832.0	14653.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	14653.0	40.14520547945205	['2019-07-31T22:24:10.919753-05:00', '2019-07-31T22:24:10.919753-05:00']	['0f23d6f2-4f16-5117-bd9f-8436ea943bea', '38b3b145-82e2-53a0-945e-553cb6414e36']	['TCGA-AP-A1E0_treatment_1', 'TCGA-AP-A1E0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:25:26.468774-05:00', '']	01	Primary	9862bae4-6ad0-4607-ab28-cc6bf73d77d0	Primary Tumor	Not Reported	582.0	110.0	OCT	700FD29A-69DC-4B34-B841-FFFA7E76A5AF	true	Solid Tissue	False	Tumor
TCGA-DI-A1BU-01A	53245616-e095-4616-89bb-6062669122da	Cystic, Mucinous and Serous Neoplasms	53245616-e095-4616-89bb-6062669122da	TCGA-DI-A1BU	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20114.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	1195.0	20114.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	20114.0	55.106849315068494	['2019-07-31T22:19:13.582223-05:00', '2019-07-31T22:19:13.582223-05:00']	['31eafe0e-20ad-5676-b50e-a44dd52a62b3', 'c71e727e-6361-589e-be9c-b15fe56817bd']	['TCGA-DI-A1BU_treatment', 'TCGA-DI-A1BU_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:21:28.833867-05:00']	01	Primary	241bfb1f-5cf8-458d-b335-18babf507e85	Primary Tumor	Not Reported	903.0	140.0	Unknown	18A286FD-E85B-48FC-B193-456AB10D24B9	false	Solid Tissue	False	Tumor
TCGA-AX-A3G4-01A	83f2cd11-0dd7-47a6-b4b3-8212faac94bb	Cystic, Mucinous and Serous Neoplasms	83f2cd11-0dd7-47a6-b4b3-8212faac94bb	TCGA-AX-A3G4	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	60.0	-22099.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	9.0	22099.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22099.0	60.54520547945206	['2019-07-31T22:24:01.852120-05:00', '2019-07-31T22:24:01.852120-05:00']	['1633b899-ede4-541a-978e-6ff2d595cb9f', 'edd4576b-1b68-5a30-9ef9-3e0bf78131df']	['TCGA-AX-A3G4_treatment', 'TCGA-AX-A3G4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:25:18.704416-05:00']	01	Primary	bb0d2369-9133-4189-a386-25feaa78c6e9	Primary Tumor	Not Reported	463.0	130.0	Unknown	7E8857D6-4347-4BC5-8655-40AAD7197789	false	Solid Tissue	False	Tumor
TCGA-AJ-A2QM-01A	d9f4a2c1-ac6d-48c6-95fe-ffbc2fa08268	Cystic, Mucinous and Serous Neoplasms	d9f4a2c1-ac6d-48c6-95fe-ffbc2fa08268	TCGA-AJ-A2QM	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24776.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	Not Reported	0.0	not reported	Endometrium	894.0	24776.0	Serous cystadenocarcinoma, NOS	yes	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24776.0	67.87945205479453	['2019-07-31T22:32:04.759437-05:00', '2019-07-31T22:32:04.759437-05:00']	['4df372b1-60ba-52b0-93b7-48970232bb46', 'e39fe0b1-f37d-5291-a51b-fb1072416dcc']	['TCGA-AJ-A2QM_treatment', 'TCGA-AJ-A2QM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:52.999864-05:00']	01	Primary	f2748bad-0575-4258-9186-118bbd471325	Primary Tumor	Not Reported	108.0	210.0	Unknown	282D10FF-370D-4252-B1CB-3410A43C8F82	false	Solid Tissue	False	Tumor
TCGA-D1-A160-01A	170bbbac-940f-4e1b-b0b8-60fa36d0fa23	Adenomas and Adenocarcinomas	170bbbac-940f-4e1b-b0b8-60fa36d0fa23	TCGA-D1-A160	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	70.0	-25673.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	112.0	25673.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25673.0	70.33698630136986	['2019-07-31T22:12:50.030132-05:00', '2019-07-31T22:12:50.030132-05:00']	['7d5bd713-96d1-5014-b55c-08eb26b1bae4', 'db639547-effb-5cbd-9c2d-12eacbd0ccd4']	['TCGA-D1-A160_treatment', 'TCGA-D1-A160_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:16:20.474453-05:00']	01	Primary	b36ecf21-9d51-43dc-b2fb-6f6156e85875	Primary Tumor	Not Reported	895.0	100.0	Unknown	F349C87E-F324-4A8E-81E1-153C99173E21	false	Solid Tissue	False	Tumor
TCGA-D1-A16E-01A	e70465f6-1922-4eb7-b646-8b01ad3ce77b	Adenomas and Adenocarcinomas	e70465f6-1922-4eb7-b646-8b01ad3ce77b	TCGA-D1-A16E	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	73.0	-26859.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1119.0	26859.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26859.0	73.58630136986301	['2019-07-31T22:34:22.341230-05:00', '2019-07-31T22:34:22.341230-05:00']	['8bd7e5b7-6bc2-5119-9e0b-bb058b9423e1', 'd832fbd1-f20c-5ded-8321-bc80a7b81d63']	['TCGA-D1-A16E_treatment_1', 'TCGA-D1-A16E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:33:42.418121-05:00', '']	01	Primary	58fc1e66-39c4-44d1-bdd3-338e0d833792	Primary Tumor	Not Reported	790.0	170.0	Unknown	DF926973-D344-48AE-A6F6-5901A4A8C846	false	Solid Tissue	False	Tumor
TCGA-AP-A1DO-01A	3348a7aa-f5c3-4fba-9968-68da5cedfd7e	Adenomas and Adenocarcinomas	3348a7aa-f5c3-4fba-9968-68da5cedfd7e	TCGA-AP-A1DO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	62.0	-22787.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	952.0	22787.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22787.0	62.43013698630137	['2019-07-31T22:15:19.707182-05:00', '2019-07-31T22:15:19.707182-05:00']	['01b54d88-e12a-5534-8be9-6286ce4638b7', 'e378758c-1a50-506a-bee0-2ce85c6c7aa7']	['TCGA-AP-A1DO_treatment_1', 'TCGA-AP-A1DO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:18:20.017598-05:00', '']	01	Primary	f2b59490-86fe-409a-89f1-e11f744e0d75	Primary Tumor	Not Reported	1210.0	220.0	OCT	EAC1A113-68BB-4D45-AB57-E59E392029BC	true	Solid Tissue	False	Tumor
TCGA-B5-A11Y-01A	c0db966b-1024-4ee3-899a-f12e3c71a42c	Adenomas and Adenocarcinomas	c0db966b-1024-4ee3-899a-f12e3c71a42c	TCGA-B5-A11Y	Corpus uteri	Not Reported	white	female	not reported	Alive	59.0	-21860.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	560.0	21860.0	Endometrioid adenocarcinoma, secretory variant	no	2010.0	No	8382/3	not reported	C54.1	Endometrium	Not Reported	not reported	21860.0	59.89041095890411	['2019-07-31T22:29:31.148722-05:00', '2019-07-31T22:29:31.148722-05:00']	['b24ec926-72e4-5c7c-ba95-b14d918ad752', 'beed18da-4b8e-51ce-af0a-eb8102903543']	['TCGA-B5-A11Y_treatment_1', 'TCGA-B5-A11Y_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:29:48.663316-05:00', '']	01	Primary	24ddff8e-237c-47a0-acde-ce602cd70739	Primary Tumor	Not Reported	244.0	580.0	OCT	4FA7876E-EF1B-4EBA-99F9-1D26099B2CA1	true	Solid Tissue	False	Tumor
TCGA-BK-A6W4-01A	8e7792b3-2b6c-47ac-acbe-3da7462a8321	Adenomas and Adenocarcinomas	8e7792b3-2b6c-47ac-acbe-3da7462a8321	TCGA-BK-A6W4	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	62.0	-22766.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	300.0	22766.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22766.0	62.37260273972603	['2019-07-31T22:24:56.113821-05:00', '2019-07-31T22:24:56.113821-05:00']	['043fa2b8-7ebe-55db-b06b-3c22d412ef54', '728d30c7-200c-50c1-85c6-d80f08642e0c']	['TCGA-BK-A6W4_treatment_1', 'TCGA-BK-A6W4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:26:04.794631-05:00', '']	01	Primary	780bb0ac-d5dd-447f-a280-3ff49d7849f2	Primary Tumor	Not Reported	118.0	180.0	Unknown	5F25185F-4F80-4137-A07C-230FB3ACE3AE	false	Solid Tissue	False	Tumor
TCGA-AW-A1PO-01A	4cb4dd07-0ce5-4de7-a0bd-546183949efe	Adenomas and Adenocarcinomas	4cb4dd07-0ce5-4de7-a0bd-546183949efe	TCGA-AW-A1PO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	66.0	-24225.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	ed373abb-a0bb-535b-a344-6a33270fed23	AW	Cureline	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	17.0	24225.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24225.0	66.36986301369863	['2019-07-31T22:18:37.639732-05:00', '2019-07-31T22:18:37.639732-05:00']	['abee0683-764c-560e-a7c5-0516c49ab588', 'ef2d4b93-0146-59e3-b0bf-3a126334bd82']	['TCGA-AW-A1PO_treatment_1', 'TCGA-AW-A1PO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:20:59.347876-05:00', '']	01	Primary	1576c6c1-b9f0-4acd-9a75-e5f2d5a4ecc1	Primary Tumor	Not Reported	331.0	190.0	OCT	B5351001-32B2-4BA9-998D-F6631F6BE705	true	Solid Tissue	False	Tumor
TCGA-EO-A3B1-01A	2cf8de9f-b305-4d98-bfd4-33377bf6138f	Cystic, Mucinous and Serous Neoplasms	2cf8de9f-b305-4d98-bfd4-33377bf6138f	TCGA-EO-A3B1	Corpus uteri	Not Reported	not reported	female	not reported	Alive	63.0	-23162.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	820.0	23162.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23162.0	63.45753424657534	['2019-07-31T22:14:35.733478-05:00', '2019-07-31T22:14:35.733478-05:00']	['4ee400d4-e725-523a-bcbc-69b3cdb89b08', 'cb93749c-075d-5f3b-8ed9-45abe13358ac']	['TCGA-EO-A3B1_treatment', 'TCGA-EO-A3B1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:17:44.620851-05:00']	01	Primary	7407e162-9e38-49d0-9957-6e98775f5475	Primary Tumor	Not Reported	163.0	90.0	Unknown	D3309430-5427-4FAD-BDD6-A6E9BABE29D2	false	Solid Tissue	False	Tumor
TCGA-D1-A0ZN-01A	916ccf0d-02ef-4ccb-824b-6b4294095a08	Adenomas and Adenocarcinomas	916ccf0d-02ef-4ccb-824b-6b4294095a08	TCGA-D1-A0ZN	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22026.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	512.0	22026.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22026.0	60.345205479452055	['2019-07-31T22:25:14.142643-05:00', '2019-07-31T22:25:14.142643-05:00']	['8126ce2b-b1e3-51db-a428-e1152951871c', 'e8ee0e93-7801-523d-8d9c-e862d9aa0cdf']	['TCGA-D1-A0ZN_treatment', 'TCGA-D1-A0ZN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:26:19.722991-05:00']	01	Primary	87d4a16c-1a19-4234-b946-aea11d70169b	Primary Tumor	Not Reported	567.0	120.0	Unknown	53DB2270-9308-47F5-BD1F-4D4C737F98AC	false	Solid Tissue	False	Tumor
TCGA-EY-A1GI-01A	16bde24f-61b8-458d-aca3-df4806abbd1b	Adenomas and Adenocarcinomas	16bde24f-61b8-458d-aca3-df4806abbd1b	TCGA-EY-A1GI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	52.0	-19117.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	710.0	19117.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19117.0	52.37534246575343	['2019-07-31T22:12:43.789769-05:00', '2019-07-31T22:12:43.789769-05:00']	['9dd3c55a-7f72-5238-92b5-be2735f9d3e6', 'aae9d72c-f9dd-50d1-9ebf-f0c2b3c5860c']	['TCGA-EY-A1GI_treatment_1', 'TCGA-EY-A1GI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:16:15.620969-05:00', '']	01	Primary	9618747c-19fc-4243-ab49-d277992544e5	Primary Tumor	Not Reported	444.0	150.0	Unknown	1D56F7CA-A3F0-4078-B8E3-A10CD97873D4	false	Solid Tissue	False	Tumor
TCGA-SL-A6J9-01A	c1f1dc90-2c67-4862-9e5f-078b861ffc6e	Adenomas and Adenocarcinomas	c1f1dc90-2c67-4862-9e5f-078b861ffc6e	TCGA-SL-A6J9	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	73.0	-26701.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	54704c4f-95dd-5a29-a680-878bb1a36612	SL	St. Joseph's Hospital AZ	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2.0	26701.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26701.0	73.15342465753425	['2019-07-31T22:29:40.453424-05:00', '2019-07-31T22:29:40.453424-05:00']	['303ecbf6-e0f8-5b8b-97de-d89fe2448971', 'dc003f42-69b7-5ac8-bdd4-931f31c0559f']	['TCGA-SL-A6J9_treatment_1', 'TCGA-SL-A6J9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:29:55.971850-05:00', '']	01	Primary	8a93e942-ee48-421a-a696-2b367c6c3867	Primary Tumor	Not Reported	86.0	280.0	OCT	DFD43EFD-E91F-487F-A737-93C57C065A49	true	Solid Tissue	False	Tumor
TCGA-B5-A1N2-01A	d79e692c-5053-4484-a180-01a094c5ff45	Cystic, Mucinous and Serous Neoplasms	d79e692c-5053-4484-a180-01a094c5ff45	TCGA-B5-A1N2	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	70.0	-25612.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	954.0															Stage IIIC1	No	0.0	not reported	Endometrium	389.0	25612.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25612.0	70.16986301369863	['2019-07-31T22:31:58.524738-05:00', '2019-07-31T22:31:58.524738-05:00']	['1df98583-271a-521f-b524-eff3f9bb7f06', '8bfe348b-2933-5ac5-9e10-78600faa949a']	['TCGA-B5-A1N2_treatment', 'TCGA-B5-A1N2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:31:48.046084-05:00']	01	Primary	a5058d90-cea2-4886-9823-501ff2262e13	Primary Tumor	Not Reported	93.0	540.0	OCT	CB8D6955-D74A-4A05-ACC3-F0DE49CC60A9	true	Solid Tissue	False	Tumor
TCGA-D1-A16X-01A	22618073-4ef0-4c3a-97b9-90ba1caa1d72	Adenomas and Adenocarcinomas	22618073-4ef0-4c3a-97b9-90ba1caa1d72	TCGA-D1-A16X	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	54.0	-19799.0	1955.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	111.0	19799.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19799.0	54.24383561643835	['2019-07-31T22:13:39.091147-05:00', '2019-07-31T22:13:39.091147-05:00']	['0e302d2a-8d7f-5e07-971e-199bbe29cf53', '25bc91ad-9658-5359-aa17-6e1072c35894']	['TCGA-D1-A16X_treatment_1', 'TCGA-D1-A16X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:17:00.385622-05:00', '']	01	Primary	6421d807-9bec-4ad4-8b75-8f9dd594a977	Primary Tumor	Not Reported	618.0	230.0	Unknown	0C395D2C-1864-448E-8FB7-09BFE5FF4C50	false	Solid Tissue	False	Tumor
TCGA-A5-A0GJ-01A	94817e78-78f5-4556-9394-610df65605e2	Adenomas and Adenocarcinomas	94817e78-78f5-4556-9394-610df65605e2	TCGA-A5-A0GJ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	44.0	-16421.0	1961.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2000.0	16421.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16421.0	44.989041095890414	['2019-07-31T22:25:29.005745-05:00', '2019-07-31T22:25:29.005745-05:00']	['a9697f93-8864-577a-b05a-40b24976ad83', 'aea681f6-5801-52ce-b126-a79682dce318']	['TCGA-A5-A0GJ_treatment_1', 'TCGA-A5-A0GJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:26:32.020768-05:00', '']	01	Primary	48fa5b7d-e488-4743-a7ce-aceb9945f00b	Primary Tumor	Not Reported	1708.0	220.0	OCT	83743C19-A9FF-42F0-947E-5697709151C5	true	Solid Tissue	False	Tumor
TCGA-B5-A0JX-01A	586d7b3f-67a8-4a22-862f-cf50de3c1598	Adenomas and Adenocarcinomas	586d7b3f-67a8-4a22-862f-cf50de3c1598	TCGA-B5-A0JX	Corpus uteri	Not Reported	white	female	not reported	Alive	62.0	-22834.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1787.0	22834.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22834.0	62.558904109589044	['2019-07-31T22:19:45.549450-05:00', '2019-07-31T22:19:45.549450-05:00']	['40ee69f8-a8b5-569e-882d-41a9614b7a93', 'eaf1675c-65a4-5577-b837-3b2581fc08dd']	['TCGA-B5-A0JX_treatment', 'TCGA-B5-A0JX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:21:53.359277-05:00']	01	Primary	f4c448e1-8415-42a4-b8d4-b71bf57ad00b	Primary Tumor	Not Reported	952.0	170.0	OCT	E511CFF9-9687-4134-B85D-37C037B71643	true	Solid Tissue	False	Tumor
TCGA-AJ-A5DV-01A	c7b3ac87-5260-4042-895a-279cd8cda620	Adenomas and Adenocarcinomas	c7b3ac87-5260-4042-895a-279cd8cda620	TCGA-AJ-A5DV	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	65.0	-23892.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	679.0	23892.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23892.0	65.45753424657535	['2019-07-31T22:30:07.029107-05:00', '2019-07-31T22:30:07.029107-05:00']	['63c1fdbd-8856-5d9c-bb21-0d924f86e087', 'a87dbe9b-af61-5eec-b2f4-f6d40bb908fa']	['TCGA-AJ-A5DV_treatment_1', 'TCGA-AJ-A5DV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:17.540980-05:00', '']	01	Primary	0e933a81-858a-4a82-9ece-b56af448a510	Primary Tumor	Not Reported	220.0	70.0	Unknown	049C45D6-6FC6-42EE-BD51-AC344D1E3CD9	false	Solid Tissue	False	Tumor
TCGA-D1-A17N-01A	001e0309-9c50-42b0-9e38-347883ee2cd3	Adenomas and Adenocarcinomas	001e0309-9c50-42b0-9e38-347883ee2cd3	TCGA-D1-A17N	Corpus uteri	Not Reported	not reported	female	not hispanic or latino	Alive	46.0	-17045.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	46.0	17045.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17045.0	46.6986301369863	['2019-07-31T22:09:55.610144-05:00', '2019-07-31T22:09:55.610144-05:00']	['6a26a01d-7746-553c-a5f7-2798efdff38b', 'd733b7ec-b2b8-5b4b-92bd-92dee7f97bf0']	['TCGA-D1-A17N_treatment_1', 'TCGA-D1-A17N_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:13:58.581823-05:00', '']	01	Primary	f93931ba-8333-4e22-a430-ca02d9da3ffc	Primary Tumor	Not Reported	451.0	110.0	Unknown	AD892375-1A50-4D9E-8235-A9A495C35B97	false	Solid Tissue	False	Tumor
TCGA-B5-A1MS-01B	b2aa0220-6387-4eea-b6d4-a4fa0f15b2d9	Cystic, Mucinous and Serous Neoplasms	b2aa0220-6387-4eea-b6d4-a4fa0f15b2d9	TCGA-B5-A1MS	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	60.0	-22068.0	1943.0	2011.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	3112.0															Stage IC	No	0.0	not reported	Endometrium		22068.0	Serous cystadenocarcinoma, NOS	no	2003.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22068.0	60.46027397260274	['2019-07-31T22:28:45.297759-05:00', '2019-07-31T22:28:45.297759-05:00']	['9e5b530f-ec1e-5c73-8e79-d35b98157eed', 'e65f1700-0cb5-5ae5-9abb-409a459e6469']	['TCGA-B5-A1MS_treatment', 'TCGA-B5-A1MS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:29:11.446277-05:00']	01	Primary	077a804e-8053-4319-80be-65d33bc2cf41	Primary Tumor	Not Reported	3117.0	440.0	OCT	5FF9FC65-FBCD-40E8-8382-DDD0B8EFD22B	true	Solid Tissue	False	Tumor
TCGA-BG-A0M6-01A	002724fa-7051-49fa-9c58-4bcb7eba4ac6	Cystic, Mucinous and Serous Neoplasms	002724fa-7051-49fa-9c58-4bcb7eba4ac6	TCGA-BG-A0M6	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	73.0	-26666.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH	671.0															Stage IIIC2	Not Reported	0.0	not reported	Endometrium	241.0	26666.0	Serous cystadenocarcinoma, NOS	yes	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26666.0	73.05753424657534	['2019-07-31T22:09:58.816644-05:00', '2019-07-31T22:09:58.816644-05:00']	['4650e484-ae66-5144-9a53-b7f7841b086d', '80930add-59eb-55a4-907e-75b402c24473']	['TCGA-BG-A0M6_treatment_1', 'TCGA-BG-A0M6_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:14:01.068796-05:00', '']	01	Primary	66e4b080-e6ef-4531-9b69-1b27f15c5669	Primary Tumor	Not Reported	618.0	320.0	OCT	39EC3673-5B31-403B-8328-9DEA5FF7CD1A	true	Solid Tissue	False	Tumor
TCGA-BG-A0M7-01A	1d9c2113-ddcb-4440-89c3-cd21cee6d401	Adenomas and Adenocarcinomas	1d9c2113-ddcb-4440-89c3-cd21cee6d401	TCGA-BG-A0M7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22096.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	1937.0	22096.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22096.0	60.536986301369865	['2019-07-31T22:13:17.007608-05:00', '2019-07-31T22:13:17.007608-05:00']	['1d000dea-f4e2-5d05-9167-287fd41901f8', 'd9973988-a655-5272-8789-e2aacdf5edf7']	['TCGA-BG-A0M7_treatment', 'TCGA-BG-A0M7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:16:42.269452-05:00']	01	Primary	d053fa9e-5d19-4940-8915-4a03cb479263	Primary Tumor	Not Reported	659.0	260.0	OCT	F9128DAE-F3D0-4738-AC20-E665F22DDC63	true	Solid Tissue	False	Tumor
TCGA-AJ-A2QO-01A	dcf1beb9-bce4-4f4c-98dd-1226d8e0c125	Adenomas and Adenocarcinomas	dcf1beb9-bce4-4f4c-98dd-1226d8e0c125	TCGA-AJ-A2QO	Corpus uteri	Not Reported	white	female	not reported	Dead	85.0	-31222.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	1045.0															Stage IB	No	0.0	not reported	Endometrium	92.0	31222.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31222.0	85.53972602739726	['2019-07-31T22:32:23.076871-05:00', '2019-07-31T22:32:23.076871-05:00']	['551bc2ea-472a-5dbc-b7eb-05dedc4d1705', '967034e4-bd02-5092-a7f2-609080272db0']	['TCGA-AJ-A2QO_treatment_1', 'TCGA-AJ-A2QO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:32:06.908564-05:00', '']	01	Primary	32be3043-2dce-42c7-bb5c-a313f2c5e3a1	Primary Tumor	Not Reported	174.0	16.0	Unknown	5351BF98-9E1D-4F4D-A3EE-26A83B867D58	false	Solid Tissue	False	Tumor
TCGA-EY-A2OQ-01A	029f0f1d-dd22-44d2-a623-cb9a33cb9438	Adenomas and Adenocarcinomas	029f0f1d-dd22-44d2-a623-cb9a33cb9438	TCGA-EY-A2OQ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22309.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	885.0	22309.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22309.0	61.12054794520548	['2019-07-31T22:10:16.737545-05:00', '2019-07-31T22:10:16.737545-05:00']	['4e38bc13-ae46-55d0-a9d0-97e84acf9ab1', 'b24a85dc-4b3f-5b43-bded-f68333ec9758']	['TCGA-EY-A2OQ_treatment_1', 'TCGA-EY-A2OQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:14:16.021509-05:00', '']	01	Primary	a5f68889-4f7d-44d7-a999-c01bcb0ee56e	Primary Tumor	Not Reported	217.0	1.0	Unknown	BD1FB0FF-176C-42D9-843E-2F2BF2EBCCC2	false	Solid Tissue	False	Tumor
TCGA-BG-A0MU-01A	a7329910-b1c7-4a18-b28e-8fad79121339	Adenomas and Adenocarcinomas	a7329910-b1c7-4a18-b28e-8fad79121339	TCGA-BG-A0MU	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	78.0	-28621.0	1932.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	617.0	28621.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28621.0	78.41369863013699	['2019-07-31T22:27:11.767249-05:00', '2019-07-31T22:27:11.767249-05:00']	['5663d573-fa1c-5751-8b0d-6b95eb3011d8', 'f920c410-cea7-5309-970b-8bc5adb439a5']	['TCGA-BG-A0MU_treatment_1', 'TCGA-BG-A0MU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:27:54.792160-05:00', '']	01	Primary	f0af3f30-3d64-4bd8-9a8f-7ff7ab9bb7b0	Primary Tumor	Not Reported	121.0	860.0	OCT	7162F7A7-7295-4736-B721-B13DAE006092	true	Solid Tissue	False	Tumor
TCGA-A5-A0GV-01A	5e3b981e-73fe-4cc9-8c89-b420e8e2f426	Adenomas and Adenocarcinomas	5e3b981e-73fe-4cc9-8c89-b420e8e2f426	TCGA-A5-A0GV	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24540.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1643.0	24540.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24540.0	67.23287671232876	['2019-07-31T22:33:39.170717-05:00', '2019-07-31T22:33:39.170717-05:00']	['90acf6df-574c-56f1-b240-cbc33f46c2d3', 'a20ab2ad-87d8-51ff-948f-ca3415f53cd6']	['TCGA-A5-A0GV_treatment_1', 'TCGA-A5-A0GV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:33:08.121820-05:00', '']	01	Primary	339926e1-61e6-4256-a808-f931aa2c17d2	Primary Tumor	Not Reported	454.0	330.0	OCT	0E6417D3-6E95-4EEF-AE93-40D69D4F6525	true	Solid Tissue	False	Tumor
TCGA-EO-A22U-01A	30bc72d5-07b5-48d2-b025-bba9bcf2f09f	Adenomas and Adenocarcinomas	30bc72d5-07b5-48d2-b025-bba9bcf2f09f	TCGA-EO-A22U	Corpus uteri	Not Reported	white	female	not reported	Alive	83.0	-30557.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1407.0	30557.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30557.0	83.71780821917808	['2019-07-31T22:15:07.033536-05:00', '2019-07-31T22:15:07.033536-05:00']	['782a304e-53c4-5a39-b015-8b7f6eaf353b', 'cb7adb2a-2b3e-5f96-9dcb-e084d856cf75']	['TCGA-EO-A22U_treatment', 'TCGA-EO-A22U_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:18:10.330834-05:00']	01	Primary	4eb2e033-34f4-4a2d-837e-c927c1e52359	Primary Tumor	Not Reported	758.0	110.0	Unknown	DB7D72BC-F9C7-4726-98F4-A4F642B125C6	false	Solid Tissue	False	Tumor
TCGA-AP-A1DV-01A	1b685c46-57b3-4052-b5b9-1f704809bf04	Adenomas and Adenocarcinomas	1b685c46-57b3-4052-b5b9-1f704809bf04	TCGA-AP-A1DV	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	59.0	-21901.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	204.0	21901.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21901.0	60.0027397260274	['2019-07-31T22:20:37.144960-05:00', '2019-07-31T22:20:37.144960-05:00']	['5006618c-9c08-561a-b3b6-e5ae6d803668', '7d1868d8-9161-584e-a6ee-c5086a9c2402']	['TCGA-AP-A1DV_treatment', 'TCGA-AP-A1DV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:22:35.041954-05:00']	01	Primary	a03f9020-3ded-4c1c-bf7e-1fa3a47e76de	Primary Tumor	Not Reported	876.0	170.0	OCT	F3163501-DD37-4C13-A921-3C2A74928BA7	true	Solid Tissue	False	Tumor
TCGA-SJ-A6ZI-01A	3c2a6e30-a507-49f6-8b1f-36eb3aa41e60	Adenomas and Adenocarcinomas	3c2a6e30-a507-49f6-8b1f-36eb3aa41e60	TCGA-SJ-A6ZI	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	64.0	-23653.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73bf98ff-1984-5b37-9963-519695e99a1d	SJ	Albert Einstein Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	631.0	23653.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23653.0	64.8027397260274	['2019-07-31T22:16:18.674861-05:00', '2019-07-31T22:16:18.674861-05:00']	['8df5752a-89d1-5aff-8277-7806bdf7e879', 'cb2eb786-9ad0-5af7-8361-153e87ed660d']	['TCGA-SJ-A6ZI_treatment_1', 'TCGA-SJ-A6ZI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:19:09.822093-05:00', '']	01	Primary	629770a3-4982-480b-a066-e85c609dfa3f	Primary Tumor	Not Reported	88.0	880.0	Unknown	2CA0FD3F-7635-4395-A13B-C3BB9D3FF0D8	false	Solid Tissue	False	Tumor
TCGA-AP-A0LE-01A	dcff8659-ecca-4798-80a3-dd6e7642ba2b	Adenomas and Adenocarcinomas	dcff8659-ecca-4798-80a3-dd6e7642ba2b	TCGA-AP-A0LE	Corpus uteri	Not Reported	white	female	not reported	Alive	57.0	-20967.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	3357.0	20967.0	Endometrioid adenocarcinoma, NOS	no	2002.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20967.0	57.443835616438356	['2019-07-31T22:32:28.870541-05:00', '2019-07-31T22:32:28.870541-05:00']	['8d17aea8-a9d0-518a-b10c-71648e9d536c', 'f20f738c-fec8-5536-aba1-e59d5a0d8a93']	['TCGA-AP-A0LE_treatment', 'TCGA-AP-A0LE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:32:11.934938-05:00']	01	Primary	9c4a32cf-de40-4996-91a9-56f1c18d69a4	Primary Tumor	Not Reported	2988.0	170.0	OCT	3EA84930-6B34-43B8-A5A8-3D2B3754155F	true	Solid Tissue	False	Tumor
TCGA-K6-A3WQ-01A	d6303a05-f705-4413-8860-506a105d5b08	Cystic, Mucinous and Serous Neoplasms	d6303a05-f705-4413-8860-506a105d5b08	TCGA-K6-A3WQ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	60.0	-22092.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8eacce23-33fb-500d-8d6f-5fc1794664f1	K6	ABS - Lahey Clinic	Uterine Corpus Endometrial Carcinoma	NCH	427.0															Stage IVB	No	0.0	not reported	Endometrium	400.0	22092.0	Serous cystadenocarcinoma, NOS	no	2012.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22092.0	60.52602739726027	['2019-07-31T22:31:40.620311-05:00', '2019-07-31T22:31:40.620311-05:00']	['64b35476-9741-5170-816e-1d2a60660a0f', '97826b3a-bd76-5325-8bf3-1c89eaf34e26']	['TCGA-K6-A3WQ_treatment_1', 'TCGA-K6-A3WQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:31:32.773186-05:00', '']	01	Primary	702c78d1-352a-4050-a17e-501bbfd0317a	Primary Tumor	Not Reported	63.0	440.0	OCT	16F848AA-C14C-45F7-A756-414615853761	true	Solid Tissue	False	Tumor
TCGA-EY-A1GU-01A	5dd28537-d24f-4a6d-a454-6f64cf37e16a	Adenomas and Adenocarcinomas	5dd28537-d24f-4a6d-a454-6f64cf37e16a	TCGA-EY-A1GU	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	66.0	-24304.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	997.0															Stage IB	No	0.0	not reported	Endometrium	378.0	24304.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24304.0	66.58630136986301	['2019-07-31T22:20:15.202038-05:00', '2019-07-31T22:20:15.202038-05:00']	['2640887f-849c-5782-b050-33c207e9c2e8', '81fcac9b-cdd5-51cf-be43-8e65f8cb3379']	['TCGA-EY-A1GU_treatment_1', 'TCGA-EY-A1GU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:22:17.361516-05:00', '']	01	Primary	ef348984-8c78-46a3-8e76-d5d974819d1b	Primary Tumor	Not Reported	189.0	380.0	Unknown	7A06A8F8-416F-41CD-B546-95DEA06996D0	false	Solid Tissue	False	Tumor
TCGA-AJ-A3NH-11A	7186180a-688a-4fcc-9a67-166eff032e4b	Cystic, Mucinous and Serous Neoplasms	7186180a-688a-4fcc-9a67-166eff032e4b	TCGA-AJ-A3NH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	90.0	-32871.0	1921.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	1.0															Stage IB	Not Reported	0.0	not reported	Endometrium	1.0	32871.0	Serous cystadenocarcinoma, NOS	yes	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	32871.0	90.05753424657534	['2019-07-31T22:22:24.596018-05:00', '2019-07-31T22:22:24.596018-05:00']	['2e65be50-2ef3-5b89-be19-2dab9dfa97af', '6bd33564-ffec-5150-a2aa-74bb98c49f6f']	['TCGA-AJ-A3NH_treatment_1', 'TCGA-AJ-A3NH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:24:01.094302-05:00', '']	11	Not Applicable	6985142f-a646-4b89-a60b-0801a3820bbd	Solid Tissue Normal	Not Reported	67.0	70.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AJ-A3NH-01A	7186180a-688a-4fcc-9a67-166eff032e4b	Cystic, Mucinous and Serous Neoplasms	7186180a-688a-4fcc-9a67-166eff032e4b	TCGA-AJ-A3NH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	90.0	-32871.0	1921.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	1.0															Stage IB	Not Reported	0.0	not reported	Endometrium	1.0	32871.0	Serous cystadenocarcinoma, NOS	yes	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	32871.0	90.05753424657534	['2019-07-31T22:22:24.596018-05:00', '2019-07-31T22:22:24.596018-05:00']	['2e65be50-2ef3-5b89-be19-2dab9dfa97af', '6bd33564-ffec-5150-a2aa-74bb98c49f6f']	['TCGA-AJ-A3NH_treatment_1', 'TCGA-AJ-A3NH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:24:01.094302-05:00', '']	01	Primary	892763d2-7038-479e-a623-8f56eeab1a27	Primary Tumor	Not Reported	67.0	130.0	Unknown	8FC0BB09-C917-4552-96A4-B4868FD33D27	false	Solid Tissue	False	Tumor
TCGA-QS-A744-01A	8e8f19bd-dbaa-4738-bad2-207f634cd63d	Adenomas and Adenocarcinomas	8e8f19bd-dbaa-4738-bad2-207f634cd63d	TCGA-QS-A744	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	86.0	-31520.0	1927.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	c4c083cd-4644-53b2-9d7e-ca2ae833c525	QS	Candler	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIB	No	0.0	not reported	Isthmus uteri	451.0	31520.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.0	Isthmus uteri	Not Reported	not reported	31520.0	86.35616438356165	['2019-07-31T22:24:59.172976-05:00', '2019-07-31T22:24:59.172976-05:00']	['12a33213-0967-53c4-baf7-90d174f101ae', '6f1a092c-63ab-5a22-b2de-2efb24bbb2b4']	['TCGA-QS-A744_treatment', 'TCGA-QS-A744_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:26:07.382598-05:00']	01	Primary	100f19f6-f2c6-456b-8a54-e6ed68b1fb05	Primary Tumor	Not Reported	44.0	310.0	Unknown	F37C9C5C-8AAA-47FB-8BAD-AE2EB0F70B4F	false	Solid Tissue	False	Tumor
TCGA-B5-A11O-01A	a59a79fd-433d-44dc-9601-4c63d599ab28	Adenomas and Adenocarcinomas	a59a79fd-433d-44dc-9601-4c63d599ab28	TCGA-B5-A11O	Corpus uteri	Not Reported	white	female	not reported	Alive	62.0	-22720.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2609.0	22720.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22720.0	62.24657534246575	['2019-07-31T22:27:05.718465-05:00', '2019-07-31T22:27:05.718465-05:00']	['ef5a4abb-5f9a-5785-bdbc-45ef5f3325a7', 'f166c518-fa80-528e-9ad3-a9bb7367e827']	['TCGA-B5-A11O_treatment_1', 'TCGA-B5-A11O_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:27:49.806846-05:00', '']	01	Primary	f3d85f05-bd2c-46fc-ac6a-0e2a7248c630	Primary Tumor	Not Reported	993.0	130.0	OCT	078AA8A2-E812-4603-9084-8414937B88E1	true	Solid Tissue	False	Tumor
TCGA-D1-A16G-01A	16e69011-c295-479f-b521-86e66fba498d	Cystic, Mucinous and Serous Neoplasms	16e69011-c295-479f-b521-86e66fba498d	TCGA-D1-A16G	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	74.0	-27065.0	1934.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	834.0															Stage IV	No	0.0	not reported	Endometrium		27065.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27065.0	74.15068493150685	['2019-07-31T22:12:46.899720-05:00', '2019-07-31T22:12:46.899720-05:00']	['2b2aa8fa-88a3-57d0-9b0b-fc69a8d73423', '2ce1e51d-937d-5861-81d1-3df10bf5369a']	['TCGA-D1-A16G_treatment_1', 'TCGA-D1-A16G_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:16:17.930705-05:00', '']	01	Primary	4c34ecb0-9351-4a55-9ff5-2062b7cb391a	Primary Tumor	Not Reported	769.0	250.0	Unknown	778F9F58-841E-48F3-B6EA-7CF58463808B	false	Solid Tissue	False	Tumor
TCGA-D1-A2G0-01A	6f661f0d-f08b-486e-8bd7-4306e1593eb9	Cystic, Mucinous and Serous Neoplasms	6f661f0d-f08b-486e-8bd7-4306e1593eb9	TCGA-D1-A2G0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	70.0	-25573.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1484.0	25573.0	Serous cystadenocarcinoma, NOS	no	2007.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25573.0	70.06301369863014	['2019-07-31T22:22:12.669710-05:00', '2019-07-31T22:22:12.669710-05:00']	['02674f23-c7f6-5daf-818a-f167d8575e44', 'ce98e0a4-9a7e-5d93-82f7-899ecaeaf42d']	['TCGA-D1-A2G0_treatment', 'TCGA-D1-A2G0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:23:50.946693-05:00']	01	Primary	134cd317-cbeb-4633-b540-b639454615f7	Primary Tumor	Not Reported	1416.0	90.0	OCT	02872006-6F7E-4FB7-B1C2-1C5DD3199FE3	true	Solid Tissue	False	Tumor
TCGA-EY-A2OM-01A	2b60ef45-336c-42e0-aa3f-577069310d1f	Adenomas and Adenocarcinomas	2b60ef45-336c-42e0-aa3f-577069310d1f	TCGA-EY-A2OM	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20398.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	694.0	20398.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20398.0	55.88493150684931	['2019-07-31T22:14:23.653599-05:00', '2019-07-31T22:14:23.653599-05:00']	['1f4cc020-97aa-5d2d-b98f-66837d8741e8', '8b06b829-8a7f-51be-a830-09ba375184b6']	['TCGA-EY-A2OM_treatment', 'TCGA-EY-A2OM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:17:34.844835-05:00']	01	Primary	2d9888f8-fa53-44a3-8e1c-20479cee4584	Primary Tumor	Not Reported	176.0	640.0	Unknown	7C46CE28-FC96-47FD-A133-B95EA93E1D8B	false	Solid Tissue	False	Tumor
TCGA-EC-A1NJ-01A	b3aa16d6-1677-445d-a8d3-46657d4f8b43	Adenomas and Adenocarcinomas	b3aa16d6-1677-445d-a8d3-46657d4f8b43	TCGA-EC-A1NJ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	73.0	-27002.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	acc43e64-d63e-554c-a488-8bf6b93bec91	EC	Asterand	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	488.0	27002.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27002.0	73.97808219178083	['2019-07-31T22:28:48.136081-05:00', '2019-07-31T22:28:48.136081-05:00']	['583f8f48-82b6-5360-93af-73f4090473f6', 'bf8c739f-1f80-5eac-a186-da47176d5dfc']	['TCGA-EC-A1NJ_treatment', 'TCGA-EC-A1NJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:29:13.894370-05:00']	01	Primary	0a6212d0-cb90-4e24-add2-6ef723d2a701	Primary Tumor	Not Reported	60.0	620.0	OCT	8E02F7D6-EBE4-46CB-B05C-B41FDCDC1141	true	Solid Tissue	False	Tumor
TCGA-AP-A0LM-01A	43e228ae-c890-444f-afbd-49385562e33a	Adenomas and Adenocarcinomas	43e228ae-c890-444f-afbd-49385562e33a	TCGA-AP-A0LM	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	33.0	-12309.0	1971.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	825.0	12309.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	12309.0	33.723287671232875	['2019-07-31T22:17:42.205279-05:00', '2019-07-31T22:17:42.205279-05:00']	['69a69e40-5118-53d8-8636-bd3d7fc1b5df', 'fbc51e68-0315-5a79-9663-7e6c6be0dabd']	['TCGA-AP-A0LM_treatment_1', 'TCGA-AP-A0LM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:20:14.689263-05:00', '']	01	Primary	c8ab800a-ec4d-4a1c-bccf-8e17f7976978	Primary Tumor	Not Reported	2019.0	200.0	OCT	BF380986-0279-41FC-AAE8-BA9772456CE6	true	Solid Tissue	False	Tumor
TCGA-B5-A3S1-01A	3789ae3f-286b-42f0-a805-320ad69ea1df	Cystic, Mucinous and Serous Neoplasms	3789ae3f-286b-42f0-a805-320ad69ea1df	TCGA-B5-A3S1	Corpus uteri	Not Reported	white	female	not reported	Alive	71.0	-26031.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	902.0	26031.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26031.0	71.31780821917808	['2019-07-31T22:15:31.574891-05:00', '2019-07-31T22:15:31.574891-05:00']	['a2b38aaa-1518-523c-890a-af4332701700', 'e1378a4d-e78c-5499-a5e4-94e3765e8554']	['TCGA-B5-A3S1_treatment', 'TCGA-B5-A3S1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:18:30.110127-05:00']	01	Primary	4715fda8-7e8e-40f5-9ddb-80349a38c626	Primary Tumor	Not Reported	127.0	140.0	OCT	72F97A0D-1245-4C80-B2D2-B7B217BEC06B	true	Solid Tissue	False	Tumor
TCGA-B5-A0JN-01A	b60f22ac-a659-4f33-b01d-820e86a9a5c9	Cystic, Mucinous and Serous Neoplasms	b60f22ac-a659-4f33-b01d-820e86a9a5c9	TCGA-B5-A0JN	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	84.0	-30933.0	1920.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	Not Reported	0.0	not reported	Endometrium	1939.0	30933.0	Serous cystadenocarcinoma, NOS	yes	2004.0	Yes	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30933.0	84.74794520547945	['2019-07-31T17:22:55.386907-05:00', '2019-07-31T17:22:55.386907-05:00']	['03baf715-289a-5971-9525-3be0eca9a7f5', '7543f14c-9eac-5ba2-97ae-badefb4c3e29']	['TCGA-B5-A0JN_treatment', 'TCGA-B5-A0JN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T10:20:15.432542-05:00']	01	Primary	684c6894-fd49-4934-8962-9628ece734fb	Primary Tumor	Not Reported	2164.0	440.0	OCT	A22F4C33-7630-4595-8415-24C87949B211	true	Solid Tissue	False	Tumor
TCGA-D1-A1NU-01A	e56491af-718f-4ca1-b3cd-0e5b3154697b	Cystic, Mucinous and Serous Neoplasms	e56491af-718f-4ca1-b3cd-0e5b3154697b	TCGA-D1-A1NU	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27272.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	402.0	27272.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27272.0	74.71780821917808	['2019-07-31T22:34:04.491440-05:00', '2019-07-31T22:34:04.491440-05:00']	['462c092a-c458-52ce-b702-036da6f52384', 'd7507d19-229a-5024-a6ac-8829617c5e74']	['TCGA-D1-A1NU_treatment_1', 'TCGA-D1-A1NU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:33:27.498360-05:00', '']	01	Primary	7901f084-c220-4865-a034-da0144d63a28	Primary Tumor	Not Reported	87.0	120.0	Unknown	08AE92E6-EDAB-4059-AF51-4A8522EDD463	false	Solid Tissue	False	Tumor
TCGA-PG-A7D5-01A	4adc20d7-5af1-4126-9073-c7d7ae465d92	Cystic, Mucinous and Serous Neoplasms	4adc20d7-5af1-4126-9073-c7d7ae465d92	TCGA-PG-A7D5	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	62.0	-23006.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	69bd8326-4904-56a0-8230-1615a777173b	PG	Montefiore Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1177.0	23006.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23006.0	63.03013698630137	['2019-07-31T22:18:28.452386-05:00', '2019-07-31T22:18:28.452386-05:00']	['556eafb4-eeb5-5301-bed7-28236be7be40', '9fcb569a-8851-555d-a1ec-6821c3877ec9']	['TCGA-PG-A7D5_treatment', 'TCGA-PG-A7D5_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:20:51.841418-05:00']	01	Primary	f408c11a-cbc3-4d31-8cf3-c204423e798f	Primary Tumor	Not Reported	618.0	100.0	OCT	2E996CFE-9F6E-432F-9B09-6FBC2A920B24	true	Solid Tissue	False	Tumor
TCGA-FL-A3WE-11A	50edd97a-f440-40af-b94c-d88eca55d845	Not Reported	50edd97a-f440-40af-b94c-d88eca55d845	TCGA-FL-A3WE	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	70c3b243-d83a-4d15-b803-999bdd1576a8	Solid Tissue Normal	Not Reported		80.0	OCT	803BA1B3-9F78-43B8-B9CA-81D309E9FEDA	true	Solid Tissue	False	Normal
TCGA-D1-A1NX-01A	df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9	Cystic, Mucinous and Serous Neoplasms	df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9	TCGA-D1-A1NX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	66.0	-24441.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	555.0	24441.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24441.0	66.96164383561644	['2019-07-31T22:32:44.120674-05:00', '2019-07-31T22:32:44.120674-05:00']	['88869daa-0ef2-51f5-8ee6-4a5ac4435d10', '98dc4683-40ad-52ae-9867-08c594ad081e']	['TCGA-D1-A1NX_treatment', 'TCGA-D1-A1NX_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:32:24.169378-05:00']	01	Primary	1e016d9f-9fab-4191-8209-bc0a8ff0bacf	Primary Tumor	Not Reported	204.0	50.0	Unknown	C2A3FA63-63A1-4424-BD92-FAEC1C377C62	false	Solid Tissue	False	Tumor
TCGA-AJ-A3EM-01A	c856e031-bbd0-431f-b44f-b3ad9b39af7b	Adenomas and Adenocarcinomas	c856e031-bbd0-431f-b44f-b3ad9b39af7b	TCGA-AJ-A3EM	Corpus uteri	Not Reported	white	female	not reported	Alive	69.0	-25557.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	677.0	25557.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25557.0	70.01917808219179	['2019-07-31T22:30:10.005455-05:00', '2019-07-31T22:30:10.005455-05:00']	['4ad72b2f-f4ce-537b-a4fa-23b78f5f0992', '987ea90d-65b9-50f5-a739-667231a027d5']	['TCGA-AJ-A3EM_treatment', 'TCGA-AJ-A3EM_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:30:20.031220-05:00']	01	Primary	7dc99437-730f-44f3-88e8-ea6d7e9dbcc1	Primary Tumor	Not Reported	296.0	9.0	Unknown	E5CE38FD-DB53-49D9-92B3-BA075BDDC5CF	false	Solid Tissue	False	Tumor
TCGA-B5-A0K9-01A	4485cc98-5d58-4eb4-8325-7d1a617b6461	Adenomas and Adenocarcinomas	4485cc98-5d58-4eb4-8325-7d1a617b6461	TCGA-B5-A0K9	Corpus uteri	Not Reported	white	female	not reported	Dead	88.0	-32289.0	1921.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	409.0															Stage II	No	0.0	not reported	Endometrium	335.0	32289.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	32289.0	88.46301369863014	['2019-07-31T17:13:42.629803-05:00', '2019-07-31T17:13:42.629803-05:00']	['9c4c7313-7287-59fc-a8cb-2b06c55ebb52', 'c96d3ae9-3d27-5d1c-8137-629d5df17dc1']	['TCGA-B5-A0K9_treatment_1', 'TCGA-B5-A0K9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T10:12:37.227058-05:00', '']	01	Primary	52a96216-708f-43f2-a923-130a1c35922d	Primary Tumor	Not Reported	182.0	600.0	OCT	8278F457-C0A5-4441-9105-3FC015E3F0EF	true	Solid Tissue	False	Tumor
TCGA-AP-A0LH-01A	7dce4215-01f6-43e9-9378-9e22c26c23a2	Cystic, Mucinous and Serous Neoplasms	7dce4215-01f6-43e9-9378-9e22c26c23a2	TCGA-AP-A0LH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	60.0	-22169.0	1942.0	2005.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	1106.0															Stage IA	No	0.0	not reported	Endometrium		22169.0	Serous cystadenocarcinoma, NOS	no	2002.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22169.0	60.73698630136986	['2019-07-31T22:23:36.994717-05:00', '2019-07-31T22:23:36.994717-05:00']	['25f78b77-bf00-5c02-87d3-651f7dc72701', 'c4bec7c6-bab7-5e5e-9c9c-a9f1156b0705']	['TCGA-AP-A0LH_treatment_1', 'TCGA-AP-A0LH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:24:59.072825-05:00', '']	01	Primary	4c657ad4-2c53-4ea9-82b5-52996e74e3ff	Primary Tumor	Not Reported	2772.0	210.0	OCT	78E73020-1173-45DA-BDBA-DFB1CF7BCB41	true	Solid Tissue	False	Tumor
TCGA-AX-A2IO-01A	8a235d4d-5ee1-4d6b-839e-e71cadcd8c39	Cystic, Mucinous and Serous Neoplasms	8a235d4d-5ee1-4d6b-839e-e71cadcd8c39	TCGA-AX-A2IO	Corpus uteri	Not Reported	white	female	not reported	Alive	83.0	-30539.0	1925.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIA	No	0.0	not reported	Endometrium	1975.0	30539.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30539.0	83.66849315068494	['2019-07-31T22:24:28.900761-05:00', '2019-07-31T22:24:28.900761-05:00']	['3094a64d-cdf0-55be-91f5-7675fbe50e6b', 'bced907c-b54c-570b-9717-e6de5a6a3360']	['TCGA-AX-A2IO_treatment_1', 'TCGA-AX-A2IO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:25:42.561638-05:00', '']	01	Primary	4873bdca-1153-4187-95b8-30ee31880ddf	Primary Tumor	Not Reported	1262.0	40.0	Unknown	5482CC06-7854-459E-8A23-81ABC45DD076	false	Solid Tissue	False	Tumor
TCGA-DF-A2KY-01A	5bf97d66-cdc6-47d0-ac74-5c6280b31072	Adenomas and Adenocarcinomas	5bf97d66-cdc6-47d0-ac74-5c6280b31072	TCGA-DF-A2KY	Corpus uteri	Not Reported	not reported	female	not reported	Alive	49.0	-18086.0			['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVA	No	0.0	not reported	Endometrium	332.0	18086.0	Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18086.0	49.55068493150685	['2019-07-31T22:19:57.306773-05:00', '2019-07-31T22:19:57.306773-05:00']	['275997ef-df5e-509c-91bd-e3b1df5a95c4', '7f87c4f0-912b-53c6-84c5-9e51629bc7d5']	['TCGA-DF-A2KY_treatment_1', 'TCGA-DF-A2KY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:22:03.098295-05:00', '']	01	Primary	5c46962c-67dc-45cd-842a-d0f71c747bbd	Primary Tumor	Not Reported		960.0	Unknown	8A35F74A-AFA4-4B2D-931B-FA2DE895F010	false	Solid Tissue	False	Tumor
TCGA-AP-A0LS-01A	c5a797d3-82ae-49dc-b2fe-0da64da271a2	Adenomas and Adenocarcinomas	c5a797d3-82ae-49dc-b2fe-0da64da271a2	TCGA-AP-A0LS	Corpus uteri	Not Reported	white	female	not reported	Alive	63.0	-23126.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	Not Reported	0.0	not reported	Endometrium	2904.0	23126.0	Endometrioid adenocarcinoma, NOS	yes	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23126.0	63.35890410958904	['2019-07-31T22:29:55.482652-05:00', '2019-07-31T22:29:55.482652-05:00']	['1c5375dd-4ad4-5ae0-9598-b653026cff01', '2057d54b-089f-5ce6-95f0-afc80c87fd84']	['TCGA-AP-A0LS_treatment', 'TCGA-AP-A0LS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:30:07.709509-05:00']	01	Primary	c6f914f3-0888-4890-9323-6386f1035d81	Primary Tumor	Not Reported	1421.0	200.0	OCT	E802CEF6-BC3F-4C35-85E8-2B37531571CD	true	Solid Tissue	False	Tumor
TCGA-AP-A0LP-01A	efae3940-d3cc-4988-bdb4-fa05d977aff5	Adenomas and Adenocarcinomas	efae3940-d3cc-4988-bdb4-fa05d977aff5	TCGA-AP-A0LP	Corpus uteri	Not Reported	white	female	not reported	Alive	76.0	-27898.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1875.0	27898.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27898.0	76.43287671232876	['2019-07-31T22:35:12.101932-05:00', '2019-07-31T22:35:12.101932-05:00']	['298eb25e-d4f8-5e8e-b2f6-827091de3b50', '77a13d54-6031-5ddd-a756-40bb04a0c83f']	['TCGA-AP-A0LP_treatment', 'TCGA-AP-A0LP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:34:21.480381-05:00']	01	Primary	d67450c1-8848-4b28-9c16-83aa7132e8c8	Primary Tumor	Not Reported	1884.0	150.0	OCT	ECA6E3D1-141B-4DB1-90B6-FE6A2E355AD3	true	Solid Tissue	False	Tumor
TCGA-AX-A1C9-01A	2714af93-e200-4b4a-9df8-7d837b37489f	Adenomas and Adenocarcinomas	2714af93-e200-4b4a-9df8-7d837b37489f	TCGA-AX-A1C9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	73.0	-26903.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	802.0	26903.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26903.0	73.7068493150685	['2019-07-31T22:14:01.334541-05:00', '2019-07-31T22:14:01.334541-05:00']	['0a758b1f-d674-525d-a6ce-421ae5ed0567', 'cd261557-6cd0-5760-92a2-919f1ba14e4a']	['TCGA-AX-A1C9_treatment', 'TCGA-AX-A1C9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:17:17.517683-05:00']	01	Primary	227cdca5-931d-4cda-a885-8e3aeb874d99	Primary Tumor	Not Reported	521.0	110.0	Unknown	54E63A5C-C0E4-408B-9911-CE822CECD362	false	Solid Tissue	False	Tumor
TCGA-AJ-A3BH-01A	a7d07151-5fc8-4c2a-a1cd-e7c7a2a9a7a7	Adenomas and Adenocarcinomas	a7d07151-5fc8-4c2a-a1cd-e7c7a2a9a7a7	TCGA-AJ-A3BH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive					['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No		not reported	Endometrium			Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported			['2019-07-31T22:27:23.778594-05:00', '2019-07-31T22:27:23.778594-05:00']	['3f0aeb62-af22-5068-8b8c-ecaa102689eb', '712d6c72-03e3-563c-a608-66fac6735f30']	['TCGA-AJ-A3BH_treatment_1', 'TCGA-AJ-A3BH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:28:04.813707-05:00', '']	01	Primary	5f692f2b-3736-4b1f-8ffe-a0ee085975df	Primary Tumor	Not Reported		100.0	Unknown	469A2D52-09E6-4B67-B8D0-D6292AC22285	false	Solid Tissue	False	Tumor
TCGA-D1-A17H-01A	6c526c42-2fb2-4dfa-8a3d-5651dd600ac7	Adenomas and Adenocarcinomas	6c526c42-2fb2-4dfa-8a3d-5651dd600ac7	TCGA-D1-A17H	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	61.0	-22389.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	852.0	22389.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22389.0	61.33972602739726	['2019-07-31T22:21:57.709159-05:00', '2019-07-31T22:21:57.709159-05:00']	['28bb8bda-d471-53ab-8d58-31720d3a0e32', 'cc6b1ba9-a429-537b-ac64-afef83990274']	['TCGA-D1-A17H_treatment_1', 'TCGA-D1-A17H_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:23:38.846775-05:00', '']	01	Primary	bf526d65-b323-418f-926a-6a0acd8f68e3	Primary Tumor	Not Reported	531.0	230.0	Unknown	E2EBC803-BE77-4936-9B6A-9E6E7E6B8FA4	false	Solid Tissue	False	Tumor
TCGA-BS-A0TG-01A	13f31bcb-befd-4ed2-adc0-dc9e9ce52b75	Adenomas and Adenocarcinomas	13f31bcb-befd-4ed2-adc0-dc9e9ce52b75	TCGA-BS-A0TG	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22043.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	2371.0	22043.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22043.0	60.391780821917806	['2019-07-31T22:12:25.239884-05:00', '2019-07-31T22:12:25.239884-05:00']	['a0fd16e3-f175-5918-9b7f-dca383e84e83', 'fe057a36-b9da-53bc-a206-9ef944b063fb']	['TCGA-BS-A0TG_treatment', 'TCGA-BS-A0TG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:16:00.063769-05:00']	01	Primary	36e44603-a1ee-4a5b-9506-49a9358bf8d0	Primary Tumor	Not Reported	1996.0	270.0	Unknown	7A7B4B4B-5EE2-4D8D-A90A-DDFB96AE49A8	false	Solid Tissue	False	Tumor
TCGA-AX-A3GI-01A	e4787c7b-40e7-483c-98c0-38da03e26b56	Cystic, Mucinous and Serous Neoplasms	e4787c7b-40e7-483c-98c0-38da03e26b56	TCGA-AX-A3GI	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	66.0	-24388.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	12.0	24388.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24388.0	66.81643835616438	['2019-07-31T22:33:51.280054-05:00', '2019-07-31T22:33:51.280054-05:00']	['10fa240c-9ae6-552a-a99a-cd6253be85f2', 'd8556c08-7ea4-54c6-88c7-b65f9a87e923']	['TCGA-AX-A3GI_treatment_1', 'TCGA-AX-A3GI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:33:17.773706-05:00', '']	01	Primary	c5cdb056-0de5-496f-a301-87f11ce50dde	Primary Tumor	Not Reported	300.0	110.0	Unknown	A803E376-399C-4841-A6AE-E82B99CD57B7	false	Solid Tissue	False	Tumor
TCGA-AP-A1E3-01A	44ac7093-a733-4c55-a964-0ba9ec141d2d	Adenomas and Adenocarcinomas	44ac7093-a733-4c55-a964-0ba9ec141d2d	TCGA-AP-A1E3	Corpus uteri	Not Reported	white	female	not reported	Alive	45.0	-16544.0	1964.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	847.0	16544.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16544.0	45.326027397260276	['2019-07-31T22:17:45.139967-05:00', '2019-07-31T22:17:45.139967-05:00']	['2369dc6d-c770-537f-8e03-30e813bf5896', 'fe48af7d-5f50-5691-bf77-ddb186acba01']	['TCGA-AP-A1E3_treatment', 'TCGA-AP-A1E3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:20:17.157990-05:00']	01	Primary	86b9fab8-8a90-4610-ac48-53f952665ac9	Primary Tumor	Not Reported	440.0	350.0	OCT	FDA2C217-5267-41CC-AC07-CBACFF8E7B8D	true	Solid Tissue	False	Tumor
TCGA-B5-A11J-01A	027b2a29-2fad-4ca8-a7cd-eb913d0205f8	Adenomas and Adenocarcinomas	027b2a29-2fad-4ca8-a7cd-eb913d0205f8	TCGA-B5-A11J	Corpus uteri	Not Reported	white	female	not reported	Alive	64.0	-23485.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1656.0	23485.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23485.0	64.34246575342466	['2019-07-31T22:10:13.741617-05:00', '2019-07-31T22:10:13.741617-05:00']	['171dd5bf-4e87-53f0-a4ce-adbe5478f20d', 'c792b410-bef5-5f4a-8cf0-38b9e12b3432']	['TCGA-B5-A11J_treatment', 'TCGA-B5-A11J_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:14:12.765745-05:00']	01	Primary	1eccac56-e4de-4ffd-a0d8-f93d7b8b63f7	Primary Tumor	Not Reported	1536.0	90.0	OCT	1F9E7FAB-ADA0-4EFF-8A86-F5344357ADED	true	Solid Tissue	False	Tumor
TCGA-B5-A1MR-01A	02af18ee-ab8e-4ac3-b22e-dec80c201058	Adenomas and Adenocarcinomas	02af18ee-ab8e-4ac3-b22e-dec80c201058	TCGA-B5-A1MR	Corpus uteri	Not Reported	white	female	not reported	Alive	65.0	-24017.0	1930.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	6859.0	24017.0	Endometrioid adenocarcinoma, NOS	no	1995.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24017.0	65.8	['2019-07-31T22:10:20.032310-05:00', '2019-07-31T22:10:20.032310-05:00']	['332578c7-1409-5142-8456-ef31512df5d6', '5962c91f-0733-59dd-8080-468fc279d953']	['TCGA-B5-A1MR_treatment', 'TCGA-B5-A1MR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:14:18.484009-05:00']	01	Primary	f2d9d82b-aa3f-44f8-b882-1381704f6cc5	Primary Tumor	Not Reported	5556.0	240.0	OCT	BA4793F4-FBB3-4953-8204-A9C360D32D76	true	Solid Tissue	False	Tumor
TCGA-D1-A161-01A	0305db4a-62ee-4ecb-bede-032981298732	Adenomas and Adenocarcinomas	0305db4a-62ee-4ecb-bede-032981298732	TCGA-D1-A161	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	78.0	-28695.0	1930.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	892.0	28695.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28695.0	78.61643835616438	['2019-07-31T22:10:30.371507-05:00', '2019-07-31T22:10:30.371507-05:00']	['2b6b0ec2-b4fd-5d34-b117-87d3a3ac016d', 'b27f6bfe-e5c0-54fd-b6df-7ea269981002']	['TCGA-D1-A161_treatment', 'TCGA-D1-A161_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:14:26.137995-05:00']	01	Primary	94ad0779-7342-4f52-a6da-aed090129cd1	Primary Tumor	Not Reported	864.0	170.0	Unknown	E68A0ED2-CBE3-40A9-8DBF-A3BBC49204DD	false	Solid Tissue	False	Tumor
TCGA-QS-A5YQ-01A	03381d49-e25f-4376-8e36-f47063a7d3fb	Adenomas and Adenocarcinomas	03381d49-e25f-4376-8e36-f47063a7d3fb	TCGA-QS-A5YQ	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	55.0	-20425.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	c4c083cd-4644-53b2-9d7e-ca2ae833c525	QS	Candler	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	759.0	20425.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20425.0	55.95890410958904	['2019-07-31T22:10:33.556036-05:00', '2019-07-31T22:10:33.556036-05:00']	['0fb5dc43-a72f-5993-929a-3ef1486249cb', '809ddc45-a597-54bf-b854-d36f3deb9cd6']	['TCGA-QS-A5YQ_treatment', 'TCGA-QS-A5YQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:14:28.585943-05:00']	01	Primary	c38114c8-744b-4919-8f2a-c8f30fba38b3	Primary Tumor	Not Reported	43.0	370.0	Unknown	D1631D6F-F055-4D35-A6DD-FE7A251BD4C2	false	Solid Tissue	False	Tumor
TCGA-EY-A3L3-01A	06728b1b-6b69-4467-8e10-a8a4e6328ac8	Cystic, Mucinous and Serous Neoplasms	06728b1b-6b69-4467-8e10-a8a4e6328ac8	TCGA-EY-A3L3	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	82.0	-30138.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	832.0	30138.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30138.0	82.56986301369864	['2019-07-31T22:10:42.233250-05:00', '2019-07-31T22:10:42.233250-05:00']	['cad43da4-7e03-5555-87a4-121b24947e13', 'e3ca0d69-45b9-5088-bc79-394be6707385']	['TCGA-EY-A3L3_treatment', 'TCGA-EY-A3L3_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:14:36.183833-05:00']	01	Primary	9895a2ad-1c08-4e2e-acca-88a3927a2c2d	Primary Tumor	Not Reported	198.0	1020.0	Unknown	DBCC8E6F-3AB9-41B2-8266-341509A9FDB3	false	Solid Tissue	False	Tumor
TCGA-EY-A2OO-01A	068016e2-7829-493c-b8be-d3b85beaab13	Cystic, Mucinous and Serous Neoplasms	068016e2-7829-493c-b8be-d3b85beaab13	TCGA-EY-A2OO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20797.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1392.0	20797.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	20797.0	56.97808219178082	['2019-07-31T22:10:45.099917-05:00', '2019-07-31T22:10:45.099917-05:00']	['3a7d238a-3953-589a-a4a3-fcd675c993a6', 'e01f2849-0f29-5eff-a940-5422e4c675b5']	['TCGA-EY-A2OO_treatment_1', 'TCGA-EY-A2OO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:14:38.631922-05:00', '']	01	Primary	e254c2ba-0de8-42f1-bc83-94adb11c71f7	Primary Tumor	Not Reported	715.0	1.0	Unknown	CC94C4BA-FBF6-4F0D-93DD-C2D98D965DF8	false	Solid Tissue	False	Tumor
TCGA-B5-A11L-01B	07b24a23-3d9f-4591-800f-8738cc232f9a	Adenomas and Adenocarcinomas	07b24a23-3d9f-4591-800f-8738cc232f9a	TCGA-B5-A11L	Corpus uteri	Not Reported	white	female	not reported	Dead	71.0	-26120.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	2240.0															Stage IC	No	0.0	not reported	Endometrium	1396.0	26120.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26120.0	71.56164383561644	['2019-07-31T22:10:55.185633-05:00', '2019-07-31T22:10:55.185633-05:00']	['79f43f37-1523-5785-8232-01f111d6ce1c', 'fdc31081-01fe-5709-a770-61d7a84f6f05']	['TCGA-B5-A11L_treatment_1', 'TCGA-B5-A11L_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:14:45.975387-05:00', '']	01	Primary	790ace35-d090-4933-bd57-5efc61889c85	Primary Tumor	Not Reported	1297.0	90.0	OCT	ABA26FE8-0C80-459A-9DF8-537D1A08A92E	true	Solid Tissue	False	Tumor
TCGA-AP-A05N-01A	08b11e0e-5b8e-45ea-9b6b-30e3185b03d7	Adenomas and Adenocarcinomas	08b11e0e-5b8e-45ea-9b6b-30e3185b03d7	TCGA-AP-A05N	Corpus uteri	Not Reported	white	female	not reported	Dead	58.0	-21254.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	726.0															Stage IA	No	0.0	not reported	Endometrium	239.0	21254.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21254.0	58.23013698630137	['2019-07-31T22:11:09.973704-05:00', '2019-07-31T22:11:09.973704-05:00']	['34dadbd5-4704-5519-9b0f-4f56e8f497bd', '753da8f8-9301-5718-a4ae-94f838f7f76c']	['TCGA-AP-A05N_treatment_1', 'TCGA-AP-A05N_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:14:58.147908-05:00', '']	01	Primary	67a90941-d6ec-4465-a727-7193504c8982	Primary Tumor	Not Reported	232.0	350.0	OCT	E4FF43F2-5CBD-4B68-9CD5-BE4E84AD67D5	true	Solid Tissue	False	Tumor
TCGA-BS-A0TE-01A	09066fbf-6a1d-46c9-a4c5-c53340c3d1ba	Adenomas and Adenocarcinomas	09066fbf-6a1d-46c9-a4c5-c53340c3d1ba	TCGA-BS-A0TE	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Dead	35.0	-12983.0	1970.0	2005.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH	146.0															Stage IVB	No	0.0	not reported	Corpus uteri		12983.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.9	Corpus uteri	Not Reported	not reported	12983.0	35.56986301369863	['2019-07-31T22:11:13.064111-05:00', '2019-07-31T22:11:13.064111-05:00']	['603f066d-4e7e-52c4-a1f1-2fbe9a5366d7', 'd70d5427-f069-50ee-80b2-6c18dd1183c5']	['TCGA-BS-A0TE_treatment', 'TCGA-BS-A0TE_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:15:00.617979-05:00']	01	Primary	2d1226a1-1c88-422b-9a8d-316bebeb65fd	Primary Tumor	Not Reported	1835.0	50.0	Unknown	8FD57BC9-19A1-4427-B68F-3E58639FEA40	false	Solid Tissue	False	Tumor
TCGA-FL-A1YI-11A	09621bd6-3eed-4af4-8416-cdacffce68d9	Not Reported	09621bd6-3eed-4af4-8416-cdacffce68d9	TCGA-FL-A1YI	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	5cd8fef0-e1f7-4d00-b2bb-357bac222d9c	Solid Tissue Normal	Not Reported		120.0	Unknown	BC17ABB4-DBAA-43FD-BBBA-C48C71BEDE62	false	Solid Tissue	False	Normal
TCGA-D1-A1NY-01A	0a9faff7-ec4d-4b5a-aa83-6fa358f72074	Adenomas and Adenocarcinomas	0a9faff7-ec4d-4b5a-aa83-6fa358f72074	TCGA-D1-A1NY	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24683.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	513.0	24683.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24683.0	67.62465753424658	['2019-07-31T22:11:16.213436-05:00', '2019-07-31T22:11:16.213436-05:00']	['7881606d-f7c3-5b9b-b820-3215466d5aac', 'ee7aec30-2ab3-5e9b-8b0a-17a90526703e']	['TCGA-D1-A1NY_treatment', 'TCGA-D1-A1NY_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:15:02.785072-05:00']	01	Primary	4d1fc186-32c8-4f12-a4c3-f683cee53737	Primary Tumor	Not Reported	199.0	110.0	Unknown	8F963009-F6C3-4F45-B714-0E96F5D5E526	false	Solid Tissue	False	Tumor
TCGA-D1-A16S-01A	0b670df6-c487-4ed6-9b48-ef4b01a1aec3	Cystic, Mucinous and Serous Neoplasms	0b670df6-c487-4ed6-9b48-ef4b01a1aec3	TCGA-D1-A16S	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	70.0	-25690.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	568.0	25690.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25690.0	70.38356164383562	['2019-07-31T22:11:22.070151-05:00', '2019-07-31T22:11:22.070151-05:00']	['80f40263-8080-5cae-a72a-bd0022c8a164', 'd524bd79-bc3b-5d80-8f06-656431ce8d04']	['TCGA-D1-A16S_treatment', 'TCGA-D1-A16S_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:15:07.613752-05:00']	01	Primary	8e157714-099f-4496-ad37-0b83c76797bc	Primary Tumor	Not Reported	177.0	290.0	Unknown	D69D2E09-B195-4F3F-B5A1-821A87852266	false	Solid Tissue	False	Tumor
TCGA-B5-A11U-01A	0b672aa4-fc13-476f-b61e-5f2c3a615c23	Adenomas and Adenocarcinomas	0b672aa4-fc13-476f-b61e-5f2c3a615c23	TCGA-B5-A11U	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	74.0	-27160.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	No	0.0	not reported	Endometrium	509.0	27160.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27160.0	74.41095890410959	['2019-07-31T22:11:24.942420-05:00', '2019-07-31T22:11:24.942420-05:00']	['8294de65-d0b7-57b1-89a7-9d9e56ed123e', 'a9964f6a-2edd-5200-9d60-f08d94beb79a']	['TCGA-B5-A11U_treatment_1', 'TCGA-B5-A11U_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:15:10.123056-05:00', '']	01	Primary	52265b60-6f79-4e28-92a9-f4f5bee5a95e	Primary Tumor	Not Reported	371.0	220.0	OCT	1EF2CB28-A515-4E9D-9148-CC1A2DF77F60	true	Solid Tissue	False	Tumor
TCGA-EO-A2CH-01A	0cc9a11f-1ac4-431d-8f94-52a3bc02b572	Cystic, Mucinous and Serous Neoplasms	0cc9a11f-1ac4-431d-8f94-52a3bc02b572	TCGA-EO-A2CH	Corpus uteri	Not Reported	not reported	female	not reported	Dead	73.0	-26966.0	1936.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH	590.0															Stage IVB	No	0.0	not reported	Endometrium		26966.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	26966.0	73.87945205479453	['2019-07-31T22:11:33.870331-05:00', '2019-07-31T22:11:33.870331-05:00']	['9f59d7e7-2c25-5d39-95c9-ebebeb98ee6b', 'bb8bbc84-1bd5-5286-b08e-27d7e372717d']	['TCGA-EO-A2CH_treatment', 'TCGA-EO-A2CH_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:15:17.961721-05:00']	01	Primary	f0906353-4c3b-4f71-9b0b-cb1477450013	Primary Tumor	Not Reported	802.0	80.0	Unknown	B4A5577E-C043-4D25-8D53-77A43C5EC0CC	false	Solid Tissue	False	Tumor
TCGA-D1-A0ZR-01A	0ce940f2-9eb1-4757-8f8f-147a4f3a1e67	Adenomas and Adenocarcinomas	0ce940f2-9eb1-4757-8f8f-147a4f3a1e67	TCGA-D1-A0ZR	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-21157.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	17.0	21157.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21157.0	57.964383561643835	['2019-07-31T22:11:36.998705-05:00', '2019-07-31T22:11:36.998705-05:00']	['184e1ed7-56e7-56f2-a803-d19d2282e3de', '1c79c103-84a2-5df3-a04c-23e6078fe081']	['TCGA-D1-A0ZR_treatment_1', 'TCGA-D1-A0ZR_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:15:20.314584-05:00', '']	01	Primary	6647e6db-bba8-4e27-b24f-fc886d777906	Primary Tumor	Not Reported	537.0	240.0	Unknown	ECC5B77F-7B6C-4C4A-A32C-1346DC3AF24D	false	Solid Tissue	False	Tumor
TCGA-D1-A16Y-01A	0e9c36fd-2d5d-48da-8364-f8c5edc3d873	Adenomas and Adenocarcinomas	0e9c36fd-2d5d-48da-8364-f8c5edc3d873	TCGA-D1-A16Y	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	56.0	-20455.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	532.0	20455.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20455.0	56.04109589041096	['2019-07-31T22:11:43.286344-05:00', '2019-07-31T22:11:43.286344-05:00']	['82762a59-3efa-5b1f-8d1f-3bf5927c05dd', 'edf27cc3-ad09-50d9-8879-63468efe772f']	['TCGA-D1-A16Y_treatment', 'TCGA-D1-A16Y_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:15:25.364231-05:00']	01	Primary	56b2dbc4-9ab6-43ef-9d86-a39d4a60a18d	Primary Tumor	Not Reported	610.0	220.0	Unknown	0A0451C4-2A58-4404-934E-3517443E4CEE	false	Solid Tissue	False	Tumor
TCGA-B5-A1MV-01A	0f36c3a2-0ba5-4c43-a3f0-78d125e5d0ac	Adenomas and Adenocarcinomas	0f36c3a2-0ba5-4c43-a3f0-78d125e5d0ac	TCGA-B5-A1MV	Corpus uteri	Not Reported	white	female	not reported	Alive	84.0	-30926.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1565.0	30926.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30926.0	84.72876712328767	['2019-07-31T22:11:52.685582-05:00', '2019-07-31T22:11:52.685582-05:00']	['81ad654f-04f2-5ca0-91c3-65fe8350599d', 'ec4d0045-02bd-5ea6-91c5-2736a0db696e']	['TCGA-B5-A1MV_treatment', 'TCGA-B5-A1MV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:15:32.856353-05:00']	01	Primary	efd221c1-8513-4129-99ba-43ab94d1a6b9	Primary Tumor	Not Reported	226.0	470.0	OCT	E536759E-F47A-4EE9-B855-AFEC6BCF5EE0	true	Solid Tissue	False	Tumor
TCGA-BG-A187-01A	0f59bb0a-135c-4793-b1a7-5ad5172ed82d	Adenomas and Adenocarcinomas	0f59bb0a-135c-4793-b1a7-5ad5172ed82d	TCGA-BG-A187	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	65.0	-24099.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	448.0	24099.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24099.0	66.02465753424657	['2019-07-31T22:11:55.669488-05:00', '2019-07-31T22:11:55.669488-05:00']	['784fd5b4-b0a5-52ec-af2c-b384621eb803', 'd3514da6-ca59-52b6-91c3-6d8386390293']	['TCGA-BG-A187_treatment_1', 'TCGA-BG-A187_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:15:35.202658-05:00', '']	01	Primary	1738b7d6-c860-449a-aae9-065ef65a149b	Primary Tumor	Not Reported	97.0	360.0	OCT	CB8E915A-CE5D-4181-9303-22BD8CBCB80D	true	Solid Tissue	False	Tumor
TCGA-EO-A22X-01A	10eb7dfa-d43d-479f-8c46-c0424207f958	Adenomas and Adenocarcinomas	10eb7dfa-d43d-479f-8c46-c0424207f958	TCGA-EO-A22X	Corpus uteri	Not Reported	not reported	female	not reported	Alive	36.0	-13245.0	1972.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	1752.0	13245.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	13245.0	36.28767123287671	['2019-07-31T22:11:58.779119-05:00', '2019-07-31T22:11:58.779119-05:00']	['09a1f203-98e9-5dd7-8548-f0557e9c6aaf', '7f11a2ae-e375-59b4-b31d-a96df7b1d6e5']	['TCGA-EO-A22X_treatment_1', 'TCGA-EO-A22X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:15:38.073406-05:00', '']	01	Primary	0c6fd9ef-cffe-4b5b-b2fb-8136285da058	Primary Tumor	Not Reported	842.0	110.0	Unknown	4D919902-FBCE-4AAC-ACD2-38A2F1D8E901	false	Solid Tissue	False	Tumor
TCGA-AX-A0IZ-01A	11285dc5-8742-477a-8692-af1b6e2c1434	Adenomas and Adenocarcinomas	11285dc5-8742-477a-8692-af1b6e2c1434	TCGA-AX-A0IZ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19364.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1333.0	19364.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19364.0	53.05205479452055	['2019-07-31T22:12:01.958961-05:00', '2019-07-31T22:12:01.958961-05:00']	['4e7e3bc3-75fe-5ad4-817d-44fd076f05d2', '81d10302-589d-5a62-be62-0151793a6cea']	['TCGA-AX-A0IZ_treatment_1', 'TCGA-AX-A0IZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:15:40.479231-05:00', '']	01	Primary	4c64f7c4-f1ee-4590-8bdc-b6a81e92b328	Primary Tumor	Not Reported	1114.0	200.0	Unknown	1DEA7C0C-3280-4E11-B0A4-13562DDF307B	false	Solid Tissue	False	Tumor
TCGA-AX-A0IZ-11A	11285dc5-8742-477a-8692-af1b6e2c1434	Adenomas and Adenocarcinomas	11285dc5-8742-477a-8692-af1b6e2c1434	TCGA-AX-A0IZ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19364.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1333.0	19364.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19364.0	53.05205479452055	['2019-07-31T22:12:01.958961-05:00', '2019-07-31T22:12:01.958961-05:00']	['4e7e3bc3-75fe-5ad4-817d-44fd076f05d2', '81d10302-589d-5a62-be62-0151793a6cea']	['TCGA-AX-A0IZ_treatment_1', 'TCGA-AX-A0IZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:15:40.479231-05:00', '']	11	Not Applicable	e6ffcb81-f76d-40ee-ac9b-f71ed0c6c92d	Solid Tissue Normal	Not Reported	1485.0	160.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BK-A6W3-01A	119b1761-a5b4-42b6-9971-ece11fb0e0f6	Adenomas and Adenocarcinomas	119b1761-a5b4-42b6-9971-ece11fb0e0f6	TCGA-BK-A6W3	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	34.0	-12590.0	1979.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	305.0	12590.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	12590.0	34.49315068493151	['2019-07-31T22:12:04.708569-05:00', '2019-07-31T22:12:04.708569-05:00']	['263c2461-e88f-5bb9-885a-65731c51c1c6', '424728c5-477a-57f2-82b8-6b6bd092f1b1']	['TCGA-BK-A6W3_treatment_1', 'TCGA-BK-A6W3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:15:42.939787-05:00', '']	01	Primary	bb8c1148-9006-4819-920e-827bcfa9adb5	Primary Tumor	Not Reported	94.0	150.0	Unknown	15A94B35-48FD-4F94-94E4-25F8084F8B91	false	Solid Tissue	False	Tumor
TCGA-D1-A17F-01A	129a49d4-edb8-4a1d-aabb-51b9ad5a8dd1	Adenomas and Adenocarcinomas	129a49d4-edb8-4a1d-aabb-51b9ad5a8dd1	TCGA-D1-A17F	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25116.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	39.0	25116.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25116.0	68.81095890410958	['2019-07-31T22:12:10.156309-05:00', '2019-07-31T22:12:10.156309-05:00']	['a3383f8f-96db-5e40-b948-641695a97e08', 'b5f7e265-6cd5-5b61-9322-faa8e910a3c6']	['TCGA-D1-A17F_treatment_1', 'TCGA-D1-A17F_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:15:47.751722-05:00', '']	01	Primary	9592e87f-f3e4-49e9-919c-6f679a4b9110	Primary Tumor	Not Reported	269.0	200.0	Unknown	62F464EA-9410-4511-8DE8-F0E62AB1E482	false	Solid Tissue	False	Tumor
TCGA-EY-A1GJ-01A	13b97e99-f6b7-4253-b7e1-230cce2d8747	Adenomas and Adenocarcinomas	13b97e99-f6b7-4253-b7e1-230cce2d8747	TCGA-EY-A1GJ	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	73.0	-26715.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	727.0	26715.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26715.0	73.1917808219178	['2019-07-31T22:12:22.368305-05:00', '2019-07-31T22:12:22.368305-05:00']	['7b61c1d2-08c9-57bd-84dd-9447af84b497', 'f262068a-8f44-5635-915f-a1d732d28a32']	['TCGA-EY-A1GJ_treatment_1', 'TCGA-EY-A1GJ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:15:57.488085-05:00', '']	01	Primary	1c956229-70f4-4ccd-aee7-f01979fce5c1	Primary Tumor	Not Reported	434.0	300.0	Unknown	505FE0B0-068C-4B2A-AA40-4657FB2E0425	false	Solid Tissue	False	Tumor
TCGA-A5-A0GD-01A	1486a031-b74d-4976-8b0b-4569e6978f49	Adenomas and Adenocarcinomas	1486a031-b74d-4976-8b0b-4569e6978f49	TCGA-A5-A0GD	Corpus uteri	Not Reported	white	female	not reported	Dead	75.0	-27399.0	1924.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH	3423.0															Stage IA	No	0.0	not reported	Endometrium	98.0	27399.0	Endometrioid adenocarcinoma, NOS	no	1999.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27399.0	75.06575342465753	['2019-07-31T22:12:28.182542-05:00', '2019-07-31T22:12:28.182542-05:00']	['61d4d334-fbb5-59d8-9d8d-f5b05fb80849', 'dffa6065-3577-52b2-90a9-5d28505c6d5e']	['TCGA-A5-A0GD_treatment_1', 'TCGA-A5-A0GD_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:16:02.677413-05:00', '']	01	Primary	f449f50a-7664-4ddc-87aa-6a061ee7190c	Primary Tumor	Not Reported	4119.0	170.0	OCT	44561792-F2F8-42F7-B697-5D7752F8430E	true	Solid Tissue	False	Tumor
TCGA-D1-A15X-01A	14c03068-8930-472a-9fd1-49c9fd4db47d	Cystic, Mucinous and Serous Neoplasms	14c03068-8930-472a-9fd1-49c9fd4db47d	TCGA-D1-A15X	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	45.0	-16532.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	909.0	16532.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	16532.0	45.293150684931504	['2019-07-31T22:12:31.092190-05:00', '2019-07-31T22:12:31.092190-05:00']	['5ef82aa3-0a03-53cc-bb75-49c73cd80a2e', '9c4236e1-86dc-5ef7-84c0-1e6fc2893d99']	['TCGA-D1-A15X_treatment_1', 'TCGA-D1-A15X_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:16:05.030215-05:00', '']	01	Primary	c81d521c-70f9-4299-87d2-02173751efc8	Primary Tumor	Not Reported	897.0	130.0	Unknown	F32EB1C9-4802-4873-8F0E-E10724DA9C15	false	Solid Tissue	False	Tumor
TCGA-EY-A5W2-01A	1944e155-b765-48c3-9602-6787c105e551	Adenomas and Adenocarcinomas	1944e155-b765-48c3-9602-6787c105e551	TCGA-EY-A5W2	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	72.0	-26498.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	516.0	26498.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26498.0	72.59726027397261	['2019-07-31T22:12:52.903590-05:00', '2019-07-31T22:12:52.903590-05:00']	['355c8539-8e1b-5d0d-abdf-69bea260650a', 'cab68deb-420a-51df-ae73-3a53bc423aac']	['TCGA-EY-A5W2_treatment', 'TCGA-EY-A5W2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:16:22.825959-05:00']	01	Primary	d50bb383-3384-47d9-92b8-1f0604ac2725	Primary Tumor	Not Reported	105.0	870.0	Unknown	C09EED3C-50CC-47CB-BA81-96D05E53D9F0	false	Solid Tissue	False	Tumor
TCGA-FL-A1YT-11A	1e5053ae-9a78-41ed-81cd-1a43756fca09	Not Reported	1e5053ae-9a78-41ed-81cd-1a43756fca09	TCGA-FL-A1YT	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	b67349d0-bc63-43e0-9b52-13095e184b94	Solid Tissue Normal	Not Reported		70.0	Unknown	4E2E650A-F057-4B4E-84FD-2ECFC6D13C4D	false	Solid Tissue	False	Normal
TCGA-AX-A1CF-01A	20dcf91a-0529-4e96-99a2-362a41fbe4a4	Adenomas and Adenocarcinomas	20dcf91a-0529-4e96-99a2-362a41fbe4a4	TCGA-AX-A1CF	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25300.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	No	0.0	not reported	Endometrium	2337.0	25300.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25300.0	69.31506849315069	['2019-07-31T22:13:23.618405-05:00', '2019-07-31T22:13:23.618405-05:00']	['c2f051d1-56b2-5b7d-8906-c5c26e591706', 'd526f076-1eca-57aa-9318-b582ec100739']	['TCGA-AX-A1CF_treatment', 'TCGA-AX-A1CF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:16:47.101231-05:00']	01	Primary	4c219685-44e4-489b-a72f-cfcba405588c	Primary Tumor	Not Reported	2284.0	130.0	Unknown	CB16E769-AFE1-4555-A65D-691266C4898E	false	Solid Tissue	False	Tumor
TCGA-AX-A1CF-11A	20dcf91a-0529-4e96-99a2-362a41fbe4a4	Adenomas and Adenocarcinomas	20dcf91a-0529-4e96-99a2-362a41fbe4a4	TCGA-AX-A1CF	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25300.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IVB	No	0.0	not reported	Endometrium	2337.0	25300.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25300.0	69.31506849315069	['2019-07-31T22:13:23.618405-05:00', '2019-07-31T22:13:23.618405-05:00']	['c2f051d1-56b2-5b7d-8906-c5c26e591706', 'd526f076-1eca-57aa-9318-b582ec100739']	['TCGA-AX-A1CF_treatment', 'TCGA-AX-A1CF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:16:47.101231-05:00']	11	Not Applicable	ca311bb9-f50f-4d7b-a18f-a0c5c5011c57	Solid Tissue Normal	Not Reported	2284.0	50.0	Unknown		false	Solid Tissue	False	Normal
TCGA-BG-A2L7-11A	214a09bb-ce52-4055-b036-065e8cb7ac7d	Adenomas and Adenocarcinomas	214a09bb-ce52-4055-b036-065e8cb7ac7d	TCGA-BG-A2L7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25091.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	612.0	25091.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25091.0	68.74246575342465	['2019-07-31T22:13:29.691040-05:00', '2019-07-31T22:13:29.691040-05:00']	['82661ec9-c8f1-5cf6-b282-fbb5c7e3d043', '9102dc7e-d93d-5801-a075-5306c4b9b07d']	['TCGA-BG-A2L7_treatment_1', 'TCGA-BG-A2L7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:16:53.108792-05:00', '']	11	Not Applicable	3339b46e-702e-46a2-baf4-0e5610791689	Solid Tissue Normal	Not Reported	141.0	320.0	OCT		true	Solid Tissue	False	Normal
TCGA-BG-A2L7-01A	214a09bb-ce52-4055-b036-065e8cb7ac7d	Adenomas and Adenocarcinomas	214a09bb-ce52-4055-b036-065e8cb7ac7d	TCGA-BG-A2L7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25091.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	612.0	25091.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25091.0	68.74246575342465	['2019-07-31T22:13:29.691040-05:00', '2019-07-31T22:13:29.691040-05:00']	['82661ec9-c8f1-5cf6-b282-fbb5c7e3d043', '9102dc7e-d93d-5801-a075-5306c4b9b07d']	['TCGA-BG-A2L7_treatment_1', 'TCGA-BG-A2L7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:16:53.108792-05:00', '']	01	Primary	68328de4-7de9-4893-a402-f15c64c7718e	Primary Tumor	Not Reported	141.0	110.0	OCT	6A14E5E4-ED0F-415A-B54B-DE16D7DC6E78	true	Solid Tissue	False	Tumor
TCGA-B5-A0JV-01A	233e947a-d5e2-48e5-a8ce-5da1abb20681	Adenomas and Adenocarcinomas	233e947a-d5e2-48e5-a8ce-5da1abb20681	TCGA-B5-A0JV	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	63.0	-23295.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2616.0	23295.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23295.0	63.821917808219176	['2019-07-31T22:13:45.143247-05:00', '2019-07-31T22:13:45.143247-05:00']	['7eaa452e-2be9-5498-865e-0275bd34a32c', 'b2dc1980-3408-56c5-bc0d-8efaf4414a91']	['TCGA-B5-A0JV_treatment', 'TCGA-B5-A0JV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:17:05.168202-05:00']	01	Primary	42199e5a-9f4f-4445-9e6e-114d47ba67fa	Primary Tumor	Not Reported	1001.0	40.0	OCT	71A1DE5B-7CE5-4884-A91E-3BE753036E4F	true	Solid Tissue	False	Tumor
TCGA-A5-A0VQ-01A	23489245-48d7-4f19-8a42-e23b1181412b	Adenomas and Adenocarcinomas	23489245-48d7-4f19-8a42-e23b1181412b	TCGA-A5-A0VQ	Corpus uteri	Not Reported	not reported	female	hispanic or latino	Alive	62.0	-22995.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	485.0	22995.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22995.0	63.0	['2019-07-31T22:33:32.945455-05:00', '2019-07-31T22:33:32.945455-05:00']	['6ff4b65e-578e-5226-8c6a-276afbfda6ec', '960f4f2b-da42-516f-8261-48d5d80923b8']	['TCGA-A5-A0VQ_treatment', 'TCGA-A5-A0VQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:33:03.383798-05:00']	01	Primary	952cb6a5-7527-470a-978e-edd44e3a368f	Primary Tumor	Not Reported	133.0	320.0	OCT	6FE81DF0-D9DF-420F-8A91-40421175A12F	true	Solid Tissue	False	Tumor
TCGA-AJ-A3EL-01A	23e1d96e-6175-4145-8267-8f0a88f54c4d	Adenomas and Adenocarcinomas	23e1d96e-6175-4145-8267-8f0a88f54c4d	TCGA-AJ-A3EL	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not reported	Alive	47.0	-17442.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	684.0	17442.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17442.0	47.78630136986301	['2019-07-31T22:13:48.092779-05:00', '2019-07-31T22:13:48.092779-05:00']	['d12f7316-7ab9-5b4f-8563-fdbcf8c02953', 'e805f4ce-753c-5b66-9c83-4f12fba5debc']	['TCGA-AJ-A3EL_treatment_1', 'TCGA-AJ-A3EL_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:17:07.753253-05:00', '']	01	Primary	f82eeaf4-aa1a-422b-b16e-790241eea904	Primary Tumor	Not Reported	317.0	20.0	Unknown	CB5EF343-EDD4-46B1-82DD-48C49FF7E778	false	Solid Tissue	False	Tumor
TCGA-FI-A2F9-01A	25e7d9d6-7381-40e1-b7ed-1d8c936b7c5c	Adenomas and Adenocarcinomas	25e7d9d6-7381-40e1-b7ed-1d8c936b7c5c	TCGA-FI-A2F9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	79.0	-28886.0	1930.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1803.0	28886.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28886.0	79.13972602739726	['2019-07-31T22:13:58.229432-05:00', '2019-07-31T22:13:58.229432-05:00']	['13b886b6-31ad-598f-9fd7-608bfd2a1e77', '5403b64c-e62d-582b-be76-64325085a36d']	['TCGA-FI-A2F9_treatment_1', 'TCGA-FI-A2F9_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:17:15.052449-05:00', '']	01	Primary	d62280fd-4b51-4ec9-9ddc-1aa04f6578f3	Primary Tumor	Not Reported	709.0	60.0	OCT	5D03E085-0588-47A8-8B1C-E243D8127325	true	Solid Tissue	False	Tumor
TCGA-BS-A0U7-01A	282ddc43-922d-4f1f-80c7-6ba2de23b7bc	Adenomas and Adenocarcinomas	282ddc43-922d-4f1f-80c7-6ba2de23b7bc	TCGA-BS-A0U7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	63.0	-23166.0	1940.0	2005.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH	935.0															Stage IC	No	0.0	not reported	Endometrium		23166.0	Endometrioid adenocarcinoma, NOS	no	2003.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23166.0	63.46849315068493	['2019-07-31T22:14:04.318374-05:00', '2019-07-31T22:14:04.318374-05:00']	['44b315fd-75ff-50e0-8ec0-1ff7ef8c247c', 'b9e5f331-24ec-5b4d-87ea-640d24b17ef0']	['TCGA-BS-A0U7_treatment_1', 'TCGA-BS-A0U7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:17:20.091489-05:00', '']	01	Primary	803c6d51-0eba-475a-9c3c-7b3401787907	Primary Tumor	Not Reported	2466.0	190.0	Unknown	BE83021F-D4D5-4ECA-8484-8A37B2FE67C0	false	Solid Tissue	False	Tumor
TCGA-A5-A0R9-01A	284174fd-1320-4617-9e99-75bd75df9bf3	Adenomas and Adenocarcinomas	284174fd-1320-4617-9e99-75bd75df9bf3	TCGA-A5-A0R9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	51.0	-18982.0	1958.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	749.0	18982.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18982.0	52.00547945205479	['2019-07-31T22:14:07.081042-05:00', '2019-07-31T22:14:07.081042-05:00']	['339de67c-c87f-5567-8418-61f2d754ece7', 'dd60a236-7b80-5637-a800-5786fdbaefe3']	['TCGA-A5-A0R9_treatment', 'TCGA-A5-A0R9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:17:22.588603-05:00']	01	Primary	986ac6ac-087f-412b-bb0c-9be10d104989	Primary Tumor	Not Reported	471.0	270.0	OCT	0AAD58D4-7865-4235-AE18-8685DC5F4FE1	true	Solid Tissue	False	Tumor
TCGA-A5-A1OF-01A	286c112d-7b73-40a1-b23c-99911388fdef	Cystic, Mucinous and Serous Neoplasms	286c112d-7b73-40a1-b23c-99911388fdef	TCGA-A5-A1OF	Corpus uteri	Not Reported	not reported	female	hispanic or latino	Alive	47.0	-17308.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	973.0	17308.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	17308.0	47.41917808219178	['2019-07-31T22:14:10.543681-05:00', '2019-07-31T22:14:10.543681-05:00']	['2d151d71-9400-5866-b94d-b47f026f531f', '5c56574b-b9b5-5411-9463-bd91887e65d0']	['TCGA-A5-A1OF_treatment_1', 'TCGA-A5-A1OF_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:17:24.999139-05:00', '']	01	Primary	68c51551-232a-4adc-a0a0-fcecd7125f59	Primary Tumor	Not Reported	128.0	210.0	OCT	C0A753A3-5202-4DD2-948E-2921AFBCB3BC	true	Solid Tissue	False	Tumor
TCGA-SL-A6JA-01A	2a19051e-3ad1-444a-9d02-f895c26ac02c	Adenomas and Adenocarcinomas	2a19051e-3ad1-444a-9d02-f895c26ac02c	TCGA-SL-A6JA	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	77.0	-28401.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	54704c4f-95dd-5a29-a680-878bb1a36612	SL	St. Joseph's Hospital AZ	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	7.0	28401.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28401.0	77.81095890410958	['2019-07-31T22:14:17.872013-05:00', '2019-07-31T22:14:17.872013-05:00']	['75acad81-6d6a-5cb6-8446-56703ae52f4d', 'fff63bc4-5160-5d59-b261-a47fba285a1c']	['TCGA-SL-A6JA_treatment_1', 'TCGA-SL-A6JA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:17:29.804420-05:00', '']	01	Primary	691fc8b9-2221-444b-8de6-960aabd0cddd	Primary Tumor	Not Reported	45.0	200.0	OCT	60CDA761-5DF1-4580-AD84-1CE9A15F31F8	true	Solid Tissue	False	Tumor
TCGA-A5-A3LO-01A	2a2bc155-ca7c-48b2-bb77-ccfd6313710a	Adenomas and Adenocarcinomas	2a2bc155-ca7c-48b2-bb77-ccfd6313710a	TCGA-A5-A3LO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23401.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	776.0	23401.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23401.0	64.11232876712329	['2019-07-31T22:14:20.613529-05:00', '2019-07-31T22:14:20.613529-05:00']	['033a2cd6-0b64-5a43-ad81-91b705778d83', '3d1887cc-5805-5b11-b193-1b4dc36de92c']	['TCGA-A5-A3LO_treatment', 'TCGA-A5-A3LO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:17:32.440509-05:00']	01	Primary	3bf209df-55b0-4f3f-b98e-9a13fe5e8955	Primary Tumor	Not Reported	182.0	160.0	OCT	2AB1F28D-151D-4AFE-807A-9F98B48C51CE	true	Solid Tissue	False	Tumor
TCGA-BS-A0V8-01A	2b76cc9c-c379-43e4-9c3f-56197a3353be	Adenomas and Adenocarcinomas	2b76cc9c-c379-43e4-9c3f-56197a3353be	TCGA-BS-A0V8	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	68.0	-24981.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	2544.0	24981.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24981.0	68.44109589041096	['2019-07-31T22:14:26.714712-05:00', '2019-07-31T22:14:26.714712-05:00']	['4ae250ef-1fe7-516e-82e8-af91b922d990', 'd850eaea-cb89-5162-84bc-82a88a97b696']	['TCGA-BS-A0V8_treatment', 'TCGA-BS-A0V8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:17:37.115066-05:00']	01	Primary	cf369a2c-d3c3-4fa3-b004-e4269530ceff	Primary Tumor	Not Reported	1410.0	120.0	Unknown	A024F121-F6C9-4CDF-B0ED-B58708DB6DFE	false	Solid Tissue	False	Tumor
TCGA-BK-A0CC-01B	2b865f8c-539f-4cb2-8f08-41709e9511e5	Cystic, Mucinous and Serous Neoplasms	2b865f8c-539f-4cb2-8f08-41709e9511e5	TCGA-BK-A0CC	Corpus uteri	Not Reported	black or african american	female	hispanic or latino	Alive	69.0	-25479.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1067.0	25479.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25479.0	69.8054794520548	['2019-07-31T17:19:50.751952-05:00', '2019-07-31T17:19:50.751952-05:00']	['8d9f977e-f86d-5d51-86f0-125038780ed2', 'af85e4ac-f4ce-532c-ad60-f6c582a60a9e']	['TCGA-BK-A0CC_treatment_1', 'TCGA-BK-A0CC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T10:17:45.049867-05:00', '']	01	Primary	23659618-8933-4944-8cb2-adf8ed51d7a5	Primary Tumor	Not Reported	645.0		FFPE	6A2AAC78-98B9-44D4-AF8D-9A132579CC2D	false	Solid Tissue	True	Tumor
TCGA-BK-A0CC-01A	2b865f8c-539f-4cb2-8f08-41709e9511e5	Cystic, Mucinous and Serous Neoplasms	2b865f8c-539f-4cb2-8f08-41709e9511e5	TCGA-BK-A0CC	Corpus uteri	Not Reported	black or african american	female	hispanic or latino	Alive	69.0	-25479.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1067.0	25479.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25479.0	69.8054794520548	['2019-07-31T17:19:50.751952-05:00', '2019-07-31T17:19:50.751952-05:00']	['8d9f977e-f86d-5d51-86f0-125038780ed2', 'af85e4ac-f4ce-532c-ad60-f6c582a60a9e']	['TCGA-BK-A0CC_treatment_1', 'TCGA-BK-A0CC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T10:17:45.049867-05:00', '']	01	Primary	ed22cb10-ebde-4019-9b6d-e19ab573ca94	Primary Tumor	Not Reported	52.0	310.0	Unknown	6A2AAC78-98B9-44D4-AF8D-9A132579CC2D	false	Solid Tissue	False	Tumor
TCGA-EO-A3AS-01A	2c3e95b5-2c63-43c7-baa2-47ef914b25a8	Adenomas and Adenocarcinomas	2c3e95b5-2c63-43c7-baa2-47ef914b25a8	TCGA-EO-A3AS	Corpus uteri	Not Reported	not reported	female	not reported	Alive	86.0	-31450.0	1923.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1046.0	31450.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31450.0	86.16438356164383	['2019-07-31T22:14:32.847629-05:00', '2019-07-31T22:14:32.847629-05:00']	['4896604c-0cf5-5425-93af-bc80f526a66c', '92901443-c7f6-51a4-8721-8dd9e3b9e2e2']	['TCGA-EO-A3AS_treatment', 'TCGA-EO-A3AS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:17:42.010872-05:00']	01	Primary	ddb6e07d-8764-4278-978d-7a878522de6d	Primary Tumor	Not Reported	850.0	70.0	Unknown	844799B1-4C96-473A-8ECB-71ACB080F95E	false	Solid Tissue	False	Tumor
TCGA-BG-A0W1-01A	2d750c67-24a2-4b12-b4f2-dbd65f2f27f0	Adenomas and Adenocarcinomas	2d750c67-24a2-4b12-b4f2-dbd65f2f27f0	TCGA-BG-A0W1	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	89.0	-32750.0	1918.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	122.0	32750.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	32750.0	89.72602739726027	['2019-07-31T22:14:42.108918-05:00', '2019-07-31T22:14:42.108918-05:00']	['a93e2a76-3c1c-5b5e-86dc-a889d27ac599', 'd0d9ddc6-34e8-5f07-9659-910ac48bff44']	['TCGA-BG-A0W1_treatment', 'TCGA-BG-A0W1_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:17:49.400946-05:00']	01	Primary	13dec3d1-c7f8-4b95-bd54-2d3136cee001	Primary Tumor	Not Reported	1014.0	100.0	OCT	BE7CC54D-8220-4AC6-9F8D-016DE4167B35	true	Solid Tissue	False	Tumor
TCGA-AX-A0IS-01A	2e5cf721-90b1-4470-b430-f055a1297c7f	Adenomas and Adenocarcinomas	2e5cf721-90b1-4470-b430-f055a1297c7f	TCGA-AX-A0IS	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	52.0	-19173.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	1858.0															Stage IC	No	0.0	not reported	Endometrium	1541.0	19173.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19173.0	52.52876712328767	['2019-07-31T22:14:48.037297-05:00', '2019-07-31T22:14:48.037297-05:00']	['46feaf6b-af9e-5574-903a-2e7dc828c9a0', 'd0266d3d-1b6e-5a98-9ece-15666d89b317']	['TCGA-AX-A0IS_treatment_1', 'TCGA-AX-A0IS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:17:54.241267-05:00', '']	01	Primary	f46f87a5-2edd-469d-9d28-a37284bd077a	Primary Tumor	Not Reported	805.0	90.0	Unknown	35606B48-9820-4F59-8090-1F8D448DB9FB	false	Solid Tissue	False	Tumor
TCGA-B5-A0K7-01A	2f0640bc-598c-4714-9e9b-7e0f2ca4567f	Adenomas and Adenocarcinomas	2f0640bc-598c-4714-9e9b-7e0f2ca4567f	TCGA-B5-A0K7	Corpus uteri	Not Reported	white	female	not reported	Alive	64.0	-23429.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1933.0	23429.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23429.0	64.18904109589042	['2019-07-31T22:14:50.895615-05:00', '2019-07-31T22:14:50.895615-05:00']	['0bfff8c2-2a88-5852-8287-2802f55b5357', '3e5c4e8d-5a8a-55ea-bd1b-7b7f72c11076']	['TCGA-B5-A0K7_treatment_1', 'TCGA-B5-A0K7_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:17:58.026417-05:00', '']	01	Primary	51e8577d-6849-422e-8f37-2ea8c400bbe5	Primary Tumor	Not Reported	184.0	1160.0	OCT	5C3818CE-5DA9-403E-B895-61DEA4BBFA57	true	Solid Tissue	False	Tumor
TCGA-A5-A0GB-01A	2f4458b6-3caf-4e33-890e-a04722badd1b	Adenomas and Adenocarcinomas	2f4458b6-3caf-4e33-890e-a04722badd1b	TCGA-A5-A0GB	Corpus uteri	Not Reported	white	female	not reported	Alive	65.0	-23883.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	997.0	23883.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23883.0	65.43287671232876	['2019-07-31T22:14:54.063987-05:00', '2019-07-31T22:14:54.063987-05:00']	['7197d523-7793-5e75-9fc6-af3694d40210', 'f4e1b5dc-961a-52a2-b73d-fe8495c12bcf']	['TCGA-A5-A0GB_treatment', 'TCGA-A5-A0GB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:18:00.520815-05:00']	01	Primary	130744ca-a9a2-4c99-8abb-20fe76e0a955	Primary Tumor	Not Reported	583.0	190.0	OCT	8AC80DBE-46DE-46D5-B900-C807CBE941A6	true	Solid Tissue	False	Tumor
TCGA-AX-A3FW-01A	3052065a-b8b1-48d3-971d-9d605292249c	Adenomas and Adenocarcinomas	3052065a-b8b1-48d3-971d-9d605292249c	TCGA-AX-A3FW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	66.0	-24419.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	17.0	24419.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24419.0	66.9013698630137	['2019-07-31T22:15:00.560646-05:00', '2019-07-31T22:15:00.560646-05:00']	['52b90767-0dc9-5975-b524-b1197ed75e93', 'fbbc28cf-2e15-50bb-8b1e-a9ee98107e79']	['TCGA-AX-A3FW_treatment_1', 'TCGA-AX-A3FW_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:18:05.201793-05:00', '']	01	Primary	d3deb563-5420-4890-b763-01ca855b4b61	Primary Tumor	Not Reported	723.0	90.0	Unknown	AAB4F0FC-D6D5-4D5F-B36C-E4D4869E1A15	false	Solid Tissue	False	Tumor
TCGA-DF-A2KR-01A	30b62630-fc6d-4620-874a-1e15fd4f40ea	Adenomas and Adenocarcinomas	30b62630-fc6d-4620-874a-1e15fd4f40ea	TCGA-DF-A2KR	Corpus uteri	Not Reported	not reported	female	not reported	Alive	84.0	-31007.0			['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No		not reported	Endometrium	1865.0	31007.0	Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31007.0	84.95068493150686	['2019-07-31T22:15:04.068233-05:00', '2019-07-31T22:15:04.068233-05:00']	['155a92d0-f44a-58c0-9d49-33190002e34c', '2250d5f3-bf65-5592-ae9f-502f202b48e4']	['TCGA-DF-A2KR_treatment', 'TCGA-DF-A2KR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:18:07.741134-05:00']	01	Primary	acdc8a17-c1b8-4f45-a1af-7c7953c346a4	Primary Tumor	Not Reported		80.0	Unknown	7252DF0D-0D16-48DD-9484-9C4B83012927	false	Solid Tissue	False	Tumor
TCGA-AX-A2HJ-01A	32398808-c46a-41bf-a0a8-e08723b40ea2	Adenomas and Adenocarcinomas	32398808-c46a-41bf-a0a8-e08723b40ea2	TCGA-AX-A2HJ	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	35.0	-13112.0	1974.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	935.0	13112.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	13112.0	35.92328767123288	['2019-07-31T22:15:09.943376-05:00', '2019-07-31T22:15:09.943376-05:00']	['4ec967a9-ecd8-5df2-a50d-46f9f46f0731', 'e93aa405-e49f-5e9f-9b58-b9fd8389f2c0']	['TCGA-AX-A2HJ_treatment', 'TCGA-AX-A2HJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:18:12.781417-05:00']	01	Primary	cced4976-8c11-4910-b5d4-6279be4851be	Primary Tumor	Not Reported	779.0	140.0	Unknown	84FF1AB9-47F4-4884-9345-43878BDEF379	false	Solid Tissue	False	Tumor
TCGA-A5-A0GH-01A	32e33897-29c8-48f2-b833-98f37204e0e7	Adenomas and Adenocarcinomas	32e33897-29c8-48f2-b833-98f37204e0e7	TCGA-A5-A0GH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-21090.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	2254.0	21090.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21090.0	57.78082191780822	['2019-07-31T22:15:16.295277-05:00', '2019-07-31T22:15:16.295277-05:00']	['31bec311-9b87-5a4e-becb-d8a9fb567801', 'c86ccec8-f08c-5efd-8ccd-c80ec68500b4']	['TCGA-A5-A0GH_treatment_1', 'TCGA-A5-A0GH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:18:17.499533-05:00', '']	01	Primary	853196b6-8c1d-462f-af8f-acf2551f633d	Primary Tumor	Not Reported	2256.0	230.0	OCT	8E29A939-5581-4176-B19E-14076F17726B	true	Solid Tissue	False	Tumor
TCGA-EY-A547-01A	3424120f-248f-451a-948c-e320c19d1b19	Adenomas and Adenocarcinomas	3424120f-248f-451a-948c-e320c19d1b19	TCGA-EY-A547	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	75.0	-27686.0	1936.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	Not Reported	0.0	not reported	Endometrium	545.0	27686.0	Endometrioid adenocarcinoma, NOS	yes	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27686.0	75.85205479452055	['2019-07-31T22:15:28.707253-05:00', '2019-07-31T22:15:28.707253-05:00']	['4b52ef2d-c6c4-5d4f-880c-012c6315d5f1', '83f289c0-5cd8-5688-9db9-efa2c7902a10']	['TCGA-EY-A547_treatment_1', 'TCGA-EY-A547_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:18:27.530934-05:00', '']	01	Primary	52338734-9eec-4793-b4a7-5cd84322e797	Primary Tumor	Not Reported	645.0	610.0	Unknown	59662419-D77B-4C25-A888-CE993D412FD1	false	Solid Tissue	False	Tumor
TCGA-D1-A179-01A	37d5c1d9-3ff5-44fe-afdc-ff430a0f3510	Cystic, Mucinous and Serous Neoplasms	37d5c1d9-3ff5-44fe-afdc-ff430a0f3510	TCGA-D1-A179	Corpus uteri	Not Reported	white	female	hispanic or latino	Dead	76.0	-28037.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	448.0															Stage IIIC	No	0.0	not reported	Endometrium	206.0	28037.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	28037.0	76.81369863013698	['2019-07-31T22:15:40.362898-05:00', '2019-07-31T22:15:40.362898-05:00']	['9bad8611-91b3-5a82-a51b-bf1aff93f46a', 'bbe7975f-fb60-578a-bb4d-277dbc880582']	['TCGA-D1-A179_treatment', 'TCGA-D1-A179_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:18:38.200149-05:00']	01	Primary	ba812542-9161-4060-93cd-8b730adb4d40	Primary Tumor	Not Reported	230.0	250.0	Unknown	F8F4C024-B723-424C-B98D-AA885C38CDFB	false	Solid Tissue	False	Tumor
TCGA-B5-A11E-01A	38a3ea92-8965-4bda-9dbd-144832975cdd	Adenomas and Adenocarcinomas	38a3ea92-8965-4bda-9dbd-144832975cdd	TCGA-B5-A11E	Corpus uteri	Not Reported	white	female	not reported	Alive	53.0	-19458.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1820.0	19458.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19458.0	53.30958904109589	['2019-07-31T22:15:49.539719-05:00', '2019-07-31T22:15:49.539719-05:00']	['636f29bc-e16e-592e-beb8-41d911f7e1e3', '9a3d0025-acb8-59da-bf52-9c4bccdfcc24']	['TCGA-B5-A11E_treatment_1', 'TCGA-B5-A11E_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:18:45.293009-05:00', '']	01	Primary	cd68a1a9-039f-4da5-9a53-3cd60a261f7f	Primary Tumor	Not Reported	198.0	890.0	OCT	2058131C-09EA-4DC7-A84A-EB055A68F1B6	true	Solid Tissue	False	Tumor
TCGA-EO-A3AZ-01A	38bf8476-fde7-423b-bbaa-15483207de39	Cystic, Mucinous and Serous Neoplasms	38bf8476-fde7-423b-bbaa-15483207de39	TCGA-EO-A3AZ	Corpus uteri	Not Reported	not reported	female	not reported	Alive	80.0	-29234.0	1931.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	826.0	29234.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	29234.0	80.0931506849315	['2019-07-31T22:15:52.446714-05:00', '2019-07-31T22:15:52.446714-05:00']	['5ae24240-f17d-5be1-8583-dc6bc23df23b', '6f41146a-6ec2-5aca-b679-e2554e0fea90']	['TCGA-EO-A3AZ_treatment_1', 'TCGA-EO-A3AZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:18:47.668896-05:00', '']	01	Primary	de7f0a98-8365-4dfc-856f-138eae9cef16	Primary Tumor	Not Reported	241.0	120.0	Unknown	EA5D2C1C-703B-46BE-8B16-C40CE4BA0B46	false	Solid Tissue	False	Tumor
TCGA-BG-A222-01A	397b2672-d014-4b57-88dd-17e66ff8be4d	Adenomas and Adenocarcinomas	397b2672-d014-4b57-88dd-17e66ff8be4d	TCGA-BG-A222	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	49.0	-18220.0	1962.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	291.0	18220.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18220.0	49.917808219178085	['2019-07-31T22:16:00.976377-05:00', '2019-07-31T22:16:00.976377-05:00']	['05449b6f-5ed0-5476-9414-33013a97f947', 'bd2eb633-c69a-5624-9d04-f24bb0e7ff1f']	['TCGA-BG-A222_treatment', 'TCGA-BG-A222_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:18:55.071759-05:00']	01	Primary	002eb27d-18c4-49d0-a977-8d2717e7ee42	Primary Tumor	Not Reported	50.0	630.0	OCT	32837D2C-0D2B-4A47-9E42-1A809CB4A25A	true	Solid Tissue	False	Tumor
TCGA-DF-A2KZ-01A	3b218ab7-5c2e-4458-a0ac-5152ec3d2b94	Adenomas and Adenocarcinomas	3b218ab7-5c2e-4458-a0ac-5152ec3d2b94	TCGA-DF-A2KZ	Corpus uteri	Not Reported	not reported	female	not reported	Alive	87.0	-31973.0			['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	826.0	31973.0	Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31973.0	87.59726027397261	['2019-07-31T22:16:09.868843-05:00', '2019-07-31T22:16:09.868843-05:00']	['3699e8c1-18a6-5ee5-b975-d286f4a44c0b', '36b28f02-115f-5576-a922-2e892bd9708a']	['TCGA-DF-A2KZ_treatment_1', 'TCGA-DF-A2KZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:19:02.558219-05:00', '']	01	Primary	76d43b40-612e-4580-abd7-d1837d8fd5d0	Primary Tumor	Not Reported		450.0	Unknown	D69C73D1-1CEB-4AF5-AAF2-8E707EF4CA38	false	Solid Tissue	False	Tumor
TCGA-D1-A167-01A	3d215e20-9eea-47e0-849e-cff1fee5634d	Adenomas and Adenocarcinomas	3d215e20-9eea-47e0-849e-cff1fee5634d	TCGA-D1-A167	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	70.0	-25575.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	478.0	25575.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25575.0	70.06849315068493	['2019-07-31T22:16:24.905269-05:00', '2019-07-31T22:16:24.905269-05:00']	['002e7d33-5ad3-51f7-aa14-80e929a8ecb0', 'faedf77f-c33d-582f-9d6c-7b8f4969d379']	['TCGA-D1-A167_treatment_1', 'TCGA-D1-A167_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:19:14.844444-05:00', '']	01	Primary	96112beb-64c2-40bc-b1f9-784581cc88e3	Primary Tumor	Not Reported	841.0	140.0	Unknown	4E67EAA4-3069-4B62-A403-9300A9FA494C	false	Solid Tissue	False	Tumor
TCGA-JU-AAVI-01A	3e41cf2f-3de9-44c1-a819-bce693baf67d	Cystic, Mucinous and Serous Neoplasms	3e41cf2f-3de9-44c1-a819-bce693baf67d	TCGA-JU-AAVI	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	61.0	-22289.0	1952.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bea84955-9db7-5390-bed1-9e3033b516d3	JU	BLN - Baylor	Uterine Corpus Endometrial Carcinoma	NCH	540.0															Stage IIIC1	No	0.0	not reported	Endometrium	236.0	22289.0	Serous cystadenocarcinoma, NOS	no	2013.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22289.0	61.06575342465754	['2019-07-31T22:16:38.007051-05:00', '2019-07-31T22:16:38.007051-05:00']	['5ff486e6-081d-5227-bded-e56c5d6b5f87', 'b3f73560-67d6-545c-9828-aa622d764e30']	['TCGA-JU-AAVI_treatment_1', 'TCGA-JU-AAVI_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:19:24.755063-05:00', '']	01	Primary	1b186f8e-06a6-488b-b4ce-f59cb0318034	Primary Tumor	Not Reported	139.0	20.0	OCT	8639CE54-3D67-4E2E-BECB-26755EE726C5	true	Solid Tissue	False	Tumor
TCGA-AX-A1CA-01A	3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee	Cystic, Mucinous and Serous Neoplasms	3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee	TCGA-AX-A1CA	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	70.0	-25817.0	1939.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	974.0	25817.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25817.0	70.73150684931507	['2019-07-31T22:16:47.533066-05:00', '2019-07-31T22:16:47.533066-05:00']	['51719bd9-e751-5a53-ae66-fdc988535629', 'e421e734-144e-5e2c-ae81-2b6908b7e337']	['TCGA-AX-A1CA_treatment_1', 'TCGA-AX-A1CA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:19:32.395426-05:00', '']	01	Primary	b627e715-006f-45ac-a168-85d37e9dc6e1	Primary Tumor	Not Reported	591.0	110.0	Unknown	5906346F-CB34-421F-BBC3-3B6D2239AA7F	false	Solid Tissue	False	Tumor
TCGA-DI-A1C3-01A	3f305a1f-1020-4ebb-82ab-fd132bcaea02	Adenomas and Adenocarcinomas	3f305a1f-1020-4ebb-82ab-fd132bcaea02	TCGA-DI-A1C3	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	38.0	-13885.0	1970.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	f4604172-411f-5330-ba30-1466d87b6d7f	DI	MD Anderson	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	739.0	13885.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	13885.0	38.04109589041096	['2019-07-31T22:16:50.394518-05:00', '2019-07-31T22:16:50.394518-05:00']	['26d5c288-b0af-5973-9eb5-21ebd0a4b987', 'a87dd9ac-58c0-5fc7-aba9-3fa3e6f9f6d0']	['TCGA-DI-A1C3_treatment_1', 'TCGA-DI-A1C3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:19:34.867392-05:00', '']	01	Primary	d4ab43b5-5ff7-4a06-8efb-f05eba3b2a7f	Primary Tumor	Not Reported	755.0	170.0	Unknown	63A6706E-823B-456E-A3BC-65755C07CF62	false	Solid Tissue	False	Tumor
TCGA-AJ-A3BF-01A	40287cdc-19dd-4370-a6a0-f324960e1148	Cystic, Mucinous and Serous Neoplasms	40287cdc-19dd-4370-a6a0-f324960e1148	TCGA-AJ-A3BF	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	65.0	-23906.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	551.0	23906.0	Papillary serous cystadenocarcinoma	no	2011.0	No	8460/3	not reported	C54.1	Endometrium	Not Reported	not reported	23906.0	65.4958904109589	['2019-07-31T22:16:56.612681-05:00', '2019-07-31T22:16:56.612681-05:00']	['444dfdac-c3b7-523a-9fb6-4326cef8fdd0', '8441dd4d-8448-544a-8bf0-105ead9800b1']	['TCGA-AJ-A3BF_treatment', 'TCGA-AJ-A3BF_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:19:39.608043-05:00']	01	Primary	ef33dd67-2e71-4a81-91dc-f5e404fb25f7	Primary Tumor	Not Reported	92.0	150.0	Unknown	3673A111-6F2E-4374-A0E7-BA436D644F0D	false	Solid Tissue	False	Tumor
TCGA-AX-A1C4-01A	40ce24c6-b331-4be2-baf9-2fa7dc855f9b	Adenomas and Adenocarcinomas	40ce24c6-b331-4be2-baf9-2fa7dc855f9b	TCGA-AX-A1C4	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	52.0	-19209.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	404.0	19209.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19209.0	52.62739726027397	['2019-07-31T22:17:02.749879-05:00', '2019-07-31T22:17:02.749879-05:00']	['71b7f65b-6e7b-5617-811c-65652dccc1b8', '860c26f2-9f9e-5801-bcb8-58410eb48469']	['TCGA-AX-A1C4_treatment', 'TCGA-AX-A1C4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:19:44.573838-05:00']	01	Primary	48977d80-9f8f-488d-9292-661d7487e089	Primary Tumor	Not Reported	575.0	120.0	Unknown	81C6DDE6-ACC3-4659-91EC-D986671B592A	false	Solid Tissue	False	Tumor
TCGA-AJ-A6NU-01A	41e14a71-95df-46d3-a357-a227a00029cf	Adenomas and Adenocarcinomas	41e14a71-95df-46d3-a357-a227a00029cf	TCGA-AJ-A6NU	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	64.0	-23498.0	1948.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	632.0	23498.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23498.0	64.37808219178082	['2019-07-31T22:17:18.269110-05:00', '2019-07-31T22:17:18.269110-05:00']	['1a185013-a5ee-5534-bbeb-52af04a9fa2d', '6ce3636b-6379-5e1e-b73c-59210b7bf1d4']	['TCGA-AJ-A6NU_treatment_1', 'TCGA-AJ-A6NU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:19:56.022017-05:00', '']	01	Primary	c1d8a26d-4b1f-455e-a378-06d4ad191c02	Primary Tumor	Not Reported	439.0	50.0	Unknown	43BA8AFC-DE95-4260-88BF-EB184430B5A4	false	Solid Tissue	False	Tumor
TCGA-AP-A0LT-01A	43714e9a-e9c4-4206-af92-1d00d2a8ae35	Adenomas and Adenocarcinomas	43714e9a-e9c4-4206-af92-1d00d2a8ae35	TCGA-AP-A0LT	Corpus uteri	Not Reported	white	female	not reported	Alive	57.0	-21107.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	1497.0	21107.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21107.0	57.827397260273976	['2019-07-31T22:17:36.104093-05:00', '2019-07-31T22:17:36.104093-05:00']	['1780bc7b-9a02-5689-afde-c779776cd6bf', '245cb558-74c0-5aec-b096-a95ec411b973']	['TCGA-AP-A0LT_treatment', 'TCGA-AP-A0LT_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:20:10.201095-05:00']	01	Primary	c94dd7a5-dd58-4702-a7d1-8199d3f8c9cc	Primary Tumor	Not Reported	1404.0	200.0	OCT	4A25211C-354E-4FC8-B81B-29766B7962D4	true	Solid Tissue	False	Tumor
TCGA-AJ-A8CW-01A	43e08773-767e-4b81-94e4-8848565c23e9	Adenomas and Adenocarcinomas	43e08773-767e-4b81-94e4-8848565c23e9	TCGA-AJ-A8CW	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	64.0	-23554.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	4.0	23554.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23554.0	64.53150684931506	['2019-07-31T22:17:39.392023-05:00', '2019-07-31T22:17:39.392023-05:00']	['8621a323-0eec-5454-be3a-119e8eabd5a3', 'a84abc8d-2cf2-5528-a5f0-fe62a83b67dd']	['TCGA-AJ-A8CW_treatment', 'TCGA-AJ-A8CW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:20:12.346792-05:00']	01	Primary	ca2da155-5ce0-4fe9-b82e-877295e4ad5e	Primary Tumor	Not Reported	840.0	90.0	Unknown	146E0540-B6F0-495F-ADD5-90F7564C14CA	false	Solid Tissue	False	Tumor
TCGA-AP-A059-01A	4549bff6-6886-4102-a1de-02691b664c52	Adenomas and Adenocarcinomas	4549bff6-6886-4102-a1de-02691b664c52	TCGA-AP-A059	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	69.0	-25311.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1461.0	25311.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25311.0	69.34520547945205	['2019-07-31T22:17:48.128649-05:00', '2019-07-31T22:17:48.128649-05:00']	['acb7d17f-61c2-5616-a447-397eb297b65c', 'c4077bee-4205-53ea-8062-19c05a3744a6']	['TCGA-AP-A059_treatment', 'TCGA-AP-A059_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:20:19.754150-05:00']	01	Primary	6d6c8e8b-3423-4380-a498-6cf5bc8b070b	Primary Tumor	Not Reported	1476.0	230.0	OCT	29A150D3-D5F0-4222-B082-6ABE35A2BB46	true	Solid Tissue	False	Tumor
TCGA-AJ-A8CV-01A	4557d1fb-9786-4780-bd33-02e9da04b7e3	Adenomas and Adenocarcinomas	4557d1fb-9786-4780-bd33-02e9da04b7e3	TCGA-AJ-A8CV	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	58.0	-21336.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1068.0	21336.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21336.0	58.45479452054794	['2019-07-31T22:17:51.021378-05:00', '2019-07-31T22:17:51.021378-05:00']	['75d14244-c9f0-56cf-9117-9e956bab128c', 'd87655eb-582a-5d4b-959b-61d2e0383b56']	['TCGA-AJ-A8CV_treatment', 'TCGA-AJ-A8CV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:20:22.240687-05:00']	01	Primary	9388a1b3-fb16-4cfb-9359-b1a3fb7fb048	Primary Tumor	Not Reported	966.0	30.0	Unknown	9A08EA28-EF0B-40CE-B2B4-0A0B0EE1EDA7	false	Solid Tissue	False	Tumor
TCGA-FI-A2D2-01A	46a1fdb9-548d-44d1-ab77-d51d44ac8198	Cystic, Mucinous and Serous Neoplasms	46a1fdb9-548d-44d1-ab77-d51d44ac8198	TCGA-FI-A2D2	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	66.0	-24260.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH	2352.0															Stage IB	No	0.0	not reported	Endometrium	1215.0	24260.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24260.0	66.46575342465754	['2019-07-31T22:17:57.083811-05:00', '2019-07-31T22:17:57.083811-05:00']	['09fecd14-df07-5796-afde-06bd727bb3a3', '6bbd9db0-e25d-5db8-b5a1-3fa7aa9c898b']	['TCGA-FI-A2D2_treatment_1', 'TCGA-FI-A2D2_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:20:27.386141-05:00', '']	01	Primary	88f8998f-3d6a-4f9d-8b82-3250d26f5065	Primary Tumor	Not Reported	975.0	70.0	OCT	75FB8F31-5C30-48C2-B4A5-2DA184DC039C	true	Solid Tissue	False	Tumor
TCGA-FL-A1YH-11A	47c49c54-95f8-42c8-94e4-411280452512	Not Reported	47c49c54-95f8-42c8-94e4-411280452512	TCGA-FL-A1YH	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	0e9c603f-5ec6-4fd7-87bb-bce23ca2c042	Solid Tissue Normal	Not Reported		310.0	Unknown	F49FD879-727C-4F5E-B4B8-6FE59B4C05FF	false	Solid Tissue	False	Normal
TCGA-A5-A0G5-01A	4806d9a6-e65d-4a82-b422-1b287980a0c6	Adenomas and Adenocarcinomas	4806d9a6-e65d-4a82-b422-1b287980a0c6	TCGA-A5-A0G5	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	73.0	-26827.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1126.0	26827.0	Clear cell adenocarcinoma, NOS	no	2008.0	No	8310/3	not reported	C54.1	Endometrium	Not Reported	not reported	26827.0	73.4986301369863	['2019-07-31T22:18:06.174510-05:00', '2019-07-31T22:18:06.174510-05:00']	['3e333e95-495d-5170-954a-3696148539a5', 'ecfdbad7-38fe-5b2b-bf45-864601a0f756']	['TCGA-A5-A0G5_treatment_1', 'TCGA-A5-A0G5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:20:34.858813-05:00', '']	01	Primary	fa7392e8-335e-4465-9272-4a19dc99412e	Primary Tumor	Not Reported	856.0	240.0	OCT	C7C6ABB1-32EE-4D2B-898A-91A1F596EC53	true	Solid Tissue	False	Tumor
TCGA-FI-A2D4-01A	490ae247-ee67-48d4-94ed-93df5b9bbefe	Adenomas and Adenocarcinomas	490ae247-ee67-48d4-94ed-93df5b9bbefe	TCGA-FI-A2D4	Corpus uteri	Not Reported	white	female	not reported	Dead	44.0	-16163.0	1965.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH	243.0															Stage IIIC	No	0.0	not reported	Endometrium		16163.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16163.0	44.28219178082192	['2019-07-31T22:18:15.279919-05:00', '2019-07-31T22:18:15.279919-05:00']	['c66873ab-1c74-560f-b865-a81cb0ac3ec8', 'f55d2476-e07f-57ea-a1d6-030068572e71']	['TCGA-FI-A2D4_treatment', 'TCGA-FI-A2D4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:20:42.064311-05:00']	01	Primary	a8393121-29df-4525-bf4f-fce0deaf25f5	Primary Tumor	Not Reported	853.0	50.0	OCT	A6419790-A6CE-47E2-8035-437820EC63EC	true	Solid Tissue	False	Tumor
TCGA-AP-A05O-01A	49431740-7ed1-4c67-8d66-730629825895	Adenomas and Adenocarcinomas	49431740-7ed1-4c67-8d66-730629825895	TCGA-AP-A05O	Corpus uteri	Not Reported	white	female	not reported	Alive	68.0	-24978.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	384.0	24978.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24978.0	68.43287671232876	['2019-07-31T22:18:18.294250-05:00', '2019-07-31T22:18:18.294250-05:00']	['23d756a9-9cf5-55b0-91f0-13288b48e198', '4630e686-5d5b-55df-a18f-4e4538ac5eb5']	['TCGA-AP-A05O_treatment', 'TCGA-AP-A05O_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:20:44.456066-05:00']	01	Primary	4f1edc7f-e2ff-40f5-8227-d89a1006042c	Primary Tumor	Not Reported	209.0	270.0	OCT	9C8BD34A-DC49-4547-850A-80DCD2D073F8	true	Solid Tissue	False	Tumor
TCGA-EO-A3B0-01A	4c2e6abf-02e1-4ef7-a0be-6a6d4069581d	Adenomas and Adenocarcinomas	4c2e6abf-02e1-4ef7-a0be-6a6d4069581d	TCGA-EO-A3B0	Corpus uteri	Not Reported	asian	female	not reported	Alive	43.0	-15954.0	1968.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	1412.0	15954.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	15954.0	43.70958904109589	['2019-07-31T22:18:34.539327-05:00', '2019-07-31T22:18:34.539327-05:00']	['01158cb0-2d20-5560-99db-a9ab3310ac2f', '3871232a-c174-5f4d-9cbd-9d74d3cc9124']	['TCGA-EO-A3B0_treatment_1', 'TCGA-EO-A3B0_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:20:56.882471-05:00', '']	01	Primary	87a5c4d3-9aa2-4a86-9cc9-f99a4b67feae	Primary Tumor	Not Reported	196.0	160.0	Unknown	5B8CD9C0-148B-4421-AA68-C1F2DF7F9B28	false	Solid Tissue	False	Tumor
TCGA-D1-A0ZZ-01A	4d3af3af-24f4-415a-9677-20b0f366a102	Cystic, Mucinous and Serous Neoplasms	4d3af3af-24f4-415a-9677-20b0f366a102	TCGA-D1-A0ZZ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	80.0	-29420.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	686.0	29420.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	29420.0	80.6027397260274	['2019-07-31T22:18:40.772025-05:00', '2019-07-31T22:18:40.772025-05:00']	['53330bd3-549c-51aa-b678-3346e83484bd', 'fdb6b901-e129-54b9-8578-85c19fc2b787']	['TCGA-D1-A0ZZ_treatment_1', 'TCGA-D1-A0ZZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:21:01.830507-05:00', '']	01	Primary	c797e9d4-3f3e-48d9-870f-e8ea6bddfd91	Primary Tumor	Not Reported	349.0	220.0	Unknown	4339EAC6-F56E-49E6-8EF9-2256165CADB5	false	Solid Tissue	False	Tumor
TCGA-BS-A0T9-01A	4eb95566-0e73-4260-853e-f7df650667a0	Adenomas and Adenocarcinomas	4eb95566-0e73-4260-853e-f7df650667a0	TCGA-BS-A0T9	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not hispanic or latino	Dead	39.0	-14253.0	1966.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH	1428.0															Stage IVB	No	0.0	not reported	Endometrium		14253.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	14253.0	39.04931506849315	['2019-07-31T22:18:50.103042-05:00', '2019-07-31T22:18:50.103042-05:00']	['a22838a0-ead2-59c5-bf1d-975911f5ca40', 'b1807c17-f004-53cd-9155-f4e06373f2ec']	['TCGA-BS-A0T9_treatment', 'TCGA-BS-A0T9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:21:08.887107-05:00']	01	Primary	3c9ff865-013f-427a-8d4d-c8e60ea346a1	Primary Tumor	Not Reported	2009.0	600.0	Unknown	C9151621-D012-48F9-B7E1-F540567E791C	false	Solid Tissue	False	Tumor
TCGA-BG-A0M9-01A	4fd1cb59-6c50-4355-9d37-a341e1f4fad9	Adenomas and Adenocarcinomas	4fd1cb59-6c50-4355-9d37-a341e1f4fad9	TCGA-BG-A0M9	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	73.0	-26708.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2270.0	26708.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26708.0	73.17260273972603	['2019-07-31T22:18:52.950078-05:00', '2019-07-31T22:18:52.950078-05:00']	['032c27f3-c02c-5276-9bba-8ef0c0c4b394', '9b48b27e-354d-5d7a-b783-f8c4eb849353']	['TCGA-BG-A0M9_treatment', 'TCGA-BG-A0M9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:21:11.283533-05:00']	01	Primary	dc487bbf-555b-423b-b7c0-3e92defa5a79	Primary Tumor	Not Reported	772.0	220.0	OCT	08D832C7-9B5F-4B6E-9C3E-2F3E58305016	true	Solid Tissue	False	Tumor
TCGA-AJ-A3BK-01A	503e6c30-1b62-4f85-bcb4-e34c009894ab	Adenomas and Adenocarcinomas	503e6c30-1b62-4f85-bcb4-e34c009894ab	TCGA-AJ-A3BK	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-24943.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	1031.0	24943.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24943.0	68.33698630136986	['2019-07-31T22:18:56.235595-05:00', '2019-07-31T22:18:56.235595-05:00']	['30f9d348-53ea-59c0-ad6b-26005004c1f6', '38667152-25fb-562a-84b4-3db79cc955e2']	['TCGA-AJ-A3BK_treatment_1', 'TCGA-AJ-A3BK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:21:13.709555-05:00', '']	01	Primary	610660f1-07aa-489f-b09f-8da0b91fee6f	Primary Tumor	Not Reported	547.0	170.0	Unknown	026350F0-3203-49E5-8CCC-9DE88B2C8625	false	Solid Tissue	False	Tumor
TCGA-AJ-A3BI-01A	525fb4fc-2167-4506-b4fa-fb896bf64cd0	Adenomas and Adenocarcinomas	525fb4fc-2167-4506-b4fa-fb896bf64cd0	TCGA-AJ-A3BI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24623.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	575.0	24623.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24623.0	67.46027397260274	['2019-07-31T22:19:05.105346-05:00', '2019-07-31T22:19:05.105346-05:00']	['19a961c6-bdb3-5294-afce-82e6ac0a525a', '71008791-010b-5a80-a159-ae6d3d31d11a']	['TCGA-AJ-A3BI_treatment', 'TCGA-AJ-A3BI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:21:21.173290-05:00']	01	Primary	b4d093ec-48a4-4edd-a88c-de51130a368c	Primary Tumor	Not Reported	137.0	19.0	Unknown	19B5518D-075F-40BE-A104-75C925F133A4	false	Solid Tissue	False	Tumor
TCGA-AX-A3FZ-01A	5262d82d-fc43-41f4-9b23-c9ac6f237ff0	Adenomas and Adenocarcinomas	5262d82d-fc43-41f4-9b23-c9ac6f237ff0	TCGA-AX-A3FZ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	33.0	-12331.0	1977.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIB	No	0.0	not reported	Endometrium	6.0	12331.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	12331.0	33.78356164383562	['2019-07-31T22:19:07.934811-05:00', '2019-07-31T22:19:07.934811-05:00']	['a9c97779-c1db-56d7-9e9b-235a362aab65', 'b393e885-8aa9-5599-9315-f9c680b86c57']	['TCGA-AX-A3FZ_treatment_1', 'TCGA-AX-A3FZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:21:23.639745-05:00', '']	01	Primary	3e114d9b-a96e-4b58-84a0-ad0ecf10b199	Primary Tumor	Not Reported	658.0	100.0	Unknown	4989F66F-57F8-4B1C-97DD-69F3036EB0BA	false	Solid Tissue	False	Tumor
TCGA-AX-A2HC-01A	53e8e07e-18f9-4c9b-9783-a5b67ceddcf7	Adenomas and Adenocarcinomas	53e8e07e-18f9-4c9b-9783-a5b67ceddcf7	TCGA-AX-A2HC	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	53.0	-19485.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1044.0	19485.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19485.0	53.38356164383562	['2019-07-31T22:19:19.741327-05:00', '2019-07-31T22:19:19.741327-05:00']	['7f3baa41-8e8f-5026-bda1-e93c874fb76f', 'e28a8158-7cf7-535b-86c4-451eaa12d50a']	['TCGA-AX-A2HC_treatment_1', 'TCGA-AX-A2HC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:21:33.410448-05:00', '']	01	Primary	1bacdcab-f02f-4c6e-89e5-4a221c2e3bc0	Primary Tumor	Not Reported	1786.0	120.0	Unknown	90DC9BBA-4666-4702-8BA1-F57253E43CDD	false	Solid Tissue	False	Tumor
TCGA-AX-A2HC-11A	53e8e07e-18f9-4c9b-9783-a5b67ceddcf7	Adenomas and Adenocarcinomas	53e8e07e-18f9-4c9b-9783-a5b67ceddcf7	TCGA-AX-A2HC	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	53.0	-19485.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1044.0	19485.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19485.0	53.38356164383562	['2019-07-31T22:19:19.741327-05:00', '2019-07-31T22:19:19.741327-05:00']	['7f3baa41-8e8f-5026-bda1-e93c874fb76f', 'e28a8158-7cf7-535b-86c4-451eaa12d50a']	['TCGA-AX-A2HC_treatment_1', 'TCGA-AX-A2HC_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:21:33.410448-05:00', '']	11	Not Applicable	82851d79-abe1-4fa0-8f28-86b2a9656dc6	Solid Tissue Normal	Not Reported	1786.0	120.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FL-A1YQ-11A	545ba049-b7c1-4b46-9ec2-9331dccd6c60	Not Reported	545ba049-b7c1-4b46-9ec2-9331dccd6c60	TCGA-FL-A1YQ	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	f6c7db6c-cf42-4e24-8ff9-aece36ee1842	Solid Tissue Normal	Not Reported		130.0	Unknown	A183E852-81EF-413C-85F0-122FB8F22DE2	false	Solid Tissue	False	Normal
TCGA-D1-A16I-01A	548ec160-4183-459f-8393-f4b4672a3251	Cystic, Mucinous and Serous Neoplasms	548ec160-4183-459f-8393-f4b4672a3251	TCGA-D1-A16I	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	62.0	-22836.0	1946.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	350.0															Stage IC	No	0.0	not reported	Endometrium		22836.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22836.0	62.56438356164384	['2019-07-31T22:19:26.815219-05:00', '2019-07-31T22:19:26.815219-05:00']	['56f0f157-f423-5d33-8edd-ffb6463df51c', 'ae66f263-4856-52b2-bc3d-702c88df34b3']	['TCGA-D1-A16I_treatment_1', 'TCGA-D1-A16I_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:21:38.658356-05:00', '']	01	Primary	62a1ff9f-f730-4703-8271-89e1a123da65	Primary Tumor	Not Reported	763.0	190.0	Unknown	3D30B053-444A-4F4D-B451-EB8746A157A2	false	Solid Tissue	False	Tumor
TCGA-QS-A8F1-01A	54ac877a-52ff-450c-9df9-b7cd3fc8e2e2	Cystic, Mucinous and Serous Neoplasms	54ac877a-52ff-450c-9df9-b7cd3fc8e2e2	TCGA-QS-A8F1	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Dead	85.0	-31386.0	1928.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	c4c083cd-4644-53b2-9d7e-ca2ae833c525	QS	Candler	Uterine Corpus Endometrial Carcinoma	NCH	135.0															Stage IIIA	No	0.0	not reported	Fundus uteri	125.0	31386.0	Serous cystadenocarcinoma, NOS	no	2013.0	No	8441/3	not reported	C54.3	Fundus uteri	Not Reported	not reported	31386.0	85.98904109589041	['2019-07-31T22:19:30.562696-05:00', '2019-07-31T22:19:30.562696-05:00']	['d147518c-61ff-5f14-a35a-a752983fea25', 'ddc7c63f-7d14-5418-9ede-7f7ca88f8d50']	['TCGA-QS-A8F1_treatment_1', 'TCGA-QS-A8F1_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:21:41.246679-05:00', '']	01	Primary	7bc29acd-1306-4439-9042-27a9115eb563	Primary Tumor	Not Reported	29.0	250.0	Unknown	563BDC27-AFA6-4DE0-AB17-8CFD93D1CA81	false	Solid Tissue	False	Tumor
TCGA-BK-A0CB-01A	59e9029a-8ddd-4447-b35a-72bc39f82a30	Adenomas and Adenocarcinomas	59e9029a-8ddd-4447-b35a-72bc39f82a30	TCGA-BK-A0CB	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-21930.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1092.0	21930.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21930.0	60.082191780821915	['2019-07-31T22:19:51.624448-05:00', '2019-07-31T22:19:51.624448-05:00']	['08300f38-dec3-5766-bc08-c806044a2990', '88b56b49-9b27-5e70-945a-2635a0f0eb30']	['TCGA-BK-A0CB_treatment', 'TCGA-BK-A0CB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:21:58.155172-05:00']	01	Primary	7678c70d-a298-4472-89a0-427af1e93d28	Primary Tumor	Not Reported	64.0	450.0	Unknown	37923E3D-3CCB-41DB-8F30-C19FDE7407CB	false	Solid Tissue	False	Tumor
TCGA-BK-A0CB-11A	59e9029a-8ddd-4447-b35a-72bc39f82a30	Adenomas and Adenocarcinomas	59e9029a-8ddd-4447-b35a-72bc39f82a30	TCGA-BK-A0CB	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-21930.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	45b0a8e5-a81b-50ab-8edb-279e96710b53	BK	Christiana Healthcare	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	1092.0	21930.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21930.0	60.082191780821915	['2019-07-31T22:19:51.624448-05:00', '2019-07-31T22:19:51.624448-05:00']	['08300f38-dec3-5766-bc08-c806044a2990', '88b56b49-9b27-5e70-945a-2635a0f0eb30']	['TCGA-BK-A0CB_treatment', 'TCGA-BK-A0CB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:21:58.155172-05:00']	11	Not Applicable	f1d2d79c-ce6a-4160-9de2-c169f0dab321	Solid Tissue Normal	Not Reported	64.0	420.0	Unknown		false	Solid Tissue	False	Normal
TCGA-FL-A1YL-11A	5a61ef1e-61eb-4794-9429-2bddbbe7d09d	Not Reported	5a61ef1e-61eb-4794-9429-2bddbbe7d09d	TCGA-FL-A1YL	Uterus, NOS										['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	aec534e3-8ee1-5c6c-abb4-f22d85bfcdda	FL	University of Hawaii - Normal Study	Uterine Corpus Endometrial Carcinoma	NCH																																										11	Not Applicable	69c9f329-8f1d-4ed6-ad22-d82371a3fc9c	Solid Tissue Normal	Not Reported		80.0	Unknown	5C686996-6F26-4A31-B53E-AC9561DAC9FC	false	Solid Tissue	False	Normal
TCGA-D1-A17K-01A	5c22c8d6-5805-455c-8e1c-e6b8006738e4	Adenomas and Adenocarcinomas	5c22c8d6-5805-455c-8e1c-e6b8006738e4	TCGA-D1-A17K	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27283.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	854.0	27283.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27283.0	74.74794520547945	['2019-07-31T22:20:00.547522-05:00', '2019-07-31T22:20:00.547522-05:00']	['9d1fcf00-fd83-51b7-8629-5f13b04f1206', 'e478cef9-e92d-5b9b-a744-f744825d6cff']	['TCGA-D1-A17K_treatment_1', 'TCGA-D1-A17K_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:22:05.233394-05:00', '']	01	Primary	ca213835-efc5-4216-a762-a6b320b516bf	Primary Tumor	Not Reported	513.0	140.0	Unknown	C9E1B85A-8637-4421-A8CD-2E4BB28B3A73	false	Solid Tissue	False	Tumor
TCGA-A5-A1OG-01A	5c3f826c-b447-457d-a90e-715bad3c7118	Cystic, Mucinous and Serous Neoplasms	5c3f826c-b447-457d-a90e-715bad3c7118	TCGA-A5-A1OG	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Dead	65.0	-23956.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH	973.0															Stage IIIC2	No	0.0	not reported	Endometrium	348.0	23956.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23956.0	65.63287671232877	['2019-07-31T22:20:03.495124-05:00', '2019-07-31T22:20:03.495124-05:00']	['d835223b-c175-5c78-bffa-0d96ffdc85a7', 'f38e343f-60f1-5e48-b394-cd519b3f5340']	['TCGA-A5-A1OG_treatment', 'TCGA-A5-A1OG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:22:07.550751-05:00']	01	Primary	4cbc8fb7-9de4-4e17-8fb2-8571a224fb8d	Primary Tumor	Not Reported	223.0	190.0	OCT	7BE01FDF-C4CF-471E-B395-8D7C4531CD6F	true	Solid Tissue	False	Tumor
TCGA-B5-A1MY-01A	5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4	Cystic, Mucinous and Serous Neoplasms	5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4	TCGA-B5-A1MY	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	62.0	-22805.0	1948.0	2010.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH	361.0															Stage IIIC2	No	0.0	not reported	Endometrium		22805.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	22805.0	62.47945205479452	['2019-07-31T22:20:09.279159-05:00', '2019-07-31T22:20:09.279159-05:00']	['00e85cf4-17b4-5421-8aaa-f71a994d19a8', '5a8c6402-cd3b-59a8-962e-68bae816ecb6']	['TCGA-B5-A1MY_treatment_1', 'TCGA-B5-A1MY_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:22:12.385607-05:00', '']	01	Primary	26189cf5-ae49-44cf-842b-35a3063ab93c	Primary Tumor	Not Reported	128.0	360.0	OCT	A5328E25-1433-4331-83B8-148780F6A6DA	true	Solid Tissue	False	Tumor
TCGA-AJ-A23N-01A	5d39e9a2-1073-4db2-b02e-db05d59563a7	Cystic, Mucinous and Serous Neoplasms	5d39e9a2-1073-4db2-b02e-db05d59563a7	TCGA-AJ-A23N	Corpus uteri	Not Reported	white	female	not reported	Dead	70.0	-25772.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH	439.0															Stage IIIA	No	0.0	not reported	Endometrium	33.0	25772.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25772.0	70.6082191780822	['2019-07-31T22:20:12.010537-05:00', '2019-07-31T22:20:12.010537-05:00']	['172b4f09-46e1-5474-89df-c355b61adacf', '30c650dd-4c8a-5f63-a5cf-c83a5dcb2f4a']	['TCGA-AJ-A23N_treatment', 'TCGA-AJ-A23N_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:22:14.982838-05:00']	01	Primary	4a5f2624-4f86-44cd-84a3-cd1403e093b6	Primary Tumor	Not Reported	84.0	130.0	Unknown	38EB6233-9777-4640-A896-26D16A9DBD8E	false	Solid Tissue	False	Tumor
TCGA-AP-A0LV-01A	5dfdfcfc-72cc-4e33-aa3f-0d744eb94330	Adenomas and Adenocarcinomas	5dfdfcfc-72cc-4e33-aa3f-0d744eb94330	TCGA-AP-A0LV	Corpus uteri	Not Reported	white	female	not reported	Alive	39.0	-14556.0	1970.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	763.0	14556.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	14556.0	39.87945205479452	['2019-07-31T22:20:18.670028-05:00', '2019-07-31T22:20:18.670028-05:00']	['3344f8fb-070c-5e93-baaf-dd4901d6976d', 'a233f64b-e481-5012-b857-a936f056ecdf']	['TCGA-AP-A0LV_treatment', 'TCGA-AP-A0LV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:22:19.876962-05:00']	01	Primary	f5c82191-3e5a-479a-b0e4-77f6ac14b3cc	Primary Tumor	Not Reported	341.0	280.0	OCT	75767B04-9FDF-4EE9-8DFF-350B60AF281C	true	Solid Tissue	False	Tumor
TCGA-EO-A1Y5-01A	5f2f2e7a-8aec-4011-b261-0c5bc68da840	Cystic, Mucinous and Serous Neoplasms	5f2f2e7a-8aec-4011-b261-0c5bc68da840	TCGA-EO-A1Y5	Corpus uteri	Not Reported	not reported	female	not reported	Alive	63.0	-23251.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Endometrium	332.0	23251.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23251.0	63.701369863013696	['2019-07-31T22:20:25.194060-05:00', '2019-07-31T22:20:25.194060-05:00']	['81bbed92-ce6a-5f9b-b0f2-73a5411bbd97', 'e7870fa8-d744-59c3-97d4-6ea0b3f51420']	['TCGA-EO-A1Y5_treatment_1', 'TCGA-EO-A1Y5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:22:24.788760-05:00', '']	01	Primary	9bed3aea-1f78-4567-bb7b-016753a9bd0b	Primary Tumor	Not Reported	223.0	110.0	Unknown	B3A96371-1CD6-4B08-BDA5-C8CD7C7DE81F	false	Solid Tissue	False	Tumor
TCGA-BS-A0U9-01B	5ffa2ec6-2d94-4b09-8fb9-3591cf38fa4f	Adenomas and Adenocarcinomas	5ffa2ec6-2d94-4b09-8fb9-3591cf38fa4f	TCGA-BS-A0U9	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	59.0	-21580.0	1947.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIA	No	0.0	not reported	Endometrium	2825.0	21580.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21580.0	59.12328767123287	['2019-07-31T22:20:31.113876-05:00', '2019-07-31T22:20:31.113876-05:00']	['c983df28-1815-5382-8e67-b3967b6032c3', 'f2520e60-1d61-5237-8c65-030326d0763d']	['TCGA-BS-A0U9_treatment', 'TCGA-BS-A0U9_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:22:29.990789-05:00']	01	Primary	99d6d536-af2c-4c9b-9995-5b4032d54479	Primary Tumor	Not Reported	1637.0	430.0	Unknown	029B0BBB-D88D-4492-AC9A-9094E0DD101C	false	Solid Tissue	False	Tumor
TCGA-FI-A2F8-01A	601734da-2d11-4745-a260-0965f58aadea	Cystic, Mucinous and Serous Neoplasms	601734da-2d11-4745-a260-0965f58aadea	TCGA-FI-A2F8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23649.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	933.0	23649.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	23649.0	64.79178082191781	['2019-07-31T22:20:34.146296-05:00', '2019-07-31T22:20:34.146296-05:00']	['66daaace-97e8-52c8-85e4-566fcc68ed88', '9c78a99b-1815-50dd-83a8-07ae7223d2fd']	['TCGA-FI-A2F8_treatment_1', 'TCGA-FI-A2F8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:22:32.447323-05:00', '']	01	Primary	500c427b-db2c-4ca4-8bad-9f573e99c32a	Primary Tumor	Not Reported	679.0	70.0	OCT	9445945A-A7AC-4C36-889B-68A50644D556	true	Solid Tissue	False	Tumor
TCGA-BG-A0VV-01A	6164588a-d03a-46fc-82fb-a32cbaa54cac	Adenomas and Adenocarcinomas	6164588a-d03a-46fc-82fb-a32cbaa54cac	TCGA-BG-A0VV	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19581.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1553.0	19581.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19581.0	53.64657534246575	['2019-07-31T22:20:52.725644-05:00', '2019-07-31T22:20:52.725644-05:00']	['2105efad-c535-50fc-9b6c-1abc93a65c97', '92be7b96-9c70-5cde-8553-90bdc6534fc9']	['TCGA-BG-A0VV_treatment', 'TCGA-BG-A0VV_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:22:47.719154-05:00']	01	Primary	cf919557-13c9-4cf1-982c-a8d8ad3bf4ee	Primary Tumor	Not Reported	217.0	130.0	OCT	42E7D5FF-18CD-4DEA-9518-9B9732BCA635	true	Solid Tissue	False	Tumor
TCGA-BG-A18B-01A	62ae3bb1-8102-4693-aee6-4d8d0d2bc515	Adenomas and Adenocarcinomas	62ae3bb1-8102-4693-aee6-4d8d0d2bc515	TCGA-BG-A18B	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19550.0	1957.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage I	No	0.0	not reported	Endometrium	470.0	19550.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19550.0	53.56164383561644	['2019-07-31T22:20:58.489473-05:00', '2019-07-31T22:20:58.489473-05:00']	['4183f104-a809-5c6f-883c-305923457040', 'a8f65561-fd60-50f9-876f-40b137c56808']	['TCGA-BG-A18B_treatment_1', 'TCGA-BG-A18B_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:22:52.459444-05:00', '']	01	Primary	2a3bc803-54c4-4544-a72d-7077dbb0b93e	Primary Tumor	Not Reported	56.0	480.0	OCT	E7006FF4-33D9-4369-A4E0-42D124EAE1E0	true	Solid Tissue	False	Tumor
TCGA-AX-A064-01A	633e6994-3e8b-4c0b-9b79-06cf4ab6f9bc	Adenomas and Adenocarcinomas	633e6994-3e8b-4c0b-9b79-06cf4ab6f9bc	TCGA-AX-A064	Corpus uteri	Not Reported	white	female	not reported	Alive	81.0	-29625.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIA	No	0.0	not reported	Endometrium	1517.0	29625.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29625.0	81.16438356164383	['2019-07-31T22:21:10.468055-05:00', '2019-07-31T22:21:10.468055-05:00']	['14fae94d-544a-58d6-8461-1f3aaf95ce41', 'ba89ab19-5591-5c86-923d-b1977ab8e4d9']	['TCGA-AX-A064_treatment', 'TCGA-AX-A064_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:02.011274-05:00']	01	Primary	3d85e546-d9f4-49ba-adbd-301118cd1307	Primary Tumor	Not Reported	1024.0	180.0	Unknown	F760DFF2-7A11-4465-8581-397ABAA76BE4	false	Solid Tissue	False	Tumor
TCGA-QS-A5YR-01A	6696cf88-3c43-482c-aabb-f1ea5cf565aa	Adenomas and Adenocarcinomas	6696cf88-3c43-482c-aabb-f1ea5cf565aa	TCGA-QS-A5YR	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	61.0	-22372.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	c4c083cd-4644-53b2-9d7e-ca2ae833c525	QS	Candler	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIB	No	0.0	not reported	Endometrium	719.0	22372.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22372.0	61.293150684931504	['2019-07-31T22:21:23.271033-05:00', '2019-07-31T22:21:23.271033-05:00']	['73d3ee91-14e0-51ca-b7f3-fb82fb08309c', 'cb8d3e78-00d3-5003-9c42-9dcaf7ad1060']	['TCGA-QS-A5YR_treatment', 'TCGA-QS-A5YR_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:11.684424-05:00']	01	Primary	ff0189ba-f127-4093-b92c-5e37388c7a54	Primary Tumor	Not Reported	118.0	280.0	Unknown	D9417AEE-FD30-42FA-986E-26C98E29C428	false	Solid Tissue	False	Tumor
TCGA-BG-A18C-01A	66e305ca-8a16-44f0-b837-85e529b7ad55	Adenomas and Adenocarcinomas	66e305ca-8a16-44f0-b837-85e529b7ad55	TCGA-BG-A18C	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	72.0	-26602.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	470.0	26602.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26602.0	72.88219178082191	['2019-07-31T22:21:26.579338-05:00', '2019-07-31T22:21:26.579338-05:00']	['5b32ad9a-4607-583b-b0ae-f7534c108f8f', '5c3ca4e3-9a2f-57c2-9408-1a4671d6e938']	['TCGA-BG-A18C_treatment', 'TCGA-BG-A18C_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:14.099411-05:00']	01	Primary	37f209b1-c738-441c-b205-eaec4e2ade4e	Primary Tumor	Not Reported	52.0	340.0	OCT	2A6FB6E4-7FBF-45EA-B9B0-C4EDC78C35E2	true	Solid Tissue	False	Tumor
TCGA-BG-A0LW-01A	68181bc9-aa8b-44ec-8601-564b30ea0561	Adenomas and Adenocarcinomas	68181bc9-aa8b-44ec-8601-564b30ea0561	TCGA-BG-A0LW	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	47.0	-17369.0	1963.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	566.0	17369.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17369.0	47.586301369863016	['2019-07-31T22:21:39.014077-05:00', '2019-07-31T22:21:39.014077-05:00']	['4278df68-abfe-558c-9aea-4848666f3327', '8bdbe7b5-265d-5352-9df6-4734cf6f1198']	['TCGA-BG-A0LW_treatment', 'TCGA-BG-A0LW_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:23:23.894941-05:00']	01	Primary	6527ec31-1d41-49c2-93ff-11615a6cba8b	Primary Tumor	Not Reported	107.0	190.0	OCT	75A97BED-AB64-46CC-AE6B-59860673D53E	true	Solid Tissue	False	Tumor
TCGA-AJ-A3QS-01A	69fc74bc-e961-40e2-9169-d7b51658eb10	Cystic, Mucinous and Serous Neoplasms	69fc74bc-e961-40e2-9169-d7b51658eb10	TCGA-AJ-A3QS	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	57.0	-21162.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	513.0	21162.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21162.0	57.97808219178082	['2019-07-31T22:21:41.942464-05:00', '2019-07-31T22:21:41.942464-05:00']	['81ea6788-6a4d-594c-b016-93bb00b4cb44', '89afbbc3-6a39-511f-b513-de30a2697d76']	['TCGA-AJ-A3QS_treatment', 'TCGA-AJ-A3QS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:23:26.403931-05:00']	01	Primary	0d33f3bb-f849-4ffa-8192-c95bf69dd5cc	Primary Tumor	Not Reported	129.0	34.0	OCT	73D1F890-5799-4166-9F9A-F9852979FD29	true	Solid Tissue	False	Tumor
TCGA-AJ-A8CT-01A	6c2232b2-80ce-4156-a0b4-ffa411b0963e	Adenomas and Adenocarcinomas	6c2232b2-80ce-4156-a0b4-ffa411b0963e	TCGA-AJ-A8CT	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	58.0	-21515.0	1954.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	82.0	21515.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21515.0	58.945205479452056	['2019-07-31T22:21:51.437774-05:00', '2019-07-31T22:21:51.437774-05:00']	['3709f5c3-8bce-56c2-9c55-2756e4ced30d', 'b0ad9250-bf04-544e-9cd7-b662617d7bc3']	['TCGA-AJ-A8CT_treatment_1', 'TCGA-AJ-A8CT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:23:34.039556-05:00', '']	01	Primary	bfe80d89-f6e6-4ec9-9d0a-8a46ed80082c	Primary Tumor	Not Reported	587.0	60.0	Unknown	67EF8128-8F99-4B19-9B64-9C5E5BD0786F	false	Solid Tissue	False	Tumor
TCGA-BG-A0VX-01A	6c2a0f37-49cd-4fd0-b126-58b35f9121df	Adenomas and Adenocarcinomas	6c2a0f37-49cd-4fd0-b126-58b35f9121df	TCGA-BG-A0VX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21425.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1043.0	21425.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21425.0	58.6986301369863	['2019-07-31T22:21:54.421465-05:00', '2019-07-31T22:21:54.421465-05:00']	['3324174b-2ec3-5bca-99dc-a6c1b0a53a2b', '647fc589-2820-52fb-a2d1-f38ccc26aa32']	['TCGA-BG-A0VX_treatment_1', 'TCGA-BG-A0VX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:23:36.453668-05:00', '']	01	Primary	5797d32b-e482-4af3-b043-ad84c84e0296	Primary Tumor	Not Reported	729.0	90.0	OCT	D0131F13-2BA5-4B20-8D3D-25743A258C06	true	Solid Tissue	False	Tumor
TCGA-AX-A2HK-01A	6fa99ae9-1d72-455e-938e-0ec0d240f5a3	Adenomas and Adenocarcinomas	6fa99ae9-1d72-455e-938e-0ec0d240f5a3	TCGA-AX-A2HK	Corpus uteri	Not Reported	white	female	not reported	Dead	77.0	-28316.0	1928.0	2005.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	90.0															Stage IIIC	No	0.0	not reported	Endometrium		28316.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28316.0	77.57808219178082	['2019-07-31T22:22:15.880206-05:00', '2019-07-31T22:22:15.880206-05:00']	['493c1d58-bfd7-5470-aaa1-93dc2d495af2', 'dd94fa65-56d6-572e-9e15-35e4d93507d3']	['TCGA-AX-A2HK_treatment_1', 'TCGA-AX-A2HK_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:23:53.488224-05:00', '']	01	Primary	ebe937b7-b2bf-45b9-8517-009e6f67b6de	Primary Tumor	Not Reported	2045.0	240.0	Unknown	DBC5CE66-3BC0-4A86-A53C-06DEF90A752B	false	Solid Tissue	False	Tumor
TCGA-A5-A0GA-01A	71fed998-8fac-4e6b-b38a-22c83e05e958	Adenomas and Adenocarcinomas	71fed998-8fac-4e6b-b38a-22c83e05e958	TCGA-A5-A0GA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	67.0	-24659.0	1939.0	2007.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH	543.0															Stage IIIC2	No	0.0	not reported	Endometrium		24659.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24659.0	67.55890410958904	['2019-07-31T22:22:33.881671-05:00', '2019-07-31T22:22:33.881671-05:00']	['6800d3ca-7360-516f-b096-8f940d648dd1', 'ac03b65f-d0a6-58ea-94c5-b90bfb3cf6aa']	['TCGA-A5-A0GA_treatment_1', 'TCGA-A5-A0GA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:24:08.339367-05:00', '']	01	Primary	5a40330f-9307-4584-9557-5d19f2357fcc	Primary Tumor	Not Reported	1312.0	320.0	OCT	36A4F391-2F46-4896-8E53-223202E42A38	true	Solid Tissue	False	Tumor
TCGA-BG-A0MO-01A	734ef97f-807c-480e-8df9-feaf041032d2	Adenomas and Adenocarcinomas	734ef97f-807c-480e-8df9-feaf041032d2	TCGA-BG-A0MO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23287.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1309.0	23287.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23287.0	63.8	['2019-07-31T22:22:36.904921-05:00', '2019-07-31T22:22:36.904921-05:00']	['016ad5f9-b42d-57d1-a484-9ca1fe1d355f', '1b233bee-34f2-552a-b0e1-5eb8ce1e039f']	['TCGA-BG-A0MO_treatment_1', 'TCGA-BG-A0MO_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:24:10.756113-05:00', '']	01	Primary	7582cbb9-42d3-496c-991d-d76bea4c434c	Primary Tumor	Not Reported	854.0	100.0	OCT	C120AC98-36D2-49AD-84A1-6EA168D2A2BA	true	Solid Tissue	False	Tumor
TCGA-D1-A17R-01A	73a0dd38-115d-48fb-b683-04aa5d612f2a	Adenomas and Adenocarcinomas	73a0dd38-115d-48fb-b683-04aa5d612f2a	TCGA-D1-A17R	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	58.0	-21382.0	1951.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	339.0															Stage IA	No	0.0	not reported	Endometrium		21382.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21382.0	58.58082191780822	['2019-07-31T22:22:40.158936-05:00', '2019-07-31T22:22:40.158936-05:00']	['5c57bd8f-8573-569b-81a6-b92af2efa9b8', '963c26af-280a-5ef2-9fec-70c2e18dcf3d']	['TCGA-D1-A17R_treatment', 'TCGA-D1-A17R_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:24:13.203962-05:00']	01	Primary	205de3e7-b078-4904-82c3-3d0f757d94a8	Primary Tumor	Not Reported	443.0	150.0	Unknown	51598364-A609-4EBC-8500-53042C9E79E9	false	Solid Tissue	False	Tumor
TCGA-EY-A54A-01A	75783dbe-e18c-4535-b9eb-2affd320e098	Adenomas and Adenocarcinomas	75783dbe-e18c-4535-b9eb-2affd320e098	TCGA-EY-A54A	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	67.0	-24822.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC2	No	0.0	not reported	Corpus uteri	447.0	24822.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.9	Corpus uteri	Not Reported	not reported	24822.0	68.0054794520548	['2019-07-31T22:22:54.619061-05:00', '2019-07-31T22:22:54.619061-05:00']	['696de390-33ae-5ab0-9d47-08c88bb73183', '71705968-3a24-5db0-8a48-2f04c84bc90c']	['TCGA-EY-A54A_treatment_1', 'TCGA-EY-A54A_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:24:25.206872-05:00', '']	01	Primary	6d890026-4221-471a-afa6-1118ed804f08	Primary Tumor	Not Reported	105.0	500.0	Unknown	E3C3D3B8-550A-4652-9B17-122BC64A437A	false	Solid Tissue	False	Tumor
TCGA-FI-A2D6-01A	787d313f-9255-4b93-8ac2-0aa8febb7909	Adenomas and Adenocarcinomas	787d313f-9255-4b93-8ac2-0aa8febb7909	TCGA-FI-A2D6	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	74.0	-27060.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH	767.0															Stage IB	No	0.0	not reported	Endometrium	273.0	27060.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27060.0	74.13698630136986	['2019-07-31T22:23:09.609327-05:00', '2019-07-31T22:23:09.609327-05:00']	['032537d8-6aed-5929-a8c7-0d4baaf8e538', 'ee1d6116-a08b-5168-ab3f-5f7a712205b0']	['TCGA-FI-A2D6_treatment', 'TCGA-FI-A2D6_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:24:37.220158-05:00']	01	Primary	08f6f51f-9c99-4581-8cda-bec9a5208ee8	Primary Tumor	Not Reported	641.0	70.0	OCT	829C7791-3872-4EAC-BEC2-6B849056A4B7	true	Solid Tissue	False	Tumor
TCGA-AX-A2HG-01A	7a2cf5ce-8317-4fff-946e-b9937afab815	Adenomas and Adenocarcinomas	7a2cf5ce-8317-4fff-946e-b9937afab815	TCGA-AX-A2HG	Corpus uteri	Not Reported	white	female	hispanic or latino	Alive	56.0	-20771.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	1163.0	20771.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20771.0	56.90684931506849	['2019-07-31T22:23:21.405857-05:00', '2019-07-31T22:23:21.405857-05:00']	['be30cb19-8b77-5966-9d16-2acff402db61', 'd6284cbf-4f23-588e-ae4f-6c96a6307f2d']	['TCGA-AX-A2HG_treatment', 'TCGA-AX-A2HG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:24:46.945790-05:00']	01	Primary	5e3d8501-5e81-443f-8b64-e02a0e0b3d1f	Primary Tumor	Not Reported	582.0	150.0	Unknown	EF863B73-4C80-42E6-8AAF-2EF72559212A	false	Solid Tissue	False	Tumor
TCGA-BS-A0TC-01A	7b7d2d2b-abe6-4f32-add0-3715096995d1	Adenomas and Adenocarcinomas	7b7d2d2b-abe6-4f32-add0-3715096995d1	TCGA-BS-A0TC	Corpus uteri	Not Reported	asian	female	not hispanic or latino	Alive	69.0	-25560.0	1935.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Fundus uteri	2602.0	25560.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.3	Fundus uteri	Not Reported	not reported	25560.0	70.02739726027397	['2019-07-31T22:23:27.479395-05:00', '2019-07-31T22:23:27.479395-05:00']	['94cbf165-19f0-56fc-908b-7050937cb943', 'e0185256-3f64-5696-88a4-99e5670fe16e']	['TCGA-BS-A0TC_treatment', 'TCGA-BS-A0TC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:24:51.792815-05:00']	01	Primary	c4c99327-b778-4e29-a111-75569ad38696	Primary Tumor	Not Reported	2227.0	120.0	Unknown	8AA64402-A062-410D-85B8-24DAD320916D	false	Solid Tissue	False	Tumor
TCGA-D1-A3DH-01A	7d22ff96-9249-46b3-9cfa-e40dc4ecebd6	Adenomas and Adenocarcinomas	7d22ff96-9249-46b3-9cfa-e40dc4ecebd6	TCGA-D1-A3DH	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	71.0	-25935.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	573.0	25935.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25935.0	71.05479452054794	['2019-07-31T22:23:33.835352-05:00', '2019-07-31T22:23:33.835352-05:00']	['220c598f-dc6c-51a9-9af0-a425354c824c', '2275e016-0860-5fd9-a236-4fe8d14ed7ea']	['TCGA-D1-A3DH_treatment_1', 'TCGA-D1-A3DH_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:24:56.521713-05:00', '']	01	Primary	5d130578-de0c-4336-92e6-02c6f11add92	Primary Tumor	Not Reported	43.0	150.0	OCT	C63CF985-CF78-42EE-A7A2-22083FED571D	true	Solid Tissue	False	Tumor
TCGA-D1-A17D-01A	7ddeddd1-b2ad-425f-94a2-9c476b959f2a	Adenomas and Adenocarcinomas	7ddeddd1-b2ad-425f-94a2-9c476b959f2a	TCGA-D1-A17D	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	58.0	-21441.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	926.0	21441.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21441.0	58.74246575342466	['2019-07-31T22:23:40.020518-05:00', '2019-07-31T22:23:40.020518-05:00']	['471289a1-110e-54d4-bcd2-a12d0f570ce8', '8935759e-cc41-5b31-8138-5db438299830']	['TCGA-D1-A17D_treatment_1', 'TCGA-D1-A17D_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:25:01.556581-05:00', '']	01	Primary	9ec5a25b-9ce1-4fde-9341-13da39bc74b0	Primary Tumor	Not Reported	541.0	160.0	Unknown	1042404C-E963-4620-BC02-E33751FDB96C	false	Solid Tissue	False	Tumor
TCGA-D1-A16Q-01A	7f4f3aed-69af-421e-817b-b258dcc0bac5	Adenomas and Adenocarcinomas	7f4f3aed-69af-421e-817b-b258dcc0bac5	TCGA-D1-A16Q	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	54.0	-19873.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	324.0	19873.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19873.0	54.446575342465756	['2019-07-31T22:23:46.222520-05:00', '2019-07-31T22:23:46.222520-05:00']	['5574349a-686f-537c-9483-a854bef571e7', '98a34762-ec10-51e9-b12b-489454074c15']	['TCGA-D1-A16Q_treatment_1', 'TCGA-D1-A16Q_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:25:06.131209-05:00', '']	01	Primary	bfe3da05-506e-4837-ac72-a285fe079c58	Primary Tumor	Not Reported	136.0	240.0	Unknown	60635568-D27E-4C72-BFF2-238CF2992925	false	Solid Tissue	False	Tumor
TCGA-B5-A1MZ-01A	838fcc2b-48b4-49dd-b8fc-ff27bbd16b17	Adenomas and Adenocarcinomas	838fcc2b-48b4-49dd-b8fc-ff27bbd16b17	TCGA-B5-A1MZ	Corpus uteri	Not Reported	white	female	not reported	Alive	54.0	-19955.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1598.0	19955.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19955.0	54.67123287671233	['2019-07-31T22:23:58.558351-05:00', '2019-07-31T22:23:58.558351-05:00']	['4ed38f78-56f5-58a6-aa3f-fbb6bc159cfa', 'b187910f-eff1-59c2-ad9a-0b9551241194']	['TCGA-B5-A1MZ_treatment_1', 'TCGA-B5-A1MZ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:25:16.255069-05:00', '']	01	Primary	cba2dcfb-5988-435c-99c1-445a36c6082f	Primary Tumor	Not Reported	114.0	130.0	OCT	071A53F9-6E40-4402-8353-BB963AFE5C33	true	Solid Tissue	False	Tumor
TCGA-A5-A2K2-01A	840ff11f-f991-4e1b-861b-98d236d573d3	Cystic, Mucinous and Serous Neoplasms	840ff11f-f991-4e1b-861b-98d236d573d3	TCGA-A5-A2K2	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28456.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	3595.0	28456.0	Serous cystadenocarcinoma, NOS	no	2003.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	28456.0	77.96164383561644	['2019-07-31T22:24:04.663108-05:00', '2019-07-31T22:24:04.663108-05:00']	['8beedc0b-23ac-57da-8692-ff5b07799c86', '9606e85e-df21-5af0-81bd-342c0ba5853c']	['TCGA-A5-A2K2_treatment', 'TCGA-A5-A2K2_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:25:21.084493-05:00']	01	Primary	8494b10e-a989-49fa-860c-2b8f0e4f93d9	Primary Tumor	Not Reported	2812.0	70.0	OCT	D8065FA8-DC0E-4F1C-8FA4-5D8A567AC24C	true	Solid Tissue	False	Tumor
TCGA-5S-A9Q8-01A	8751429b-4a11-451e-b978-dc9e9db0eb36	Adenomas and Adenocarcinomas	8751429b-4a11-451e-b978-dc9e9db0eb36	TCGA-5S-A9Q8	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	51.0	-18785.0	1962.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	9f66a0e0-7425-5bdd-bf78-3952a44d6328	5S	Holy Cross	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	313.0	18785.0	Endometrioid adenocarcinoma, NOS	no	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	18785.0	51.465753424657535	['2019-07-31T22:24:16.948620-05:00', '2019-07-31T22:24:16.948620-05:00']	['0e3912e1-87b3-5b83-9c4a-37e41c0a218a', '610bbc3f-3888-5d71-b2ed-29af76ac3d7b']	['TCGA-5S-A9Q8_treatment_1', 'TCGA-5S-A9Q8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:25:31.379305-05:00', '']	01	Primary	e5004b9a-a75d-4908-924f-d46e53d33e6b	Primary Tumor	Not Reported	103.0	690.0	OCT	3F89A501-BE16-4E08-9846-41B4BBDDFCF9	true	Solid Tissue	False	Tumor
TCGA-AX-A05W-01A	87e44856-eb9a-475f-96b1-047b7f77b0da	Adenomas and Adenocarcinomas	87e44856-eb9a-475f-96b1-047b7f77b0da	TCGA-AX-A05W	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22200.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIB	No	0.0	not reported	Endometrium	2450.0	22200.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22200.0	60.821917808219176	['2019-07-31T22:24:20.018841-05:00', '2019-07-31T22:24:20.018841-05:00']	['9c3acc2f-b852-5345-876b-4559f9c22245', 'be3c981b-54f6-5287-9e05-aad09e92a735']	['TCGA-AX-A05W_treatment_1', 'TCGA-AX-A05W_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:25:33.874699-05:00', '']	01	Primary	dbdf67e1-e4c2-499c-b701-f1f322242e84	Primary Tumor	Not Reported	1935.0	210.0	Unknown	4C960E79-D109-4C4C-B99F-F73D4DD73B40	false	Solid Tissue	False	Tumor
TCGA-AJ-A3IA-01A	8a0a58a0-5c12-4366-af43-4fd25f8ff454	Cystic, Mucinous and Serous Neoplasms	8a0a58a0-5c12-4366-af43-4fd25f8ff454	TCGA-AJ-A3IA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28470.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	Not Reported	0.0	not reported	Endometrium	633.0	28470.0	Serous cystadenocarcinoma, NOS	yes	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	28470.0	78.0	['2019-07-31T22:24:26.210298-05:00', '2019-07-31T22:24:26.210298-05:00']	['b774bff9-6bb0-5134-8bbe-161997a63981', 'e48b4dce-333c-5863-a705-8dd028cd06f7']	['TCGA-AJ-A3IA_treatment', 'TCGA-AJ-A3IA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:25:38.962916-05:00']	01	Primary	0fb7ceae-cf5d-4e98-8ad8-114947b6e7e3	Primary Tumor	Not Reported	66.0	35.0	Unknown	883486F6-0EDF-4BBC-8412-67F31351427B	false	Solid Tissue	False	Tumor
TCGA-D1-A16V-01A	8b19c8ac-68e6-4dc8-aec9-1556e62ca20f	Adenomas and Adenocarcinomas	8b19c8ac-68e6-4dc8-aec9-1556e62ca20f	TCGA-D1-A16V	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	78.0	-28635.0	1931.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	120.0															Stage IIIC	No	0.0	not reported	Endometrium	43.0	28635.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28635.0	78.45205479452055	['2019-07-31T22:24:34.678810-05:00', '2019-07-31T22:24:34.678810-05:00']	['0b5906f7-d802-5f84-813c-0e371f8ace82', '47242ef7-fa76-56e4-b010-83aeb7b84913']	['TCGA-D1-A16V_treatment', 'TCGA-D1-A16V_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:25:47.589666-05:00']	01	Primary	67d0886e-54be-4771-aee7-63adf4a475b7	Primary Tumor	Not Reported	609.0	410.0	Unknown	92EA83B6-8041-4449-BAE6-5060C32966D0	false	Solid Tissue	False	Tumor
TCGA-AX-A3FT-01A	8b4cf993-1e16-4009-a37f-a629528b7d7e	Adenomas and Adenocarcinomas	8b4cf993-1e16-4009-a37f-a629528b7d7e	TCGA-AX-A3FT	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23543.0	1946.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	6.0	23543.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23543.0	64.5013698630137	['2019-07-31T22:24:37.665981-05:00', '2019-07-31T22:24:37.665981-05:00']	['88f5a942-2e80-5429-a4eb-48ba788ed706', 'a813bcfb-5f99-5ff2-8f53-8f6842292720']	['TCGA-AX-A3FT_treatment_1', 'TCGA-AX-A3FT_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:25:50.000568-05:00', '']	01	Primary	6176a2e7-9c0b-4a9c-b8d6-cf669419959d	Primary Tumor	Not Reported	524.0	110.0	Unknown	EF16D53F-14A2-4127-B5F7-F318EC60C5C0	false	Solid Tissue	False	Tumor
TCGA-BG-A0M0-01A	8bf0b156-6eb4-45e8-9cbb-0979efbea898	Adenomas and Adenocarcinomas	8bf0b156-6eb4-45e8-9cbb-0979efbea898	TCGA-BG-A0M0	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	66.0	-24427.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	588.0	24427.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24427.0	66.92328767123287	['2019-07-31T22:24:47.152057-05:00', '2019-07-31T22:24:47.152057-05:00']	['001809bd-11a9-5bdc-8abd-682e42f4297a', '7d8bfce8-0793-5bda-9687-0123f0f24a37']	['TCGA-BG-A0M0_treatment', 'TCGA-BG-A0M0_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:25:57.379385-05:00']	01	Primary	e3f599db-19cf-4086-8e5d-d3527119120f	Primary Tumor	Not Reported	147.0	800.0	OCT	BDDACDFC-E3D4-4EA7-9591-DB6371713E8E	true	Solid Tissue	False	Tumor
TCGA-AX-A3FS-01A	8c6b9b54-58eb-4d5f-b8a9-8007163db457	Adenomas and Adenocarcinomas	8c6b9b54-58eb-4d5f-b8a9-8007163db457	TCGA-AX-A3FS	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	82.0	-30102.0	1928.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	7.0	30102.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30102.0	82.47123287671234	['2019-07-31T22:24:50.172952-05:00', '2019-07-31T22:24:50.172952-05:00']	['0bbc2e25-f483-5390-9aec-edd9531f8305', '918cebbf-03fe-54c7-bbff-22c8c8054d9e']	['TCGA-AX-A3FS_treatment', 'TCGA-AX-A3FS_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['', '2019-04-28T14:25:59.885233-05:00']	01	Primary	272d64f9-0b4b-4136-adff-66c5401fc1d2	Primary Tumor	Not Reported	609.0	80.0	Unknown	1AEA9AC0-3B22-4819-9542-1F6A6AD474BC	false	Solid Tissue	False	Tumor
TCGA-EO-A3AU-01A	8e225f5f-49c1-4a39-a8b5-41fea6a79819	Adenomas and Adenocarcinomas	8e225f5f-49c1-4a39-a8b5-41fea6a79819	TCGA-EO-A3AU	Corpus uteri	Not Reported	not reported	female	not reported	Alive	72.0	-26406.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	1543.0	26406.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26406.0	72.34520547945205	['2019-07-31T22:24:53.214836-05:00', '2019-07-31T22:24:53.214836-05:00']	['6db1164d-c40a-59f7-85d8-ff4f2cd5930c', 'a93700a8-f34c-5c2d-88c8-7920e2cf7d45']	['TCGA-EO-A3AU_treatment_1', 'TCGA-EO-A3AU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:26:02.428246-05:00', '']	01	Primary	c9d250d6-ab13-4feb-a747-aa3ebfa43503	Primary Tumor	Not Reported	393.0	130.0	Unknown	B1D13355-6346-4FA4-950A-84114901515C	false	Solid Tissue	False	Tumor
TCGA-EO-A22S-11A	8f2d3495-8ce7-4f6e-a41d-8cfae5750937	Adenomas and Adenocarcinomas	8f2d3495-8ce7-4f6e-a41d-8cfae5750937	TCGA-EO-A22S	Corpus uteri	Not Reported	not reported	female	not reported	Alive	58.0	-21328.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1872.0	21328.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21328.0	58.43287671232877	['2019-07-31T22:25:02.345841-05:00', '2019-07-31T22:25:02.345841-05:00']	['654d80b8-017c-5e00-8c16-3c549dffbcc2', '6c44fbd4-5976-5484-9e81-2817197df8de']	['TCGA-EO-A22S_treatment_1', 'TCGA-EO-A22S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:26:09.848205-05:00', '']	11	Not Applicable	30d3a824-a35a-4c47-91eb-ad2217f390de	Solid Tissue Normal	Not Reported	1052.0	80.0	Unknown		false	Solid Tissue	False	Normal
TCGA-EO-A22S-01A	8f2d3495-8ce7-4f6e-a41d-8cfae5750937	Adenomas and Adenocarcinomas	8f2d3495-8ce7-4f6e-a41d-8cfae5750937	TCGA-EO-A22S	Corpus uteri	Not Reported	not reported	female	not reported	Alive	58.0	-21328.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1872.0	21328.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	21328.0	58.43287671232877	['2019-07-31T22:25:02.345841-05:00', '2019-07-31T22:25:02.345841-05:00']	['654d80b8-017c-5e00-8c16-3c549dffbcc2', '6c44fbd4-5976-5484-9e81-2817197df8de']	['TCGA-EO-A22S_treatment_1', 'TCGA-EO-A22S_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:26:09.848205-05:00', '']	01	Primary	745f2cc5-f0f1-49d1-899e-72b823802b08	Primary Tumor	Not Reported	919.0	100.0	Unknown	DB26485C-BE5C-4874-B79D-7FCFFFF70C4E	false	Solid Tissue	False	Tumor
TCGA-AJ-A2QL-11A	9002fc6c-26de-4b8f-8985-a4814cd3daf7	Adenomas and Adenocarcinomas	9002fc6c-26de-4b8f-8985-a4814cd3daf7	TCGA-AJ-A2QL	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22057.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	602.0	22057.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22057.0	60.43013698630137	['2019-07-31T22:25:08.108625-05:00', '2019-07-31T22:25:08.108625-05:00']	['4f97ab32-906a-5607-a8e1-30b37a12a264', 'e218b1cf-29c0-5021-8b2f-c6108b4ec008']	['TCGA-AJ-A2QL_treatment', 'TCGA-AJ-A2QL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:26:14.784097-05:00']	11	Not Applicable	635f5364-1934-4130-9641-a1a6caff2e59	Solid Tissue Normal	Not Reported	138.0	100.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AJ-A2QL-01A	9002fc6c-26de-4b8f-8985-a4814cd3daf7	Adenomas and Adenocarcinomas	9002fc6c-26de-4b8f-8985-a4814cd3daf7	TCGA-AJ-A2QL	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22057.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	73c4efaa-5d6f-5df9-9179-2b8c56cf6153	AJ	International Genomics Conosrtium	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC1	No	0.0	not reported	Endometrium	602.0	22057.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22057.0	60.43013698630137	['2019-07-31T22:25:08.108625-05:00', '2019-07-31T22:25:08.108625-05:00']	['4f97ab32-906a-5607-a8e1-30b37a12a264', 'e218b1cf-29c0-5021-8b2f-c6108b4ec008']	['TCGA-AJ-A2QL_treatment', 'TCGA-AJ-A2QL_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:26:14.784097-05:00']	01	Primary	9884f8d6-3a49-4613-aa45-855be115e01b	Primary Tumor	Not Reported	138.0	170.0	Unknown	4AD4E8D1-5DA7-4134-A0C0-0AF1C3A8BCD4	false	Solid Tissue	False	Tumor
TCGA-DF-A2KU-01A	95eefb47-3f96-4a6d-8773-4d22843f0a6a	Adenomas and Adenocarcinomas	95eefb47-3f96-4a6d-8773-4d22843f0a6a	TCGA-DF-A2KU	Corpus uteri	Not Reported	not reported	female	not reported	Alive					['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	bd439172-ab1d-57cc-a1ee-7282ceebd41a	DF	Ontario Institute for Cancer Research	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No		not reported	Endometrium	3067.0		Endometrioid adenocarcinoma, NOS	no		No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported			['2019-07-31T22:25:40.740348-05:00', '2019-07-31T22:25:40.740348-05:00']	['3a46c7d6-8b71-5290-b6e6-7d1087707645', 'e4f76860-c1f8-5f10-b979-503d75caba06']	['TCGA-DF-A2KU_treatment_1', 'TCGA-DF-A2KU_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:26:42.045336-05:00', '']	01	Primary	341b9ad3-2aa4-4e8c-9a41-1915ab6cdba8	Primary Tumor	Not Reported		380.0	Unknown	6F425E9F-E02A-4EFB-A0DE-00BF09D9BB98	false	Solid Tissue	False	Tumor
TCGA-D1-A169-01A	9a599f57-0e8d-4e1f-a181-791f5fdeadb7	Adenomas and Adenocarcinomas	9a599f57-0e8d-4e1f-a181-791f5fdeadb7	TCGA-D1-A169	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	63.0	-23238.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IV	No	0.0	not reported	Endometrium	1135.0	23238.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23238.0	63.66575342465753	['2019-07-31T22:25:52.922949-05:00', '2019-07-31T22:25:52.922949-05:00']	['60931503-e023-5d1e-9134-99aad0add33b', 'a4461901-15be-5e89-932b-23db942c34f5']	['TCGA-D1-A169_treatment_1', 'TCGA-D1-A169_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:26:51.822885-05:00', '']	01	Primary	9b36f264-55c3-4e08-a151-4b356871520c	Primary Tumor	Not Reported	800.0	180.0	Unknown	F7B4C0DC-2259-4A0A-81D3-E145EFA91279	false	Solid Tissue	False	Tumor
TCGA-AP-A0L8-01A	9aa8c2b4-db32-4899-bf0c-d578cb175e90	Cystic, Mucinous and Serous Neoplasms	9aa8c2b4-db32-4899-bf0c-d578cb175e90	TCGA-AP-A0L8	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	70.0	-25733.0	1930.0	2004.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	1484.0															Stage IIIC2	No	0.0	not reported	Endometrium		25733.0	Serous cystadenocarcinoma, NOS	no	2000.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25733.0	70.5013698630137	['2019-07-31T22:25:56.066376-05:00', '2019-07-31T22:25:56.066376-05:00']	['250dcdf9-601d-5a12-a9b3-04a45ab42968', 'd602a5df-060d-5d39-b2af-cd35f774b133']	['TCGA-AP-A0L8_treatment_1', 'TCGA-AP-A0L8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:26:54.669728-05:00', '']	01	Primary	d1a7a58f-7a35-4a94-a337-051ae56ded00	Primary Tumor	Not Reported	3510.0	110.0	OCT	A708C154-A635-4423-A1A0-BB1FC23D3613	true	Solid Tissue	False	Tumor
TCGA-A5-A3LP-01A	9becf65d-01f2-4e84-a256-106002e22526	Cystic, Mucinous and Serous Neoplasms	9becf65d-01f2-4e84-a256-106002e22526	TCGA-A5-A3LP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	74.0	-27131.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	455.0	27131.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27131.0	74.33150684931506	['2019-07-31T22:26:04.949840-05:00', '2019-07-31T22:26:04.949840-05:00']	['63fe62b7-1e26-5fc5-a9cb-becaeac66d7b', '732e0c74-cfc6-563d-b1e6-02c281b20dde']	['TCGA-A5-A3LP_treatment', 'TCGA-A5-A3LP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:27:01.531272-05:00']	01	Primary	6d328d5d-7225-437a-afb1-d293d2d45866	Primary Tumor	Not Reported	111.0	150.0	OCT	A20CDB07-D90C-42B7-AE0A-254E27C6153B	true	Solid Tissue	False	Tumor
TCGA-BG-A0MG-01A	9cde90c8-2be0-4328-a032-ff1dc19e66fd	Adenomas and Adenocarcinomas	9cde90c8-2be0-4328-a032-ff1dc19e66fd	TCGA-BG-A0MG	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	73.0	-26957.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1477.0	26957.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26957.0	73.85479452054794	['2019-07-31T22:26:10.924499-05:00', '2019-07-31T22:26:10.924499-05:00']	['72656f0e-d49d-5f08-82b1-99989496ddbe', 'aadfd0ed-c3cb-5f7e-8f34-efe90b8a1237']	['TCGA-BG-A0MG_treatment', 'TCGA-BG-A0MG_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:27:06.253529-05:00']	01	Primary	96b6826d-8a4c-45f5-8cd3-b5988aa5fd0e	Primary Tumor	Not Reported	980.0	240.0	OCT	65A0B84A-72AD-42E2-B0DB-DA8D2BD54E9B	true	Solid Tissue	False	Tumor
TCGA-D1-A101-01A	9da5ecd0-a287-4e67-84b6-af9077a98009	Adenomas and Adenocarcinomas	9da5ecd0-a287-4e67-84b6-af9077a98009	TCGA-D1-A101	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	60.0	-22078.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	53.0	22078.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22078.0	60.487671232876714	['2019-07-31T22:26:17.279538-05:00', '2019-07-31T22:26:17.279538-05:00']	['1a69ff9e-1d7b-5c93-9646-47a367eb1a29', '65b1f9ae-5407-5241-a34f-244da7fe314b']	['TCGA-D1-A101_treatment', 'TCGA-D1-A101_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:27:11.023396-05:00']	01	Primary	34fcec04-7c8f-4964-83eb-c7f81c475c79	Primary Tumor	Not Reported	349.0	150.0	Unknown	2D6287C8-9C22-4046-8F14-3886DDE62695	false	Solid Tissue	False	Tumor
TCGA-BG-A3PP-11A	9f92080f-f6e0-42db-a02b-b3069664f6d0	Cystic, Mucinous and Serous Neoplasms	9f92080f-f6e0-42db-a02b-b3069664f6d0	TCGA-BG-A3PP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	82.0	-30227.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	681.0	30227.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30227.0	82.81369863013698	['2019-07-31T22:26:23.457121-05:00', '2019-07-31T22:26:23.457121-05:00']	['1b785a2b-d020-5e7f-a5b1-e963b7d53daf', 'b7e48094-6fa6-509e-b289-82ec1f865547']	['TCGA-BG-A3PP_treatment_1', 'TCGA-BG-A3PP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:27:16.019437-05:00', '']	11	Not Applicable	65b6c8b0-ae4a-410a-8e35-f7d8abeecfc6	Solid Tissue Normal	Not Reported	143.0	190.0	OCT		true	Solid Tissue	False	Normal
TCGA-BG-A3PP-01A	9f92080f-f6e0-42db-a02b-b3069664f6d0	Cystic, Mucinous and Serous Neoplasms	9f92080f-f6e0-42db-a02b-b3069664f6d0	TCGA-BG-A3PP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	82.0	-30227.0	1929.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	No	0.0	not reported	Endometrium	681.0	30227.0	Serous cystadenocarcinoma, NOS	no	2011.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30227.0	82.81369863013698	['2019-07-31T22:26:23.457121-05:00', '2019-07-31T22:26:23.457121-05:00']	['1b785a2b-d020-5e7f-a5b1-e963b7d53daf', 'b7e48094-6fa6-509e-b289-82ec1f865547']	['TCGA-BG-A3PP_treatment_1', 'TCGA-BG-A3PP_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:27:16.019437-05:00', '']	01	Primary	b3533e99-9a5d-46a5-8d7e-d1b6192d5edd	Primary Tumor	Not Reported	143.0	320.0	OCT	728D12CF-B846-49B7-8B16-463460CAD5C0	true	Solid Tissue	False	Tumor
TCGA-AP-A0LO-01A	a081da6f-51f3-4555-a6b8-736f8c6cda39	Adenomas and Adenocarcinomas	a081da6f-51f3-4555-a6b8-736f8c6cda39	TCGA-AP-A0LO	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	45.0	-16493.0	1960.0	2007.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	1016.0															Stage IA	No	0.0	not reported	Endometrium		16493.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	16493.0	45.18630136986302	['2019-07-31T22:26:32.164046-05:00', '2019-07-31T22:26:32.164046-05:00']	['55c9dfc2-0933-5e78-9e9d-e719a12cafb9', 'c87aa114-38ac-5726-99d7-070550b8559a']	['TCGA-AP-A0LO_treatment', 'TCGA-AP-A0LO_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:23.322956-05:00']	01	Primary	9846d8f3-5b22-48e9-b972-a0fe9f509fb4	Primary Tumor	Not Reported	1894.0	140.0	OCT	DC0116C2-788E-46F5-A4AC-115D857C1F85	true	Solid Tissue	False	Tumor
TCGA-EY-A72D-01A	a12df3d7-c560-4e7d-a482-1025a6e5b465	Adenomas and Adenocarcinomas	a12df3d7-c560-4e7d-a482-1025a6e5b465	TCGA-EY-A72D	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	87.0	-31818.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage II	Not Reported	0.0	not reported	Endometrium	179.0	31818.0	Endometrioid adenocarcinoma, NOS	yes	2013.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	31818.0	87.17260273972603	['2019-07-31T22:26:35.270776-05:00', '2019-07-31T22:26:35.270776-05:00']	['49732276-e5ab-5fea-98fe-dfc0c5f4d4cc', '9f7a76e3-a665-5365-8f96-984ec6966dee']	['TCGA-EY-A72D_treatment', 'TCGA-EY-A72D_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:27:25.624046-05:00']	01	Primary	f661c070-cff5-4fdc-bb26-9f1a3ef2592a	Primary Tumor	Not Reported	120.0	340.0	Unknown	6F2C081B-8D36-4DB4-9846-67DC1D3964E0	false	Solid Tissue	False	Tumor
TCGA-AX-A2H7-01A	a1780432-860e-4bff-9b66-a1e25c0076fe	Adenomas and Adenocarcinomas	a1780432-860e-4bff-9b66-a1e25c0076fe	TCGA-AX-A2H7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	87.0	-32100.0	1921.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	772.0															Stage IC	No	0.0	not reported	Endometrium	772.0	32100.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	32100.0	87.94520547945206	['2019-07-31T22:26:38.117792-05:00', '2019-07-31T22:26:38.117792-05:00']	['315b14aa-f4e7-5df3-9968-9be063f71479', '4aff596f-5bba-566b-9f7b-c597e18c154a']	['TCGA-AX-A2H7_treatment', 'TCGA-AX-A2H7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:28.431958-05:00']	01	Primary	7077ce1b-d224-4313-9d71-1a3eee54ffaf	Primary Tumor	Not Reported	951.0	160.0	Unknown	76630DF8-2D08-4CF8-8B07-ACCE872B3ED1	false	Solid Tissue	False	Tumor
TCGA-AX-A2H7-11A	a1780432-860e-4bff-9b66-a1e25c0076fe	Adenomas and Adenocarcinomas	a1780432-860e-4bff-9b66-a1e25c0076fe	TCGA-AX-A2H7	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	87.0	-32100.0	1921.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	772.0															Stage IC	No	0.0	not reported	Endometrium	772.0	32100.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	32100.0	87.94520547945206	['2019-07-31T22:26:38.117792-05:00', '2019-07-31T22:26:38.117792-05:00']	['315b14aa-f4e7-5df3-9968-9be063f71479', '4aff596f-5bba-566b-9f7b-c597e18c154a']	['TCGA-AX-A2H7_treatment', 'TCGA-AX-A2H7_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:28.431958-05:00']	11	Not Applicable	e8858e3a-f7e0-4e71-875f-6273e5cb169d	Solid Tissue Normal	Not Reported	951.0	140.0	Unknown		false	Solid Tissue	False	Normal
TCGA-EY-A1GE-01A	a28beb70-d309-45b8-a2ba-40558f3c8f4f	Adenomas and Adenocarcinomas	a28beb70-d309-45b8-a2ba-40558f3c8f4f	TCGA-EY-A1GE	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	67.0	-24667.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	741.0	24667.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24667.0	67.58082191780822	['2019-07-31T22:26:44.049014-05:00', '2019-07-31T22:26:44.049014-05:00']	['16fba6c0-2e12-599b-b807-b811c2666eda', 'db85fdb2-ef42-5d45-9d98-f3bb3ffccbb5']	['TCGA-EY-A1GE_treatment_1', 'TCGA-EY-A1GE_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:27:33.056171-05:00', '']	01	Primary	8673d69f-530e-4c33-ba96-25cd44adea7b	Primary Tumor	Not Reported	506.0	410.0	Unknown	432813D0-4B52-4941-940C-5725BCE4211A	false	Solid Tissue	False	Tumor
TCGA-A5-A0GN-01A	a2a2dbda-d10c-49c4-86a8-61baf6160cda	Adenomas and Adenocarcinomas	a2a2dbda-d10c-49c4-86a8-61baf6160cda	TCGA-A5-A0GN	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	65.0	-24020.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1841.0	24020.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24020.0	65.8082191780822	['2019-07-31T22:26:47.166616-05:00', '2019-07-31T22:26:47.166616-05:00']	['ca7cd085-c216-51aa-b48b-5ade175dccfa', 'cdf39145-85f0-5072-856b-054cf6fa7a05']	['TCGA-A5-A0GN_treatment', 'TCGA-A5-A0GN_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:27:35.314844-05:00']	01	Primary	f6f9c40b-1e58-47a3-b518-9694fb5ff2cf	Primary Tumor	Not Reported	1354.0	340.0	OCT	7A76BDC7-62D9-4A8D-AAEF-CECF9F819D58	true	Solid Tissue	False	Tumor
TCGA-AP-A5FX-01A	a633d316-59a4-45ae-8bf8-135cfbd27656	Cystic, Mucinous and Serous Neoplasms	a633d316-59a4-45ae-8bf8-135cfbd27656	TCGA-AP-A5FX	Corpus uteri	Not Reported	black or african american	female	not reported	Dead	68.0	-25063.0	1942.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	1099.0															Stage IIIC1	No	0.0	not reported	Endometrium	1026.0	25063.0	Serous cystadenocarcinoma, NOS	no	2010.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25063.0	68.66575342465754	['2019-07-31T22:27:08.755910-05:00', '2019-07-31T22:27:08.755910-05:00']	['077ecaa8-a216-5b2e-bf4a-51460727e665', '59d9ccb0-1130-5204-8080-95ad631ca47a']	['TCGA-AP-A5FX_treatment_1', 'TCGA-AP-A5FX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:27:52.155877-05:00', '']	01	Primary	b37ba34a-5f2e-46a9-9334-79e6782d40dc	Primary Tumor	Not Reported	878.0	300.0	OCT	AF38CD86-2F5A-46A3-903A-81A8067F2456	true	Solid Tissue	False	Tumor
TCGA-B5-A0JR-01A	a766d113-bc3f-4448-a4e5-f391fb0c0e22	Adenomas and Adenocarcinomas	a766d113-bc3f-4448-a4e5-f391fb0c0e22	TCGA-B5-A0JR	Corpus uteri	Not Reported	white	female	not reported	Alive	73.0	-26814.0	1933.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1731.0	26814.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26814.0	73.46301369863014	['2019-07-31T22:27:14.776445-05:00', '2019-07-31T22:27:14.776445-05:00']	['c71ed997-6f9d-52fa-9da6-8ead75c82d5e', 'd525ff07-ba20-515e-a548-eba05bd605cc']	['TCGA-B5-A0JR_treatment_1', 'TCGA-B5-A0JR_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:27:57.193887-05:00', '']	01	Primary	07381a09-5cbd-4744-86ec-41a81e470204	Primary Tumor	Not Reported	1407.0	100.0	OCT	B3CF4DE2-8755-4585-92C5-F8EE350C1C50	true	Solid Tissue	False	Tumor
TCGA-BS-A0UM-01A	a7c565fc-c711-4b63-9549-4cd74d1f57c2	Adenomas and Adenocarcinomas	a7c565fc-c711-4b63-9549-4cd74d1f57c2	TCGA-BS-A0UM	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	64.0	-23400.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2644.0	23400.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23400.0	64.10958904109589	['2019-07-31T22:27:20.873781-05:00', '2019-07-31T22:27:20.873781-05:00']	['a3b8a104-e7ae-5ca8-a261-a1af91f2cb9c', 'f86d765a-e914-554f-8902-7c44d38b72c0']	['TCGA-BS-A0UM_treatment_1', 'TCGA-BS-A0UM_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:28:02.453518-05:00', '']	01	Primary	6f70f18e-5c53-4f1f-a63d-62bd27039b8d	Primary Tumor	Not Reported	2072.0	90.0	Unknown	97354B28-9E9A-4DBD-B0C7-79C1165AD1CA	false	Solid Tissue	False	Tumor
TCGA-EY-A1GX-01A	a7fd6522-8953-461f-9e5f-fdeb7d180d46	Adenomas and Adenocarcinomas	a7fd6522-8953-461f-9e5f-fdeb7d180d46	TCGA-EY-A1GX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	76.0	-27962.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	1127.0															Stage IIIA	No	0.0	not reported	Endometrium	197.0	27962.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27962.0	76.6082191780822	['2019-07-31T22:27:26.694400-05:00', '2019-07-31T22:27:26.694400-05:00']	['0e070553-66a4-57a2-83a2-7f790e72568a', '2e803209-934e-5057-ac22-b2e4f59b52c9']	['TCGA-EY-A1GX_treatment_1', 'TCGA-EY-A1GX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:28:07.058293-05:00', '']	01	Primary	a6a446ff-6dcf-4311-ac05-afb34fcb19a7	Primary Tumor	Not Reported	172.0	370.0	Unknown	4AD600AE-7CE0-4BBA-B4FC-0EB8C460502B	false	Solid Tissue	False	Tumor
TCGA-AX-A3GB-01A	aa3ad7c0-37cf-4337-945e-cefeee801bbb	Adenomas and Adenocarcinomas	aa3ad7c0-37cf-4337-945e-cefeee801bbb	TCGA-AX-A3GB	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	73.0	-26724.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	440.0	26724.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26724.0	73.21643835616439	['2019-07-31T22:27:50.963238-05:00', '2019-07-31T22:27:50.963238-05:00']	['06f55a96-ffcd-55c9-8436-f28ab96a839c', 'a33154cb-f4bd-562c-9e08-1ea9485a4785']	['TCGA-AX-A3GB_treatment', 'TCGA-AX-A3GB_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:28:26.604053-05:00']	01	Primary	b473b052-e1f3-40d2-bf32-7873263973c9	Primary Tumor	Not Reported	469.0	80.0	Unknown	50C8217A-6834-46E9-9727-5B6B3D37347D	false	Solid Tissue	False	Tumor
TCGA-BG-A0LX-01A	ac1d3946-fe6c-4bd8-b02c-638799cb0f67	Adenomas and Adenocarcinomas	ac1d3946-fe6c-4bd8-b02c-638799cb0f67	TCGA-BG-A0LX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	57.0	-20928.0	1953.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	614.0	20928.0	Endometrioid adenocarcinoma, NOS	no	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20928.0	57.33698630136986	['2019-07-31T22:28:00.906523-05:00', '2019-07-31T22:28:00.906523-05:00']	['11195dd5-186d-5161-962e-04a47c1ac589', '29470147-1ea9-5cf9-b1d5-a422a62d321c']	['TCGA-BG-A0LX_treatment_1', 'TCGA-BG-A0LX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:28:34.192518-05:00', '']	01	Primary	99cdf3a0-90dc-4992-b75a-11dd41928d43	Primary Tumor	Not Reported	120.0	250.0	OCT	4306E592-FA36-4AB9-BF84-7232CC599A64	true	Solid Tissue	False	Tumor
TCGA-B5-A3FA-01A	ac9ec63a-c3b6-4d0c-b1a9-7c72dbad456c	Adenomas and Adenocarcinomas	ac9ec63a-c3b6-4d0c-b1a9-7c72dbad456c	TCGA-B5-A3FA	Corpus uteri	Not Reported	white	female	not reported	Alive	73.0	-26850.0	1931.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	2929.0	26850.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26850.0	73.56164383561644	['2019-07-31T22:28:06.407353-05:00', '2019-07-31T22:28:06.407353-05:00']	['2176d6d4-66de-550d-8825-c9875f6900de', '8352456b-9961-58af-a2df-092254af1008']	['TCGA-B5-A3FA_treatment_1', 'TCGA-B5-A3FA_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:28:38.845261-05:00', '']	01	Primary	6ba7181f-0fd1-4158-ad8d-2ce4513ab53f	Primary Tumor	Not Reported	2679.0	510.0	OCT	1CA1DEC3-AD70-40F7-859B-24A27F47C904	true	Solid Tissue	False	Tumor
TCGA-AP-A1DQ-01A	ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0	Cystic, Mucinous and Serous Neoplasms	ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0	TCGA-AP-A1DQ	Corpus uteri	Not Reported	white	female	not reported	Dead	76.0	-27815.0	1932.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	1423.0															Stage IIIC1	No	0.0	not reported	Endometrium	1276.0	27815.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	27815.0	76.20547945205479	['2019-07-31T22:28:09.352078-05:00', '2019-07-31T22:28:09.352078-05:00']	['bc799570-1022-5ad9-9c7d-96f05e735efe', 'f2e53561-249f-5281-8cab-f2bc9a0a4e80']	['TCGA-AP-A1DQ_treatment', 'TCGA-AP-A1DQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:28:41.359772-05:00']	01	Primary	812485e9-fbb8-431b-8c49-d2f1a9391457	Primary Tumor	Not Reported	1074.0	100.0	OCT	F5983E58-F466-42CF-8905-B942D2BDF702	true	Solid Tissue	False	Tumor
TCGA-B5-A5OC-01A	ae8a4958-5407-4c01-93c3-8090862533ae	Adenomas and Adenocarcinomas	ae8a4958-5407-4c01-93c3-8090862533ae	TCGA-B5-A5OC	Corpus uteri	Not Reported	black or african american	female	not reported	Alive	71.0	-26109.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIB	No	0.0	not reported	Endometrium	1249.0	26109.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26109.0	71.53150684931506	['2019-07-31T22:28:17.906850-05:00', '2019-07-31T22:28:17.906850-05:00']	['480b91ab-910b-5bac-ad43-dca37c364126', 'fb1f947b-da02-5759-8e79-b9e190527071']	['TCGA-B5-A5OC_treatment', 'TCGA-B5-A5OC_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:28:49.124865-05:00']	01	Primary	69ac12c0-a986-44ac-8687-134ccb12ac21	Primary Tumor	Not Reported	732.0	750.0	OCT	2B1515A6-001A-46AF-952C-D393944DE57F	true	Solid Tissue	False	Tumor
TCGA-B5-A11Q-01A	af852215-5a4b-44b4-8e8e-b887dcb3cf8c	Adenomas and Adenocarcinomas	af852215-5a4b-44b4-8e8e-b887dcb3cf8c	TCGA-B5-A11Q	Corpus uteri	Not Reported	white	female	not reported	Alive	64.0	-23538.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7ba314ab-f65a-5ebf-8544-32eda22698a2	B5	Duke	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIA	No	0.0	not reported	Endometrium	976.0	23538.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23538.0	64.4876712328767	['2019-07-31T22:28:26.696583-05:00', '2019-07-31T22:28:26.696583-05:00']	['562755f1-7760-5339-a1a6-61e0ea997562', '9bc0ffaa-75f6-5a59-9284-3fb18baee886']	['TCGA-B5-A11Q_treatment_1', 'TCGA-B5-A11Q_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:28:56.812953-05:00', '']	01	Primary	c9b18c70-4d2b-4cd8-b0a8-a4226edab816	Primary Tumor	Not Reported	702.0	120.0	OCT	5117F490-9CE1-465F-BDF7-7B545B314703	true	Solid Tissue	False	Tumor
TCGA-AX-A2H4-11A	afa79b18-2ac6-4179-9c8c-5fa4d1d09a7e	Cystic, Mucinous and Serous Neoplasms	afa79b18-2ac6-4179-9c8c-5fa4d1d09a7e	TCGA-AX-A2H4	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	66.0	-24234.0	1940.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	916.0															Stage IIIA	No	0.0	not reported	Endometrium		24234.0	Serous cystadenocarcinoma, NOS	no	2006.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24234.0	66.3945205479452	['2019-07-31T22:28:29.735521-05:00', '2019-07-31T22:28:29.735521-05:00']	['034af59b-5a06-55d2-b842-413567ec649a', '06510c54-2987-512f-b350-c467ea164ee9']	['TCGA-AX-A2H4_treatment', 'TCGA-AX-A2H4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:28:59.175099-05:00']	11	Not Applicable	2dcab8f6-8f1d-4f26-a08a-8d80b56a2890	Solid Tissue Normal	Not Reported	1981.0	180.0	Unknown		false	Solid Tissue	False	Normal
TCGA-AX-A2H4-01A	afa79b18-2ac6-4179-9c8c-5fa4d1d09a7e	Cystic, Mucinous and Serous Neoplasms	afa79b18-2ac6-4179-9c8c-5fa4d1d09a7e	TCGA-AX-A2H4	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	66.0	-24234.0	1940.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH	916.0															Stage IIIA	No	0.0	not reported	Endometrium		24234.0	Serous cystadenocarcinoma, NOS	no	2006.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24234.0	66.3945205479452	['2019-07-31T22:28:29.735521-05:00', '2019-07-31T22:28:29.735521-05:00']	['034af59b-5a06-55d2-b842-413567ec649a', '06510c54-2987-512f-b350-c467ea164ee9']	['TCGA-AX-A2H4_treatment', 'TCGA-AX-A2H4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:28:59.175099-05:00']	01	Primary	47b7fd2a-3437-4991-8c7c-7ff6ba88ef86	Primary Tumor	Not Reported	1981.0	120.0	Unknown	5230A27B-4AA6-4ED9-90BB-98C6671E0B2E	false	Solid Tissue	False	Tumor
TCGA-A5-A0RA-01A	afd710b8-d172-4ac4-9973-e969db1ed231	Adenomas and Adenocarcinomas	afd710b8-d172-4ac4-9973-e969db1ed231	TCGA-A5-A0RA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-25060.0	1941.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	884.0	25060.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	25060.0	68.65753424657534	['2019-07-31T22:28:33.122269-05:00', '2019-07-31T22:28:33.122269-05:00']	['778d9f52-fdff-5736-b77a-bd0338744023', '9638559e-52a6-5423-abef-153337732e62']	['TCGA-A5-A0RA_treatment', 'TCGA-A5-A0RA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'no']	['', '2019-04-28T14:29:01.633608-05:00']	01	Primary	4ed231ee-0e54-4ac5-8278-1061ad3972a2	Primary Tumor	Not Reported	492.0	270.0	OCT	EB6E4309-9CE1-468A-A94B-907874BDE9DE	true	Solid Tissue	False	Tumor
TCGA-BS-A0UV-01A	b19425ab-a82f-4c2a-bf58-d1bd30511d74	Adenomas and Adenocarcinomas	b19425ab-a82f-4c2a-bf58-d1bd30511d74	TCGA-BS-A0UV	Corpus uteri	Not Reported	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	55.0	-20266.0	1950.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	2228.0	20266.0	Endometrioid adenocarcinoma, NOS	no	2005.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20266.0	55.52328767123288	['2019-07-31T22:28:38.834021-05:00', '2019-07-31T22:28:38.834021-05:00']	['372d402f-e76f-54fa-b08f-26f27fa10928', '9cb639e3-877c-5a07-a5a9-95b265b15172']	['TCGA-BS-A0UV_treatment_1', 'TCGA-BS-A0UV_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:29:06.617122-05:00', '']	01	Primary	30945527-528a-448e-8db4-2e0c31c9016d	Primary Tumor	Not Reported	1902.0	80.0	Unknown	9414D0B9-3126-42E9-8189-7C1EC38B2AAB	false	Solid Tissue	False	Tumor
TCGA-PG-A917-01A	b1b9173c-b370-4fe5-a263-c807e8a9709c	Adenomas and Adenocarcinomas	b1b9173c-b370-4fe5-a263-c807e8a9709c	TCGA-PG-A917	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	74.0	-27104.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	69bd8326-4904-56a0-8230-1615a777173b	PG	Montefiore Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	212.0	27104.0	Endometrioid adenocarcinoma, NOS	no	2012.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27104.0	74.25753424657535	['2019-07-31T22:28:41.941938-05:00', '2019-07-31T22:28:41.941938-05:00']	['1a4bcd82-3c46-554a-a446-15b5ff91cec3', '3762e1a0-4f16-5c10-8737-fb55808e11bb']	['TCGA-PG-A917_treatment', 'TCGA-PG-A917_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:29:08.983073-05:00']	01	Primary	4f849148-48bb-4e89-b0b9-f7ec6e85e0b9	Primary Tumor	Not Reported	583.0	390.0	OCT	9836008F-81F7-4029-9A28-10AB6021DFEA	true	Solid Tissue	False	Tumor
TCGA-AP-A0LJ-01A	b4a520ae-f259-48c8-823e-c10b9b8a133a	Adenomas and Adenocarcinomas	b4a520ae-f259-48c8-823e-c10b9b8a133a	TCGA-AP-A0LJ	Corpus uteri	Not Reported	white	female	not reported	Alive	42.0	-15577.0	1962.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1421.0	15577.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	15577.0	42.676712328767124	['2019-07-31T22:28:57.646896-05:00', '2019-07-31T22:28:57.646896-05:00']	['0aedb67e-1ddf-58bf-9679-462d6162fcf9', '0b8a4d89-5041-5499-afde-a3403664b1de']	['TCGA-AP-A0LJ_treatment', 'TCGA-AP-A0LJ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:29:21.262527-05:00']	01	Primary	be3ed392-4d9f-4eaf-8a56-d251846df4da	Primary Tumor	Not Reported	2290.0	680.0	OCT	859CBF70-D72E-4843-B3AA-6226B707AA2B	true	Solid Tissue	False	Tumor
TCGA-AX-A06J-01A	b6819b52-6f01-4011-9bd3-a1a00397e0c9	Adenomas and Adenocarcinomas	b6819b52-6f01-4011-9bd3-a1a00397e0c9	TCGA-AX-A06J	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	71.0	-26000.0	1937.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	913.0	26000.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26000.0	71.23287671232876	['2019-07-31T22:29:03.952206-05:00', '2019-07-31T22:29:03.952206-05:00']	['3d47647b-b5ab-5673-832f-36582f08741d', '6e1e7672-6e95-50c4-aa0e-59773bd344db']	['TCGA-AX-A06J_treatment', 'TCGA-AX-A06J_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:29:26.282443-05:00']	01	Primary	fa750459-78d8-4dd7-890b-45729bad112a	Primary Tumor	Not Reported	662.0	200.0	Unknown	553324CE-44B8-416F-B965-074CE5FF9834	false	Solid Tissue	False	Tumor
TCGA-BG-A0MI-01A	b8588e0f-aad6-4ded-845e-3cff67a48d8f	Adenomas and Adenocarcinomas	b8588e0f-aad6-4ded-845e-3cff67a48d8f	TCGA-BG-A0MI	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	83.0	-30334.0	1924.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH	714.0															Stage IA	No	0.0	not reported	Endometrium		30334.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30334.0	83.10684931506849	['2019-07-31T22:29:06.827425-05:00', '2019-07-31T22:29:06.827425-05:00']	['6122e669-a6d0-5f9b-89ab-8a52e1128891', 'b5283fc0-84d1-5672-a8b8-acb3714e2413']	['TCGA-BG-A0MI_treatment', 'TCGA-BG-A0MI_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:29:28.790700-05:00']	01	Primary	f030dae4-bd6f-4d0d-96e0-12b299057338	Primary Tumor	Not Reported	1014.0	100.0	OCT	1A0F6DD8-22A2-4A00-8AAD-04710DBBDFED	true	Solid Tissue	False	Tumor
TCGA-AX-A1C8-01A	bad34c92-1e64-4187-a0b4-061105fd13ba	Cystic, Mucinous and Serous Neoplasms	bad34c92-1e64-4187-a0b4-061105fd13ba	TCGA-AX-A1C8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	77.0	-28452.0	1932.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	776.0	28452.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	28452.0	77.95068493150686	['2019-07-31T22:29:12.589418-05:00', '2019-07-31T22:29:12.589418-05:00']	['076571f0-ffb7-5a0b-be2b-94b336210741', '0ed6b81a-29d4-591c-b16f-8c0a2196310d']	['TCGA-AX-A1C8_treatment_1', 'TCGA-AX-A1C8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'no']	['2019-04-28T14:29:33.924340-05:00', '']	01	Primary	83e4dfb0-f240-476b-bc25-f9f52c960af5	Primary Tumor	Not Reported	475.0	100.0	Unknown	5F0E78BA-B827-4DB6-99EB-5FA3D3598793	false	Solid Tissue	False	Tumor
TCGA-AP-A05A-01A	c350b53b-3c27-4b9e-8b57-d7b6a1205a1f	Cystic, Mucinous and Serous Neoplasms	c350b53b-3c27-4b9e-8b57-d7b6a1205a1f	TCGA-AP-A05A	Corpus uteri	Not Reported	white	female	not reported	Dead	81.0	-29914.0	1925.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a5cf850f-79ad-5963-9ecb-983a892661d8	AP	MSKCC	Uterine Corpus Endometrial Carcinoma	NCH	1944.0															Stage II	No	0.0	not reported	Endometrium	1199.0	29914.0	Serous cystadenocarcinoma, NOS	no	2006.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	29914.0	81.95616438356164	['2019-07-31T22:29:49.624860-05:00', '2019-07-31T22:29:49.624860-05:00']	['2ef259b3-b982-5425-9c29-aed7393b1800', '4933367b-9c09-5a61-a131-ca2177460440']	['TCGA-AP-A05A_treatment', 'TCGA-AP-A05A_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:30:03.009139-05:00']	01	Primary	482153fb-e69d-4748-9cf4-e281ec141518	Primary Tumor	Not Reported	1479.0	260.0	OCT	1DAE9968-7D20-45A9-B2BC-5F32F6EC7A08	true	Solid Tissue	False	Tumor
TCGA-A5-A2K4-01A	c4f8f33f-a07c-4dfb-be24-c52d577bd640	Cystic, Mucinous and Serous Neoplasms	c4f8f33f-a07c-4dfb-be24-c52d577bd640	TCGA-A5-A2K4	Corpus uteri	Not Reported	white	female	not reported	Dead	69.0	-25270.0	1940.0	2011.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH	871.0															Stage IIIA	No	0.0	not reported	Endometrium		25270.0	Serous cystadenocarcinoma, NOS	no	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	25270.0	69.23287671232876	['2019-07-31T22:29:52.513153-05:00', '2019-07-31T22:29:52.513153-05:00']	['40491dc3-a7da-5038-8cfd-206a8a5cb312', 'c6796838-6855-5f6d-bd6f-cb519b6ebb2b']	['TCGA-A5-A2K4_treatment', 'TCGA-A5-A2K4_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:30:05.340888-05:00']	01	Primary	825524a8-ede8-44b2-9c4a-8375ac14387a	Primary Tumor	Not Reported	849.0	140.0	OCT	CB29CD1C-584B-42EA-BF1D-11B6DF8EA756	true	Solid Tissue	False	Tumor
TCGA-D1-A15Z-01A	c5df9142-27f6-4d97-933e-c79ea9199362	Adenomas and Adenocarcinomas	c5df9142-27f6-4d97-933e-c79ea9199362	TCGA-D1-A15Z	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	72.0	-26638.0	1936.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH	58.0															Stage IB	No	0.0	not reported	Endometrium		26638.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	26638.0	72.98082191780821	['2019-07-31T22:29:58.510487-05:00', '2019-07-31T22:29:58.510487-05:00']	['27428922-0981-5672-88c7-c326046a8b13', '4022dab4-2357-5bbd-a965-817f18876ff1']	['TCGA-D1-A15Z_treatment_1', 'TCGA-D1-A15Z_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:30:09.890271-05:00', '']	01	Primary	7a961c2f-2e7f-4eb0-945b-9f0d59923962	Primary Tumor	Not Reported	884.0	160.0	Unknown	280F86BF-4834-4FA9-B153-DE7BE312E619	false	Solid Tissue	False	Tumor
TCGA-AX-A2H5-01A	c88e3901-f3ee-436a-ba80-143c8eab7d69	Cystic, Mucinous and Serous Neoplasms	c88e3901-f3ee-436a-ba80-143c8eab7d69	TCGA-AX-A2H5	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	67.0	-24757.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	2167.0	24757.0	Serous cystadenocarcinoma, NOS	no	2005.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24757.0	67.82739726027397	['2019-07-31T22:30:12.962989-05:00', '2019-07-31T22:30:12.962989-05:00']	['57c6e796-a4e8-56ce-9a7d-1c6fe208cb9f', '95a7a730-476b-5069-9f63-3652c25c345f']	['TCGA-AX-A2H5_treatment_1', 'TCGA-AX-A2H5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:30:22.459069-05:00', '']	01	Primary	44eb96b4-5e4f-460b-bc51-add38cbc76a1	Primary Tumor	Not Reported	2206.0	100.0	Unknown	BF4BE7F8-7D37-4CB2-B340-FAE14155F257	false	Solid Tissue	False	Tumor
TCGA-AX-A2H5-11A	c88e3901-f3ee-436a-ba80-143c8eab7d69	Cystic, Mucinous and Serous Neoplasms	c88e3901-f3ee-436a-ba80-143c8eab7d69	TCGA-AX-A2H5	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	67.0	-24757.0	1938.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	2167.0	24757.0	Serous cystadenocarcinoma, NOS	no	2005.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24757.0	67.82739726027397	['2019-07-31T22:30:12.962989-05:00', '2019-07-31T22:30:12.962989-05:00']	['57c6e796-a4e8-56ce-9a7d-1c6fe208cb9f', '95a7a730-476b-5069-9f63-3652c25c345f']	['TCGA-AX-A2H5_treatment_1', 'TCGA-AX-A2H5_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:30:22.459069-05:00', '']	11	Not Applicable	9793e609-348f-4aa6-9705-ec236604f085	Solid Tissue Normal	Not Reported	2206.0	130.0	Unknown		false	Solid Tissue	False	Normal
TCGA-A5-A0GQ-01A	c8d672ed-9910-4f80-b222-38c833f55850	Adenomas and Adenocarcinomas	c8d672ed-9910-4f80-b222-38c833f55850	TCGA-A5-A0GQ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	76.0	-28078.0	1931.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	932c7c29-cacf-5deb-b70e-fb7595f6800b	A5	Cedars Sinai	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	2247.0	28078.0	Endometrioid adenocarcinoma, NOS	no	2007.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	28078.0	76.92602739726027	['2019-07-31T22:30:16.047894-05:00', '2019-07-31T22:30:16.047894-05:00']	['c687623c-9fb3-5af2-9b9c-2efcfab2413f', 'dfe64641-8403-5e30-9550-1deef9160a07']	['TCGA-A5-A0GQ_treatment', 'TCGA-A5-A0GQ_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:30:24.833024-05:00']	01	Primary	4805287e-cd6d-48ff-ac6d-19d01052bf8b	Primary Tumor	Not Reported	1022.0	140.0	OCT	7B57FD81-AA42-4C76-BF65-0BA2B3451065	true	Solid Tissue	False	Tumor
TCGA-D1-A175-01A	f0b3ab10-43f8-48a8-b460-66ceaaf637db	Adenomas and Adenocarcinomas	f0b3ab10-43f8-48a8-b460-66ceaaf637db	TCGA-D1-A175	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	48.0	-17802.0	1961.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IC	No	0.0	not reported	Endometrium	202.0	17802.0	Endometrioid adenocarcinoma, NOS	no	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	17802.0	48.772602739726025	['2019-07-31T22:35:20.361559-05:00', '2019-07-31T22:35:20.361559-05:00']	['504387e3-8483-54d6-930b-87ed3e89ac8b', '8c59e5d0-addc-508c-8c1b-b3fe11b06f28']	['TCGA-D1-A175_treatment', 'TCGA-D1-A175_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:34:28.841510-05:00']	01	Primary	07bfbb0c-b58b-4364-b12e-dca462c5b43e	Primary Tumor	Not Reported	566.0	200.0	Unknown	4A0D74F3-74A0-4CAE-960B-71D37DF4F4DE	false	Solid Tissue	False	Tumor
TCGA-EY-A212-01A	37981e2c-4761-4f82-aaf2-4e6963a71603	Cystic, Mucinous and Serous Neoplasms	37981e2c-4761-4f82-aaf2-4e6963a71603	TCGA-EY-A212	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	83.0	-30680.0	1927.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	310.0	TCGA-EY-A212	Patient had a previous colorectal tumor. No systemic radiation or chemotherapy.	16124	Notification	37981e2c-4761-4f82-aaf2-4e6963a71603	2013-05-16T00:00:00	22a8c2b4-aa50-543a-84d8-284035fdc4f8	case	2018-08-23T16:28:11.210272-05:00	37981e2c-4761-4f82-aaf2-4e6963a71603	released	Prior malignancy	Approved	TCGA-EY-A212	Stage IIIC1	Not Reported	0.0	not reported	Endometrium	110.0	30680.0	Papillary serous cystadenocarcinoma	yes	2010.0	No	8460/3	not reported	C54.1	Endometrium	Not Reported	not reported	30680.0	84.05479452054794	['2019-07-31T22:15:34.117291-05:00', '2019-07-31T22:15:34.117291-05:00']	['2025919e-8fee-5a03-8d58-7d8101277621', '56a1ca3a-4fad-583d-87f8-37a9401cfd91']	['TCGA-EY-A212_treatment', 'TCGA-EY-A212_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:18:33.293125-05:00']	01	Primary	996c027f-d9c7-4a2c-8154-5ef9573fb0d0	Primary Tumor	Not Reported	112.0	290.0	Unknown	3E8012E3-97F1-48A2-B1C0-5C814DF8EE01	false	Solid Tissue	False	Tumor
TCGA-AX-A06L-01A	f4a7f2ff-be76-48d3-9f59-9223db33680e	Adenomas and Adenocarcinomas	f4a7f2ff-be76-48d3-9f59-9223db33680e	TCGA-AX-A06L	Corpus uteri	Not Reported	white	female	not reported	Alive	63.0	-23294.0	1943.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1845.0	23294.0	Endometrioid adenocarcinoma, NOS	no	2006.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23294.0	63.81917808219178	['2019-07-31T22:35:38.791260-05:00', '2019-07-31T22:35:38.791260-05:00']	['5cfbda68-70ae-50f0-9817-479a5ed5d894', 'a70c725b-b893-5790-ad07-933ed2f11072']	['TCGA-AX-A06L_treatment', 'TCGA-AX-A06L_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:34:43.286864-05:00']	01	Primary	cacec107-78de-47c7-9386-dbefcfc1f07a	Primary Tumor	Not Reported	1499.0	250.0	Unknown	926937F8-6057-4D39-BB3B-0115B0ACFE1A	false	Solid Tissue	False	Tumor
TCGA-EY-A214-01A	4125e3e5-51c0-4577-9935-10cd086fc415	Adenomas and Adenocarcinomas	4125e3e5-51c0-4577-9935-10cd086fc415	TCGA-EY-A214	Corpus uteri	Not Reported	white	female	not reported	Alive	66.0	-24136.0	1944.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH		['TCGA-EY-A214', 'TCGA-EY-A214']	['Patient had a previous ductal carcinoma in situ treated with locoregional radiation. No systemic chemotherapy.', 'Patient had a previous ductal carcinoma in situ treated with locoregional radiation. No systemic chemotherapy.']	['16123', '16125']	['Notification', 'Notification']	['4125e3e5-51c0-4577-9935-10cd086fc415', '4125e3e5-51c0-4577-9935-10cd086fc415']	['2013-05-16T00:00:00', '2013-05-16T00:00:00']	['2993bc19-a8c4-52f6-a51f-7b751a4a75e5', 'a55c1c57-b798-56e8-b3b8-949f9db3bbaf']	['case', 'case']	['2018-08-23T16:28:11.210272-05:00', '2018-08-23T16:32:20.747393-05:00']	['4125e3e5-51c0-4577-9935-10cd086fc415', '4125e3e5-51c0-4577-9935-10cd086fc415']	['released', 'released']	['Prior malignancy', 'History of acceptable prior treatment related to a prior/other malignancy']	['Approved', 'Approved']	['TCGA-EY-A214', 'TCGA-EY-A214']	Stage IIIC1	Not Reported	0.0	not reported	Endometrium	438.0	24136.0	Endometrioid adenocarcinoma, NOS	yes	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	24136.0	66.12602739726027	['2019-07-31T22:17:08.583712-05:00', '2019-07-31T22:17:08.583712-05:00']	['1e1fe118-9a3d-5d96-9855-2075379c7802', '1eff7b34-e693-58a9-880a-af3df9258007']	['TCGA-EY-A214_treatment', 'TCGA-EY-A214_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:19:49.272122-05:00']	01	Primary	5ed2b603-507e-4bef-bacd-46d0e98badb4	Primary Tumor	Not Reported	160.0	330.0	Unknown	90B0CBB0-3AC0-44F8-9C49-310CFFE0370C	false	Solid Tissue	False	Tumor
TCGA-D1-A15V-01A	f7010b87-a559-4501-99f9-0fcca1e986e1	Cystic, Mucinous and Serous Neoplasms	f7010b87-a559-4501-99f9-0fcca1e986e1	TCGA-D1-A15V	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	68.0	-24886.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	7fe1c0d8-e66c-5384-bdc9-7544b8e390b3	D1	Mayo Clinic	Uterine Corpus Endometrial Carcinoma	NCH																Stage IB	No	0.0	not reported	Endometrium	1201.0	24886.0	Serous cystadenocarcinoma, NOS	no	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	24886.0	68.18082191780822	['2019-07-31T22:35:51.456892-05:00', '2019-07-31T22:35:51.456892-05:00']	['30a144db-a061-560f-8b25-ac5de0663151', 'b3442fbd-0bc6-5afc-bbbe-e5ebbacba46d']	['TCGA-D1-A15V_treatment_1', 'TCGA-D1-A15V_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:34:53.084235-05:00', '']	01	Primary	8bf1146c-8442-47b5-83af-f7899d4a94a6	Primary Tumor	Not Reported	895.0	250.0	Unknown	597F20F2-AE36-4A9F-A7AF-1647CB56B453	false	Solid Tissue	False	Tumor
TCGA-AX-A1CP-01A	e297551c-a662-4677-b00d-0d9be232adca	Cystic, Mucinous and Serous Neoplasms	e297551c-a662-4677-b00d-0d9be232adca	TCGA-AX-A1CP	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	84.0	-30737.0	1924.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-AX-A1CP	unknown treatment history	20763	Notification	e297551c-a662-4677-b00d-0d9be232adca	2014-06-16T00:00:00	2c516725-bfb2-59d7-aeee-537c48c309df	case	2018-08-23T16:28:11.210272-05:00	e297551c-a662-4677-b00d-0d9be232adca	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-AX-A1CP	Stage IA	Not Reported	0.0	not reported	Endometrium	1107.0	30737.0	Serous cystadenocarcinoma, NOS	yes	2008.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	30737.0	84.21095890410959	['2019-07-31T22:33:14.417432-05:00', '2019-07-31T22:33:14.417432-05:00']	['58439707-19bc-5397-bbb4-68af79ec6be2', 'ee5603c0-2eb8-54a8-906e-9125227a4fdb']	['TCGA-AX-A1CP_treatment', 'TCGA-AX-A1CP_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'yes']	['', '2019-04-28T14:32:48.695492-05:00']	01	Primary	28542436-6afd-4198-9efe-2b69768277b0	Primary Tumor	Not Reported	1080.0	110.0	Unknown	E2F94D2B-C53B-4112-AFBB-06A6751CAE4B	false	Solid Tissue	False	Tumor
TCGA-EY-A1GQ-01A	8636db4d-a67b-4d8a-b02f-15fce553cf17	Adenomas and Adenocarcinomas	8636db4d-a67b-4d8a-b02f-15fce553cf17	TCGA-EY-A1GQ	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	76.0	-27905.0	1934.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-EY-A1GQ	Patient had a previous melanoma of the foot. No systemic radiation or chemotherapy.	16126	Notification	8636db4d-a67b-4d8a-b02f-15fce553cf17	2013-05-16T00:00:00	306d1e1b-0ebe-50e2-bb7a-741c751d24b2	case	2018-08-23T16:28:11.210272-05:00	8636db4d-a67b-4d8a-b02f-15fce553cf17	released	Prior malignancy	Approved	TCGA-EY-A1GQ	Stage IB	Not Reported	0.0	not reported	Endometrium	544.0	27905.0	Endometrioid adenocarcinoma, NOS	yes	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	27905.0	76.45205479452055	['2019-07-31T22:24:14.132068-05:00', '2019-07-31T22:24:14.132068-05:00']	['127c8ad3-bc6f-5c71-9702-a1a72486120f', 'dd963ed0-4dbe-591b-9106-f46e58b4808e']	['TCGA-EY-A1GQ_treatment_1', 'TCGA-EY-A1GQ_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T14:25:28.850191-05:00', '']	01	Primary	2ce5197d-0239-4df1-85fc-47ae27324028	Primary Tumor	Not Reported	274.0	160.0	Unknown	9A8D1D19-18D8-483B-BD87-B686D25C617F	false	Solid Tissue	False	Tumor
TCGA-BG-A221-01A	e7e667be-9b31-4870-9c38-740098f37213	Adenomas and Adenocarcinomas	e7e667be-9b31-4870-9c38-740098f37213	TCGA-BG-A221	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	84.0	-30960.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-BG-A221	unknown treatment history	20770	Notification	e7e667be-9b31-4870-9c38-740098f37213	2014-06-16T00:00:00	34b18337-5196-5f24-854c-2a99ae06a557	case	2018-08-23T16:28:11.210272-05:00	e7e667be-9b31-4870-9c38-740098f37213	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-BG-A221	Stage IB	Not Reported	0.0	not reported	Endometrium	55.0	30960.0	Endometrioid adenocarcinoma, NOS	yes	2010.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30960.0	84.82191780821918	['2019-07-31T22:34:25.629505-05:00', '2019-07-31T22:34:25.629505-05:00']	['46830e0c-e0aa-582a-b41c-af0ccaec9133', '54302cd4-2071-5dda-a850-0217ad6ea790']	['TCGA-BG-A221_treatment_1', 'TCGA-BG-A221_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:33:44.772397-05:00', '']	01	Primary	d96882db-9a46-493a-a26b-efb7bddf34ff	Primary Tumor	Not Reported	99.0	240.0	OCT	58D68577-9022-4EF3-82E9-6EE159D41947	true	Solid Tissue	False	Tumor
TCGA-BG-A0MA-01A	f85bc60b-ab07-4b24-820b-6860b198e910	Adenomas and Adenocarcinomas	f85bc60b-ab07-4b24-820b-6860b198e910	TCGA-BG-A0MA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	60.0	-22036.0	1948.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH	326.0															Stage IB	No	0.0	not reported	Endometrium		22036.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22036.0	60.37260273972603	['2019-07-31T22:36:12.624630-05:00', '2019-07-31T22:36:12.624630-05:00']	['0df877e1-4db1-558c-8841-3d961fc9c5f1', '1eccd229-359d-53f4-bafd-0b86f5c981a4']	['TCGA-BG-A0MA_treatment', 'TCGA-BG-A0MA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:35:10.559751-05:00']	01	Primary	8b7459ed-d1d7-4499-b057-12bc9a5bc488	Primary Tumor	Not Reported	805.0	130.0	OCT	E5908692-5B04-407B-818A-D202756DD880	true	Solid Tissue	False	Tumor
TCGA-BG-A0MA-11A	f85bc60b-ab07-4b24-820b-6860b198e910	Adenomas and Adenocarcinomas	f85bc60b-ab07-4b24-820b-6860b198e910	TCGA-BG-A0MA	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	60.0	-22036.0	1948.0	2008.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH	326.0															Stage IB	No	0.0	not reported	Endometrium		22036.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	22036.0	60.37260273972603	['2019-07-31T22:36:12.624630-05:00', '2019-07-31T22:36:12.624630-05:00']	['0df877e1-4db1-558c-8841-3d961fc9c5f1', '1eccd229-359d-53f4-bafd-0b86f5c981a4']	['TCGA-BG-A0MA_treatment', 'TCGA-BG-A0MA_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['no', 'no']	['', '2019-04-28T14:35:10.559751-05:00']	11	Not Applicable	ccc915fc-752a-44d0-8cff-0d1e7b58c280	Solid Tissue Normal	Not Reported	1134.0	120.0	OCT		true	Solid Tissue	False	Normal
TCGA-FI-A2CX-01A	dffc7091-bc27-452c-ad94-1ee214107593	Adenomas and Adenocarcinomas	dffc7091-bc27-452c-ad94-1ee214107593	TCGA-FI-A2CX	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	82.0	-30224.0	1926.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-FI-A2CX	Patient had a previous basaloid squamous cell carcinoma of the forehead. No systemic radiation or chemotherapy.	16121	Notification	dffc7091-bc27-452c-ad94-1ee214107593	2013-05-16T00:00:00	3a6a1a92-44ed-53ac-bd25-63e2b72895dc	case	2018-08-23T16:28:11.210272-05:00	dffc7091-bc27-452c-ad94-1ee214107593	released	Prior malignancy	Approved	TCGA-FI-A2CX	Stage IB	Not Reported	0.0	not reported	Endometrium	2031.0	30224.0	Endometrioid adenocarcinoma, NOS	yes	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30224.0	82.8054794520548	['2019-07-31T22:32:56.218948-05:00', '2019-07-31T22:32:56.218948-05:00']	['7221354a-9684-5e26-81f2-bc817c0cd495', '759a432f-97b4-5b91-bc4a-b7feef85dfa0']	['TCGA-FI-A2CX_treatment_1', 'TCGA-FI-A2CX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:32:33.802365-05:00', '']	01	Primary	b6d24830-0d69-44d7-94cf-7dfdc49e52c4	Primary Tumor	Not Reported	1067.0	80.0	OCT	0F6F56E4-C4F9-4915-BE4E-1FBF4C6D93AD	true	Solid Tissue	False	Tumor
TCGA-BS-A0U8-01A	fb7475df-30cc-4316-b9ac-37cbeeb6ba2b	Adenomas and Adenocarcinomas	fb7475df-30cc-4316-b9ac-37cbeeb6ba2b	TCGA-BS-A0U8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	55.0	-20402.0	1949.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	6157d8b4-5413-564a-b391-9b055a95eaf5	BS	University of Hawaii	Uterine Corpus Endometrial Carcinoma	NCH																Stage IIIC	No	0.0	not reported	Endometrium	2963.0	20402.0	Endometrioid adenocarcinoma, NOS	no	2004.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	20402.0	55.895890410958906	['2019-07-31T22:36:24.401627-05:00', '2019-07-31T22:36:24.401627-05:00']	['607c343e-0703-5c87-9365-10cb01d8618b', '8950771a-2a87-5274-9f01-e72266673b0a']	['TCGA-BS-A0U8_treatment', 'TCGA-BS-A0U8_treatment_1']	['Radiation Therapy, NOS', 'Pharmaceutical Therapy, NOS']	['released', 'released']	['yes', 'yes']	['', '2019-04-28T14:35:20.021307-05:00']	01	Primary	e3e23393-8597-4091-a343-cd544111c63b	Primary Tumor	Not Reported	2432.0	190.0	Unknown	EAE30BBB-B895-42B9-8AAB-937278A3EBB0	false	Solid Tissue	False	Tumor
TCGA-AX-A3G3-01A	16745dfb-8b28-4f5d-9ef1-2aa31ccb7293	Cystic, Mucinous and Serous Neoplasms	16745dfb-8b28-4f5d-9ef1-2aa31ccb7293	TCGA-AX-A3G3	Corpus uteri	Not Reported	white	female	not reported	Alive	58.0	-21308.0	1951.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	11e33baf-15f1-5a74-a940-307c42b74f36	AX	Gynecologic Oncology Group	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-AX-A3G3	unknown treatment history	20767	Notification	16745dfb-8b28-4f5d-9ef1-2aa31ccb7293	2014-06-16T00:00:00	5975d593-b58e-5c45-afbc-ca1b7050695d	case	2018-08-23T16:28:11.210272-05:00	16745dfb-8b28-4f5d-9ef1-2aa31ccb7293	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-AX-A3G3	Stage IIIA	Not Reported	0.0	not reported	Endometrium	42.0	21308.0	Serous cystadenocarcinoma, NOS	yes	2009.0	No	8441/3	not reported	C54.1	Endometrium	Not Reported	not reported	21308.0	58.37808219178082	['2019-07-31T22:12:37.266474-05:00', '2019-07-31T22:12:37.266474-05:00']	['ec694fb2-c4f8-593f-a738-7126b58b9ddb', 'f439094c-f8d9-583b-857a-dbe1c4f015c1']	['TCGA-AX-A3G3_treatment_1', 'TCGA-AX-A3G3_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['not reported', 'not reported']	['2019-04-28T14:16:09.914969-05:00', '']	01	Primary	5efdace8-5790-4239-8e8a-6349f88b10dd	Primary Tumor	Not Reported	713.0	140.0	Unknown	3D86258F-2C9B-4DF2-86C5-E12B3FCB480D	false	Solid Tissue	False	Tumor
TCGA-BG-A0MS-01A	a798a8cc-4e72-4a8c-9e20-74a14deafd12	Adenomas and Adenocarcinomas	a798a8cc-4e72-4a8c-9e20-74a14deafd12	TCGA-BG-A0MS	Corpus uteri	Not Reported	white	female	not hispanic or latino	Alive	53.0	-19547.0	1956.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	a0a89c77-9121-5b8a-a93f-dd92606c651c	BG	University of Pittsburgh	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-BG-A0MS	Prior to resection of TCGA tumor, patient had pharmaceutical treatment for a prior left breast cancer. Following the mastectomy, patient had 5 years of Tamoxifen and 6-8 cycles of chemotherapy.	28351	Notification	a798a8cc-4e72-4a8c-9e20-74a14deafd12	2015-05-05T00:00:00	5eaf6227-e270-574d-9afd-f1d0783f242b	case	2018-08-23T16:28:11.210272-05:00	a798a8cc-4e72-4a8c-9e20-74a14deafd12	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-BG-A0MS	Stage IIIC1	Not Reported	0.0	not reported	Endometrium	1882.0	19547.0	Endometrioid adenocarcinoma, NOS	yes	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	19547.0	53.553424657534244	['2019-07-31T17:21:08.639748-05:00', '2019-07-31T17:21:08.639748-05:00']	['687fb40f-fc6c-5a73-8c28-dad23074668a', '9314546a-c286-59b2-970d-7b55c7672991']	['TCGA-BG-A0MS_treatment_1', 'TCGA-BG-A0MS_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['yes', 'yes']	['2019-04-28T10:18:50.367695-05:00', '']	01	Primary	ef7f78eb-314b-4cf2-b45b-810c84c6aa7b	Primary Tumor	Not Reported	420.0	560.0	OCT	7BE89F2D-74E5-4D9E-8270-A216D79ADCD7	true	Solid Tissue	False	Tumor
TCGA-EO-A3KX-01A	fe2e89f7-8f4d-420a-a551-4877cf0fd1d3	Adenomas and Adenocarcinomas	fe2e89f7-8f4d-420a-a551-4877cf0fd1d3	TCGA-EO-A3KX	Corpus uteri	Not Reported	white	female	hispanic or latino	Alive	80.0	-29260.0	1931.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8c5f8b02-c621-5bd5-b91f-d8a72974feff	EO	University Health Network	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	1170.0	29260.0	Endometrioid adenocarcinoma, NOS	no	2011.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	29260.0	80.16438356164383	['2019-07-31T22:36:43.655282-05:00', '2019-07-31T22:36:43.655282-05:00']	['206479ba-2dc2-50b8-a8bb-3aa3f72065e8', 'a3f5b14c-0c42-59d0-8f57-64c6b0f72033']	['TCGA-EO-A3KX_treatment_1', 'TCGA-EO-A3KX_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:35:34.676221-05:00', '']	01	Primary	a5cae971-eeb4-4a9e-afec-01814eab967e	Primary Tumor	Not Reported	184.0	150.0	Unknown	BB1CD473-0D98-414E-801B-09037E1BF43E	false	Solid Tissue	False	Tumor
TCGA-EY-A1G8-01A	db3a4986-55d5-4ecc-be73-59725dce3c33	Adenomas and Adenocarcinomas	db3a4986-55d5-4ecc-be73-59725dce3c33	TCGA-EY-A1G8	Corpus uteri	Not Reported	white	female	not hispanic or latino	Dead	83.0	-30517.0	1925.0	2009.0	['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	8ec8229a-8ae5-53de-8768-215b5ce53aa8	EY	University of North Carolina	Uterine Corpus Endometrial Carcinoma	NCH	456.0	TCGA-EY-A1G8	unknown treatment history	20773	Notification	db3a4986-55d5-4ecc-be73-59725dce3c33	2014-06-16T00:00:00	6b9f3381-43d7-5d01-b0d5-f011cb0885fa	case	2018-08-23T16:32:20.747393-05:00	db3a4986-55d5-4ecc-be73-59725dce3c33	released	History of unacceptable prior treatment related to a prior/other malignancy	Approved	TCGA-EY-A1G8	Stage IB	No	0.0	not reported	Endometrium		30517.0	Endometrioid adenocarcinoma, NOS	no	2008.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	30517.0	83.6082191780822	['2019-07-31T22:32:13.377628-05:00', '2019-07-31T22:32:13.377628-05:00']	['c589efaa-8c25-5419-a93b-a9419f5450b1', 'ca239b3c-a104-5101-be77-1425fac0c419']	['TCGA-EY-A1G8_treatment_1', 'TCGA-EY-A1G8_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:32:00.035323-05:00', '']	01	Primary	e95dde06-f397-4b0c-a854-dc91aa3c6f31	Primary Tumor	Not Reported	771.0	100.0	Unknown	2454950F-8B3D-4690-98CA-B94C79F99552	false	Solid Tissue	False	Tumor
TCGA-PG-A914-01A	ff6b5fc8-0572-4b58-b3a5-bcda41badbc8	Cystic, Mucinous and Serous Neoplasms	ff6b5fc8-0572-4b58-b3a5-bcda41badbc8	TCGA-PG-A914	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	73.0	-26992.0	1940.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	69bd8326-4904-56a0-8230-1615a777173b	PG	Montefiore Medical Center	Uterine Corpus Endometrial Carcinoma	NCH																Stage IA	No	0.0	not reported	Endometrium	687.0	26992.0	Serous surface papillary carcinoma	no	2013.0	No	8461/3	not reported	C54.1	Endometrium	Not Reported	not reported	26992.0	73.95068493150686	['2019-07-31T22:36:58.297243-05:00', '2019-07-31T22:36:58.297243-05:00']	['74c1d7b2-6f44-56eb-8103-82b72c794065', 'f948624f-f941-5342-ba97-f1f3d18780c8']	['TCGA-PG-A914_treatment_1', 'TCGA-PG-A914_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'yes']	['2019-04-28T14:35:47.483737-05:00', '']	01	Primary	6086978b-8f73-458e-9624-b99bcd6b50c8	Primary Tumor	Not Reported	263.0	260.0	OCT	B073614D-A6E3-4A83-96C4-1F189F8D16B4	true	Solid Tissue	False	Tumor
TCGA-FI-A2F4-01A	43476c88-86bc-4a65-9327-f0d24a41c971	Adenomas and Adenocarcinomas	43476c88-86bc-4a65-9327-f0d24a41c971	TCGA-FI-A2F4	Corpus uteri	Not Reported	black or african american	female	not hispanic or latino	Alive	64.0	-23621.0	1945.0		['Uterus, NOS', 'Corpus uteri']	TCGA-UCEC	['Epithelial Neoplasms, NOS', 'Cystic, Mucinous and Serous Neoplasms', 'Not Reported', 'Adenomas and Adenocarcinomas']	Uterine Corpus Endometrial Carcinoma	TCGA	cee96273-f2ef-52a4-8f36-64f19a81eb32	FI	Washington University	Uterine Corpus Endometrial Carcinoma	NCH		TCGA-FI-A2F4	Patient had a previous pheochromocytoma of the adrenal gland. No systemic radiation or chemotherapy.	16119	Notification	43476c88-86bc-4a65-9327-f0d24a41c971	2013-05-16T00:00:00	793c4670-bdae-5d97-a875-8281c8d4c512	case	2018-08-23T16:32:20.747393-05:00	43476c88-86bc-4a65-9327-f0d24a41c971	released	Prior malignancy	Approved	TCGA-FI-A2F4	Stage IC	Not Reported	0.0	not reported	Endometrium	2230.0	23621.0	Endometrioid adenocarcinoma, NOS	yes	2009.0	No	8380/3	not reported	C54.1	Endometrium	Not Reported	not reported	23621.0	64.71506849315068	['2019-07-31T22:17:30.013640-05:00', '2019-07-31T22:17:30.013640-05:00']	['064110e9-72bf-58ae-a402-31d992b68763', '3c12b331-e51a-529c-87e6-dce892fc320e']	['TCGA-FI-A2F4_treatment_1', 'TCGA-FI-A2F4_treatment']	['Pharmaceutical Therapy, NOS', 'Radiation Therapy, NOS']	['released', 'released']	['no', 'no']	['2019-04-28T14:20:05.374970-05:00', '']	01	Primary	79ca02f0-936e-4485-9cb3-85afa2cee9a3	Primary Tumor	Not Reported	860.0	60.0	OCT	B57570A5-2AE1-4D8B-9284-AB5769DDFDA6	true	Solid Tissue	False	Tumor
